Sentence,class,file
Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 151–154International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  151Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S5708 5Anemia and health performance score evaluation  as decisive factors for noninvasive mechanical  ventilation decisions in AeCOPD: are there   new key cornerstones?,Non-OADS,/arxiv_data1/oa_pdf/21/b8/copd-9-151.PMC3912044.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/21/b8/copd-9-151.PMC3912044.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/b8/copd-9-151.PMC3912044.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/be/ccid-7-043.PMC3912046.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 43–49Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  43OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S5529 6The role of rehabilitative camouflage   after cervicofacial reconstructive surgery:   a preliminary study giovanni nicoletti1–3 andrea sasso1 alberto Malovini4,5 luisa Ponchio6 silvia scevola2 angela Faga1–3 aldo Pontone1 1Plastic and reconstructive  surgery, Department of Clinical  surgical Diagnostic and Pediatric  sciences, 2advanced Technologies  for regenerative Medicine and  Inductive surgery research Centre,   University of Pavia, Pavia, Italy; 3Plastic  and reconstructive surgery Unit,   salvatore Maugeri research and Care  Institute, Pavia, Italy; 4Department of  Computer engineering and systems  science, University of Pavia, Pavia,   Italy; 5laboratory of Informatics and  systems engineering for Clinical  research, 6Oncology Unit, salvatore  Maugeri research and Care Institute,   Pavia, Italy Correspondence: giovanni nicoletti   Plastic surgery Unit, University of Pavia,  salvatore Maugeri research and Care  Institute, Via salvatore Maugeri 10,   27100 Pavia, Italy   Tel +39 0382 592 222;   +39 338 5778146 (mobile)   Fax +39 0382 592 220   email giovanni.nicoletti@unipv.i t;  giovanni.nicoletti@fsm.i tAbstract:  A randomized, prospective, controlled study was carried out at the Plastic and  Reconstructive Surgery Unit of the University of Pavia, Salvatore Maugeri Research and Care  Institute, Pavia, Italy, to evaluate the psychological benefits from corrective medical camouflage  (CMC) following surgical treatment for skin cancer of the face.",Non-OADS,/arxiv_data1/oa_pdf/46/be/ccid-7-043.PMC3912046.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/46/be/ccid-7-043.PMC3912046.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/be/ccid-7-043.PMC3912046.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/3c/ccide-6-009.PMC3912047.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dentistry 2014:6 9–13Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  9OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCIDE.S5431 9evaluation of the s tability and antimicrobial  activity of an ethanolic extract of Libidibia ferrea raquel de Oliveira  Marreiro1 Maria Fulgência Costa lima  Bandeira1 Tatiane Pereira de souza2 Mailza Costa de almeida1 Katiana Bendaham1 gisely naura Venâncio1 Isis Costa rodrigues2 Cristiane nagai Coelho1 Patrícia sâmea lêdo lima  Milério1 glauber Palma de Oliveira1 nikeila Chacon de Oliveira  Conde1 1school of Dentistry, Federal  University of amazonas, Manaus,   amazonas; 2school of Pharmacy,   Federal University of amazonas,   Manaus, amazonas, Brazil Correspondence: gisely naura Venâncio   school of Dentistry, Federal University of  amazonas, Waldemar Pedrosa avenue,   1539, Downtown, 69025-050,   Manaus, amazonas, Brazil   T el +92 8839 0595   email ginaura@gmail.co mAbstract:  Biofilm is a dense, whitish, noncalcified aggregate of bacteria, with desquamated  epithelial cells and food debris creating conditions for an imbalance of resident oral microflora  and favoring the destruction of hard and soft tissues by development of caries and gingivitis.",Non-OADS,/arxiv_data1/oa_pdf/a1/3c/ccide-6-009.PMC3912047.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/a1/3c/ccide-6-009.PMC3912047.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a1/3c/ccide-6-009.PMC3912047.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/36/dhps-6-007.PMC3912048.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2014:6 7–14Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  7Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S5775 6Pharmacists’ knowledge and attitudes about  natural health products: a mixed-methods study nadir Kheir Hoda Y gad Safae e abu-Y ousef college of Pharmacy, Qatar University,   al Tarfa, Doha, Qatar correspondence: nadir Kheir   college of Pharmacy, Qatar University,  al Tarfa, Doha 2713, Qatar   email nadirk@qu.edu.q aObjectives:  To explore knowledge and attitude of pharmacists in Qatar towards natural health  products (NHPs).",Non-OADS,/arxiv_data1/oa_pdf/e1/36/dhps-6-007.PMC3912048.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/e1/36/dhps-6-007.PMC3912048.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/36/dhps-6-007.PMC3912048.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 39–51Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  39Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S3931 8Abiraterone in the treatment of metastatic  castration-resistant prostate cancer elahe A Mostaghel Division of Clinical Research, Fred  Hutchinson Cancer Research Center,   Seattle, wA, USA Correspondence: elahe A Mostaghel   Fred Hutchinson Cancer Research  Center, Lab D4-345, Office D5-104,   1100 Fairview Ave N, MS D5-100   Seattle, wA 98109, USA   Tel +1 206 667 3506   Fax +1 206 667 5456   email emostagh@fhcrc.or gAbstract:  Androgen deprivation therapy remains the single most effective treatment for the  initial therapy of advanced prostate cancer, but is uniformly marked by progression to castration- resistant prostate cancer (CRPC).",Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/NCT01424930.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Avail - able from: http://clinicaltrials.gov/show/NCT01543776.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/ NCT01655147.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/NCT01588782.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/NCT01487863.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available  from: http://clinicaltrials.gov/show/NCT01867710.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available  from: http://clinicaltrials.gov/show/NCT01508234.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/NCT01637402.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/NCT01650194.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available  from: http://clinicaltrials.gov/show/NCT01949337.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/NCT01946165.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available  from: http://clinicaltrials.gov/show/NCT00268476.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/NCT01715285.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/ NCT01780220.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/NCT01023061.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available  from: http://clinicaltrials.gov/show/NCT01717053.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
Available from: http://clinicaltrials.gov/show/ NCT01751451.,Non-OADS,/arxiv_data1/oa_pdf/12/d5/cmar-6-039.PMC3912049.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/17/btt-8-039.PMC3912050.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/9b/17/btt-8-039.PMC3912050.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/9b/17/btt-8-039.PMC3912050.pdf
"OncoImmunology 2013; 2:e26904; http://dx.doi.org/10.4161/onci.26904Linking oncogenesis and immune system evasion  in acquired resistance to EGFR-targeting antibodies Lessons from a preclinical model Greta Garrido, a ilem r abasa, and Belinda s ánchez* Tumor Immunology Direction; Molecular Immunology Institute; Center of Molecular Immunology; h avana, Cuba Keywords:  acquired resistance, EGFR, monoclonal antibodies, MHCI alterations Abbreviations: APM, antigen processing machinery; β2-m, β2-microglobulin; CTL, cytotoxic T lymphocyte;   EGFR, epidermal growth factor receptor; HC, heavy chain; IFN γ, interferon γ ; mAb, monoclonal antibody.",Non-OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
Nat Med 2012; 18:221-3; PMID:22270724 ;  http://dx.doi.org/10.1038/nm.2609 2.,OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
Cancer Discov 2013; 3:658-73;  PMID:23729478 ; http://dx.doi.org/10.1158/2159- 8290.CD-12-05585.,Non-OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
Cancer Immunol  Immunother 2007; 56:1701-10; PMID:17415565 ;  http://dx.doi.org/10.1007/s00262-007-0313-4 6.,Non-OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
J Immunol 2011; 187:4954- 66; PMID:21984704 ; http://dx.doi.org/10.4049/ jimmunol.1003477 7.,Non-OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
Oncogene 2013; Forthcoming;  PMID:23975426 ; http://dx.doi.org/10.1038/ onc.2013.2888.,OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
Clin Cancer Res  2013; 19:1858-72;  PMID:23444227 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
Cancer Res 2004; 64:215-20;  PMID:14729627 ; http://dx.doi.org/10.1158/0008- 5472.CAN-2522-2 10.,Non-OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
Clin Cancer Res 2011; 17:4400-13;  PMID :21586626 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/fd/onci-2-e26904.PMC3912052.pdf
"OncoImmunology 2013; 2:e27138;http://dx.doi.org/10.4161/onci.27138Rewiring cancer cell death to enhance   oncolytic viro-immunotherapy samuel T w orkenhe and Karen L Mossman* Department of Pathology and Molecular Medicine; McMaster Immunology r esearch Centre; Institute for Infectious Disease r esearch;  McMaster u niversity; h amilton, ON Canada Keywords:  chemotherapy, danger-associated molecular patterns, immunogenic cell death, mitoxantrone, oncolytic virus Oncolytic viruses are novel immunotherapeutic agents that appear to mediate potent antineoplastic effects in both  preclinical and clinical settings.",Non-OADS,/arxiv_data1/oa_pdf/d0/25/onci-2-e27138.PMC3912054.pdf
Nat Biotechnol 2012; 30:658-70; PMID:22781695 ;  http://dx.doi.org/10.1038/nbt.2287 2.,Non-OADS,/arxiv_data1/oa_pdf/d0/25/onci-2-e27138.PMC3912054.pdf
Nat Med  2013 ; 19:329-36; PMID:23396206 ;  http://dx.doi.org/10.1038/nm.3089 3.,OADS,/arxiv_data1/oa_pdf/d0/25/onci-2-e27138.PMC3912054.pdf
J Exp Med 2005 ; 202:1691 -701;  PMID:16365148 ; http://dx.doi.org/10.1084/ jem.200509155.,Non-OADS,/arxiv_data1/oa_pdf/d0/25/onci-2-e27138.PMC3912054.pdf
Science  2011 ; 334:1573 -7; PMID:22174255 ;  http://dx.doi.org/10.1126/science.1208347 7.,Non-OADS,/arxiv_data1/oa_pdf/d0/25/onci-2-e27138.PMC3912054.pdf
Immunity  2013 ; 38:729- 41; PMID:23562161 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/25/onci-2-e27138.PMC3912054.pdf
Nat Rev Cancer  2012 ; 12:860-75; PMID :23151605 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/25/onci-2-e27138.PMC3912054.pdf
"OncoImmunology 2013; 2:e26688;http://dx.doi.org/10.4161/onci.26688When breast cancer cells start to fend   the educational process of NK cells off emilie Mamessier*, Charlotte Bourgin, and Daniel Olive INserM u Mr1068; Marseille, France Keywords:  NK cells, education, breast cancer, anti-tumor immunity, TGF β The notion of natural killer (NK)-cell education has recently emerged, and accumulating evidence indicates  that the terminal differentiation of NK cells can be achieved in the periphery.",Non-OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
Adv Immunol  2006; 90:1-50;  PMID:16730260 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
J Clin Invest  2011; 121:3609-22;  PMID:21841316 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
Cancer Res 2011; 71:6621-32;  PMID:21937679 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-07924.,Non-OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
Cancer Res 2011; 71:5412-22;  PMID:21708957 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
J Immunol 2013; 190:2424- 36; PMID:23359508 ; http://dx.doi.org/10.4049/ jimmunol.1200140 7.,Non-OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
Nat Rev Immunol  2010; 10:554-67;  PMID:20616810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
J Immunol 2013; Forthcoming;  PMID:24038086 ; http://dx.doi.org/10.4049/ jimmunol.1301159 10.,Non-OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
J Clin Invest  1993; 92:2569-76;  PMID:7504687 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/75/onci-2-e26688.PMC3912055.pdf
"OncoImmunology 2013; 2:e27158; http://dx.doi.org/10.4161/onci.27158Immunological effects of chemotherapy   in spontaneous breast cancers Guido Kroemer1,2,3,4,5,*, Lorenzo Galluzzi1,2,6, and Laurence Zitvogel6,7, 8,9 1Université Paris Descartes/Paris V; s orbonne Paris Cité; Paris, France; 2equipe 11 labellisée par la Ligue n ationale contre le Cancer; Centre de r echerche des Cordeliers;   Paris, France; 3Inser M, U848; Villejuif, France; 4Metabolomics and Cell Biology Platforms; Gustave r oussy; Villejuif, France; 5Pôle de Biologie; Hôpital e uropéen Georges  Pompidou; a P-HP; Paris, France; 6Gustave r oussy Cancer Campus; Villejuif, France; 7Inser M, U1015; Villejuif, France; 8Université Paris- saclay; Faculté de Médecine;   Le Kremlin Bicêtre, France; 9Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507; Villejuif, France Keywords:  HER2, CD8+ T lymphocytes, MMTV- NeuT  mice, oncogene addiction, p53, trastuzumab",Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
"Nat Med 2012; 18:344-6,  author reply 346; PMID:22395693 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
J Pathol  2011 ; 224:56-66; PMID:21480230 ;  http://dx.doi.org/10.1002/path.2837 3.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Oncoimmunology  2013 ; 2:e23510 ;  PMID:23687621 ; http://dx.doi.org/10.4161/ onci.23510 4.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Annu Rev Immunol 2013 ; 31:51-72;  PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008 5.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Immunity  2013 ; 38:729- 41; PMID:23562161 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Science   2012 ; 337:1678 -84; PMID:23019653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Science  2011 ; 334:1573 -7; PMID:22174255 ;  http://dx.doi.org/10.1126/science.1208347 9.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Nat Rev Clin Oncol 2011 ; 8:151-60;  PMID:21364688 ; http://dx.doi.org/10.1038/ nrclinonc.2010.223 10.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Nat Rev Drug Discov 2012 ; 11:215-33;  PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626 11.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
J  Clin Invest 2008 ; 118:1991 -2001 ; PMID:18523649 ;  http://dx.doi.org/10.1172/JCI3518012.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Nat Med  2005 ; 11:312-9;  PMID :15711557 ; http://dx.doi.org/10.1038/nm1196 13.,OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Cancer Immunol Immunother   2008 ; 57:907-12; PMID:18004566 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Nature  2010 ;  464:302-5; PMID:20220849 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Eur J Immunol 2013 ; 43:2718 -29;  PMID:23843024 ; http://dx.doi.org/10.1002/ eji.201242505,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Cancer Cell  2010 ; 18:160-70;  PMID:20708157 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Proc Natl Acad Sci U S A 2011 ; 108:7142 - 7; PMID:21482773 ; http://dx.doi.org/10.1073/ pnas.1016569108 19.,OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Oncoimmunology  2013 ; 2:e24567 ;  PMID:23802090 ; http://dx.doi.org/10.4161/ onci.24567 20.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Oncoimmunology  2013 ; 2:e22789 ;  PMID:23482847 ; http://dx.doi.org/10.4161/ onci.2278921.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Oncoimmunology   2012 ; 1:28-37; PMID:22720209 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Cancer Res  2012 ; 72:4417 -28; PMID:22773664 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Oncoimmunology  2013 ; 2:e25396 ;  PMID:23894726 ; http://dx.doi.org/10.4161/ onci.25396 24.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Nat Rev Immunol 2011 ; 11:852-63;  PMID:22116087 ; http://dx.doi.org/10.1038/nri3108 25.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Cancer Discov   2011 ; 1:54-67; PMID:22039576 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Oncoimmunology   2013 ; 2:e24720 ; PMID:24073365 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
J Clin Oncol 2013 ; 31:860-7; PMID:23341518 ;  http://dx.doi.org/10.1200/JCO.2011.41.0902 29.,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
Oncoimmunology  2012 ; 1:1323 - 43; PMID:23243596 ; http://dx.doi.org/10.4161/ onci.22009,Non-OADS,/arxiv_data1/oa_pdf/d4/8b/onci-2-e27158.PMC3912056.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 89–101International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  89ExpErt OpInIO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJGM.S5180 0Myelofibrosis-associated complications:  pathogenesis, clinical manifestations, and effects  on outcomes tariq I Mughal1 Kris Vaddi2 nicholas J Sarlis2 Srdan Verstovsek3 1tufts University School of Medicine,   Boston, MA, 2Incyte Corporation,   Wilmington, DE, 3Department of  Leukemia, University of texas MD  Anderson Cancer Center, Houston,   tx, USA Correspondence: Srdan Verstovsek   Department of Leukemia, University of  texas MD Anderson Cancer Center,  Unit 428, 1515 Holcombe Blvd, Houston,  tx 77030, USA   tel +1 713 745 3429   Fax +1 713 794 4297   Email sverstov@mdanderson.or gAbstract:  Myelofibrosis (MF) is a rare chronic BCR-ABL1  (breakpoint cluster region-Abelson  murine leukemia viral oncogene homologue 1)-negative myeloproliferative neoplasm character - ized by progressive bone marrow fibrosis, inefficient hematopoiesis, and shortened survival.",Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
Available from: http://clinicaltrials.gov/show/NCT0117828 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
Available from: http://ir.celgene.com/phoenix.,Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
"Available from: http://www.newswire.ca/en/story/1003655/- pr-jakavi-the-first-medication-to-receive-health-canada-approval-to- treat-patients-with-myelofibrosi s. Accessed July 17, 2013.",Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
Available from:  http://www.novartis.com/newsroom/media-releases/en/2012/1636508.,Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
Available from: http://clinicaltrials.gov/ show/NCT0093454 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
Available from: http://clinicaltrials.gov/ show/NCT0050989 9.,Non-OADS,/arxiv_data1/oa_pdf/2b/e0/ijgm-7-089.PMC3912063.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/d3/amep-5-015.PMC3912064.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 15–23Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  15ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5196 3A review of the literature: direct   and video laryngoscopy with simulation   as educational intervention Allison A Vanderbilt1 Julie Mayglothling1 Nicholas J Pastis2 Douglas Franzen3 1School of Medicine, Virginia  Commonwealth University, Richmond,   VA, 2Division of Pulmonary and  Critical Care, Medical University  of South Carolina, SC, 3School of  Medicine, University of Washington,   WA, USA Correspondence: Allison A Vanderbilt   School of Medicine, Virginia   Commonwealth University, 730 East   Broad St Suite 4200 Box 980466,   Richmond, VA 23298, USA   Tel +1 804 827 8490   Fax +1 804 827 0663   Email avanderbilt@vcu.ed uIntroduction:  A review of the literature was conducted to analyze the impact of  simulation-based  training for direct and video laryngoscopy (VL) skills for health care professionals and health  care students.",Non-OADS,/arxiv_data1/oa_pdf/f7/d3/amep-5-015.PMC3912064.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/f7/d3/amep-5-015.PMC3912064.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/d3/amep-5-015.PMC3912064.pdf
"The Korean Society for Radiation OncologyPatterns of care and treatment outcomes for primary  thyroid lymphoma: a single institution study Hyejung Cha, MD1, Jun Won Kim, MD1, Chang-Ok Suh, MD, PhD1,  Jin Seok Kim, MD, PhD2, June-Won Cheong, MD, PhD2, Jeongshim Lee, MD1,  Ki Chang Keum, MD, PhD1, Chang Geol Lee, MD1, Jaeho Cho, MD, PhD1 Departments of 1Radiation Oncology and 2Internal Medicine, Yonsei University College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(4):177-184 http://dx.doi.org/10.3857/roj.2013.31.4.177 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  The aim of this study was to analyze the patterns of care and treatment outcomes in patients with primary thyroid  lymphoma (PTL) in a single institution.",Non-OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
"Tel: +82-2-2228-8113, Fax: +82-2-312-9033, E-mail: jjhmd@yuhs.ac CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
"Hyejung Cha , et al 178 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.177tissue as a result of chronic inflammation, but the exact  mechanism of malignant transformation from Hashimoto  thyroiditis to MALT lymphoma is unknown.",OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
179 Outcomes of primary thyroid lymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.1773.8 to 220.8 months).,Non-OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
"Hyejung Cha , et al 180 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.177by adjuvant treatment except for the case of 1 patient, and  adjuvant treatment included chemotherapy alone (n = 2), RT  alone (n = 4), or chemotherapy followed by RT (n = 1).",Non-OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
"181 Outcomes of primary thyroid lymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.177total thyroidectomy, CR, PR, SD, and PD after initial treatment  were observed in 15, 1, 1, and 1 patients, respectively.",Non-OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
"Hyejung Cha , et al 182 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.177hospital and the treatment regimen and response were  unknown.",OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
183 Outcomes of primary thyroid lymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.177determining clinical course of such rare disease as PTL.,Non-OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
"Hyejung Cha , et al 184 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.177Conflicts of Interests No potential conflict of interest relevant to this article was  reported.",Non-OADS,/arxiv_data1/oa_pdf/5c/c4/roj-31-177.PMC3912230.pdf
"The Korean Society for Radiation OncologyEffect of early chemoradiotherapy in patients   with limited stage small cell lung cancer In-Bong Ha, MD1, Bae-Kwon Jeong, MD1,2, Hojin Jeong, PhD1, Hoon-Sik Choi, MD1,  Gyu-Young Chai, MD, PhD1,2, Myoung-Hee Kang, MD2,3, Hoon Gu Kim, MD, PhD2,3,  Gyeong-Won Lee, MD, PhD2,3, Jae-Beom Na, MD, PhD2,4, Ki-Mun Kang, MD, PhD1,2 1Department of Radiation Oncology, Gyeongsang National University School of Medicine, Jinju; 2Institute of Health Science,  Gyeongsang National University, Jinju; Departments of 3Internal Medicine and 4Diagnostic Radiology,  Gyeongsang National University School of Medicine, Jinju, KoreaRadiat Oncol J 2013;31(4):185-190 http://dx.doi.org/10.3857/roj.2013.31.4.185 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  We evaluated the effect of early chemoradiotherapy on the treatment of patients with limited stage small cell lung  cancer (LS-SCLC).",Non-OADS,/arxiv_data1/oa_pdf/18/ad/roj-31-185.PMC3912231.pdf
"Tel: +82-55-750-9202, Fax: +82-55-750-9229, E-mail: jsk92@gnu.ac.kr  CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/ad/roj-31-185.PMC3912231.pdf
"In-Bong Ha , et al 186 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.185(CCRT) regimen was superior to a sequential one in terms of  OS with an acceptable toxicity, thus CCRT has become the  standard management for LS-SCLC [6,7].",Non-OADS,/arxiv_data1/oa_pdf/18/ad/roj-31-185.PMC3912231.pdf
187CCRT for limited stage small cell lung cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.185more than 25% or new lesions were identified.,Non-OADS,/arxiv_data1/oa_pdf/18/ad/roj-31-185.PMC3912231.pdf
"In-Bong Ha , et al 188 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.185nine patients (29%), distant metastasis in three patients (9.7%),  and both local recurrence and distance metastasis in three  patients (9.7%).",OADS,/arxiv_data1/oa_pdf/18/ad/roj-31-185.PMC3912231.pdf
189CCRT for limited stage small cell lung cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.185survival.,Non-OADS,/arxiv_data1/oa_pdf/18/ad/roj-31-185.PMC3912231.pdf
"In-Bong Ha , et al 190 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.185the treatment of small-cell lung cancer?",Non-OADS,/arxiv_data1/oa_pdf/18/ad/roj-31-185.PMC3912231.pdf
"The Korean Society for Radiation OncologyLong-term results of forward intensity-modulated radiation  therapy for patients with early-stage breast cancer Boram Ha, MD1, Hyun Suk Suh, MD1, Jihae Lee, MD1, Kyung-Ja Lee, MD1,  Rena Lee, PhD1, Byung In Moon, MD2 Departments of 1Radiation Oncology and 2General Surgery, Ewha Womans University College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(4):191-198 http://dx.doi.org/10.3857/roj.2013.31.4.191 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  To observe long-term clinical outcomes for patients with early-stage breast cancer treated with forward intensity- modulated radiation therapy (IMRT), including local control and clinical toxicities.",Non-OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
"Tel: +82-2-2650-5331, Fax: +82-2-2654-0363, E-mail: hyunssuh@ ewha.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
"Boram Ha, et al 192 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.191algorithms were equivalent in removing the hot spots and  no significant differences were detected between the two  techniques.",OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
193Forward IMRT for breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.191dose as well as the lung volume (Fig.,Non-OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
"Boram Ha, et al 194 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.191Results 1.",OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
"195Forward IMRT for breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.191Discussion and Conclusion In this single institutional retrospective study, the forward  IMRT technique used in our clinic showed excellent local  control and a low rate of clinical toxicities as well as good  cosmetic outcomes.",Non-OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
"Boram Ha, et al 196 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.191  The aim of this study was to observe long-term local control  in patients treated with breast forward-IMRT and the local  control rate was 99.1% at 5 years and 97.8% at 10 years.",Non-OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
"197Forward IMRT for breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.191impact of the surgical technique on cosmesis, the shape of  the treated breast should be compared with the appearance  of the unilateral breast after surgery and the degree of each  difference should be measured and graded.",Non-OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
"Boram Ha, et al 198 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.191volumes and organs at risk in adjuvant radiotherapy of early  breast cancer: national guidelines and contouring atlas by  the Danish Breast Cancer Cooperative Group.",OADS,/arxiv_data1/oa_pdf/63/b5/roj-31-191.PMC3912232.pdf
"The Korean Society for Radiation OncologyWhole pelvic intensity-modulated radiotherapy for high- risk prostate cancer: a preliminary report Ji Hyeon Joo, MD1, Yeon Joo Kim, MD1, Young Seok Kim, MD1, Eun Kyung Choi, MD1,  Jong Hoon Kim, MD1, Sang-wook Lee, MD1, Si Yeol Song, MD1, Sang Min Yoon, MD1,  Su Ssan Kim, MD1, Jin-hong Park, MD1, Yuri Jeong, MD1, Hanjong Ahn, MD2,  Choung-Soo Kim, MD2, Jae-Lyun Lee, MD3, Seung Do Ahn, MD1 Departments of 1Radiation Oncology, 2Urology, and 3Oncology, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, KoreaRadiat Oncol J 2013;31(4):199-205 http://dx.doi.org/10.3857/roj.2013.31.4.199 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  To assess the clinical efficacy and toxicity of whole pelvic intensity-modulated radiotherapy (WP-IMRT) for high-risk  prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/e6/1a/roj-31-199.PMC3912233.pdf
"Tel: +82-2-3010-5614, Fax: +82-2-3010-6950,  E-mail: ysk@amc.seoul.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/1a/roj-31-199.PMC3912233.pdf
"Ji Hyeon Joo , et al 200 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.199progression-free survival rates were similar in both arms [3-5].",OADS,/arxiv_data1/oa_pdf/e6/1a/roj-31-199.PMC3912233.pdf
201WP-IMRT for high-risk prostate cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.199Criteria for Adverse Events (CTCAE) ver.,Non-OADS,/arxiv_data1/oa_pdf/e6/1a/roj-31-199.PMC3912233.pdf
"Ji Hyeon Joo , et al 202 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.199acute grade 3 GU toxicity was an increase in urinary frequency,  with voiding intervals of less than 1 hour.",OADS,/arxiv_data1/oa_pdf/e6/1a/roj-31-199.PMC3912233.pdf
203WP-IMRT for high-risk prostate cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.199>15%.,Non-OADS,/arxiv_data1/oa_pdf/e6/1a/roj-31-199.PMC3912233.pdf
"Ji Hyeon Joo , et al 204 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.199for proper setup and rectal sparing.",OADS,/arxiv_data1/oa_pdf/e6/1a/roj-31-199.PMC3912233.pdf
205WP-IMRT for high-risk prostate cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.1996.,Non-OADS,/arxiv_data1/oa_pdf/e6/1a/roj-31-199.PMC3912233.pdf
"The Korean Society for Radiation OncologyRe-irradiation of unresectable recurrent head and neck  cancer: using Helical Tomotherapy as image-guided  intensity-modulated radiotherapy Songmi Jeong, MD1, Eun Jung Yoo, MD1, Ji Yoon Kim, MD1,  Chi Wha Han, MD2, Ki Jun Kim, MD3, Chul Seung Kay, MD1 Departments of 1Radiation Oncology, 2Internal Medicine, and 3Diagnostic Radiology,  The Catholic University of Korea College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(4):206-215 http://dx.doi.org/10.3857/roj.2013.31.4.206 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  Re-irradiation (re-RT) is considered a treatment option for inoperable locoregionally recurrent head and neck cancer  (HNC) after prior radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
"Tel: +82-32-280-6026, Fax:  +82-32-280-6024, E-mail: kaycs@catholic.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
207Tomotherapy for re-RT of recurrent HNC www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.206treatment of choice for previously irradiated recurrent HNC  is salvage surgery.,Non-OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
"Songmi Jeong , et al 208 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.206tolerance and allowed the cumulative dose to exceed the  limits.",OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
209Tomotherapy for re-RT of recurrent HNC www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.206uninvolved nodal regions was performed in the 3 patients with  regional recurrence (patient no.,Non-OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
"Songmi Jeong , et al 210 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.206and radiographic response while 2 had partial response.",OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
211Tomotherapy for re-RT of recurrent HNC www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.20643.8 to 75.1 months).,Non-OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
"Songmi Jeong , et al 212 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.206sites, improvement of locoregional therapeutic ratio was  regarded as the key of cure.",OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
"213Tomotherapy for re-RT of recurrent HNC www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.206dose of OARs, therefore relatively low re-irradiation dose was  considered in those patients.",Non-OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
"Songmi Jeong , et al 214 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.206decision-making in selecting treatment option of Tomotherapy  re-irradiation for recurrent HNC and radiation treatment  planning was performed by the same radiation oncologist  with uniform treatment strategy.",OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
215Tomotherapy for re-RT of recurrent HNC www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.206after reirradiation of recurrent squamous cell head and neck  cancer: implications for defining the targets.,Non-OADS,/arxiv_data1/oa_pdf/83/e3/roj-31-206.PMC3912234.pdf
"The Korean Society for Radiation OncologyShort-course palliative radiotherapy   for uterine cervical cancer Dong Hyun Kim, MD1, Ju Hye Lee, MD1, Yong Kan Ki, MD1, Ji Ho Nam, MD2, Won Taek Kim, MD1,3,  Ho Sang Jeon, PhD2, Dahl Park, PhD1, Dong Won Kim, MD1,3 1Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Busan;  2Department of Radiation Oncology, Pusan National University Yangsan Hospital, Yangsan; 3Department of Radiation  Oncology, Pusan National University School of Medicine, Busan, KoreaRadiat Oncol J 2013;31(4):216-221 http://dx.doi.org/10.3857/roj.2013.31.4.216 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  The purpose of this retrospective study was to evaluate the efficacy and feasibility of short-course  hypofractionated radiotherapy (RT) for the palliation of uterine cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/5a/5d/roj-31-216.PMC3912235.pdf
"Tel: +82-51-240-7383, Fax: +82-51-248-5747, E-mail: dongwk51@hanmail.net CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/5d/roj-31-216.PMC3912235.pdf
"217Short-course radiotherapy for palliation of cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.216well tolerated and effects on vaginal bleeding and discharge  were seen after 2 or 3 fractions [5,6].",Non-OADS,/arxiv_data1/oa_pdf/5a/5d/roj-31-216.PMC3912235.pdf
"Dong Hyun Kim , et al 218 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.216would be caused to the patients.",Non-OADS,/arxiv_data1/oa_pdf/5a/5d/roj-31-216.PMC3912235.pdf
219Short-course radiotherapy for palliation of cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.216in this study are comparable to those reported by other series.,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/roj-31-216.PMC3912235.pdf
"Dong Hyun Kim , et al 220 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.2163.7 Gy delivered twice daily in 4 fractions, to a single doses of  8 Gy in 1 fraction [17].",Non-OADS,/arxiv_data1/oa_pdf/5a/5d/roj-31-216.PMC3912235.pdf
221Short-course radiotherapy for palliation of cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.21618.,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/roj-31-216.PMC3912235.pdf
"The Korean Society for Radiation OncologyPrognostic factors for survivals from first relapse in breast  cancer patients: analysis of deceased patients Haeyoung Kim, MD1, Doo Ho Choi, MD2, Won Park, MD2, Seung Jae Huh, MD2, Seok Jin Nam, MD3,  Jeong Eon Lee, MD3, Jin Seok Ahn, MD4, Young-Hyuck Im, MD4 1Department of Radiation Oncology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong; Departments of  2Radiation Oncology, 3Surgery, 4Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(4):222-227 http://dx.doi.org/10.3857/roj.2013.31.4.222 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  This study was performed to evaluate prognostic factors for survival from first relapse (SFFR) in stage I–III breast cancer  patients.",Non-OADS,/arxiv_data1/oa_pdf/45/30/roj-31-222.PMC3912236.pdf
"Tel: +82-2-3410-2436, Fax: +82-2-3410-2619,  E-mail: doho.choi@samsung.com CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/30/roj-31-222.PMC3912236.pdf
223Prognostic factors for survivals in deceased breast cancer patients www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.222at the time of their breast cancer diagnosis [2-4].,Non-OADS,/arxiv_data1/oa_pdf/45/30/roj-31-222.PMC3912236.pdf
"Haeyoung Kim , et al 224 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.222(4), surgery (3), hormonal therapy (3), no treatment (3),  surgery followed by chemotherapy (1), or surgery followed  by radiotherapy (1), respectively.",OADS,/arxiv_data1/oa_pdf/45/30/roj-31-222.PMC3912236.pdf
225Prognostic factors for survivals in deceased breast cancer patients www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.222the first relapse were prognosticators for SFFR among patients  who died of breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/45/30/roj-31-222.PMC3912236.pdf
"Haeyoung Kim , et al 226 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.222third of these patients had triple-negative tumors.",OADS,/arxiv_data1/oa_pdf/45/30/roj-31-222.PMC3912236.pdf
227Prognostic factors for survivals in deceased breast cancer patients www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.222Conflict of Interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/45/30/roj-31-222.PMC3912236.pdf
"The Korean Society for Radiation OncologyTumor bed volumetric changes during breast   irradiation for the patients with breast cancer Mi Joo Chung, MD1, Young Jin Suh, MD2, Hyo Chun Lee, MD1, Dae Gyu Kang, MS1,  Eun Joong Kim, MS1, Sung Hwan Kim, MD1, Jong Hoon Lee, MD1 Departments of 1Radiation Oncology and 2Surgery, St. Vincent’s Hospital,  The Catholic University of Korea College of Medicine, Suwon, KoreaRadiat Oncol J 2013;31(4):228-233 http://dx.doi.org/10.3857/roj.2013.31.4.228 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  The aim of this study was to evaluate changes in breast tumor bed volume during whole breast irradiation (WBI).",Non-OADS,/arxiv_data1/oa_pdf/bc/ea/roj-31-228.PMC3912237.pdf
"Tel: +82-31-249-8440, Fax: +82-31-242-3734, E-mail: koppul@catholic.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/ea/roj-31-228.PMC3912237.pdf
229Lumpectomy cavity changes www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.228probability of local control.,Non-OADS,/arxiv_data1/oa_pdf/bc/ea/roj-31-228.PMC3912237.pdf
"Mi Joo Chung , et al 230 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.228fractions using 6 to 15 MV photons, followed by a boost dose  of 9 Gy to the tumor bed, achieving a total dose of 59.4 Gy.",OADS,/arxiv_data1/oa_pdf/bc/ea/roj-31-228.PMC3912237.pdf
231Lumpectomy cavity changes www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.228lesions (6.7%) in the lower inner quadrant.,Non-OADS,/arxiv_data1/oa_pdf/bc/ea/roj-31-228.PMC3912237.pdf
"Mi Joo Chung , et al 232 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.228according to the study of Huh et al.",OADS,/arxiv_data1/oa_pdf/bc/ea/roj-31-228.PMC3912237.pdf
233Lumpectomy cavity changes www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.228National Surgical Adjuvant Breast and Bowel Project Protocol  B-06.,Non-OADS,/arxiv_data1/oa_pdf/bc/ea/roj-31-228.PMC3912237.pdf
http://dx.doi.org/10.1007/s12282-013- 0457-3.,Non-OADS,/arxiv_data1/oa_pdf/bc/ea/roj-31-228.PMC3912237.pdf
"The Korean Society for Radiation OncologyEsophageal tolerance to high-dose   stereotactic radiosurgery Bo Mi Lee, MD, Sei Kyung Chang, MD, Seung Young Ko, BS, Seung Hoon Yoo, PhD, Hyun Soo Shin, MD Department of Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam, KoreaRadiat Oncol J 2013;31(4):234-238 http://dx.doi.org/10.3857/roj.2013.31.4.234 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  Esophageal tolerance is needed to guide the safe administration of stereotactic radiosurgery (SRS).",Non-OADS,/arxiv_data1/oa_pdf/46/32/roj-31-234.PMC3912238.pdf
"co.kr  CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/32/roj-31-234.PMC3912238.pdf
"235Esophageal tolerance to stereotactic radiosurgery www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.234Treatment was designed to provide a single fraction of 16  to 22 Gy (median, 19 Gy) prescribed to the 90% isodose line  encompassing the planning target volume (PTV) planned  by intensity-modulated radiotherapy except one case.",Non-OADS,/arxiv_data1/oa_pdf/46/32/roj-31-234.PMC3912238.pdf
"Bo Mi Lee, et al 236 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.234months).",OADS,/arxiv_data1/oa_pdf/46/32/roj-31-234.PMC3912238.pdf
"237Esophageal tolerance to stereotactic radiosurgery www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.234significantly different from those in group 2 (p = 0.002 and p  = 0.008, respectively).",Non-OADS,/arxiv_data1/oa_pdf/46/32/roj-31-234.PMC3912238.pdf
"Bo Mi Lee, et al 238 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.234heterogeneous patient population, limited to generalize  our results.",OADS,/arxiv_data1/oa_pdf/46/32/roj-31-234.PMC3912238.pdf
"The Korean Society for Radiation OncologyThe deep inspiration breath hold technique using Abches  reduces cardiac dose in patients undergoing left-sided  breast irradiation Ha Yoon Lee, MD, Jee Suk Chang, MD, Ik Jae Lee, MD, PhD, Kwangwoo Park, PhD, Yong Bae Kim, MD, PhD,   Chang Ok Suh, MD, PhD, Jun Won Kim, MD, Ki Chang Keum, MD, PhD Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(4):239-246 http://dx.doi.org/10.3857/roj.2013.31.4.239 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  We explored whether the deep inspiration breath hold (DIBH) technique using Abches during left-sided breast irradiation  was effective for minimizing the amount of radiation to the heart and lung compared to free breathing (FB).",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
"Tel: +82-2-2228-8112, Fax: +82-2-2227-7823,  E-mail: kckeum@yuhs.ac CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
"Ha Yoon Lee , et al 240 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.239mortality.",OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
"241Reduction of cardiac dose using Abches www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.239indices, the contralateral breast and just below the xiphoid  process, respectively.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
"Ha Yoon Lee , et al 242 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.239free-form deformable registration algorithm with essentially  limitless degrees of freedom designed to expedite the  delineation of target volumes and organs at risk.",OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
243Reduction of cardiac dose using Abches www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.2392.,Non-OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
"Ha Yoon Lee , et al 244 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.239We assessed the overall treatment time for each patient.",OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
245Reduction of cardiac dose using Abches www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.239time breathing trace and a balloon valve that is triggered  to automatically inflate when the patient inspire to their  preset DIBH level.,Non-OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
"Ha Yoon Lee , et al 246 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.23912.",OADS,/arxiv_data1/oa_pdf/7e/fa/roj-31-239.PMC3912239.pdf
"The Korean Society for Radiation OncologyEfficient approach for determining four-dimensional  computed tomography-based internal target volume in  stereotactic radiotherapy of lung cancer Seung-Gu Yeo, MD, PhD, Eun Seog Kim, MD, PhD Department of Radiation Oncology, Soonchunhyang University College of Medicine, Cheonan, KoreaRadiat Oncol J 2013;31(4):247-251 http://dx.doi.org/10.3857/roj.2013.31.4.247 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  This study aimed to investigate efficient approaches for determining internal target volume (ITV) from four-dimensional  computed tomography (4D CT) images used in stereotactic body radiotherapy (SBRT) for patients with early-stage non-small cell  lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/d7/f0/roj-31-247.PMC3912240.pdf
"Tel: +82-41-570-3551, Fax: +82-41-592-3809, E-mail: radio@schmc.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/f0/roj-31-247.PMC3912240.pdf
"Seung-Gu Yeo  and Eun Seog Kim 248 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.247fractions within 1 week, with steep increases in the tumoricidal  effect; 60 Gy in three fractions is presumed to be equal to  as much as 150 Gy in conventional fractionation [2].",Non-OADS,/arxiv_data1/oa_pdf/d7/f0/roj-31-247.PMC3912240.pdf
2494D CT-based ITV in lung SBRT www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.247analyzed using Spearman correlation coefficient.,OADS,/arxiv_data1/oa_pdf/d7/f0/roj-31-247.PMC3912240.pdf
Seung-Gu Yeo  and Eun Seog Kim 250 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.247a given patient because breathing characteristics are quite  variable among patients [10].,Non-OADS,/arxiv_data1/oa_pdf/d7/f0/roj-31-247.PMC3912240.pdf
2514D CT-based ITV in lung SBRT www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.247Acknowledgments This work was supported by the Soonchunhyang University  Research Fund.,Non-OADS,/arxiv_data1/oa_pdf/d7/f0/roj-31-247.PMC3912240.pdf
"The Korean Society for Radiation OncologyDosimetric evaluation of Tomotherapy and four-box field  conformal radiotherapy in locally advanced rectal cancer Mina Yu, MD1, Hong Seok Jang, MD2, Dong Min Jeon, MS2, Geum Seong Cheon, BA2,  Hyo Chun Lee, MD1, Mi Joo Chung, MD1, Sung Hwan Kim, MD1, Jong Hoon Lee, MD1 1Department of Radiation Oncology, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, Suwon;  2Department of Radiation Oncology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(4):252-259 http://dx.doi.org/10.3857/roj.2013.31.4.252 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  To report the results of dosimetric comparison between intensity-modulated radiotherapy (IMRT) using Tomotherapy  and four-box field conformal radiotherapy (CRT) for pelvic irradiation of locally advanced rectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
"Tel: +82-31-249-7560, Fax: +82-31-257-3734, E-mail: koppul@catholic.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
253 Tomotherapy in rectal cancer patients www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.252chemoradiotherapy [2-5].,Non-OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
"Mina Yu , et al 254 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.252space, the entire sacral hollow, and regional lymphatics (Fig.",Non-OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
255 Tomotherapy in rectal cancer patients www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.252Results 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
"Mina Yu , et al 256 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.252incidence of late toxicities in SC-RT vs. LC-CRT was 28.3% vs.  27% (p = 0.810), and the incidence of severe late toxicities was  10.1% vs. 7.1% (p = 0.360).",OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
"257 Tomotherapy in rectal cancer patients www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.252investigating prostate cancer, gynecologic cancer, and anal  cancer have proven these advantages [23-26].",Non-OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
"Mina Yu , et al 258 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.252study, dose conformality of Tomotherapy was better than  that of four-box field CRT.",OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
259 Tomotherapy in rectal cancer patients www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.252of short-course preoperative radiotherapy combined with  total mesorectal excision for rectal cancer: increased bowel  dysfunction in irradiated patients.,Non-OADS,/arxiv_data1/oa_pdf/aa/47/roj-31-252.PMC3912241.pdf
"The Korean Society for Radiation OncologyStereotactic body radiotherapy for   solitary spine metastasis  Sunyoung Lee, MD1, Mison Chun, MD2, MiJo Lee, MD3  1Department of Radiation Oncology, Sun Medical Center, Daejeon; 2Department of Radiation Oncology, Ajou University School  of Medicine, Suwon; 3Department of Radiation Oncology, Eulji Universtiy School of Medicine, Daejeon, KoreaRadiat Oncol J 2013;31(4):260-266 http://dx.doi.org/10.3857/roj.2013.31.4.260 pISSN 2234-1900 · eISSN 2234-3156  Case Report A clear consensus has not been established regarding the best treatment for solitary bone metastasis.",Non-OADS,/arxiv_data1/oa_pdf/7c/73/roj-31-260.PMC3912242.pdf
"Tel: +82-42-609-1900, Fax: +82-42-609-1919, E-mail: sunlight1018@hanmail.net CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/73/roj-31-260.PMC3912242.pdf
"261SBRT for solitary spine metastasis www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.260(range, 73% to 78%) of the prescribed dose.",Non-OADS,/arxiv_data1/oa_pdf/7c/73/roj-31-260.PMC3912242.pdf
"Sunyoung Lee , et al 262 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.2602.",OADS,/arxiv_data1/oa_pdf/7c/73/roj-31-260.PMC3912242.pdf
263SBRT for solitary spine metastasis www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.260palliative chemotherapy was continued.,Non-OADS,/arxiv_data1/oa_pdf/7c/73/roj-31-260.PMC3912242.pdf
"Sunyoung Lee , et al 264 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.260 Fig.",OADS,/arxiv_data1/oa_pdf/7c/73/roj-31-260.PMC3912242.pdf
"265SBRT for solitary spine metastasis www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.260detected, and the unambiguous detection of truly solitary  metastases is possible at an earlier stage.",Non-OADS,/arxiv_data1/oa_pdf/7c/73/roj-31-260.PMC3912242.pdf
"Sunyoung Lee , et al 266 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.260including 30 Gy in 10 fractions, 26 Gy in 6 fractions, 20 Gy  in 5 fractions, and a single 8 Gy fraction [16,17].",OADS,/arxiv_data1/oa_pdf/7c/73/roj-31-260.PMC3912242.pdf
"The Korean Society for Radiation OncologyA patient who has survived for a long period with repeated  radiotherapies for multifocal extrahepatic metastases from  hepatocellular carcinoma Sunmi Jo, MD1, Hye Kyung Shim, MD2 Departments of 1Radiation Oncology and 2Nuclear Medicine, Inje University Haeundae Paik Hospital, Busan, KoreaRadiat Oncol J 2013;31(4):267-272 http://dx.doi.org/10.3857/roj.2013.31.4.267 pISSN 2234-1900 · eISSN 2234-3156  Case Report Although significant advances in the treatment of intrahepatic lesions, it is reported that the prognosis for patients with  hepatocellular carcinoma (HCC) who have extrahepatic metastasis remains poor.",Non-OADS,/arxiv_data1/oa_pdf/f6/35/roj-31-267.PMC3912243.pdf
"Tel: +82-51-797-3810, Fax: +82-51-797-3830, E-mail: smjo@paik.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/35/roj-31-267.PMC3912243.pdf
Sunmi Jo and Hye Kyung Shim 268 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.267of the mass revealed metastatic HCC.,OADS,/arxiv_data1/oa_pdf/f6/35/roj-31-267.PMC3912243.pdf
269A long-term survivor with metastatic HCC www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.267left teres minor muscles area was aggravated and hard fixed  mass was palpable again.,Non-OADS,/arxiv_data1/oa_pdf/f6/35/roj-31-267.PMC3912243.pdf
Sunmi Jo and Hye Kyung Shim 270 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.267possible to carry on ordinary activities.,Non-OADS,/arxiv_data1/oa_pdf/f6/35/roj-31-267.PMC3912243.pdf
271A long-term survivor with metastatic HCC www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.267patient was in compatible with oligo-recurrence when he  visited our hospital at first.,Non-OADS,/arxiv_data1/oa_pdf/f6/35/roj-31-267.PMC3912243.pdf
Sunmi Jo and Hye Kyung Shim 272 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.4.267the new era of cancer therapy.,Non-OADS,/arxiv_data1/oa_pdf/f6/35/roj-31-267.PMC3912243.pdf
 http://dx.doi.org/10.4082/kjfm.2014.35.1.1 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/41/7f/kjfm-35-1.PMC3912260.pdf
  http://dx.doi.org/10.4082/kjfm.2014.35.1.11 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/15/54/kjfm-35-11.PMC3912261.pdf
"Keywords:  Coffee; Bone Density; Premenopause; Asian Continental Ancestry Group Received: August 29, 2012,  Accepted: December 30, 2013 *Corresponding Author: Sang Min Park T el: +82-2-2072-3331, Fax: +82-2-766-3276E-mail: sangmin.park.snuh@gmail.com Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and America.1) Korea is currently the 11th largest coffee consumer  in the world, and the consumption rate has sharply increased in recent years, making coffee an important environmental exposure.",Non-OADS,/arxiv_data1/oa_pdf/15/54/kjfm-35-11.PMC3912261.pdf
Available from: http://www.nof.org.,Non-OADS,/arxiv_data1/oa_pdf/15/54/kjfm-35-11.PMC3912261.pdf
  http://dx.doi.org/10.4082/kjfm.2014.35.1.19 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/23/1a/kjfm-35-19.PMC3912262.pdf
"Keywords:  Health Promotion; Physical Examination; Primary Care Physicians Received: August 31, 2011,  Accepted: October 21, 2013 *Corresponding Author: Eal-Whan Park T el: +82-41-550-3997, Fax: +82-41-550-7163E-mail: ewpark@dku.edu Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.that encourage the improvement of health status, and involves  management of nutrition, control of body weight, exercise, smoking cessation, moderation of drinking habits, good sleep habits, and stress management.",Non-OADS,/arxiv_data1/oa_pdf/23/1a/kjfm-35-19.PMC3912262.pdf
Available from: http://knhanes.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/23/1a/kjfm-35-19.PMC3912262.pdf
Available from: http://www.cnpp.usda.gov/Publica tions/DietaryGuidelines/2010/ PolicyDoc/Chapter2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/1a/kjfm-35-19.PMC3912262.pdf
 http://dx.doi.org/10.4082/kjfm.2014.35.1.2 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/fb/7c/kjfm-35-2.PMC3912263.pdf
"Keywords:  Alcohols; Questionnaires; Drinking Received: August 27, 2013,  Accepted: December 12, 2013 *Corresponding Author: Jong Sung Kim T el: +82-42-280-8172, Fax: +82-42-280-7879E-mail: jskim@cnuh.co.kr Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Medical personnel may use a va riety of questionnaires in  order to discover alcohol use disorders at an early stage.",Non-OADS,/arxiv_data1/oa_pdf/fb/7c/kjfm-35-2.PMC3912263.pdf
Available from: http://pubs.niaaa.nih.,Non-OADS,/arxiv_data1/oa_pdf/fb/7c/kjfm-35-2.PMC3912263.pdf
Available from: http://www.kalia.or.kr/inc/abc_down.asp?url=board_notice%5E798%5E1.,Non-OADS,/arxiv_data1/oa_pdf/fb/7c/kjfm-35-2.PMC3912263.pdf
Available from: http://www.cdc.go.kr/CDC/cms/content/07/17407_view.html.,Non-OADS,/arxiv_data1/oa_pdf/fb/7c/kjfm-35-2.PMC3912263.pdf
Available from: http://www.bokjiro.go.kr/data/statusView.do?board_sid=297&data_sid=5769227.,OADS,/arxiv_data1/oa_pdf/fb/7c/kjfm-35-2.PMC3912263.pdf
 http://dx.doi.org/10.4082/kjfm.2014.35.1.28 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/5f/f4/kjfm-35-28.PMC3912264.pdf
"Keywords:  Korea; Women; Smoking; Smoking Rate; Cotinine Received: August 31, 2011,  Accepted: May 2, 2013 *Corresponding Author: Jungun Lee T el: +82-31-390-2416, Fax: +82-31-390-2588E-mail: tracheo@naver.com Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Smoking is an important public health issue for women,  since it affects the development and health of the fetus during pregnancy 1-3) and increases the risk of lung, stomach, cervical,  bladder, oral, and laryngeal cancer.4) The Korean Institute for  Health and Social Affairs reported that the percentage of Korean women smokers increased from 5.1% in 1992 to 7.4% in 2008.",Non-OADS,/arxiv_data1/oa_pdf/5f/f4/kjfm-35-28.PMC3912264.pdf
  http://dx.doi.org/10.4082/kjfm.2014.35.1.35 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/d2/28/kjfm-35-35.PMC3912265.pdf
"Keywords:  Lung Age; Smoking; Male; Spirometry; Forced Expiratory Volume 1; Obesity Received: August 31, 2010,  Accepted: December 10, 2013 *Corresponding Author: Hong Soo Lee T el: +82-2-2650-5165, Fax: +82-2-2650-2439E-mail: dongyn@kornet.net Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutrition Examination Survey (Ministry of Health and Welfare,  2007), 45.0% of Korean men were smokers.",Non-OADS,/arxiv_data1/oa_pdf/d2/28/kjfm-35-35.PMC3912265.pdf
 http://dx.doi.org/10.4082/kjfm.2014.35.1.42 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/kjfm-35-42.PMC3912266.pdf
 http://dx.doi.org/10.4082/kjfm.2014.35.1.44 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/d5/be/kjfm-35-44.PMC3912267.pdf
"Y ours Sincerely *Corresponding Author: Viroj Wiwanitkit T el: +86-66-89-243-8832, Fax: +86-66-2-413-2436E-mail: wviroj@yahoo.com Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/be/kjfm-35-44.PMC3912267.pdf
"Context Matters advance online publication, 6 November 2012; http://globenewswire.com/news-release/2012/11/06/502781/10011322/en/Use-of-Efﬁcacy- and-Effectiveness-Often-Misleading-and-May-Skew-Reimbursement-Decisions.html.",Non-OADS,/arxiv_data1/oa_pdf/ad/0b/ctg201313a.PMC3912314.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/A Primer on Effectiveness and Efﬁcacy Trials Singal et al .",OADS,/arxiv_data1/oa_pdf/ad/0b/ctg201313a.PMC3912314.pdf
"Although previously reported in adults,18this association was not replicated in recent adult-onset IBD GWAS and meta-analysis, where rs2297518 was not asso- ciated with either CD or UC, and rs1137933 was not includedin the meta-analysis (http://medicine.yale.edu/intmed/ibdgc/index.aspx; Supplementary Tables 11 and 12).",Non-OADS,/arxiv_data1/oa_pdf/31/2e/ctg201317a.PMC3912315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Clinical and Tr anslational Gastroenterology website (http://www.nature.com/ctg)iNOS Contributes to Very Early Onset IBD Dhillon et al.",Non-OADS,/arxiv_data1/oa_pdf/31/2e/ctg201317a.PMC3912315.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/MicroRNA Proﬁle in Pancreatic Cysts Lee et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/1c/ctg201318a.PMC3912316.pdf
"2013, ISBN 3-900051-07-0, http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/82/ab/ctg201319a.PMC3912317.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/A Primer on Predictive Models Waljee et al.",Non-OADS,/arxiv_data1/oa_pdf/82/ab/ctg201319a.PMC3912317.pdf
"2007;35(1): 9-19, http://dx.doi.org/10.1002/jcu.20298.",Non-OADS,/arxiv_data1/oa_pdf/2f/cd/cln-69-02-087.PMC3912319.pdf
"2003;13:68-79, http://dx.doi.org/10.1007/BF03323636.",Non-OADS,/arxiv_data1/oa_pdf/2f/cd/cln-69-02-087.PMC3912319.pdf
"2000;217(1):240-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/cd/cln-69-02-087.PMC3912319.pdf
"2005;33(2):47-52, http://dx.doi.org/10.1002/ jcu.20089.",Non-OADS,/arxiv_data1/oa_pdf/2f/cd/cln-69-02-087.PMC3912319.pdf
"1997;23(6):851-6, http://dx.doi.org/10.1016/S0301-5629(97)00029-X.",Non-OADS,/arxiv_data1/oa_pdf/2f/cd/cln-69-02-087.PMC3912319.pdf
"1997;52(12):917-23, http://dx.doi.org/10.1016/ S0009-9260(97)80224-3.",Non-OADS,/arxiv_data1/oa_pdf/2f/cd/cln-69-02-087.PMC3912319.pdf
"2012;262:450-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/cd/cln-69-02-087.PMC3912319.pdf
"2012;38(12):2065-71, http://dx.doi.org/10.1016/j.ultrasmedbio.",OADS,/arxiv_data1/oa_pdf/2f/cd/cln-69-02-087.PMC3912319.pdf
"1999;281(17):1658-9, http://dx.doi.org/10.1001/jama.281.17.1658.",Non-OADS,/arxiv_data1/oa_pdf/62/ab/cln-69-02-083.PMC3912320.pdf
"2004;115(6):3142-55, http://dx.doi.org/10.1121/1.1738687.",Non-OADS,/arxiv_data1/oa_pdf/62/ab/cln-69-02-083.PMC3912320.pdf
"1991;42:135-59, http://dx.doi.org/10.1146/annurev.",Non-OADS,/arxiv_data1/oa_pdf/62/ab/cln-69-02-083.PMC3912320.pdf
"2003;1254(1):481-5, http://dx.doi.org/10.1016/S0531-5131(03)010 24-0.",Non-OADS,/arxiv_data1/oa_pdf/62/ab/cln-69-02-083.PMC3912320.pdf
"2001;110(1):416-24, http://dx.doi.org/10.1121/1.1375843.",Non-OADS,/arxiv_data1/oa_pdf/62/ab/cln-69-02-083.PMC3912320.pdf
"2000;126(4):459- 69, http://dx.doi.org/10.1016/S1095-6433(00)00232-4.",Non-OADS,/arxiv_data1/oa_pdf/62/ab/cln-69-02-083.PMC3912320.pdf
"1999;106(5):2812-20, http://dx.doi.org/10.1121/1.428129.",Non-OADS,/arxiv_data1/oa_pdf/62/ab/cln-69-02-083.PMC3912320.pdf
"2004;65(3):229-41, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/ab/cln-69-02-083.PMC3912320.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/cf/ef/mtna201369a.PMC3912325.pdf
AMBER 12 <http://ambermd.org/>.,Non-OADS,/arxiv_data1/oa_pdf/ce/ff/mtna201371a.PMC3912326.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/ce/ff/mtna201371a.PMC3912326.pdf
"1990;4(Pt 4):613-21, http://dx.doi.org/10.1038/eye.1990.86.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"1996;74(1):13-33, http://dx.doi.org/10.1007/BF00202069.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2007;25(12):2454-62, http://dx.doi.org/10.1097/HJH.0b013e3282ef79f7.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2003;44(8):3578-85, http://dx.doi.org/10.1167/ iovs.03-0097.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2006; 26(10):2252-9, http://dx.doi.org/10.1161/01.ATV.0000240050.15321.fe.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2000;224(3):166-71, http://dx.doi.org/10.1046/j.1525-1373.2000.22 416.x.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2010;41(5):562-71, http://dx.doi.org/10.3928/15428877-20100726-05.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2002;420(6917):868-74, http://dx.doi.org/10.1038/nature01323.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2009;72(1):68-74, http://dx.doi.org/10.1590/S0004- 27492009000100014.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2003;44(4):1753-9, http://dx.doi.org/10.1167/iovs.02-0496.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2005;139(3):537-40, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2006;83(6):1325-34, http://dx.doi.org/10.1016/j.exer.2006.07.007.",OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"1996;271(2):736-41, http://dx.doi.org/10.1074/jbc.271.2.736.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"1996;16(4):585-90, http://dx.doi.org/10.1161/01.ATV.16.4.585.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"1990;97(2):171-8, http://dx.doi.org/10.1016/S0161-6420 (90)32619-2.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2008;29(7):367-74, http://dx.doi.org/10.1016/j.tips.2008.05.003.",OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2009;2009:752406, http://dx.doi.org/10.1155/2009/752406.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2002;22(7):1208- 12, http://dx.doi.org/10.1161/01.ATV.0000022847.38083.B6.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2013;29(8):709-14, http://dx.doi.org/10.1089/jop.2012.0142.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2006;3:1, http://dx.doi.org/10.1186/ 1742-4682-3-1.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2001;132(4):587-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2002;22(8):1257-66, http://dx.doi.org/10.1161/01.ATV.0000021412.56621.A2.CLINICS 2014;69(2):145-149 Candesartan and the choroid/sclera complex Torres RJ et al.",Non-OADS,/arxiv_data1/oa_pdf/14/59/cln-69-02-145.PMC3912332.pdf
"2012;4(4):235-44, http://dx.doi.org/10.1177/1759720X12 453092.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2005;19(3):467-85, http://dx.doi.org/10.1016/j.berh.",OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2010;62(3):323-34, http://dx.doi.org/10.1002/acr.20102.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2006;54(12):3761-73, http://dx.doi.org/10.1002/art.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2011;70(1):172-15, http://dx.doi.org/10.1136/ard.2010.129924.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2008;58(10):2958-67, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"1988;31(3):315-24, http://dx.doi.org/10.1002/art.1780310302.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"1995;30(1):44-48, http://dx.doi.org/10.1002/art.1780380107.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2005;7(4):R796-R806, http://dx.doi.org/10.1186/ar1740.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2011;66(5):731-6, http://dx.doi.org/10.1590/S1807-593220 11000500004.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2001;60(7):641–9, http://dx.doi.org/10.1136/ard.60.7.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2003;48(4):955-62, http://dx.doi.org/10.1002/art.10877.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2004;63(6):740-3, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2000; 215(3):846-51, http://dx.doi.org/10.1148/radiology.215.3.r00jn20846.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2010;69(10):1845-8, http://dx.doi.org/10.1136/ard.2009.125179.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"1996;10(3):435-53, http://dx.doi.org/10.1016/S0950-3579(96) 80043-4.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2011; 13:R83, http://dx.doi.org/10.1186/ar3353.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2012;64(2): 190-6, http://dx.doi.org/10.1002/acr.20652.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"1990;116(6):921-3, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2012;71(Supp II):i86-i88, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2010;69(5):851-5, http://dx.doi.org/10.1136/ard.2009.119156.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2011; 70(3):500-7, http://dx.doi.org/10.1136/ard.2010.131573.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2013;72(5):665-71, http://dx.doi.org/10.1136/annrheumdis-2012-201469.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2009;60(7):1915-22, http://dx.doi.org/10.1002/art.24596.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2013;65(4):512-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2012;64(1):67-76, http://dx.doi.org/10.1002/art.33312.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2007;19(1):55-60, http://dx.doi.org/10.1097/BOR.",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2000;43(12):2762-70, http://dx.doi.org/ 10.1002/1529-0131(200012)43:12 ,2762::AID-ANR16 .3.0.CO;2-#.Painless Synovitis: Ultrasound trial Pereira DF et al.CLINICS 2014;69(2):93-100 100",Non-OADS,/arxiv_data1/oa_pdf/6f/f2/cln-69-02-093.PMC3912334.pdf
"2010;44(4):269-72, http://dx.doi.org/ 10.3109/00365591003636612.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"2009;53(8):1094-6, http://dx.doi.org/10.1111/j.1399-6576.2009.01983.x.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"2010;10:7, http://dx.doi.org/10.1186/1471-2253-10-7.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1991;35(7):557-67, http://dx.doi.org/10.1111/j.1399-6576.1991.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"2010; 113(2):470-81, http://dx.doi.org/10.1097/ALN.0b013e3181dcd88f.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"2005;103(3):460-9, http://dx.doi.org/ 10.1097/00000542-200509000-00006.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"2012;16(1):R18, http://dx.doi.org/10.1186/cc11175.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"2001;95(2):114-25, http://dx.doi.org/10.1006/jsre.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1996;40(6):671-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1992;21(3):173-81, http://dx.doi.org/10.1002/pros.2990210302.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1997;31(3):259-63, http://dx.doi.org/10.3109/00365599709070344.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1993;79(5):1136-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1990;16(1):49-56, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1990;18(12):1479-80, http://dx.doi.org/10.1097/00003246-199012000-000 31.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1989;46(2):135-41, http://dx.doi.org/10.1016/ 0022-4804(89)90216-3.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1980;XV(3):267-71, http://dx.doi.org/10.1016/0090-4295(80)90441-0.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1982;10(2):201-27, http://dx.doi.org/10.1007/BF01062336.",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"1989;33(2):146-51, http://dx.doi.org/10.1111/j.1399-6576.1989.tb02878.x.CLINICS 2014;69(2):120-127 Dilutional hyponatremic shock Hahn RG and Geba ¨ck T 127",Non-OADS,/arxiv_data1/oa_pdf/c3/34/cln-69-02-120.PMC3912335.pdf
"2010;140(3-4):287-96, http://dx.doi.org/10.1016/j.vetmic.2009.",OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"2003;3(12):757-71, http://dx.doi.org/10.1016/S1473-3099(03)00830-2.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"2005;18(5):376-86, http://dx.doi.org/10.1097/01.qco.0000178824.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"2008;109(4):c182-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"1980;17(6):827-36, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"1991;13(4):705-9, http://dx.doi.org/10.1093/ clinids/13.4.705.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"2002;30(5):535-40, http://dx.doi.org/10.1177/ 147323000203000511.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"1997;25(3):720-4, http://dx.doi.org/10.1086/513767.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"2010;15(2):152-9, http://dx.doi.org/10.1111/j.1365-3156.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"2008;28(4):383-94, http://dx.doi.org/10.1016/j.semnephrol.2008.",OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"2004;98(1):8-14, http://dx.doi.org/10.1159/000079922.",Non-OADS,/arxiv_data1/oa_pdf/e8/05/cln-69-02-106.PMC3912336.pdf
"2004;51(2):241-8, http://dx.doi.org/10.1016/j.jaad.2003.12.040.",OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"1998;38(1):1-17, http://dx.doi.org/10.1016/S0190- 9622(98)70532-8.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"1999;67(1):258-9, http://dx.doi.org/10.1016/S0003-4975(98)01208-9.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2003;75(4):1075-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"1995;118(3):493-5, http://dx.doi.org/ 10.1016/S0039-6060(05)80364-2.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2007;21(1):129-35, http://dx.doi.org/10.1007/ s00464-005-0690-8.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2008;18(2):209- 16, http://dx.doi.org/10.1016/j.thorsurg.2008.01.008.",OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2009;209(2):e12-5, http://dx.doi.org/ 10.1016/j.jamcollsurg.2009.04.015.",OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2010;20(1):1-6, http://dx.doi.org/10.1089/lap.2009.0223.12.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2003;76(3):886-91, http://dx.doi.org/10.1016/S0003-4975(03)008 95-6.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2013;68(3):311-5, http://dx.doi.org/10.6061/clinics/2013(03) OA05.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2004;2(5):343-9, http://dx.doi.org/ 10.1046/j.1439-0353.2004.04765.x.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2002;21(2):271-92, http://dx.doi.org/10.1016/S0167-6296(01)00130-8.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2007;17(3):172-6, http://dx.doi.org/10.1007/s10286-007- 0420-5.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2012;66(3):387-92, http://dx.doi.org/10.1016/j.jaad.2011.",OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2008;19(2):101-4, http://dx.doi.org/10.1080/09546 630701418754.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2008;54(4):740-64, http://dx.doi.org/10.1016/j.eururo.2008.06.080.",OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2008;54(3):543-62, http://dx.doi.org/10.1016/j.eururo.2008.06.047.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2009;34(8):e990-1, http://dx.doi.org/10.1111/j.1365-2230.2009.03645.x.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2003;9(2):85-9, http://dx.doi.org/10.1034/j.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2004;115(8):1909-16, http://dx.doi.org/10.1016/j.clinph.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2009; 69(3):327-37, http://dx.doi.org/10.2165/00003495-200969030-00008.CLINICS 2014;69(2):101-105 Plantar Hyperhidrosis after Sympathectomy Costa Jr AS et al.",Non-OADS,/arxiv_data1/oa_pdf/e8/84/cln-69-02-101.PMC3912338.pdf
"2004;1644(1):9-15, http://dx.doi.org/10.1016/j.bbamcr.2003.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2010;53(5-6):273-80, http://dx.doi.org/10.1016/j.vph.2010.09.007.",OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2008;269(2):199-225, http://dx.doi.org/10.1016/j.canlet.2008.03.009.",OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2005;591(1-2):123-46, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2011;82(5):757-61, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2010;391(3):1500- 5, http://dx.doi.org/10.1016/j.bbrc.2009.12.101.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2007;16(2):247-57, http://dx.doi.org/10.1016/j.niox.2006.",OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2010;87(5):869-75, http://dx.doi.org/10.1189/jlb.0909610.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
http://dx.doi.org/10.1016/j.mvr.2013.07.007.,OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2011;11(1):12, http://dx.doi.org/10.1186/1475-2867-11-12.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2012;83(6):1000-7, http://dx.doi.org/10.1016/j.fitote.2012.06.002.",OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2009;75(5):478-82, http://dx.doi.org/10.1055/s-0029-1185315.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2010;24(20): 1927-32, http://dx.doi.org/10.1080/14786419.2010.490913.28.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"1991;15(2):117-26, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2002;195(8):973-82, http://dx.doi.org/10.1084/jem.20011782.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/cln-69-02-134.PMC3912339.pdf
"2004;221(1–2):21-32, http://dx.doi.org/10.1016/ j.mce.2004.04.006.",OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2010;21(1):111-6, http://dx.doi.org/10.1007/s00 192-009-0995-6.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2008; 14(2):132-5, http://dx.doi.org/10.1016/j.ctcp.2008.01.002.",OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2007;23:308-16, http://dx.doi.org/10.1016/j.reprotox.2006.11.012.",OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2009;16(2):301-6, http://dx.doi.org/10.1097/gme.0b013e318186d7e2.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2004;28(6):433-9, http://dx.doi.org/10.1016/j.cellbi.2004.03.011.",OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2005;206(1):17-28, http://dx.doi.org/10.1007/s00232-005-0770-7.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2002;185(2):165-76, http://dx.doi.org/10.1007/s00232-001-0117-y.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2013;10(14(1)):60, http://dx.doi.org/10.1186/1471-2350-14-60.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2003;5(10):902-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2011;28(2):239-50, http://dx.doi.org/10.1159/000331736.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2003;308(3):518-22, http://dx.doi.org/10.1016/S0006-291X(03) 01436-0.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2000;62(1):143-9, http://dx.doi.org/10.1095/biolreprod62.1.143.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2013;75(2):152-8, http://dx.doi.org/ 10.1016/j.maturitas.2013.03.003.",OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2008;3(1):12, http://dx.doi.org/10.1186/1749-799X-3- 12.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2000;45(2):454-62, http://dx.doi.org/10.1016/S0008- 6363(99)00359-4.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2001;25(4):402-8, http://dx.doi.org/10.1006/meth.2001.1262.29.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2004;42(11):5189-98, http://dx.doi.org/10.1128/JCM.42.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"1994;78(1):216-24, http://dx.doi.org/10.1210/jc.78.1.216.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2005;39(1):75-85, http://dx.doi.org/10.2144/05391RV01.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2005;12(5):589-600, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2006;13(1):72-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2012;21(6): 674-82, http://dx.doi.org/10.1089/jwh.2011.3153.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2000;29(1):79-89.37, http://dx.doi.org/10.1016/S0891-5849(00)00322-1.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2013;68(2):253-62, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"1998;77(7):751-7, http://dx.doi.org/10.1080/j.1600-0412.1998.770710.x.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2013; 140(8):1703-12, http://dx.doi.org/10.1242/dev.091819.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2011;95(6):2100-6.e2, http://dx.doi.org/10.1016/j.fertnstert.2011.02.036.",OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2012;287(45):38316-26, http://dx.doi.org/10.1074/jbc.M112.412817.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2006;250(1-2):106-13, http://dx.doi.org/ 10.1016/j.mce.2005.12.032.",OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2004;55(1):69-75, http://dx.doi.org/ 10.1203/01.PDR.0000100758.66805.CE.Genistein-induced uterine fluid accumulation Chinigarzadeh A et al.CLINICS 2014;69(2):111-119 118",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2004;287(6):C1636-45, http://dx.doi.org/10.1152/ajpcell.00236.2003.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2001;16(5):997-1006, http://dx.doi.org/ 10.1093/humrep/16.5.997.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/cln-69-02-111.PMC3912340.pdf
"2007;26(8):782-95, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2008;34(7):497-505, http://dx.doi.org/10.1590/S1806-37132008000700010.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2003; 75(12):1928-33, http://dx.doi.org/10.1097/01.TP.0000066351.87480.9E.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2003;167(4):490-511, http://dx.doi.org/10.1164/rccm.200207-670SO.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2005;18(1):15-21, http://dx.doi.org/10.1111/ j.1432-2277.2004.00018.x.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2002;21(1):57, http://dx.doi.org/10.1016/S1053-2498(01)00440- 5.",OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2013;39(2):173-180, http://dx.doi.org/ 10.1590/S1806-37132013000200008.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2007;33(4):448-53, http://dx.doi.org/10.1590/S1806-37132007000400015.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"1965;16:482-8, http://dx.doi.org/10.1161/01.RES.16.5.482.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"1999;67(3):343-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2008;85(1):278-86, http://dx.doi.org/ 10.1016/j.athoracsur.2007.07.092.",OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2009;41(10):4114-9, http://dx.doi.org/10.1016/j.transproceed.2009.09.087.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2004;78(9):1251-8, http://dx.doi.org/10.1097/ 01.TP.0000142679.45418.96.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2003;76(8):1150-4, http://dx.doi.org/10.1097/01.TP.0000080983.14161.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2007;124(1):98-108, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"1994;11(5):447-72, http://dx.doi.org/10.1089/neu.1994.11.447.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"1998;65(12):1533-42, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"1999;116(1 Suppl):2S-8S, http://dx.doi.org/10.1378/chest.116.suppl_1.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"1999;30(10): 2174-9, http://dx.doi.org/10.1161/01.STR.30.10.2174.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"1963;141(3584):930-2, http://dx.doi.org/10.1126/ science.141.3584.930.CLINICS 2014;69(2):128-133 Steroids in donors for lung transplantation Araujo LF et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/23/cln-69-02-128.PMC3912341.pdf
"2013;68(10):1325-32, http://dx.doi.org/10.6061/clinics/2013(10) 06.",Non-OADS,/arxiv_data1/oa_pdf/ec/d5/cln-69-02-152.PMC3912342.pdf
"2004 CABI (H ISBN 9780851997223):337-52, http://dx.doi.org/10.1079/ 9780851997223.0337.",Non-OADS,/arxiv_data1/oa_pdf/ec/d5/cln-69-02-152.PMC3912342.pdf
Retrieved from http://www.jsad.com/jsad/downloadarticle/ Spatial_Dynamics_of_Alcohol_Availability_Neighborhood_Structure_and_Violen/1486.pdf .,OADS,/arxiv_data1/oa_pdf/5b/29/11121_2013_Article_373.PMC3912373.pdf
Retrieved from http://www.cdc.gov/pcd/issues/2004/ jan/03_0024.htm .,OADS,/arxiv_data1/oa_pdf/5b/29/11121_2013_Article_373.PMC3912373.pdf
Retrieved from http://www.jsad.com/jsad/downloadarticle/The_ Spatial_Dynamics_of_Violence_and_Alcohol_Outlets/1426.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5b/29/11121_2013_Article_373.PMC3912373.pdf
http://www.clarkhill.vcu.edu/ research.html .,Non-OADS,/arxiv_data1/oa_pdf/5b/29/11121_2013_Article_373.PMC3912373.pdf
Retrieved from http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/5b/29/11121_2013_Article_373.PMC3912373.pdf
Retrieved from http://www.jsad.com/jsad/downloadarticle/ Alcohol_Availability_and_Homicide_in_New_Orleans_Conceptual_Considerations/671.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5b/29/11121_2013_Article_373.PMC3912373.pdf
"Crime in the United States ,2008 .http://www.fbi.gov/ucr/ cius2008/data/table_01.html .",Non-OADS,/arxiv_data1/oa_pdf/5b/29/11121_2013_Article_373.PMC3912373.pdf
http://www.census.gov/census2000/states/va.html .,OADS,/arxiv_data1/oa_pdf/5b/29/11121_2013_Article_373.PMC3912373.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.8These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/6d/46/177.PMC3912409.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.157743.113.",Non-OADS,/arxiv_data1/oa_pdf/6d/46/177.PMC3912409.pdf
Data access Whole-genome bisulfite sequencing and gene expression datahave been submitted to the NCBI Gene Expression Omnibus(GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession num- ber GSE49629.EBV-induced hypomethylated blocks Genome Research 183 www.genome.org,OADS,/arxiv_data1/oa_pdf/6d/46/177.PMC3912409.pdf
"Studies including large numbers of patients per tumor type have identified recurrent mutations, copy number variants, epi- genetic changes, and genomic rearrangements specific for certain cancer types (http://cancergenome.nih.gov/; The International Cancer Genome Consortium 2010; The Cancer Genome Atlas Re- search Network 2011).",Non-OADS,/arxiv_data1/oa_pdf/50/87/200.PMC3912411.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/50/87/200.PMC3912411.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.8These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/50/87/200.PMC3912411.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.161026.113.",Non-OADS,/arxiv_data1/oa_pdf/50/87/200.PMC3912411.pdf
The software is available from https://github.com/Vityay/1-2-3-SV.,Non-OADS,/arxiv_data1/oa_pdf/50/87/200.PMC3912411.pdf
Data access The SNP-array data have been submitted to the NCBI Gene Ex- pression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) un- der accession number GSE47633.,OADS,/arxiv_data1/oa_pdf/50/87/200.PMC3912411.pdf
http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/50/87/200.PMC3912411.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.12Present address: Department of Gen etic Medicine and Development, University of Geneva Medical School, 1211 Geneva, Switzerland 13These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/a7/f3/212.PMC3912412.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.152132.112.",OADS,/arxiv_data1/oa_pdf/a7/f3/212.PMC3912412.pdf
"2010; http://flux.sammeth.net/index.html) (see Methods sections ‘‘Read Mapping and Processing’’ and ‘‘Gene, Transcript, and Exon Quantifications’’).",Non-OADS,/arxiv_data1/oa_pdf/a7/f3/212.PMC3912412.pdf
2010; http://flux.sammeth.net/index.html).,Non-OADS,/arxiv_data1/oa_pdf/a7/f3/212.PMC3912412.pdf
"(2012) obtained byInfinium HumanMethylation450 BeadChip microarrays, availableonline at https://www.ebi.ac.uk/ega/datasets/EGAD00010000254, and included the samples of the data set for which we have both methylation and gene expression data in our analyses.",OADS,/arxiv_data1/oa_pdf/a7/f3/212.PMC3912412.pdf
"Data access Sequencing and expression array data have been submitted to the European Genome-Phenome Archive (EGA; http://www.ebi.ac.uk/ega/), which is hosted by the European Bioinformatics Institute (EBI), under accession number EGAS00001000374.",OADS,/arxiv_data1/oa_pdf/a7/f3/212.PMC3912412.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c5/34/227.PMC3912413.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.6Corresponding author E-mail hunterk@mail.nih.govArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/c5/34/227.PMC3912413.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.166223.113.",Non-OADS,/arxiv_data1/oa_pdf/c5/34/227.PMC3912413.pdf
"To test the relevance to human disease, the human homolog to each gene was queried using the Gene expression-based Out- come for Breast cancer Online (GOBO, http://co.bmc.lu.se/gobo/) (Ringner et al.",OADS,/arxiv_data1/oa_pdf/c5/34/227.PMC3912413.pdf
"This study uti- lized the high-performance computational capabilities of the Bio- wulf Linux cluster at the National Institutes of Health, Bethesda, MD (http://biowulf.nih.gov).",OADS,/arxiv_data1/oa_pdf/c5/34/227.PMC3912413.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9f/e7/241.PMC3912414.pdf
"After six months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.Present addresses:11Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA;12Division of Hematology/Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ 85054, USA;13Department of Molecular Biology and Lewis-Sigler Institute for Integrative Geno- mics, Princeton University, 144 Carl Icahn Laboratory, Princeton, NJ08544, USA.",Non-OADS,/arxiv_data1/oa_pdf/9f/e7/241.PMC3912414.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.158253.113.",Non-OADS,/arxiv_data1/oa_pdf/9f/e7/241.PMC3912414.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/82/08/251.PMC3912415.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.Present addresses:5Novartis Institutes for Biomedical Research, 250 Massachusetts Ave., Cambridge, MA 02139, USA;6UBS Investment Bank, Zurich 8050, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/82/08/251.PMC3912415.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.160150.113.",OADS,/arxiv_data1/oa_pdf/82/08/251.PMC3912415.pdf
Data access Microarray data have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces-sion numbers GSM1267162–GSM1267166.,OADS,/arxiv_data1/oa_pdf/82/08/251.PMC3912415.pdf
Department of Statistics M1012: 1–7.http://stat.fsu.edu/techreports/M1012.pdf.,OADS,/arxiv_data1/oa_pdf/82/08/251.PMC3912415.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.7These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/d5/a3/260.PMC3912416.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.157750.113.",Non-OADS,/arxiv_data1/oa_pdf/d5/a3/260.PMC3912416.pdf
Data access The DNA and RNA sequencing data of zebrafish from this studyhave been submitted to the NCBI Gene Expression Omnibus(GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE44269.,OADS,/arxiv_data1/oa_pdf/d5/a3/260.PMC3912416.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1b/59/267.PMC3912417.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.9These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/1b/59/267.PMC3912417.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.143891.112.",OADS,/arxiv_data1/oa_pdf/1b/59/267.PMC3912417.pdf
"Construction of mouse–rat ortholog reference database Sequence libraries in FASTA format containing all annotatedmouse and rat open reading frames (ORFs) were obtained from http://uswest.ensembl.org/index.html, and converted to protein sequence using blast2protein.",OADS,/arxiv_data1/oa_pdf/1b/59/267.PMC3912417.pdf
Accession numbers for indi- vidual data sets submitted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) are listed in Supplemen-tal Table S8.,OADS,/arxiv_data1/oa_pdf/1b/59/267.PMC3912417.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ce/e9/281.PMC3912418.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.3Corresponding author E-mail mbronner@caltech.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/ce/e9/281.PMC3912418.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.161182.113.",Non-OADS,/arxiv_data1/oa_pdf/ce/e9/281.PMC3912418.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5b/d7/291.PMC3912419.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.7Corresponding author E-mail falkuraya@kfshrc.edu.saArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/5b/d7/291.PMC3912419.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.160572.113.",Non-OADS,/arxiv_data1/oa_pdf/5b/d7/291.PMC3912419.pdf
2009) (http://samtools.sourceforge.net/).,Non-OADS,/arxiv_data1/oa_pdf/5b/d7/291.PMC3912419.pdf
Data access Exome variants and array data sets included in the paper are available through the link http://sgp.kfshrc.edu.sa/bioinf/db/ variants/dg/downloads.,OADS,/arxiv_data1/oa_pdf/5b/d7/291.PMC3912419.pdf
"Novel variants were submitted to NCBI’s ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/; accession numbers:SCV000108550, SCV000108551, SCV000108552, SCV000108553,SCV000108405, SCV000108406, SCV000108407, SCV000108408, SCV000108409) and LOVD ( http://www.lovd.nl/3.0/home; var- iant IDs: 0000022851, 0000022850, 0000022849, 0000022848,0000022846, 0000022844, 0000022845, 0000022852).",Non-OADS,/arxiv_data1/oa_pdf/5b/d7/291.PMC3912419.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/89/99/300.PMC3912420.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/89/99/300.PMC3912420.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.156224.113.",Non-OADS,/arxiv_data1/oa_pdf/89/99/300.PMC3912420.pdf
SMASH source code i s available for download from http://www-hsc.usc.edu/ ;valouev/SMASH/SMASH.html.Competing interest statement Anton Valouev is an author of a provisional patent application that includes the SMASH SV detection algorithm.,Non-OADS,/arxiv_data1/oa_pdf/89/99/300.PMC3912420.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.6These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.162883.113.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
"To demonstrate t h ea d v a n t a g e so fT I G R A ,w ec o m p a r ei tw i t ha l t e r n a t i v ea p - proaches that employ other widely used assemblers, such as Velvet (Zerbino and Birney 2008), SGA (Simpson and Durbin 2010), Phrap (http://www.phrap.org), and SPAdes (Bankevich et al.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
"We aligned the assembled contigs to the reference sequence using cross_match (http://www.phrap.org/phredphrapconsed.html) and considered a breakpoint to be correctly assembled if one of its de- rivative contigs aligned in a configuration compatible with the ground truth, i.e., indicating a deletion of similar size ( <10% dif- ference) with similar breakpoint coordinates ( <5 bp apart).",Non-OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
"Cross_match alignment and SV calling In our experiments, we used cross_match (http://www.phrap.org/phredphrapconsed.html) to examine whether a contig containedan SV breakpoint.",OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
"We ran SPAdes-2.5.0 in the single-cell mode on low-coverage data using ‘‘spades.py–sc–only-assembler-s –o.’’ We ran it in the whole genome mode on high-coveragedata using ‘‘spades.py–only-assembler -s –o.’’ Manual inspection of TIGRA contigs To manually inspect TIGRA contigs, we used the human BLATsearch tool (http://genome.ucsc.edu/cgi-bin/hgBlat?command = start).",OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
Data We downloaded the HiSeq NA12878 BAM file we used in this study from ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/working/ 20120117_ceu_trio_b37_decoy/.,OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
We d ownloaded the low-depth CEU BAM files from http://ftp-trace.ncbi.nih.gov/1000genomes/ftp/pilot_data/data/ and from http://ftp-trace.ncbi.nih.gov/1000genomes/ ftp/data/.,OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
We obtained the 442 MEI breakpoints by extracting PCR- validated NA12878 sites from ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/pilot_data/paper_data_sets/companion_papers/mapping_structural_variation/union.2010_06.MobileElementInsertions.,OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
We downloaded the dbRIP files from http://dbrip.brocku.ca/ dbRIPdownload/.,OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
Software availability TIGRA is available at http://bioinformatics.mdanderson.org/main/TIGRA.,OADS,/arxiv_data1/oa_pdf/5d/42/310.PMC3912421.pdf
"After six months, it is available un-der a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.4Corresponding authors E-mail adp002@ucsd.edu E-mail ytliu@ucsd.edu E-mail vbafna@cs.ucsd.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/c8/cd/318.PMC3912422.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.161497.113.",OADS,/arxiv_data1/oa_pdf/c8/cd/318.PMC3912422.pdf
Data access The sequencing data have been deposited at the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under ac- cession number SRX353044.,OADS,/arxiv_data1/oa_pdf/c8/cd/318.PMC3912422.pdf
The AmBre software is available athttp://bix.ucsd.edu/AmBre.,OADS,/arxiv_data1/oa_pdf/c8/cd/318.PMC3912422.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9e/b3/329.PMC3912423.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.4Corresponding author E-mail kladde@ufl.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/9e/b3/329.PMC3912423.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.161737.113.",Non-OADS,/arxiv_data1/oa_pdf/9e/b3/329.PMC3912423.pdf
"To facilitate pattern recognition,aligned sequences were uploaded into a web-based hierarchical clustering program called MethylMapper (http://genome.ufl.",OADS,/arxiv_data1/oa_pdf/9e/b3/329.PMC3912423.pdf
"Sequences were divided by barcode, using FASTools (http://genome.ufl.edu/ rivalab/fastools/), then aligned to theMAPit-patch reference library by BLAST.",OADS,/arxiv_data1/oa_pdf/9e/b3/329.PMC3912423.pdf
Data access Raw 454 sequence reads have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE50047.,Non-OADS,/arxiv_data1/oa_pdf/9e/b3/329.PMC3912423.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.4Corresponding author E-mail federico.santoni@unige.chArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.163832.113.",Non-OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
"In order to prove the reliability of this engine, we downloaded the HapMap WGS data sets (BAM) of the CEU trio (NA12891, father; NA12892, mother; NA12878, child) from the 1000 Genomes Project and the cor-responding HapMap genotyped SNPs from ftp://ftp.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
"After annotation and filtering, the algorithm identified 2927 putative somatic variants, 1522 (52%) of these being already validated as somatic by the TCGA consortium and registered in the COSMIC database (http://www.sanger.",OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
"Relationships (family pedigrees, tumor-normal or unrelated individuals) are provided to VariantMaster through a TFAM file(http://pngu.mgh.harvard.edu/ ;purcell/plink/).",Non-OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
HapMap genotyped SNPs were downloaded from ftp://ftp.ncbi.nlm.nih.gov/hapmap/genotypes/2010-08_phaseII + II.,OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
"Aligned reads (BAM) of eight paired tumor samples + germline were downloaded from https://tcga-data.nci.nih.gov/, and the re- spective annotations were obtained from COSMIC (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/).",OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
Technical notes VariantMaster is written in python2.7 and is released as executablefor Linux systems (http://sourceforge.net/projects/variantmaster/).,OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
It imports PySam (http://code.google.com/p/pysam) and a custom- ized wrapped version of BEDTools (Quinlan and Hall 2010).,Non-OADS,/arxiv_data1/oa_pdf/ad/de/349.PMC3912425.pdf
"2012) (Human Mutation virtual issue, ‘‘Recommendations and Standards for the Reporting and Databasing of Genetic Variations’’; http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-1004/ homepage/virtual_issue_recommendatations_and_standards_for_ the_reporting_and_databasing_.htm).",Non-OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"The Variation Ontology (VariO; http://variationontology.org) was developed to annotate effects of variants in different types of databases such as LSDBs, central, variation effect or frequency databases, ethnic/national variation databases, benchmark data sets, and variant management software.",OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"Each of /C2112014 Vihinen This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.1Corresponding author E-mail mauno.vihinen@med.lu.se Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.157495.113.",Non-OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
The Evidence Ontology (ECO; http://www.evidenceontology.,Non-OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"Furthermore, VariO fulfills the 5-Star vocabulary requirements (http://bvatant.blogspot.fr/2012/02/ is-your-linked-data-vocabulary- 5-star_9588.html) and AMOR Manifesto principles (http:// knowledgecraver.blogspot.com.es/2013/04/the-amor-manifesto.",Non-OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"html) developed based on Tim Berners Lee’s 5 Star Linked Open Data rating (http://www.w3.org/DesignIssues/LinkedData.html).The goals of these suggestions are to make data (ontologies) acces- sible, also in machine readable format including nonproprietary format(s), use open standards, provide metadata, full term descrip- tions, have a stable Universal Resource Identifier (URI), and link to and reuse other ontologies and vocabularies.",OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"Availability and browser In addition to the OBO format, VariO is available as OWL and OWX files at http://variationontology.org.",OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
VariO is participating in the OBO Foundry (http://www.obofoundry.org/) project (Smith et al.,OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"VariO terms are also accessible via The National Center for Biomedical Ontology (NCBO; BioPortal http://bioportal.bioontology.org/) and the On- tology Lookup Service (http://www.ebi.ac.uk/ontology-lookup/ init.do), where terms can be searched for.",OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
Variations representing the four diseases were collected from the literature and from WASbase (http://structure.bmc.lu.se/idbase/ WASbase) and annotated with VariO terms.,OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
VariO is compliant with the VarioML variation data exchange format (http://varioml.org/) (Byrne et al.,OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"2012), which is used, e.g., in the Cafe ´Variome exchange portal (http://cafevariome.org/) for variation data produced, e.g., in diagnostic laboratories.",OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
Software availability VariO and VariOtator are available at http://variationontology.org.,OADS,/arxiv_data1/oa_pdf/c2/0d/356.PMC3912426.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: D.S.B., J.R.V.H., J.Y., C.L.F., E.N.R., A.P.F., D.D., J.E.C., Y.Z.",Non-OADS,/arxiv_data1/oa_pdf/89/4c/srep03904.PMC3912440.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3904 | DOI: 10.1038/srep03904 11",Non-OADS,/arxiv_data1/oa_pdf/89/4c/srep03904.PMC3912440.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/26/64/srep03951.PMC3912472.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3951 | DOI: 10.1038/srep03951 4",Non-OADS,/arxiv_data1/oa_pdf/26/64/srep03951.PMC3912472.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3955 | DOI: 10.1038/srep03955 8",Non-OADS,/arxiv_data1/oa_pdf/2c/4e/srep03955.PMC3912474.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3952 | DOI: 10.1038/srep03952 5",Non-OADS,/arxiv_data1/oa_pdf/62/00/srep03952.PMC3912476.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 Figure 8 |Risk of bias assessment for randomized controlled trials.",Non-OADS,/arxiv_data1/oa_pdf/7a/cb/srep03948.PMC3912477.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3960 | DOI: 10.1038/srep03960 6",Non-OADS,/arxiv_data1/oa_pdf/0a/6d/srep03960.PMC3912480.pdf
"aegypti mosquitoes were created in the University of Maryland, College Park, Institute for Bioscience and BiotechnologyResearch’s Insect Transformation Facility (http://www.ibbr.umd.edu/facilities/itf) by injecting preblastoderm embryos (Higgs white eye strain) with Mos-1 vector- containing plasmids (pMos) and plasmids expressing Mos-1 transposase (pKhspMos82) 52in addition to a plasmid mixture for monitoring the quality of injections consisting of a minimal piggyBac vector (pBac QC) and a source of piggyBac transposase (phsp-Pbac)53.",Non-OADS,/arxiv_data1/oa_pdf/1b/e6/srep03954.PMC3912481.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1b/e6/srep03954.PMC3912481.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3954 | DOI: 10.1038/srep03954 7",Non-OADS,/arxiv_data1/oa_pdf/1b/e6/srep03954.PMC3912481.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3949 | DOI: 10.1038/srep03949 9",Non-OADS,/arxiv_data1/oa_pdf/e9/3c/srep03949.PMC3912482.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/16/b5/srep03903.PMC3912484.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3903 | DOI: 10.1038/srep03903 7",Non-OADS,/arxiv_data1/oa_pdf/16/b5/srep03903.PMC3912484.pdf
"81172587 and 81372896, to D. Xiao) Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/0a/96/srep03963.PMC3912485.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3963 | DOI: 10.1038/srep03963 8",Non-OADS,/arxiv_data1/oa_pdf/0a/96/srep03963.PMC3912485.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3962 | DOI: 10.1038/srep03962 7",Non-OADS,/arxiv_data1/oa_pdf/20/98/srep03962.PMC3912486.pdf
"Database search and Bioinformatics analysis .MATE sequences were searched from the database on the BLAST server (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi and http://rice.plantbiology.msu.edu) by using keyword, domain name and BLAST against characterized Arabidopsis MATEs.",OADS,/arxiv_data1/oa_pdf/65/a5/srep03964.PMC3912489.pdf
Multiple amino acid sequences were aligned with the help of ClustalW alignment tool(http://www.ebi.ac.uk/Tools/clustalw2/index.html).,OADS,/arxiv_data1/oa_pdf/65/a5/srep03964.PMC3912489.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3964 | DOI: 10.1038/srep03964 11,Non-OADS,/arxiv_data1/oa_pdf/65/a5/srep03964.PMC3912489.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3964 | DOI: 10.1038/srep03964 12",Non-OADS,/arxiv_data1/oa_pdf/65/a5/srep03964.PMC3912489.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201310136/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi   .org/10.1016/j.cell.2013.05.06 0 Baudouin, S., and P. Scheiffele.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3717-11.201 2 Boucard, A.A., A.A. Chubykin, D. Comoletti, P. Taylor, and T.C.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.06.00 5 Craig, A.M., and Y .",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
http://dx.doi.org/10.1016/   j.conb.2007.01.01 1protease inhibitor cocktail (Roche).,OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
http://dx.doi.org/10.1111/ j.1460-9568.2011.07638.,Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1074/jbc.M110.12618 5 Missler, M., and T.C.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1016/S0168-9525(97)01324- 3 Okaty, B.W., K. Sugino, and S.B.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.0626-11.201 1 Paronetto, M.P., V. Messina, E. Bianchi, M. Barchi, G. Vogel, C. Moretti, F.  Palombi, M. Stefanini, R. Geremia, S. Richard, and C. Sette.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/   10.1083/jcb.20081113 8 Rajan, P., C. Dalgliesh, C.F.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"10:82. http://dx.doi.org/10.1186/1471-2121-10-8 2 Richard, S., N. Torabi, G.V.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1371/journal.pgen.001007 4 Sadakata, T., W. Kakegawa, A. Mizoguchi, M. Washida, R. Katoh-Semba, F.  Shutoh, T. Okamoto, H. Nakashima, K. Kimura, M. Tanaka, et al.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2279-06.200 7 Saito, H., H. Tsumura, S. Otake, A. Nishida, T. Furukawa, and N. Suzuki.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10   .1016/j.bbrc.2005.04.04 3 Schwenk, F., U. Baron, and K. Rajewsky.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/   10.1093/nar/23.24.508 0 Shen, K., and P. Scheiffele.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/   10.1146/annurev.neuro.051508.13530 2 Siddiqui, T.J., R. Pancaroglu, Y. Kang, A. Rooyakkers, and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0470-10.201 0 Stoss, O., T. Novoyatleva, M. Gencheva, M. Olbrich, N. Benderska, and S.  Stamm.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"27:8– 21. http://dx.doi.org/10.1016/j.mcn.2004.04.01 1 Sudarov, A., and A.L.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"2:26. http://dx.doi.org/10.1186/1749-8104-2-2 6 Südhof, T.C.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1038/nature0745 6 Taniguchi, H., L. Gollan, F.G. Scholl, V. Mahadomrongkul, E. Dobler, N.  Limthong, M. Peck, C. Aoki, and P. Scheiffele.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0032-07.200 7 Taniguchi, H., M. He, P. Wu, S. Kim, R. Paik, K. Sugino, D. Kvitsiani, Y. Fu, J.  Lu, Y. Lin, et al.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1016/j.cell.2010.04.03 5 Venables, J.P., C. Vernet, S.L.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10   .1093/hmg/8.6.95 9 Zheng, S., and D.L.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.10.00 9Darnell, R.B.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1146/annurev-neuro-062912-11432 2 de Wit, J., E. Sylwestrak, M.L.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.12.01 9 Dean, C., F.G. Scholl, J. Choih, S. DeMaria, J. Berger, E. Isacoff, and P.  Scheiffele.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1038/nn107 4 Di Fruscio, M., T. Chen, and S. Richard.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi   .org/10.1073/pnas.96.6.271 0 Ehrmann, I., C. Dalgliesh, Y. Liu, M. Danilenko, M. Crosier, L. Overman, H.M.  Arthur, S. Lindsay, G.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1261/rna.189031 0 Futai, K., C.D.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1811-12.201 3 Galarneau, A., and S. Richard.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"10:47. http://dx.doi.org/10.1186/1471-2199-10-4 7 Gehman, L.T., P. Meera, P. Stoilov, L. Shiue, J.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1101/gad.182477.11 1 Graf, E.R., Y. Kang, A.M. Hauner, and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.1253-05.200 6 Hanawa, H., P.F.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.11.02 8 Klausberger, T. 2009.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
http://dx.doi.org/10.1111/j.1460-9568.2009.06913.,Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1371/journal.pgen.100333 7 Lancaster, M.A., D.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1038/nm.238 0 Lawrence, J.J. 2008.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1016/j.tins.2008.03.00 8 Lipscombe, D., A. Andrade, and S.E.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi   .org/10.1016/j.bbamem.2012.09.01 8 Madisen, L., T.A.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
"http://dx.doi.org/10.1038/nn.246 7 Masland, R.H. 2004.",OADS,/arxiv_data1/oa_pdf/e4/11/JCB_201310136.PMC3912522.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub ­ lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by ­nc­sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201309119/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1091/mbc.9.4.94 5 Altman, R., and D.R.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1083/   jcb.138.1.11 9 Artiles, K., S. Anastasia, D. McCusker, and D.R.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1371/journal.pgen.100072 7 Barral, Y., M. Parra, S. Bidlingmaier, and M. Snyder.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi   .org/10.1101/gad.13.2.17 6 Bastajian, N., H. Friesen, and B.J.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"3:1012.  http://dx.doi.org/10.1038/ncomms201 5 Futcher, B.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/342039a 0 Hadwiger, J.A., C. Wittenberg, H.E.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/   10.1073/pnas.86.16.625 5 Hall, D.D., D.D.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1093/emboj/17.15.437 0 Hartwell, L.H., and M.W.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1083/jcb.75.2.42 2 Harvey, S.L., and D.R.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi   .org/10.1016/S0960­9822(03)00049­ 6 Harvey, S.L., A. Charlet, W. Haas, S.P.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/j.cell.2005.05.02 9 Harvey, S.L., G. Enciso, N.E.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/j.cell.2010.12.00 1 Janssens, V., and J. Goris.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1042/0264 ­  6021:353041 7 Johnston, G.C., J.R. Pringle, and L.H.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/0014­4827(77)90154­ 9 Jorgensen, P., and M. Tyers.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/j.cub.2004.11.02 7 Jorgensen, P., J.L.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1126/science.107085 0 Jorgensen, P., I. Rupes, J.R. Sharom, L. Schneper, J.R. Broach, and M. Tyers.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1101/gad.122880 4 Kellogg, D.R.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi   .org/10.1242/jcs.0090 8 Kellogg, D.R., and A.W.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1083/jcb.130.3.67 5 Kettenbach, A.N., and S.A. Gerber.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1021/ac201894 j Laabs, T.L., D.D.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1128/MCB.20.11.4049­4061.200 0 Ma, X.J., Q. Lu, and M. Grunstein.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1101/gad.10.11.132 7 Mazanka, E., and E.L. Weiss.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1091/mbc.E10­02­017 4 Mazanka, E., J. Alexander, B.J.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1371/journal .pgen   .100350 7 Beausoleil, S.A., J. Villén, S.A. Gerber, J.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi   .org/10.1038/nbt124 0 Belenguer, P., L. Pelloquin, M.L.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/   10.1006/bbrc.1997.625 3 Bhoite, L.T., Y. Yu, and D.J.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1101/gad.92160 1 Bishop, A.C., J.A.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/3503014 8 Bobola, N., R.P.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/S0092­8674(00)81048­ X Boersema, P.J., R. Raijmakers, S. Lemeer, S. Mohammed, and A.J.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/nprot   .2009.2 1 Breeden, L., and G.E.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1101/gad.5.7.118 3 Caplan, A.J., and M.G.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1101/gad.180460 9 Colman­Lerner, A., T.E.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/S0092­8674(01)00596­ 7 Cross, F.R.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/0092 ­8674(91)   90394­ E Dephoure, N., and S.P.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/   10.1016/j.ymeth.2011.03.00 8 Di Como, C.J., H. Chang, and K.T.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/351754a 0 Di Talia, S., J.M.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/   nature0607 2 Di Talia, S., H. Wang, J.M.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1371/ journal.pbio.100022 1 Dohrmann, P.R., G. Butler, K. Tamai, S. Dorland, J.R. Greene, D.J.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1101/gad.6.1.9 3 Doolin, M.T., A.L.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1046/j.1365­ 2958.2001.02388. x Elias, J.E., and S.P.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/nmeth101 9 Eng, J.K., A.L.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
http://dx.doi   .org/10.1016/1044­0305(94)80016­ 2,OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/   10.1016/j.molcel.2007.04.02 3 Villén, J., and S.P.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"3:1630– 1638. http://dx.doi.org/10.1038/nprot.2008.15 0 Voth, W.P., Y. Yu, S. Takahata, K.L.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/sj.emboj.760185 9 Weiss, E.L., C. Kurischko, C. Zhang, K. Shokat, D.G.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1083/jcb.20020309 4 Yaglom, J.A., A.L.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1083/jcb.20060915 3 Zhao, Y ., G. Boguslawski, R.S.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
http://dx.doi.org/10.1074/jbc.272 .13  .8256controls transcriptional asymmetry.,OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/   10.1371/journal.pbio.006020 3 McCusker, D., C. Denison, S. Anderson, T.A.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/ncb156 8 McCusker, D., A. Royou, C. Velours, and D. Kellogg.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"23:3336– 3347. http://dx.doi.org/10.1091/mbc.E11­10­083 4 McMillan, J.N., M.S.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/ncb107 8 Mortensen, E.M., H. McDonald, J. Yates III, and D.R.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1091/mbc.01­10­050 0 Nash, R., G. Tokiwa, S. Anand, K. Erickson, and A.B.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/   0092­8674(91)90444­ 4 Newcomb, L.L., J.A.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1128/EC.2.1.143­149.200 3 Nurse, P. 1975.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1038/256547a 0 O’Conalláin, C., M.T.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1007/s00438005108 4 Ogas, J., B.J.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1101/gad.11.19.252 2 Pramila, T., S. Miles, D. GuhaThakurta, D. Jemiolo, and L.L.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1101/gad.103430 2 Rappsilber, J., Y. Ishihama, and M. Mann.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1021/ac026117 i Richardson, H.E., C.W.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi   .org/10.1016/0092­8674(87)90458­ 2 Sbia, M., E.J.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi   .org/10.1074/jbc.M80019620 0 Shulewitz, M.J., C.J.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1074/jbc.M111.28162 6 Thomas, B.J., and R. Rothstein.",Non-OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
"http://dx.doi.org/10.1016/   0092­8674(89)90584­ 9 Turner, J.J., J.C. Ewald, and J.M.",OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
http://dx.doi.org/10.1016/j.cub.2012.02.04 1,OADS,/arxiv_data1/oa_pdf/20/24/JCB_201309119.PMC3912523.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
Online sup - plemental material is available at http://www.jcb.org/cgi/content/full/   jcb.201305036/DC1.,Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.4161/cc.6.20.479 3 Barnhart, M.C., P.H.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"194:229– 243. http://dx.doi.org/10.1083/jcb.20101201 7 Bassett, E.A., J. DeNizio, M.C.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1016/   j.devcel.2012.02.00 1 Bernad, R., P. Sánchez, T. Rivera, M. Rodríguez-Corsino, E. Boyarchuk, I. Vassias,  D. Ray-Gallet, A. Arnaoutov, M. Dasso, G. Almouzni, and A. Losada.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1083/jcb.20100513 6 Black, B.E., L.E.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.12.01 8 Blower, M.D., and G.H.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1038/3508704 5 Camahort, R., B. Li, L. Florens, S.K.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.05.01 3 Camahort, R., M. Shivaraju, M. Mattingly, B. Li, S. Nakanishi, D. Zhu, A.  Shilatifard, J.L.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1016/j.molcel.2009.07.02 2 Carroll, C.W., K.J.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"189:1143– 1155. http://dx.doi.org/10.1083/jcb.20100101 3 Cho, U.S., and S.C. Harrison.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi   .org/10.1007/978-1-60327-015-1_3 0 Conde e Silva, N., B.E.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1016/S0168-9525(97)01298- 5 Kato, T., N. Sato, S. Hayama, T. Yamabuki, T. Ito, M. Miyamoto, S. Kondo, Y .",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-07-130 7 Kelley, L.A., and M.J. Sternberg.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
http://dx.doi   .org/10.1038/nprot.2009.,Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1038/ncb212 9 Luger, K., A.W.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1038/3844 4 Maia, A.F., C.S.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.4161/cc.6.11.427 1 Maiato, H., J. DeLuca, E.D.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1371/journal   .pgen.100206 8 Mendiburo, M.J., J. Padeken, S. Fülöp, A. Schepers, and P. Heun.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1126/science.120688 0 Miell, M.D., C.J.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1038/nsmb.257 4 Mizuguchi, G., H. Xiao, J. Wisniewski, M.M.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1016/j.cell.2007.04.02 6 Moree, B., C.B.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1083/jcb.20110607 9 Moreno-Moreno, O., S. Medina-Giró, M. Torras-Llort, and F. Azorín.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1016/j.cub.2011.07.04 1 Padeganeh, A., J. Ryan, J. Boisvert, A.M. Ladouceur, J.F.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1016/j.cub.2013.03.03 7 Panchenko, T., T.C.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"46:8634– 8646. http://dx.doi.org/10.1021/bi602521 5 Phansalkar, R., P. Lapierre, and B.G.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1007/s10577-012-9299- 7 Pidoux, A.L., E.S.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1016/j.molcel.2009.01.01 9 Przewloka, M.R., Z. Venkei, V .M.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1016/j.cub.2011.02.00 5 Robinett, C.C., A.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1083/   jcb.135.6.168 5Dalal, Y ., H. Wang, S. Lindsay, and S. Henikoff.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1371/journal.pbio.005021 8 Dambacher, S., W. Deng, M. Hahn, D. Sadic, J. Fröhlich, A. Nuber, C. Hoischen,  S. Diekmann, H. Leonhardt, and G. Schotta.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"3:101– 110. http://dx.doi.org/10.4161/nucl.1895 5 Dechassa, M.L., K. Wyns, M. Li, M.A.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"2:313. http://dx.doi.org/10.1038/ncomms132 0 Dunleavy, E.M., G. Almouzni, and G.H.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.4161/nucl.2.2.1521 1 Dunleavy, E.M., W. Zhang, and G.H.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1038/nsmb.260 2 Erhardt, S., B.G.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1038/ncb139 7 Foltz, D.R., L.E.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.11.00 2 Furuyama, T., and S. Henikoff.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1016/j.cell   .2009.04.04 9 Gascoigne, K.E., K. Takeuchi, A. Suzuki, T. Hori, T. Fukagawa, and I.M.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.03.03 1 Goshima, G., R. Wollman, S.S. Goodwin, N. Zhang, J.M.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1126/   science.114131 4 Hasson, D., T. Panchenko, K.J.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1038/nsmb.256 2 Hayashi, T., Y .",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1016/   j.cell.2004.09.00 2 Hemmerich, P., S. Weidtkamp-Peters, C. Hoischen, L. Schmiedeberg, I. Erliandri,  and S. Diekmann.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1083/jcb.20071005 2 Henikoff, S., and T. Furuyama.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1007/   s00412-012-0372- y Heun, P., S. Erhardt, M.D.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"10:303– 315. http://dx.doi.org/10.1016/j.devcel.2006.01.01 4 Hori, T., W.H.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1083/   jcb.20121010 6 Hu, H., Y .",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi   .org/10.1101/gad.204511 1 Jansen, L.E., B.E.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
176:795– 805. http://dx.doi.org/10.1083/jcb.20070106 6,Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"137:1173– 1174. http://dx.doi.org/10.1016/j.cell.2009.06.01 0 Schittenhelm, R.B., F. Althoff, S. Heidmann, and C.F.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1242/jcs.06793 4 Screpanti, E., A.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1083/jcb.136.3.50 1 Shivaraju, M., R. Camahort, M. Mattingly, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1074/jbc.M110.18364 0 Shuaib, M., K. Ouararhni, S. Dimitrov, and A. Hamiche.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/   10.1093/nar/gki40 8 Stoler, S., K. Rogers, S. Weitze, L. Morey, M. Fitzgerald-Hayes, and R.E.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1016/S0960-9822(02)70783- 5 Tachiwana, H., W. Kagawa, T. Shiga, A. Osakabe, Y .",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"476:232– 235. http://dx.doi.org/10.1038/nature1025 8 Vermaak, D., H.S.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"http://dx.doi.org/10.1128/MCB.22.21.7553-7561.200 2 Yoda, K., S. Ando, S. Morishita, K. Houmura, K. Hashimoto, K. Takeyasu, and  T. Okazaki.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
"45:263– 269. http://dx.doi.org/10.1016/j.molcel.2011.12.01 0 Zhou, Z., H. Feng, B.R.",OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
http://dx.doi.org/10.1038/nature0985 4,Non-OADS,/arxiv_data1/oa_pdf/88/3f/JCB_201305036.PMC3912524.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.06.01 8 Destaing, O., E. Planus, D. Bouvard, C. Oddou, C. Badowski, V. Bossy, A.  Raducanu, B. Fourcade, C. Albiges-Rizo, and M.R.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1091/mbc.E10-07-058 0 Domogatskaya, A., S. Rodin, and K. Tryggvason.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1146/annurev-cellbio-101011-15575 0 Dovas, A., A. Patsialou, A.S. Harney, J. Condeelis, and D. Cox.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
http://dx.doi   .org/10.1111/j.1365-2818.2012.03667.,Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1101/gad.48670 8 Even-Ram, S., and K.M.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.ceb.2005.08.01 5 Farina, K.L., J.B. Wyckoff, J. Rivera, H. Lee, J.E.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi .org/  10.1101/gad.9.15.189 6 Friedl, P., J. Locker, E. Sahai, and J.E.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10   .1038/ncb254 8 Fukumura, D., D.G.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
http://dx.doi   .org/10.1111/j.1549-8719.2010.00029.,Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1038/ncb165 8 Giampieri, S., C. Manning, S. Hooper, L. Jones, C.S.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/ 10.3791/127 8 Gligorijevic, B., J. Wyckoff, H. Yamaguchi, Y. Wang, E.T.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1242/jcs.09272 6 Goel, S., D.G.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/   10.1152/physrev.00038.201 0 Gonzalez, C. 2013.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"13:172– 183. http://dx.doi.org/10.1038/nrc346 1 Gouzi, M., Y.H.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1002/dvdy.2254 4 Hagedorn, E.J., and D.R.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.05.00 2 Hagedorn, E.J., H. Yashiro, J.W.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"17:187– 198. http://dx.doi.org/10.1016/j.devcel.2009.06.00 6 Hagedorn, E.J., J.W.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1083/jcb.20130109 1 Halfter, W., J. Candiello, H. Hu, P. Zhang, E. Schreiber, and M. Balasubramani.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.4161/cam.2247 9 Hallmann, R., N. Horn, M. Selg, O. Wendler, F. Pausch, and L.M.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"137:2863– 2874. http://dx.doi.org/10.1242/dev.05346 2 Alexander, S., B. Weigelin, F. Winkler, and P. Friedl.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1016/j.ceb.2013.07.00 1 Altincicek, B., M. Fischer, M. Fischer, K. Lüersen, M. Boll, U. Wenzel, and  A. Vilcinskas.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.dci.2010.06.01 0 Azzali, G. 2007.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.2353/ajpath.2007.06044 7 Baluk, P., S. Morikawa, A. Haskell, M. Mancuso, and D.M.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/   10.1016/S0002-9440(10)63540- 7 Baluk, P., J. Fuxe, H. Hashizume, T. Romano, E. Lashnits, S. Butz, D.  Vestweber, M. Corada, C. Molendini, E. Dejana, and D.M.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10   .1084/jem.2006259 6 Beaucher, M., J. Goodliffe, E. Hersperger, S. Trunova, H. Frydman, and A.  Shearn.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1016/j.ydbio.2006.09.01 9 Beaucher, M., E. Hersperger, A. Page-McCaw, and A. Shearn.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.ydbio.2006.12.00 1 Beerling, E., L. Ritsma, N. Vrisekoop, P.W.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1242/jcs.07272 8 Birbeck, M.S., and D.N.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.ydbio.2005.11.00 6 Butcher, D.T., T. Alliston, and V.M.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1038/nrc254 4 Cavallo-Medved, D., D. Rudy, G. Blum, M. Bogyo, D. Caglic, and B.F. Sloane.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1016/j.yexcr.2009.01.02 1 Chen, M.B., J.A.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1039/c3ib40149 a Chen, W.T.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1002/jez.140251020 6 Cheung, M., M.C.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/   j.devcel.2004.12.01 0 Chishima, T., Y. Miyagi, X. Wang, H. Yamaoka, H. Shimada, A.R.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.21   .122303.12030 6 Coussens, L.M., B. Fingleton, and L.M.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1126/science.106710 0 Deem, T.L., and J.M.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10   .1182/blood-2004-02-066 5 DeNardo, D.G., J.B. Barreto, P. Andreu, L. Vasquez, D. Tawfik, N. Kolhatkar, and  L.M.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1074/jbc.R20003120 0 Nakaya, Y., and G. Sheng.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.canlet.2013.02.03 7 Nakaya, Y., E.W.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/ncb173 9 Nakaya, Y., E.W.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1083/jcb.20130207 5 Nguyen-Ngoc, K.V ., K.J.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/nrm288 9 Overall, C.M., and O. Kleifeld.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/   nrc182 1 Ozbek, S., P.G.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1091/mbc.E10-03-025 1 Page-McCaw, A.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/nrm212 5 Pastor-Pareja, J.C., F. Grawe, E. Martín-Blanco, and A. García-Bellido.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1016/j.devcel.2004.07.02 2 Petrova, T.V ., T. Karpanen, C. Norrmén, R. Mellor, T. Tamakoshi, D. Finegold,  R. Ferrell, D. Kerjaschki, P. Mortimer, S. Ylä-Herttuala, et al.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/nm109 4 Pflicke, H., and M. Sixt.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.cell.2011.11.00 4 Pöschl, E., U. Schlötzer-Schrehardt, B. Brachvogel, K. Saito, Y. Ninomiya, and  U. Mayer.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1242/dev.0103 7 Ratzinger, G., P. Stoitzner, S. Ebner, M.B.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1189/jlb.100766 6 Robinson, B.D., and J.G.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.2217/fon.09.7 9 Roh-Johnson, M., J.J. Bravo-Cordero, A. Patsialou, V.P.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/onc.2013.37 7 Rossant, J., and P.P.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
136:701– 713. http://dx.doi.org/10.1242/dev.01717 8mature vasculature.,Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1152/   physrev.00014.200 4 Hanahan, D., and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.01 3 Henry, M.D., and K.P.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)81708- 0 Hiramatsu, R., T. Matsuoka, C. Kimura-Yoshida, S.W.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.devcel.2013.09.02 6 Hohenester, E., and P.D.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.4161/cam.2183 1 Hotary, K., X.Y .",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1101/gad.145180 6 Hynes, R.O.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1083/jcb.20110904 1 Ihara, S., E.J.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10   .1038/ncb223 3 Jain, R.K. 1988.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1242/jcs.07100 1 Johnson, R.P., S.H.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10   .1242/dev.0236 3 Kalluri, R. 2003.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/   10.1038/nrc109 4 Kedrin, D., B. Gligorijevic, J. Wyckoff, V.V.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/nmeth.126 9 Khoshnoodi, J., V .",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1002/jemt.2056 4 Kienast, Y ., L. von Baumgarten, M. Fuhrmann, W.E.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1038/nm.207 2 Kilarski, W.W., E. Güç, J.C. Teo, S.R.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1371/journal.pone.005713 5 Lämmermann, T., B.L.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/nature0688 7 Li, S., D. Edgar, R. Fässler, W. Wadsworth, and P.D.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/S1534-5807(03)00128- X Lin, M., P. Jackson, A.M. Tester, E. Diaconu, C.M.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.2353/ajpath.2008.08008 1 Linder, S., C. Wiesner, and M. Himmel.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/   284067a 0 Madsen, C.D., and E. Sahai.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.06.01 3 Mammoto, T., and D.E.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1242/dev   .02416 6 McKee, K.K., D. Harrison, S. Capizzi, and P.D.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
http://dx.doi.org/10.1074/jbc.M70296320 0,Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.2353/ajpath.2010.09051 0 Wang, S., M.B.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"203:1519– 1532. http://dx.doi.org/10.1084/jem.2005121 0 Weis, S., J. Cui, L. Barnes, and D. Cheresh.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1083/   jcb.20040813 0 Williams, M., C. Burdsal, A. Periasamy, M. Lewandoski, and A. Sutherland.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1002/dvdy.2371 1 Williamson, R.A., M.D.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1093/hmg/6.6.83 1 Wolf, K., M. Te Lindert, M. Krause, S. Alexander, J. Te Riet, A.L.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1083/jcb.20121015 2 Wyckoff, J.B., Y .",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-06-182 3 Yadav, R., K.Y .",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/sj.bjp.070726 7 Yurchenco, P.D.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1101/cshperspect.a00491 1 Zervantonakis, I.K., S.K.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1038/ncb182 5Rottiers, P., F. Saltel, T. Daubon, B. Chaigne-Delalande, V. Tridon, C. Billottet,  E. Reuzeau, and E. Génot.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1242/jcs.05744 8 Roussos, E.T., S. Goswami, M. Balsamo, Y. Wang, R. Stobezki, E. Adler, B.D.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1007/s10585-011-9388- 6 Rowe, R.G., and S.J.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10   .1016/j.tcb.2008.08.00 7 Schoumacher, M., R.D.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1083/jcb.20090911 3 Seiler, C., G. Davuluri, J. Abrams, F.J. Byfield, P.A.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1371/journal   .pbio.100138 6 Senger, D.R., and G.E.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1101/cshperspect.a00509 0 Sharma-Kishore, R., J.G.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/   10.1016/S1534-5807(03)00168- 0 Sherwood, D.R., J.A.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.cell.2005.03.03 1 Shook, D., and R. Keller.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/j.mod.2003.06.00 5 Singh, B., C. Fleury, F. Jalalvand, and K. Riesbeck.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1101/gad.9.15.188 3 Stoletov, K., V .",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1242/jcs.06944 3 Thompson, R.D., K.E.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1182/blood   .V97.6.185 4 Valastyan, S., and R.A. Weinberg.",Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/   j.cell.2011.09.02 4 van Rijnsoever, C., V .",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi   .org/10.1038/nmeth.126 3 van Zijl, F., G. Krupitza, and W. Mikulits.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
"http://dx.doi.org/10.1016/   j.devcel.2005.11.00 7 V oisin, M.B., A. Woodfin, and S. Nourshargh.",OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
29:1193– 1199. http://dx.doi.org/10.1161/ATVBAHA.109.18745 0,Non-OADS,/arxiv_data1/oa_pdf/e9/b7/JCB_201311112.PMC3912525.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201309066/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1113/jphysiol.2006.11379 5 Bolis, A., S. Coviello, I. Visigalli, C. Taveggia, A. Bachi, A.H. Chishti, T.  Hanada, A. Quattrini, S.C. Previtali, A. Biffi, and A. Bolino.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
http://dx.doi.org/10.1523/   JNEUROSCI.1423-09.200 9Establishment of immortalized MEFs Primary MEFs were obtained from WT and KO mice at E13.5.,OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
Four miRNAs for LRP1 were designed by BLOCK- iT RNAi Designer (https://rnaidesigner.lifetechnologies.com/rnaiexpress)  based on the mouse LRP1 sequence (GenBank/EMBL/DDBJ accession no.,Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1083/jcb.20030217 5 Okazaki, M., S. Usui, M. Ishigami, N. Sakai, T. Nakamura, Y. Matsuzawa, and  S. Yamashita.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1161/01.ATV.0000155017.60171.8 8 Pelkmans, L., and A. Helenius.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
3:311– 320. http://dx.doi.org/10.1034/j.1600-0854.2002.30501.,Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi   .org/10.1016/j.biochi.2012.05.00 1 Saenko, E.L., A.V.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"274:37685– 37692. http://dx.doi.org/10.1074/jbc.274.53.3768 5 Sotgia, F., J.K. Lee, K. Das, M. Bedford, T.C.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10   .1074/jbc.M00532120 0 Steinmetz, M.O., and A. Akhmanova.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10   .1016/j.tibs.2008.08.00 6 Takahashi, J., Y. Itoh, K. Fujimori, M. Imamura, Y. Wakayama, Y. Miyagoe- Suzuki, and S. Takeda.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10   .1002/jgm.65 1 Tinsley, J.M., D.J.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10   .1016/j.devcel.2010.11.00 8 Vale, R.D.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00111- 9 Venkateswarlu, K., T. Hanada, and A.H. Chishti.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"118:2471– 2484. http://dx.doi.org/10.1242/jcs.0236 9 Venkateswarlu, K., K.G.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"120:792– 801. http://dx.doi.org/10.1242/jcs.0337 3 Wang, X., S.-R. Lee, K. Arai, S.-R. Lee, K. Tsuji, G.W.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1021/bi701169 w Zhang, H., P.H.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1074/jbc.M31067920 0Bovenschen, N., J. Herz, J.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1182/blood-2002-07-208 1 Czech, M.P.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80696- 0 Donaldson, J.G.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi   .org/10.1074/jbc.R30002620 0 Durbeej, M., M.D.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1177/00221554980460040 4 Franchini, M., and M. Montagnana.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1515/CCLM.2011.15 4 Fujita, A., and Y. Kurachi.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1006/bbrc.1999.189 3 Guo, W.X., M. Nichol, and J.P. Merlie.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi   .org/10.1016/S0014-5793(96)01216- 1 Haenggi, T., and J.-M. Fritschy.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10   .1007/s00018-005-5461- 0 Hanada, T., L. Lin, E.V.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1074/jbc.M00071520 0 Hayer, A., M. Stoeber, D. Ritz, S. Engel, H.H.",Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi   .org/10.1083/jcb.20100308 6 Herz, J., and D.K.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1016/   0092-8674(92)90511- A Hirokawa, N. 1998.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/   10.1126/science.279.5350.51 9 Hirokawa, N., and Y. Noda.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1152/physrev.00023.200 7 Hirokawa, N., S. Niwa, and Y. Tanaka.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.09.03 9 Horiguchi, K., T. Hanada, Y. Fukui, and A.H. Chishti.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1083/jcb.20060403 1 Hsueh, Y.-P. 2006.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1146/annurev.biochem.74.082803.13335 4 Kanai, Y., Y. Okada, Y. Tanaka, A. Harada, S. Terada, and N. Hirokawa.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi.org/10.1016/j.neuron.2004.07.02 2 Kounnas, M.Z., R.D.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
"http://dx.doi   .org/10.1016/0092-8674(95)90320- 8 Lenting, P.J., J.G.",OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
http://dx.doi.org/10.1074/jbc.274.34.2373 4,Non-OADS,/arxiv_data1/oa_pdf/5a/ac/JCB_201309066.PMC3912526.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1016/j.cad.2008.01.01 3 Aichholzer, O., W. Aigner, F. Aurenhammer, T. Hackl, B. Jüttler, and M. Rabl.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1016/j.cad.2008.08.00 8 Arakawa, Y ., H. Bito, T. Furuyashiki, T. Tsuji, S. Takemoto-Kimura, K. Kimura, K.  Nozaki, N. Hashimoto, and S. Narumiya.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1083/jcb.20021014 9 Aurenhammer, F. 1991.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/   10.1145/116873.11688 0 Barzik, M., T.I.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"280:28653– 28662. http://dx.doi.org/10.1074/jbc.M50395720 0 Bear, J.E., and F.B.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1242/jcs.03812 5 Bear, J.E., T.M.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1016/S0092-8674(02)00731- 6 Bilancia, C.G., J.D.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1016/j.devcel.2007.03.01 4 Blum, H. 1967.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1016/   j.jneumeth.2008.02.00 9 Etienne-Manneville, S., and A.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1038/nature0114 8 Fanti, Z., M.E.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"71:870– 881. http://dx.doi.org/10.1002/dneu.2086 6 Gallo, G. 2006.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1242/jcs.0308 4 Gates, J., J.P. Mahaffey, S.L.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1242/dev.0284 9 Gates, J., S.H.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1016/j.ydbio.2009.06.03 0 Gertler, F.B., K. Niebuhr, M. Reinhard, J. Wehland, and P. Soriano.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)81341- 0 Goode, B.L., and M.J. Eck.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1146/annurev.biochem.75.103004.14264 7 Gupton, S.L., K. Eisenmann, A.S. Alberts, and C.M.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"120:3475– 3487. http://dx.doi.org/10.1242/jcs.00604 9 Hansen, S.D., and R.D.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1083/jcb.20100301 4 Hodgson, L., P. Nalbant, F. Shen, and K. Hahn.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10   .1242/dev.01633 7 Homem, C.C.F., and M. Peifer.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1091/mbc   .E09-02-014 4 Jaffe, A.B., and A.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1146/annurev   .cellbio.21.020604.15072 1 Lizárraga, F., R. Poincloux, M. Romao, G. Montagnac, G. Le Dez, I. Bonne, G.  Rigaill, G. Raposo, and P. Chavrier.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1002/neu.2025 8 Mayya, N., and V.T.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/   10.1016/0167-8655(94)00087- J McKerracher, L., and H. Higuchi.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1089/neu.2006.23.30 9 Meijering, E., M. Jacob, J.C.F.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1002/cyto.a.2002 2 Morse, B.S., S.M.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1016/0262-8856(94)90057- 4 Mueller, B.K., H. Mack, and N. Teusch.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1038/nature0466 5 Philippar, U., E.T.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1016/   j.devcel.2008.09.00 3 Qi, Y., J.K. Wang, M. McMillian, and D.M.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1083/jcb.20070812 3 Schirenbeck, A., T. Bretschneider, R. Arasada, M. Schleicher, and J. Faix.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi   .org/10.1038/ncb126 6 Sebök, A., N. Nusser, B. Debreceni, Z. Guo, M.F.",Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1016/   S1361-8415(02)00110- X Tek, H., and B.B.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/   10.1023/A:102375331700 8 Woo, S., and T.M.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4209-05.200 6 Yang, C., L. Czech, S. Gerboth, S.-i.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
"http://dx.doi.org/10.1371/journal.pbio   .005031 7 Yuan, X.B., M. Jin, X. Xu, Y .Q.",OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
http://dx.doi.org/10.1038/ncb89 5,Non-OADS,/arxiv_data1/oa_pdf/b7/ea/JCB_201306067.PMC3912527.pdf
http://dx.doi.org/10.1083/jcb.201307164)  now demonstrate that polysomes associate with early en - dosomes that undergo kinesin 3– and dynein-dependent   long-range motility.,Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"More importantly, the reduc - tion of early endosome numbers in yup1  mutants results in an Hop-on hop-off: Polysomes take a tour of the cell   on endosomes Isabel M. Palacios Zoology Department, University of Cambridge, Cambridge CB2 3EJ, England, UK © 2014 Palacios  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi   .org/10.1093/emboj/cdf29 6 Zhang, J., L. Zhuang, Y. Lee, J.F.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1242/jcs.07525 9Support was provided by the Department of Zoology and School of Biology,  University of Cambridge.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
http://dx.doi.org/10.1111/ j.1600-0854.2008.00848.,Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1091/mbc.E11-03-021 1 Baumann, S., T. Pohlmann, M. Jungbluth, A. Brachmann, and M. Feldbrügge.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi   .org/10.1242/jcs.10121 2 Baumann, S., J. Konig, J. Koepke, and M. Feldbrugge.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1002/embr.20133803 7 Bisbal, M., J. Wojnacki, D. Peretti, A. Ropolo, J. Sesma, I. Jausoro, and A.  Cáceres.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10   .1016/0092-8674(92)90306- W Court, F.A., W.T.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"28:11024– 11029. http://dx.doi.org/10.1523/JNEUROSCI.2429-08.200 8 Egan, M.J., M.A.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1016/j.mib.2012.10.00 3 Elvira, G., S. Wasiak, V. Blandford, X.K.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1074/mcp.M500255-   MCP20 0 Fuchs, U., G. Hause, I. Schuchardt, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1105/tpc.105.03938 8 Genz, C., J. Fundakowski, O. Hermesh, M. Schmid, and R.P.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1074/jbc.M113.48643 1 Higuchi, Y., P. Ashwin, Y. Roger, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/ 10.1083/jcb.20130716 4 Kanai, Y., N. Dohmae, and N. Hirokawa.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1016/j.neuron.2004.07.02 2 König, J., S. Baumann, J. Koepke, T. Pohlmann, K. Zarnack, and M. Feldbrügge.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00508- 6 Lenz, J.H., I. Schuchardt, A. Straube, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"http://dx.doi.org/10.1038/sj.emboj.760111 9 Schuster, M., S. Kilaru, G. Fink, J. Collemare, Y. Roger, and G. Steinberg.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
"22:3645– 3657. http://dx.doi.org/10.1091/mbc.E11-03-021 7 Tcherkezian, J., P.A.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
http://dx.doi.org/   10.1016/j.cell.2010.04.00 8,OADS,/arxiv_data1/oa_pdf/22/f6/JCB_201401019.PMC3912529.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201305037/DC1.,Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1038/ncb212 2 Carvalho, R.F., M. Beutler, K.J.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1038/nn165 5 Chen, J., X.F.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1073/pnas.92.11.494 7 Choi, J., J. Chen, S.L.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1126/science.273.5272.23 9 Clackson, T., W. Yang, L.W.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1126/science.797363 8 Dong, H., S. Qin, and H.-X.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1371/journal.pcbi.100083 3 Egea, J., and R. Klein.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1016/j.tcb   .2007.03.00 4 Egea, J., U.V .",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1016/j.neuron.2005.06.02 9 Gale, N.W., S.J.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80276- 7 Grunwald, I.C., M. Korte, D. Wolfer, G.A.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"32:1027– 1040. http://dx.doi.org/10.1016/S0896-6273(01)00550- 5 Himanen, J.-P., M.J. Chumley, M. Lackmann, C. Li, W.A.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1038/nn123 7 Himanen, J.P., L. Yermekbayeva, P.W.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
http://dx.doi   .org/10.1074/jbc.M110.16473 1with the original anisotropy image.,Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1038/sj.emboj.760131 5 Wimmer-Kleikamp, S.H., P.W.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1083/jcb.20031200 1 Wittig, I., H.P.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1038/nprot.2006.6 2 Wybenga-Groot, L.E., B. Baskin, S.H.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"106:745– 757. http://dx.doi.org/10.1016/S0092-8674(01)00496- 2 Yang, W., T.P.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1016/S0960-894X(03)00707- 8 Zimmer, M., A. Palmer, J. Köhler, and R. Klein.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1038/ncb104 5Holmberg, J., D.L.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"408:203– 206. http://dx.doi.org/10.1038/3504157 7 Janes, P.W., E. Nievergall, and M. Lackmann.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1016/j.semcdb.2012.01.00 1 Kayser, M.S., A.C. McClelland, E.G.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.3072-06.200 6 Klein, R. 2009.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1038/nn.223 1 Lauterbach, J., and R. Klein.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"26:11575– 11581. http://dx.doi.org/10.1523/JNEUROSCI.2697-06.200 6 Lemmon, M.A., and J. Schlessinger.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1016/j.cell.2010.06.01 1 Lim, B.K., N. Matsuda, and M.M.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1038/nn203 3 Marquardt, T., R. Shirasaki, S. Ghosh, S.E.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1016/j.cell.2005.01.02 0 Muthuswamy, S.K., M. Gilman, and J.S.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1091/mbc.E03-09-067 4 Pasquale, E.B.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1016/j.cell.2008.03.01 1 Qiao, F., and J.U.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10   .1371/journal.pbio.100059 7 Runnels, L.W., and S.F.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1016/S0006-3495(95)80030- 5 Salaita, K., P.M. Nair, R.S.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/   10.1126/science.118172 9 Seiradake, E., K. Harlos, G. Sutton, A.R.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10   .1038/nsmb.178 2 Seiradake, E., A. Schaupp, D. del Toro Ruiz, R. Kaufmann, N. Mitakidis, K.  Harlos, A.R.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi.org/10.1038/nsmb.261 7 Squire, A., P.J.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1016/j.jsb.2003.10.01 3 Stein, E., A.A. Lane, D.P.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1101/gad.12.5.66 7 Varma, R., and S. Mayor.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1038/2956 3 Vearing, C., F.T.",Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"http://dx.doi   .org/10.1158/0008-5472.CAN-05-075 8 Wang, L., R. Klein, B. Zheng, and T. Marquardt.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
"71:263– 277. http://dx.doi.org/10.1016/j.neuron.2011.06.02 1 Whitney, M.L., K.G.",OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
http://dx.doi.org/10.1074/jbc.M10319120 0,Non-OADS,/arxiv_data1/oa_pdf/9a/da/JCB_201305037.PMC3912530.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201307164/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1111/j.1600-   0854.2008.00848. x Aichinger, C., K. Hansson, H. Eichhorn, F. Lessing, G. Mannhaupt, W. Mewes, and  R. Kahmann.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1007/s00438-003-0926- z Ainger, K., D. Avossa, F. Morgan, S.J.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"123:431– 441. http://dx.doi.org/10.1083/jcb.123.2.43 1Electron microscopy Hyphal strains were prepared and processed as described previously  (Steinberg, 2012).",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/nrm265 2 Hirsch, C.A., and H.H.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1002/neu.1032 3 Jung, M.K., I.B.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1002/   cm.97022030 4 Kanai, Y., N. Dohmae, and N. Hirokawa.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/j.neuron.2004.07.02 2 Knowles, R.B., J.H.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1074/mcp.M111.01121 3 König, J., S. Baumann, J. Koepke, T. Pohlmann, K. Zarnack, and M. Feldbrügge.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/   10.1016/S0962-8924(01)02144- 4 Lemmon, M.A.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
4:201– 213. http://dx.doi.org/10.1034/j.1600-0854.2004.00071.,Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi   .org/10.1016/S0955-0674(00)00117- 4 Lenz, J.H., I. Schuchardt, A. Straube, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/sj.emboj.760111 9 Liao, L.L., A.P.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/   0005-2787(76)90230- 6 Luby-Phelps, K. 2000.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/0006-291X(70)90460- 2 Miaczynska, M., L. Pelkmans, and M. Zerial.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/j.ceb.2004.06.00 5 Nielsen, E., F. Severin, J.M.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/1407 5 Pálfy, M., A. Reményi, and T. Korcsmáros.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi   .org/10.1016/j.tcb.2007.12.00 4 Patterson, G.H., and J. Lippincott-Schwartz.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1126/science.107495 2 Politz, J.C., R.A. Tuft, and T. Pederson.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/ncb118 4 Schiel, J.A., C. Childs, and R. Prekeris.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/j.tcb.2013.02.00 3 Schmid, M., A. Jaedicke, T.G.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/j.cub.2006.06.02 5Ashe, M.P., S.K.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi   .org/10.1093/emboj/20.22.646 4 Baumann, S., T. Pohlmann, M. Jungbluth, A. Brachmann, and M. Feldbrügge.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi   .org/10.1242/jcs.10121 2 Becht, P., E. Vollmeister, and M. Feldbrügge.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1128/EC.4.1.121-133.200 5 Becht, P., J. König, and M. Feldbrügge.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1242/jcs.0328 7 Bisbal, M., J. Wojnacki, D. Peretti, A. Ropolo, J. Sesma, I. Jausoro, and A.  Cáceres.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1046/j.1365-2958.2001   .02699. x Brangwynne, C.P., G.H.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/j.tcb.2009.04.00 4 Carlton, J.G., and J. Martin-Serrano.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"316:1908– 1912. http://dx.doi.org/10.1126/science.114342 2 Carrasco, L., M. Barbacid, and D. Vazquez.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/   0005-2787(73)90381- X Chavrier, P., R.G.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/   0092-8674(90)90369- P Cohen, R.S.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1042/BC2004005 6 Cundliffe, E., M. Cannon, and J. Davies.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1083/jcb.72.1.17 4 Dienstbier, M., F. Boehl, X. Li, and S.L.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1101/   gad.53100 9 Egan, M.J., M.A.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/j.mib.2012.10.00 3 Egan, M.J., K. Tan, and S.L.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1074/mcp.M500255-   MCP20 0 Emery, G., and J.A.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1016/j.ceb   .2006.06.00 9 Forrest, K.M., and E.R.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10   .1016/S0960-9822(03)00451- 2 Fuchs, U., G. Hause, I. Schuchardt, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1105/tpc.105.03938 8 Gillooly, D.J., I.C.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
http://dx.doi.org/10.1093/emboj/19.17.457 7,Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/nchembio.30 4 Schuster, M., S. Kilaru, P. Ashwin, C. Lin, N.J. Severs, and G. Steinberg.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi   .org/10.1038/emboj.2010.36 0 Schuster, M., S. Kilaru, G. Fink, J. Collemare, Y. Roger, and G. Steinberg.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1091/mbc.E11-03-021 7 Schuster, M., R. Lipowsky, M.A.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1007/s00018-008-8354- 1 Sorkin, A., and M. Von Zastrow.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/nrm88 3 Steinberg, G. 2007.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/nrmicro161 8 Steinberg, G. 2012.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi   .org/10.1371/journal.pone.003818 1 Steinberg, G., and J. Perez-Martin.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/   10.1016/j.tcb.2007.11.00 8 Steinberg, G., M. Schuster, U. Theisen, S. Kilaru, A.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1083/jcb.20120108 7 Straube, A., I. Weber, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/sj.emboj.760064 4 Tamura, K., D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1093/molbev/msr12 1 Van Der Sluijs, P., M. Hull, A. Zahraoui, A. Tavitian, B. Goud, and I. Mellman.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1073/   pnas.88.14.631 3 Vida, T.A., and S.D.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1083/jcb.128.5.77 9 Vollmeister, E., K. Schipper, S. Baumann, C. Haag, T. Pohlmann, J.",Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1111/j.1574-   6976.2011.00296. x Wedlich-Söldner, R., M. Bölker, R. Kahmann, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi   .org/10.1093/emboj/19.9.197 4 Wedlich-Söldner, R., I. Schulz, A. Straube, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1091/mbc.01-10-047 5 Wedlich-Söldner, R., A. Straube, M.W.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi   .org/10.1093/emboj/cdf29 6 Zarnack, K., and M. Feldbrügge.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1128/EC.00030-1 0 Zeigerer, A., J. Gilleron, R.L.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/nature1113 3 Zerial, M., and H. McBride.",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
"http://dx.doi.org/10.1038/3505205 5 Zhang, J., L. Zhuang, Y .",OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
http://dx.doi.org/10.1242/jcs.07525 9,Non-OADS,/arxiv_data1/oa_pdf/ab/be/JCB_201307164.PMC3912533.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201308028/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201308028.d v. We thank S. Ben-Yehuda, S. Even-Ram, R. Gabizon, I. Gahali-Sass, E. Metzer,  U. Sass, O. Schonberger, and H. Wille for useful discussions; H. Falk, L. Friedkin,  N. Moshkowitz, and T. Mosevitzky for excellent technical assistance; S. Johansson   for advice on fibronectin; L. Stitz for the W226 mAb; and D. Barritault for  HM.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1146/annurev   .neuro.31.060407.12562 0 Arnold, J.E., C. Tipler, L. Laszlo, J.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1002/path.171176041 2 Backström, E., B.J.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc   .C30004920 0 Basler, K., B. Oesch, M. Scott, D. Westaway, M. Wälchli, D.F.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"2:336. http://dx.doi   .org/10.1038/ncomms134 1 Giloh, H., and J.W.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1126/science.711212 6 Godsave, S.F., H. Wille, P. Kujala, D. Latawiec, S.J.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4474-08.200 8 Godsave, S.F., H. Wille, J. Pierson, S.B.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1016/j.neurobiolaging.2012.12.01 5 Goold, R., S. Rabbanian, L. Sutton, R. Andre, P. Arora, J. Moonga, A.R.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"2:281. http://dx.doi.org/10.1038/ncomms128 2 Goswami, D., K. Gowrishankar, S. Bilgrami, S. Ghosh, R. Raghupathy, R.  Chadda, R. Vishwakarma, M. Rao, and S. Mayor.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1016/j.cell.2008.11.03 2 Haka, A.S., I. Grosheva, E. Chiang, A.R.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1091/mbc.E09-07-055 9 Hansen, C.G., G. Howard, and B.J.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1242/jcs.08431 9 Harder, T., P. Scheiffele, P. Verkade, and K. Simons.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1083/jcb.141.4.92 9 Harmey, J.H., D. Doyle, V. Brown, and M.S.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1006/bbrc.1995.172 3 Harper, J.D., C.M.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1126/science.279.5352.82 7 Hermann, R., P. Walther, and M. Müller.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1007/BF0247320 0 Hijazi, N., Z. Kariv-Inbal, M. Gasset, and R. Gabizon.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc.M41131420 0 Hope, J., L.J.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc.M50012220 0 Huff, M.E., W.E.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1016/j.sbi.2003.10.01 0 Jeffrey, M., C.M.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1006/neur.1996.001 4 Jen, A., C.J.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1242/jcs.05809 9 Kaneko, K., M. Vey, M. Scott, S. Pilkuhn, F.E.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
http://dx.doi.org/10   .1073/pnas.94.6.233 3PrP isoforms are encoded by the same chromosomal gene.,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"46:417– 428. http://dx.doi.org/10.1016/0092-8674(86)90662- 8 Bate, C., M. Salmona, L. Diomede, and A. Williams.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc.M31306120 0 Ben-Zaken, O., S. Tzaban, Y. Tal, L. Horonchik, J.D.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/ jbc.M30115220 0 Berson, J.F., A.C. Theos, D.C. Harper, D. Tenza, G. Raposo, and M.S.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1083/jcb.20030207 2 Bessen, R.A., and R.F.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1016/j.tins.2011.10.00 2 Bolton, D.C., M.P.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1083/jcb.110.3.74 3 Borchelt, D.R., A. Taraboulos, and S.B.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1093/glycob/3.4.31 9 Bouzamondo-Bernstein, E., S.D.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1021/bi800801 f Caughey, B., and G.J.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/   225100a 0 Conner, S.D., and S.L.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/nature0145 1 Demart, S., J.G.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1006/bbrc.1999.173 0 Dron, M., M. Moudjou, J. Chapuis, M.K.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1074/jbc.M109.08385 7 Ewers, H., W. Romer, A.E.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/ncb199 9 Fivaz, M., F. Vilbois, S. Thurnheer, C. Pasquali, L. Abrami, P.E.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
http://dx.doi   .org/10.1093/emboj/cdf39 8,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc.272.10.632 4 Naslavsky, N., H. Shmeeda, G. Friedlander, A. Yanai, A.H. Futerman, Y.  Barenholz, and A. Taraboulos.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/   jbc.274.30.2076 3 Nishida, N., D.A.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc.M41088320 0 Novitskaya, V., N. Makarava, A. Bellon, O.V.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1074/jbc.M60134920 0 Oesch, B., D. Westaway, M. Wälchli, M.P.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1016/0092-8674(85)90333- 2 Patil, S.M., A. Mehta, S. Jha, and A.T. Alexandrescu.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/   10.1021/bi101908 m Peretz, D., R.A. Williamson, K. Kaneko, J. Vergara, E. Leclerc, G. Schmitt- Ulms, I.R.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10   .1038/3508909 0 Perrier, V ., J. Solassol, C. Crozet, Y .",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
http://dx.doi.org/10.1111/j.1471-4159.2004.02356.,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1083/   jcb.20030414 0 Peters, P.J., E. Bos, and A. Griekspoor.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1128/JVI.02467-1 0 Pimpinelli, F., S. Lehmann, and I. Maridonneau-Parini.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
233:353– 363. http://dx.doi.org/10.1111/j.1365-2818.2009.03140.,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1126/science.680176 2 Prusiner, S.B., M.P.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10   .1016/0092-8674(83)90168- X Prusiner, S.B., M. Scott, D. Foster, K.M.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1016/   0092-8674(90)90134- Z Qi, Y., J.K. Wang, M. McMillian, and D.M.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1021/bi300201 e Resenberger, U.K., A. Harmeier, A.C. Woerner, J.L.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/3633 7 Leclerc, E., D. Peretz, H. Ball, L. Solforosi, G. Legname, J. Safar, A. Serban,  S.B.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"326:475– 483. http://dx.doi.org/10.1016/S0022-2836(02)01365- 7 Li, R., T. Liu, B.S.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc.M90022020 0 Mahal, S.P., C.A.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1073/pnas.071005410 4 Makarava, N., V.G.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc.M90053320 0 Mallucci, G., A. Dickinson, J. Linehan, P.C.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/   10.1126/science.109018 7 Marijanovic, Z., A. Caputo, V. Campana, and C. Zurzolo.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1371/journal.ppat.100042 6 Mayor, S., and F.R.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1091/mbc.6.7.92 9 Mayor, S., K.G.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1126/science.751658 2 McKinley, M.P., A. Taraboulos, L. Kenaga, D. Serban, A. Stieber, S.J.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1016/   0896-6273(90)90028- E Meyer, R.K., M.P.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1073/pnas.83.8.231 0 Mironov, A. Jr., D. Latawiec, H. Wille, E. Bouzamondo-Bernstein, G. Legname,  R.A. Williamson, D. Burton, S.J.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1210/endo-127-1-12 6 Mouillet-Richard, S., M. Ermonval, C. Chebassier, J.L.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1126/science   .289.5486.192 5 Naiki, H., K. Higuchi, M. Hosokawa, and T. Takeda.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
http://dx.doi.org/10.1016/0003-2697(89)90046- 8,OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1083/jcb.20060917 4 Taguchi, Y., Z.D.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1091/mbc   .E08-06-063 5 Tanaka, K.A., K.G.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/nmeth.f.31 4 Taraboulos, A., M. Rogers, D.R.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1073/pnas.87.21.826 2 Taraboulos, A., D. Serban, and S.B.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1083/jcb.110.6.211 7 Taraboulos, A., A.J.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1091/mbc.3.8.85 1 Taraboulos, A., M. Scott, A. Semenov, D. Avrahami, L. Laszlo, and S.B.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1083/jcb.129.1.12 1 Towbin, H., T. Staehelin, and J. Gordon.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
http://dx.doi.org/10.1111/j.1432-1033.1988.tb14246.,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1021/bi025958 g Veith, N.M., H. Plattner, C.A.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1016/j.ejcb.2008.08.00 1 Wadia, J.S., M. Schaller, R.A. Williamson, and S.F.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1371/journal.pone.000331 4 Warner, R.G., C. Hundt, S. Weiss, and J.E.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1074/jbc.M11040620 0 Wegmann, S., M. Miesbauer, K.F.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1007/s00424-007-0433- x Wille, H., M.D.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10   .1073/pnas.090900610 6 Williamson, R.A., D. Peretz, C. Pinilla, H. Ball, R.B.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
http://dx.doi.org/10.1371/journal.pone.000931 6et al.,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/emboj.2011.8 6 Rogers, M., D. Serban, T. Gyuris, M. Scott, T. Torchia, and S.B.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10   .1073/pnas.90.8.318 2 Römer, W., L. Berland, V. Chambon, K. Gaus, B. Windschiegl, D. Tenza,  M.R.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/nature0599 6 Sabharanjak, S., P. Sharma, R.G.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"2:411– 423. http://dx.doi.org/10.1016/S1534-5807(02)00145- 4 Safar, J.G., S.J.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1099/vir.0.80947- 0 Sanan, D.A., and R.G.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1177/39.8.190690 8 Schätzl, H.M., L. Laszlo, D.M.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1016/j.bbrc.2003.10.15 0 Scott, M.R., R. Köhler, D. Foster, and S.B.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"1:986– 997. http://dx.doi.org/10.1002/pro.556001080 4 Serban, D., A. Taraboulos, S.J.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1212/WNL.40.1.11 0 Sharma, P., R. Varma, R.C.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1021/   bi971093 9 Simons, K., and M.J. Gerl.",Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/   nrm297 7 Snijder, B., R. Sacher, P. Rämö, E.M. Damm, P. Liberali, and L. Pelkmans.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1038/nature0828 2 Speare, J.O., D.K.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi   .org/10.1021/bi00474a02 8 Stahl, N., M.A.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
"http://dx.doi.org/10.1021/bi00059a01 6 Stuermer, C.A., M.F.",OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
22:3591– 3601. http://dx.doi.org/10.1093/emboj/cdg34 4,Non-OADS,/arxiv_data1/oa_pdf/11/26/JCB_201308028.PMC3912534.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1083/jcb.20061108 0 Detmer, S.A., C. Vande Velde, D.W. Cleveland, and D.C. Chan.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1093/hmg/ddm31 4 Dorn, G.W., II, C.F.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.110.23674 5 Friedman, J.R., L.L.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1126/science.120738 5 Hales, K.G., and M.T.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"90:121– 129. http://dx.doi.org/10.1016/S0092-8674(00)80319- 0 Hamasaki, M., N. Furuta, A. Matsuda, A. Nezu, A. Yamamoto, N. Fujita, H.  Oomori, T. Noda, T. Haraguchi, Y. Hiraoka, et al.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1016/S0925-4773(02)00141- 7 Inden, M., Y. Kitamura, H. Takeuchi, T. Yanagida, K. Takata, Y. Kobayashi,   T. Taniguchi, K. Yoshimoto, M. Kaneko, Y. Okuma, et al.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1038/   ng127 0 Ishihara, N., Y. Eura, and K. Mihara.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1242/jcs.0156 5 Ishikawa, F., T. Akimoto, H. Yamamoto, Y. Araki, T. Yoshie, K. Mori, H.  Hayashi, K. Nose, and M. Shibanuma.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1093/   jb/mvp05 2 Kasahara, A., S. Cipolat, Y. Chen, G.W.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1126/   science.124135 9 Kornmann, B., E. Currie, S.R.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1126/science.117508 8 Ngoh, G.A., K.N.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1074/jbc.M112.35917 4 Olichon, A., L.J.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1016/S0014-5793(02)02985- X Orso, G., D. Pendin, S. Liu, J. Tosetto, T.J. Moss, J.E.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1038/nature0828 0 Osterwalder, T., K.S.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1073/   pnas.22130329 8 Ozcan, U., E. Yilmaz, L. Ozcan, M. Furuhashi, E. Vaillancourt, R.O.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1126/science.112829 4 Papanicolaou, K.N., R.J. Khairallah, G.A.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201306121/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1038/emboj.2012.20 2 Brand, A.H., and N. Perrimon.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"133:1460–   1469. http://dx.doi.org/10.1093/brain/awq08 2 Casas-Tinto, S., Y. Zhang, J. Sanchez-Garcia, M. Gomez-Velazquez, D.E.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"20:2144– 2160. http://dx.doi.org/10.1093/hmg/ddr10 0 Cerqua, C., V. Anesti, A. Pyakurel, D. Liu, D. Naon, G. Wiche, R. Baffa, K.S.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1038/embor.2010.15 1 Chen, H., S.A. Detmer, A.J.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1083/jcb.20021104 6 Chen, H., A. Chomyn, and D.C. Chan.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"280:26185– 26192. http://dx.doi.org/10.1074/jbc.M50306220 0 Chen, Y., G. Csordás, C. Jowdy, T.G.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.112.26658 5 Cipolat, S., O. Martins de Brito, B. Dal Zilio, and L. Scorrano.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1038/   nature0753 4 de Brito, O.M., and L. Scorrano.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1038/emboj.2010.17 7 De Stefani, D., A. Raffaello, E. Teardo, I. Szabò, and R. Rizzuto.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
http://dx.doi.org/10.1038/nature1023 0,Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1128/MCB.00911-1 0 Ranganayakulu, G., R.A. Schulz, and E.N.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1006/   dbio.1996.998 7 Ryoo, H.D., P.M. Domingos, M.J. Kang, and H. Steller.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1038/sj.emboj.760147 7 Ryoo, H.D., J. Li, and M.J. Kang.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1371/journal   .pone.007577 4 Santel, A., and M.T.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi   .org/10.1242/jcs.0047 9 Schneeberger, M., M.O.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi   .org/10.1091/mbc.E04-06-047 5 Solá, S., R.E.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/10.1038/emboj.2009.8 9 Ziviani, E., R.N.",Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
"http://dx.doi.org/   10.1073/pnas.091348510 7 Züchner, S., I.V.",OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
http://dx.doi   .org/10.1038/ng134 1,Non-OADS,/arxiv_data1/oa_pdf/cd/f7/JCB_201306121.PMC3912536.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/   full/jcb.201304015/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.110.23123 3 Brinker, A., C. Scheufler, F. V on Der Mulbe, B. Fleckenstein, C. Herrmann, G.  Jung, I. Moarefi, and F.U.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/   10.1074/jbc.M10900220 0 Cartier, A., A.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1242/jcs.08579 5 Chen, C.Y ., and W.E.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1016/j.anai.2011.01.02 7 Cliff, M.J., R. Harris, D. Barford, J.E.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/   10.1016/j.str.2005.12.00 9 Conn, P.M., A. Ulloa-Aguirre, J. Ito, and J.A.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1359/   jbmr.08022 8 Filipeanu, C.M., R. de Vries, A.H. Danser, and D.R.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1016/j   .bbamcr.2010.11.02 0 Fujimori, K., Y .",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1074/jbc.M00768820 0 Gallant, M.A., R. Samadfam, J.A.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1016/j.jsb.2009.10.00 5 Morita, I., M. Schindler, M.K.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.2332/allergolint.08-RAI-003 3 Oksche, A., R. Schülein, C. Rutz, U. Liebenhoff, J. Dickson, H. Müller, M.  Birnbaumer, and W. Rosenthal.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"276:32642– 32647. http://dx.doi.org/10.1074/jbc.M10421220 0 Parent, A., E. Hamelin, P. Germain, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1042/BJ2008086 7 Parent, A., S.J.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1074/jbc.M110.14225 7 Petäjä-Repo, U.E., M. Hogue, S. Bhalla, A. Laperrière, J.P. Morello, and M.  Bouvier.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"21:1628– 1637. http://dx.doi.org/10.1093/emboj/21.7.162 8 Rodrigo-Brenni, M.C., and R.S.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/   10.1016/j.devcel.2012.10.01 2 Rosenbaum, E.E., K.S.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.09.01 6 Roy, S.J., I. Glazkova, L. Fréchette, C. Iorio-Morin, C. Binda, D. Pétrin, P. Trieu,  M. Robitaille, S. Angers, T.E.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi   .org/10.1210/me.2013-109 1 Sakisaka, T., T. Meerlo, J. Matteson, H. Plutner, and W.E.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1093/emboj/cdf60 3 Scheufler, C., A. Brinker, G. Bourenkov, S. Pegoraro, L. Moroder, H. Bartunik, F.U.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80830- 2 Schuligoi, R., E. Sturm, P. Luschnig, V .",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1159/00031383 6 Sikorski, R.S., M.S.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1016/0092-8674(90)90745- Z Tadevosyan, A., G. Vaniotis, B.G.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1038/nrm291 8 Tanaka, K., K. Ogawa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1359/JBMR.04121 1 Gallant, M.A., D. Slipetz, E. Hamelin, M.D.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10   .1016/j.ejphar.2006.11.05 8 García-Cardeña, G., R. Fan, V .",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1038/3393 4 Gazda, L., W. Pokrzywa, D. Hellerschmied, T. Löwe, I. Forné, F. Mueller-Planitz,  T. Hoppe, and T. Clausen.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1016/j.cell.2012.12.02 5 Gorska, M., U. Popowska, A. Sielicka-Dudzin, A. Kuban-Jankowska, W.  Sawczuk, N. Knap, G. Cicero, and F. Wozniak.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.2741/405 0 Hartl, F.U., A. Bracher, and M. Hayer-Hartl.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10   .1038/nature1031 7 He, F., Z.H.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10   .1016/B978-0-12-394300-2.00005- 3 Hohwy, M., L. Spadola, B. Lundquist, P. Hawtin, J. Dahmén, I. Groth-Clausen, E.  Nilsson, S. Persdotter, K. von Wachenfeldt, R.H. Folmer, and K. Edman.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10   .1021/jm701509 k Imai, J., H. Yashiroda, M. Maruya, I. Yahara, and K. Tanaka.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/   10.4161/cc.2.6.58 6 Jackson, S.E.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1007/128_2012_35 6 Kanekiyo, T., T. Ban, K. Aritake, Z.L.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1111/j.1742-4658.2011   .08456. x Kumasaka, T., K. Aritake, H. Ago, D. Irikura, T. Tsurumura, M. Yamamoto, M.  Miyano, Y .",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/   10.1074/jbc.M109.01834 1 Labrecque, P ., S.J.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/   10.1371/journal.pone.006576 7 Lachance, V ., A. Cartier, S. Génier, S. Munger, P. Germain, P. Labrecque, and  J.L.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1074/jbc.M111.26781 5 Lappano, R., and M. Maggiolini.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1051/   medsci/2012281001 7 Leskelä, T.T., P .M.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1074/jbc.M61089620 0 Luo, J., and J.L.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"278:50908– 50914. http://dx.doi.org/10.1074/jbc.M30763720 0 Magalhaes, A.C., H. Dunn, and S.S. Ferguson.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
http://dx.doi.org/10.1111/j.1476-5381.2011.01552.,Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.2174/18722141179435185 1 Urade, Y., and O. Hayaishi.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10   .1016/S0167-4838(00)00161- 8 Urade, Y ., M. Ujihara, Y .",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1152/   ajpheart.00657.201 1 Vassart, G., and S. Costagliola.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/   10.1038/nrendo.2011.2 0 Wang, X., J.S.",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1161/   CIRCRESAHA.112.26870 6 Wu, B., P. Li, Y .",OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1007/   978-0-387-39975-1_ 3 Zhou, Y ., N. Shaw, Y .",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi.org/10.1096/fj.10-16486 3 Zhu, T., F. Gobeil, A. Vazquez-Tello, M. Leduc, L. Rihakova, M. Bossolasco,  G. Bkaily, K. Peri, D.R.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
"http://dx.doi   .org/10.1139/y05-14 7 Zuiderweg, E.R., E.B.",Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
http://dx.doi.org/10.1007/128_2012_32 3,Non-OADS,/arxiv_data1/oa_pdf/e1/ff/JCB_201304015.PMC3912537.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7a/49/srep03950.PMC3912618.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3950 | DOI: 10.1038/srep03950 9",Non-OADS,/arxiv_data1/oa_pdf/7a/49/srep03950.PMC3912618.pdf
"http://informahealthcare.com/iht ISSN: 0895-8378 (print), 1091-7691 (electronic) Inhal Toxicol, 2014; 26(1): 1–13 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/08958378.2013.845273 RESEARCH ARTICLE Cumulative Retrospective Exposure Assessment (REA) as a predictor of amphibole asbestos lung burden: validation procedures and results for industrial hygiene and pathology estimates James O. Rasmuson1, Victor L. Roggli2, Fred W. Boelter3, Eric J. Rasmuson1, and Charles F. Redinger4 1Chemistry & Industrial Hygiene, Wheat Ridge, CO, USA,2Department of Pathology, Medical Center, Duke University, Durham, NC, USA, 3Environ International Corporation, Chicago, IL, USA, and4Redinger 360 Inc., Harvard, MA, USA Abstract Context : A detailed evaluation of the correlation and linearity of industrial hygiene retrospective exposure assessment (REA) for cumulative asbestos exposure with asbestos lung burden analysis (LBA) has not been previously performed, but both methods are utilized for case- control and cohort studies and other applications such as setting occupational exposure limits.Objective : (a) To correlate REA with asbestos LBA for a large number of cases from varied industries and exposure scenarios; (b) to evaluate the linearity, precision, and applicability of both industrial hygiene exposure reconstruction and LBA; and (c) to demonstrate validationmethods for REA.Methods : A panel of four experienced industrial hygiene raters independently estimated the cumulative asbestos exposure for 363 cases with limited exposure details in which asbestos LBA had been independently determined.",Non-OADS,/arxiv_data1/oa_pdf/44/50/IHT-26-1.PMC3912627.pdf
"http://informahealthcare.com/iht ISSN: 0895-8378 (print), 1091-7691 (electronic) Inhal Toxicol, 2014; 26(1): 36–47 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/08958378.2013.851305 RESEARCH ARTICLE Component-specific, cigarette particle deposition modeling in the human respiratory tract Bahman Asgharian1, Owen T. Price1, Caner U. Yurteri2, Colin Dickens2, and John McAughey2 1Department of Security Engineering & Applied Sciences, Applied Research Associates, Raleigh, NC, USA and2British American Tobacco, GR&D Centre, Southampton, UK Abstract Inhalation of cigarette smoke particles (CSP) leads to adverse health effects in smokers.",Non-OADS,/arxiv_data1/oa_pdf/d7/5d/IHT-26-36.PMC3912629.pdf
Available from: http://www.bat-science.com [Last accessed: 28 Oct 2013].,Non-OADS,/arxiv_data1/oa_pdf/d7/5d/IHT-26-36.PMC3912629.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/e4/eb/ATM-9-23.PMC3912682.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/e4/eb/ATM-9-23.PMC3912682.pdf
Available  from: http://www.en.wikipedia.org/wiki/Demographics_of_Saudi_Arabia.,Non-OADS,/arxiv_data1/oa_pdf/61/30/ATM-9-45.PMC3912688.pdf
Available from: http://www.nap.edu.,Non-OADS,/arxiv_data1/oa_pdf/61/30/ATM-9-45.PMC3912688.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/95/a7/ATM-9-8.PMC3912693.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ amiajnl-2013-001882).,OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
"Data collection and standardization W e collected information about the GW AS and theirphenotype variables from two publicly availabledbGaP sources: (1) dbGaP web pages (http://www .ncbi.nlm.nih.gov/gap), and (2) the dbGaP FTP site(ftp://ftp.ncbi.nlm.nih.gov/dbgap).",OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1 Mailman MD, Feolo M, Jin Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
ISO 3166-2. http://www.iso.,Non-OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
http://sourceforge.net/projects/pyparsing/.,Non-OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
32 Chaput M. Whoosh 2.4.1. http://pypi.python.org/pypi/Whoosh/.,Non-OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
http://www.genome.gov/gwastudies.,OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
2012. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
http://en.wikipedia.org/wiki/Precision_and_recall (accessed 10 Mar 2013).36 Van Rijsbergen CJ.,Non-OADS,/arxiv_data1/oa_pdf/50/54/amiajnl-2013-001882.PMC3912702.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1W u T .,Non-OADS,/arxiv_data1/oa_pdf/33/43/amiajnl-2013-001719.PMC3912707.pdf
http://en.wikipedia.org/wiki/Network_neutrality 12 Lee TB.,Non-OADS,/arxiv_data1/oa_pdf/33/43/amiajnl-2013-001719.PMC3912707.pdf
2006 [cited 2010 1/3/2010]; http://dig.csail.,OADS,/arxiv_data1/oa_pdf/33/43/amiajnl-2013-001719.PMC3912707.pdf
Attachment 2006. http://ata.dev.vtcus.com/docs/policy- white-papers/net_neutrality.pdf?sfvrsn=2 17 Krim J.,Non-OADS,/arxiv_data1/oa_pdf/33/43/amiajnl-2013-001719.PMC3912707.pdf
2009 [cited 2013; http://www.hhs.gov/ocr/privacy/hipaa/ administrative/enforcementrule/hitechenforcementifr.html 44 Council PSS.,OADS,/arxiv_data1/oa_pdf/33/43/amiajnl-2013-001719.PMC3912707.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/To cite Gospodarevskaya E, Westbrook JI.",Non-OADS,/arxiv_data1/oa_pdf/33/5f/amiajnl-2013-002240.PMC3912708.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ amiajnl-2013-001789).,OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Anderson KM, Marsh CA, Flemming AC, et al.Quality measurement enabled by health IT: overview, possibilities, and challenges .",Non-OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
3 August 2009. http://www.qualitymeasures.ahrq.gov/expert/expert-commentary.aspx?id=16458 (accessed 15 Oct).,Non-OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
ONC Data Brief 2012. http://www.healthit.gov/media/pdf/ ONC_Data_Brief_AHA_2011.pdf (accessed 5 Mar 2013).,OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
"Centers for Medicare & Medicaid Services, 2010. https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/MU_Stage1_ReqOverview.pdf(accessed 5 Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
"Oakbrook Terrace, IL, 2012. http://www.jointcommission.org/ speci ﬁcations_manual_for_national_hospital_inpatient_quality_measures.aspx (accessed 15 Oct 2012).10 Dolin RH, Mattison JE, Cohn S, et al.",Non-OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
2011. http://www.cdc.gov/nhsn/pdfs/ ﬁnal-ach-ssi-guidance.pdf (accessed 10 Dec 2012).,OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
"Washington, DC: Centers for Medicare and Medicaid Services, 2012. http://www.hospitalcompare.hhs.gov/ (accessed 10 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
J Healthc Qual 2012. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
American Medical News 2012. http://www.ama-assn.org/amednews/2012/04/02/prsb0402.,Non-OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
"Sacramento, CA: California Department of Public Health, 2012. http://www.cdph.ca.gov/programs/ hai/Pages/SurgicalSiteInfections-Report.aspx (accessed 9 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
Healthc Inform 2012. http://www.healthcare-informatics.com/article/ report-ehi-forum-moving-ehrs-transactions-analytics (accessed 5 Mar 2013).,OADS,/arxiv_data1/oa_pdf/29/b3/amiajnl-2013-001789.PMC3912717.pdf
"It also provides an alphabetized list of websites and topics related to genomics (genomic resources)http://www.cdc.gov/genomics/ Evaluation of Genomic Applications in Practice and Prevention (EGAPP) 83 Established in 2004 by the CDC ’sO fﬁce of Public Health Genomics Goal: “establish a systematic, evidence based process for assessing genetic tests and the application of genetic technology in transition from research to clinical and public health practice ” http://www.egappreviews.org GeneTests12 Sponsored by the University of Washington, Seattle and Bioreference LaboratoriesProvides authoritative information from global genetic experts on genetic testing and its use in diagnosis, management and treatmentof diseasewww.genetests.org Genetic Testing Registry (GTR) 84 Established in 2012 by the NIHGoal: to provide “a central location for the voluntary submission of genetic test information by providers (including) the test ’s purpose, methodology, validity, evidence of the test ’s usefulness, and laboratory contacts and credentials (in order to) advance the public health and research into the genetic basis of health and disease ” Intended audience: providers and researchersNo NIH oversight (voluntary submission of information)GTR to replace GeneTests Laboratory directory in 2013http://www.ncbi.nlm.nih.gov/gtr Genomic Applications in Practice and Prevention Network (GAPPNet) 85 Established in 2009 by the CDC ’sO fﬁce of Public Health Genomics, the National Cancer Institute ’s Division of Cancer Control and Population Sciences and other stakeholdersGoal: “to accelerate and streamline effective and responsible use of validated and useful genomic knowledge and applications, such as genetic tests, technologies, and family history, into clinical and public health practice ” http://www.cdc.gov/genomics/translation/GAPPNet Genomics Applications in Practice and Prevention Knowledge Base (GAPP KB) 86 Supported by the CDC ’sO fﬁce of Public Health Genomics Goal: to provide access to information on applications of genomic research to healthcare.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
"This site provides links to four other sitesthat provide information on genomic applications (GAPPFinder), genomic test evidence (the evidence aggregator), genomic researchstudies archive (the project locator), and the online journal of genomic research ( PLoS Currents: Evidence on Genomic Tests ) http://www.hugenavigator.net/GAPPKB/home.do Human Genome Epidemiology Network (HuGENet) 87 Established by the CDC ’sO fﬁce of Public Health Genomics A volunteer collaborative effort “to help translate genetic research ﬁndings into opportunities for preventive medicine and public health.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
"” http://www.cdc.gov/genomics/hugenet Institute of Medicine of the National Academies: Roundtable on Translating Genomic-Based Research for Health88 A non-pro ﬁt, multidisciplinary collaborative effort of leaders from academia, industry and government to translate genomic research ﬁndings into health care, education and policy improvements http://www.iom.edu/Activities/Research/GenomicbasedResearch.aspx Online Mendelian Inheritance of Man —(OMIM)89 A catalog of human genes and genetic disorders maintained by experts in genetics at Johns Hopkins University Intended audience: providers and researchershttp://www.omim.org Pharmacogenomics Knowledgebase (PharmGKB) 90 An authoritative “pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype –phenotype relationships.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
"” http://www.pharmgkb.org US DHHS Secretary ’s Advisory Committee on Heritable Disorders in Newborns and Children —(SACHDNC)91 92 A website containing information on the SACHDNC ’s recommendations to the secretary of the US Department of Health and Human Services on the “most appropriate application of universal newborn screening tests, technologies, policies, guidelines and standards.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
"” http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/ Shoenbill K, et al.J Am Med Inform Assoc 2014; 21:171–180.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Lose EJ.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.himss.org/ASP/topics clinicalDecision.asp.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.fda.gov/ MedicalDevices/DeviceRegulationandGuidance/IVDRegulatoryAssistance/ ucm124105.htm.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.fda.gov/downloads/ AdvisoryCommittees?CommitteesMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/MolecularandClinicalGeneticsPanel/UCM245660.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.ncbi.nlm.nih.gov/sites/GeneTests.,OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://ghr.nlm.nih.gov/ glossary=personalizedmedicine.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://oba.od.nih.gov/SACGHS/sacghs_documents.html.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.23andme.com.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.decodeme.com.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
"http://www.navigenics.com.37 Bunnik EM, Schermer MH, Janssens AC.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.gao.gov/products/GAO.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
3 August 2012. http://www.ftc.gov/bcp/edu/pubs/consumer/health/hea02.shtm.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.hhs.gov/ocr/privacy/.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.healthcare.gov/law/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.cdc.gov/ genomics/ 83 EGAPP Work Group.,OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.egappreviews.org.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.ncbi.nlm.nih.gov/gtr/.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.cdc.gov/genomics/translation/GAPPNet.,OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.hugenavigator.net/GAPPKB/home.do.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.cdc.gov/ genomics/hugenet.,OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.iom.edu/Activities/Research/GenomicBasedResearch.aspx.,OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.omim.org.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.pharmgkb.org.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.uspreventiveservicestaskforce.org/methods.htm.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
http://www.abmg.org.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
"http://www.bioethics,gov/cms/sites/ default/ ﬁles/PrivacyProgress508.pdf.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amiajnl-2013-001694.PMC3912723.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ amiajnl-2012-001377).,OADS,/arxiv_data1/oa_pdf/b1/af/amiajnl-2012-001377.PMC3912724.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Xierali IM, Chun-Ju H, Puffer JC, et al.",Non-OADS,/arxiv_data1/oa_pdf/b1/af/amiajnl-2012-001377.PMC3912724.pdf
http://www.opencongress.org/bill/111-h1/show(accessed 5 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/b1/af/amiajnl-2012-001377.PMC3912724.pdf
https://www.cchit.org/ ﬁnd-cchit (accessed 20 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/b1/af/amiajnl-2012-001377.PMC3912724.pdf
"Various methods, ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.6.269 pISSN 2234-7550 ·eISSN 2234-5930 Jong-Wan Kim Department of Orthodontics, Section of Dentistry, Seoul National University Bundang  Hospital, 82, Gumi-ro 173 beon-gil, Bundang-gu, Seongnam 463-707, Korea TEL: +82-31-787-7549   FAX: +82-31-787-4068 E-mail: kimjongwan@hotmail.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/91/a9/jkaoms-39-269.PMC3912779.pdf
"Likewise, lack of bone mass hampers  implant restoration in the posterior maxillary region.ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.6.274 pISSN 2234-7550 ·eISSN 2234-5930 Il-Kyu Kim Department of Oral and Maxillofacial Surgery, Department of Dentistry, Inha  University School of Medicine, 27, Inhang-ro, Jung-gu, Incheon 400-711, Korea TEL: +82-32-890-2470   FAX: +82-32-890-2475 E-mail: kik@inha.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/09/11/jkaoms-39-274.PMC3912780.pdf
TGF-β and IGF play an important role EDITORIALhttp://dx.doi.org/10.5125/jkaoms.2013.39.6.255 pISSN 2234-7550 ·eISSN 2234-5930,Non-OADS,/arxiv_data1/oa_pdf/db/a4/jkaoms-39-255.PMC3912781.pdf
"Tibia can also be used as a bone graft due to its low  complication rate, simple technique, and sufficient cancellous  bone including cortical bone compared to any other site ex- cept the jaw.ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.6.257 pISSN 2234-7550 ·eISSN 2234-5930 Il-Kyu Kim Department of Oral and Maxillofacial Surgery, Department of Dentistry, Inha  University School of Medicine, 27, Inhang-ro, Jung-gu, Incheon 400-711, Korea TEL: +82-32-890-2470   FAX: +82-32-890-2475 E-mail: kik@inha.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/53/d9/jkaoms-39-257.PMC3912782.pdf
"However, the radiogram ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.6.263 pISSN 2234-7550 ·eISSN 2234-5930 Chul-Hwan Kim Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook  University, 119, Dandae-ro, Dongnam-gu, Cheonan 330-714, Korea TEL: +82-41-550-1996   FAX: +82-41-551-8988 E-mail: kimchoms@dankook.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/2f/d3/jkaoms-39-263.PMC3912783.pdf
"In	patients	with	moyamoya	 disease,	it	is	extremely	important	to	prevent	cerebral	ischemic	 attacks	and	intracerebral	bleeding	caused	by	ﬂuctuating	blood	CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.6.289 pISSN 2234-7550 ·eISSN 2234-5930 Mika Seto Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka  University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan TEL: +81-092-801-1011   FAX: +81-092-801-1044 E-mail: myamyu43729@yahoo.co.jp    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/d0/a6/jkaoms-39-289.PMC3912784.pdf
"Nonetheless, concerns of early failure or long-term  stability to TMJ prosthesis such as knee or hip joint remain  after multiple complication from the installation of Proplast- Teﬂon (Vitek Inc., Houston, TX, USA) in TMJ in the United CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.6.297 pISSN 2234-7550 ·eISSN 2234-5930 Jong-Ki Huh Department of Oral and Maxillofacial Surgery, Gangnam Severance Hospital,  College of Dentistry, Yonsei University, 211, Eonju-ro, Gangnam-gu, Seoul  135-720, Korea TEL: +82-2-2019-4560   FAX: +82-2-3463-4052 E-mail: omshuh@yuhs.ac     This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/f9/d7/jkaoms-39-297.PMC3912785.pdf
"Histologically, all cases of HCCC demonstrate the features CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.6.283 pISSN 2234-7550 ·eISSN 2234-5930 Woong Nam Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei  University, 50, Yonsei-ro, Seodaemoon-gu, Seoul 120-752, Korea TEL: +82-2-2228-2971   FAX: +82-2-2227-8022 E-mail: omsnam@yuhs.ac    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/80/f2/jkaoms-39-283.PMC3912786.pdf
"CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.6.292 pISSN 2234-7550 ·eISSN 2234-5930 Kwang-Ho Park Department of Oral and Maxillofacial Surgery, Gangnam Severance Hospital,  College of Dentistry, Yonsei University, 211, Eonju-ro, Gangnam-gu, Seoul  135-720, Korea TEL: +82-2-2019-4560   FAX: +82-2-3463-4052 E-mail: omspark@yuhs.ac    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/c0/46/jkaoms-39-292.PMC3912787.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/49/ahmt-4-079.PMC3912854.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpAdolescent Health, Medicine and Therapeutics 2013:4 79–87Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  79Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S29462Raltegravir for Hiv -1 infected children   and adolescents: efficacy, safety,   and pharmacokinetics Kajal B Larson Jennifer R King edward P Acosta Department of Pharmacology and  T oxicology, University of Alabama  at Birmingham, Birmingham, AL, USA Correspondence: edward P Acosta   Department of Pharmacology and  Toxicology, Division of Clinical  Pharmacology, School of Medicine,  Volker Hall – Room 258, University   of Alabama at Birmingham,   1670 University Boulevard,   Birmingham, AL 35294-0019, USA   Tel +1 205 934 2655   Fax +1 205 934 6201   email eacosta@uab.ed uAbstract:  Raltegravir was the first HIV integrase strand-transfer inhibitor to be approved by  the US FDA, in October 2007, for the treatment of HIV -1 infection in combination with other  antiretroviral agents.",Non-OADS,/arxiv_data1/oa_pdf/da/49/ahmt-4-079.PMC3912854.pdf
"Available  from: http://www.who.int/mediacentre/factsheets/fs360/en/index.htm l.  Accessed March 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/da/49/ahmt-4-079.PMC3912854.pdf
"Available from: http://www.who.int/hiv/topics/mtct/en/index.htm l.  Accessed March 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/da/49/ahmt-4-079.PMC3912854.pdf
Available from: http://www.who.int/hiv/topics/paediatric/en/index.,Non-OADS,/arxiv_data1/oa_pdf/da/49/ahmt-4-079.PMC3912854.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2009/022145s004lbl.pd f. Accessed March 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/da/49/ahmt-4-079.PMC3912854.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/da/49/ahmt-4-079.PMC3912854.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/49/ahmt-4-079.PMC3912854.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2014; 36(4): 265–275 !2014 Informa UK Ltd. DOI: 10.3109/09638288.2013.785602 REVIEW A systematic review on how to conduct evaluations in community-based rehabilitation Marie Grandisson1,2, Miche `le He ´bert1, and Rachel Thibeault1 1School of Rehabilitation, Faculty of Health Sciences, University of Ottawa, Canada and2Occupational Therapy Department, Universite ´du Que´bec a`Trois-Rivie `res, Canada Abstract Purpose : Community-based rehabilitation (CBR) must prove that it is making a significant difference for people with disabilities in low- and middle-income countries.",Non-OADS,/arxiv_data1/oa_pdf/c3/f4/DRE-36-265.PMC3913006.pdf
Geneva: WHO Press; 2010.Available from: http://www.who.int/disabilities/cbr/en/ [lastaccessed 12 Apr 2013].,Non-OADS,/arxiv_data1/oa_pdf/c3/f4/DRE-36-265.PMC3913006.pdf
Available from: http://www.who.int/ disabilities/cbr/en/ [last accessed 12 Apr 2013].,Non-OADS,/arxiv_data1/oa_pdf/c3/f4/DRE-36-265.PMC3913006.pdf
Available from: http://www.casp-uk.net [last accessed 12 Apr2013].,Non-OADS,/arxiv_data1/oa_pdf/c3/f4/DRE-36-265.PMC3913006.pdf
Available from: http://www.who.int/disabilities/cbr/en/ [last accessed 12 Apr 2013].,Non-OADS,/arxiv_data1/oa_pdf/c3/f4/DRE-36-265.PMC3913006.pdf
Available from: http://unipd-centrodirittiumani.it/public/docs/34011_planning.pdf [lastaccessed 12 Apr 2013].,Non-OADS,/arxiv_data1/oa_pdf/c3/f4/DRE-36-265.PMC3913006.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2014; 36(4): 339–343 !2014 Informa UK Ltd. DOI: 10.3109/09638288.2013.791728 REHABILITATION IN PRACTICE Questionnaire assessment of usual practice in mood and cognitive assessment in Scottish stroke units Rosalind A. Lees1, Niall M. Broomfield2, and Terence J. Quinn1 1Institute of Cardiovascular and Medical Sciences and2Institute of Health and Well Being, University of Glasgow, Glasgow, United Kingdom Abstract Purpose : National and International guidelines recommend cognition and mood assessment for all stroke survivors.",Non-OADS,/arxiv_data1/oa_pdf/f6/9c/DRE-36-339.PMC3913011.pdf
We hosted the questionnaire on an open-access web-site (http://www.surveymonkey.com/s/N7QXYW9).,OADS,/arxiv_data1/oa_pdf/f6/9c/DRE-36-339.PMC3913011.pdf
This focus group study was conducted according to the stan- dards of the Market Research Society (http://www.mrs.org.uk/standards/#standards).,Non-OADS,/arxiv_data1/oa_pdf/50/8f/CMT-17-29.PMC3913012.pdf
Acknowledgements   The author is supported by the COST Action  BM1004 (http://www.cost-essea.com/).,Non-OADS,/arxiv_data1/oa_pdf/b9/11/ASL-16-15.PMC3913013.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004137).,Non-OADS,/arxiv_data1/oa_pdf/19/ec/bmjopen-2013-004137.PMC3913022.pdf
http://www.aihw.gov.au/publication-detail/?,Non-OADS,/arxiv_data1/oa_pdf/19/ec/bmjopen-2013-004137.PMC3913022.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004295).,Non-OADS,/arxiv_data1/oa_pdf/f7/4a/bmjopen-2013-004295.PMC3913023.pdf
"Quality and Outcomes Framework (QOF), Guidance — Updated August 2004, 2004:59. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4088693.pdf(accessed 18 Oct, 2013).",OADS,/arxiv_data1/oa_pdf/f7/4a/bmjopen-2013-004295.PMC3913023.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004208).,Non-OADS,/arxiv_data1/oa_pdf/fe/4f/bmjopen-2013-004208.PMC3913024.pdf
2009. http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/fe/4f/bmjopen-2013-004208.PMC3913024.pdf
http://www.stata-journal.com/article.html?,Non-OADS,/arxiv_data1/oa_pdf/fe/4f/bmjopen-2013-004208.PMC3913024.pdf
"2008. http://bm.dk/ 8 Dalager-Pedersen M, Koch K, Wernich Thomsen R, et al.BMJ Open 2014; 4:e004208.",Non-OADS,/arxiv_data1/oa_pdf/fe/4f/bmjopen-2013-004208.PMC3913024.pdf
2005. http://www.dors.dk/sw1147.asp (accessed 8 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/fe/4f/bmjopen-2013-004208.PMC3913024.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003269).,Non-OADS,/arxiv_data1/oa_pdf/13/f0/bmjopen-2013-003269.PMC3913025.pdf
http://www.afro.who.int/index.php?option=com_content&view=article&id=2486:rotavirus-surveillance-in-the-african-region&catid=1980&Itemid=2737(accessed 26 Jul 2013).,OADS,/arxiv_data1/oa_pdf/13/f0/bmjopen-2013-003269.PMC3913025.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003888).,Non-OADS,/arxiv_data1/oa_pdf/75/1d/bmjopen-2013-003888.PMC3913026.pdf
http://acg.jhsph.edu.,Non-OADS,/arxiv_data1/oa_pdf/75/1d/bmjopen-2013-003888.PMC3913026.pdf
http://acg.jhsph.edu 25.,Non-OADS,/arxiv_data1/oa_pdf/75/1d/bmjopen-2013-003888.PMC3913026.pdf
"Secondary Local Health Integration Networks, 2006. http://www.lhins.on.ca/ 27.",Non-OADS,/arxiv_data1/oa_pdf/75/1d/bmjopen-2013-003888.PMC3913026.pdf
"Secondary Health Force Ontario: Family Practice Models, 2013. http://www.healthforceontario.ca/en/Home/Physicians/Training_%7C_Practising_in_Ontario/Physician_Roles/ Family_Practice_Models 28.",Non-OADS,/arxiv_data1/oa_pdf/75/1d/bmjopen-2013-003888.PMC3913026.pdf
2008. http://www.acreu.ca/pdf/pub5/08-03.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/75/1d/bmjopen-2013-003888.PMC3913026.pdf
doi:10.1136/bmjopen-2013- 004389 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004389).,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/bmjopen-2013-004389.PMC3913027.pdf
Randomisation will be performed using the secure online service provided by SealedEnvelope (http://www.sealedenvelope.com).,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/bmjopen-2013-004389.PMC3913027.pdf
2010. http://www.nice.org.uk/nicemedia/live/12695/47195/47195.pdf (accessed Mar 2010).,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/bmjopen-2013-004389.PMC3913027.pdf
2010. http://www.nice.org.uk/nicemedia/live/11748/47177/47177.pdf (accessed Mar 2010).,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/bmjopen-2013-004389.PMC3913027.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004596).,Non-OADS,/arxiv_data1/oa_pdf/41/e8/bmjopen-2013-004596.PMC3913028.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004214).,Non-OADS,/arxiv_data1/oa_pdf/09/47/bmjopen-2013-004214.PMC3913034.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/09/47/bmjopen-2013-004214.PMC3913034.pdf
"1, D-30625 Hannover, Germany * Corresponding author: Burkhard Tümmler (tuemmler.burkhard@mh-hannover.de) F1000Prime Reports 2014, 6:9 (doi:10.12703/P6-9) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/9 Abstract Pseudomonas aeruginosa , the type species of pseudomonads, is an opportunistic pathogen that colonizes a wide range of niches.",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"Recentwork has made P. aeruginosa into a model organism for the study of bacterial genome integrity in the context of Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:9 http://f1000.com/prime/reports/b/6/9",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"Exopolysaccharide biosynthesis, Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:9 http://f1000.com/prime/reports/b/6/9",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"Besides these global genome-wide approaches,more thematically-oriented research is prospering in the Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:9 http://f1000.com/prime/reports/b/6/9",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"Lee DG, Urbach JM,Wu G,Liberati NT, Feinbaum RL,Miyata S, Diggins LT,HeJ,Saucier M,Déziel E,Friedman L,LiL,Grills G, Montgomery K,Kucherlapati R,Rahme LG,Ausubel FM:Genomic Page 5of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:9 http://f1000.com/prime/reports/b/6/9",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:9 http://f1000.com/prime/reports/b/6/9",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"Blanka A, Schulz S, Eckweiler D, Franke R, Bielecka A, Nicolai T, Casilag F, Düvel J, Abraham W, Kaever V, Häussler S: Identification of the alternative sigma factor SigX regulon and its Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:9 http://f1000.com/prime/reports/b/6/9",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"Leiman PG, Basler M, Ramagopal UA, Bonanno JB, Sauder JM, Pukatzki S, Burley SK, Almo SC, Mekalanos JJ: Type VI secretion Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:9 http://f1000.com/prime/reports/b/6/9",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:9 http://f1000.com/prime/reports/b/6/9",Non-OADS,/arxiv_data1/oa_pdf/d0/5d/biolrep-06-09.PMC3913036.pdf
"http://informahealthcare.com/jas ISSN: 0277-0903 (print), 1532-4303 (electronic) J Asthma, 2014; 51(1): 51–57 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/02770903.2013.843096 ASTHMA IN THE PRIMARY CARE SETTING Asthma care practicing among general practitioners in Lebanon: a cross-sectional study Hani Lababidi, MD, FCCP, FACP1, Amani K. Abu-Shaheen, MPH2, Iyad A. Bou Mehdi, DM3, and Mohamad A. AL-Tannir, DMD, MPH2 1Pulmonary & Critical Care Department, King Fahad Medical City Hospital, Riyadh, Saudi Arabia,2Research and Scientific Publication Center, King Fahad Medical City Hospital, Riyadh, Saudi Arabia, and3Medical School, Lebanese University, Beirut, Lebanon Abstract Objectives : The aim of this study was to characterize the current practice of asthma among general practitioners (GPs) in Lebanon.",Non-OADS,/arxiv_data1/oa_pdf/88/38/JAS-51-51.PMC3913077.pdf
Available from: http://www.who.int/chp/knowledge/publica- tions/adherence [last accessed 2 Apr 2013].,Non-OADS,/arxiv_data1/oa_pdf/88/38/JAS-51-51.PMC3913077.pdf
Available from: http://www.gina.com[last accessed 13 Apr 2013].,Non-OADS,/arxiv_data1/oa_pdf/88/38/JAS-51-51.PMC3913077.pdf
"Making a difference in the manage- ment of asthma: a guide for respiratory therapists 2003, 02-1964.Available from: http://www.nhlbi.nih.gov/health/prof/lung/asthma/asth_respir.pdf [last accessed 5 May 2013].",Non-OADS,/arxiv_data1/oa_pdf/88/38/JAS-51-51.PMC3913077.pdf
"http://informahealthcare.com/bmg ISSN: 1040-9238 (print), 1549-7798 (electronic) Editor: Michael M. Cox Crit Rev Biochem Mol Biol, 2014; 49(1): 59–68 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/10409238.2013.857291 REVIEW ARTICLE Signaling pathways controlling skeletal muscle mass Marc A. Egerman and David J.",Non-OADS,/arxiv_data1/oa_pdf/45/99/BMG-49-59.PMC3913083.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003839).,Non-OADS,/arxiv_data1/oa_pdf/5c/87/bmjopen-2013-003839.PMC3913087.pdf
"The department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, theprivate-public funded Top Institute Pharma (http://www.tipharma.nl, includes cofunding from universities, government and industry), the Dutch Medicines Evaluation Board and the Dutch Ministry of Health.",Non-OADS,/arxiv_data1/oa_pdf/5c/87/bmjopen-2013-003839.PMC3913087.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/87/bmjopen-2013-003839.PMC3913087.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/28/4a/bmjopen-2013-004311.PMC3913088.pdf
"Bruising in children who are assessed for suspected physical abuse Alison Mary Kemp,1Sabine Ann Maguire,1Diane Nuttall,1Peter Collins,2 Frank Dunstan1 1Early Years Research Programme, Institute of Primary Care and Public Health, College of Biomedicaland Life Sciences, School ofMedicine, Cardiff University, Cardiff, UK 2Department of Haematology, Institute of Infection andImmunity, School of Medicine, Cardiff University, Cardiff, UK Correspondence to Professor Alison Kemp, PrimaryCare and Public Health, Schoolof Medicine, Cardiff University, 4th Floor Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS,UK; kempam@cardiff.ac.uk Received 25 April 2013 Revised 5 August 2013 Accepted 7 August 2013Published Online First16 September 2013 ▸http://dx.doi.org/10.1136/ archdischild-2013-304689 To cite: Kemp AM, Maguire SA, Nuttall D, et al.",Non-OADS,/arxiv_data1/oa_pdf/6f/b0/archdischild-2013-304339.PMC3913107.pdf
"See: http://creativecommons.org/licenses/by/3.0/ REFERENCES 1 Fagan J, Dore MM.",Non-OADS,/arxiv_data1/oa_pdf/6f/b0/archdischild-2013-304339.PMC3913107.pdf
"https://www.education.gov.uk/ publications/standard/publicationDetail/Page1/DCSF-00305-2010 7 Brinkmann B, Püschel K, Mätzsch T. Forensic dermatological aspects of the battered child syndrome.",Non-OADS,/arxiv_data1/oa_pdf/6f/b0/archdischild-2013-304339.PMC3913107.pdf
"To view these ﬁles please visit the journal online (http://dx.doi.org/ 10.1136/sextrans-2012- 050655) 1University College London, Medical School, London, UK 2Sexual Health In Practice, Heart of England NHS Foundation Trust, Birmingham, UK 3Research Department of Infection and Population Health, University College London, London, UK 4Killick Street Health Centre, Islington, London, UK Correspondence to Timesh D Pillay, University College London, Medical School, Rockefeller Building, University Street, London WC1E 6BT , UK; t.pillay@ucl.ac.uk Accepted 23 August 2012 Published Online First 8 October 2012ABSTRACT Background This longitudinal study aimed to evaluate the impact of a multifaceted educational intervention (Sexual Health in Practice, SHIP) on general practice HIV testing rates in a high prevalence London area.",Non-OADS,/arxiv_data1/oa_pdf/6d/7d/postgradmedj-2012-050655rep.PMC3913108.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/7d/postgradmedj-2012-050655rep.PMC3913108.pdf
http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/SexualHealth ProﬁlesAndIndex/SexualHealthPro ﬁlesPerformance/ 32.,Non-OADS,/arxiv_data1/oa_pdf/6d/7d/postgradmedj-2012-050655rep.PMC3913108.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/heartjnl-2013-305021).,Non-OADS,/arxiv_data1/oa_pdf/21/d7/heartjnl-2013-305021.PMC3913109.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ To cite Ferreira VM, Piechnik SK, Firoozan S, et al.Heart 2014; 100:351.",Non-OADS,/arxiv_data1/oa_pdf/21/d7/heartjnl-2013-305021.PMC3913109.pdf
"ORIGINAL ARTICLE Myocardial scar burden predicts survival bene ﬁt with implantable cardioverter de ﬁbrillator implantation in patients with severe ischaemiccardiomyopathy: in ﬂuence of gender Deborah H Kwon,1,2Rory Hachamovitch,1Aderonke Adeniyi,1Benjamin Nutter,1 Zoran B Popovic,1,2Bruce L Wilkoff,1Milind Y Desai,1,2Scott D Flamm,2 Thomas Marwick3 1Heart and Vascular Institute, Cleveland Clinic, Cleveland,Ohio, USA 2Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA 3Menzies Research Institute of Tasmania, Hobart, Australia Correspondence to Dr Deborah H Kwon, Department of CardiovascularMedicine, Cleveland Clinic,9500 Euclid Avenue, J1-5, Cleveland, OH 44195, USA; kwond@ccf.org Received 26 July 2013 Revised 13 September 2013 Accepted 8 October 2013 Published Online First1 November 2013 ▸http://dx.doi.org/10.1136/ heartjnl-2013-305072 To cite: Kwon DH, Hachamovitch R, Adeniyi A, et al.Heart 2014; 100:206– 213.ABSTRACT Objective We sought to assess the impact of myocardial scar burden (MSB) on the associationbetween implantable cardioverter de ﬁbrillator (ICD) implantation and mortality in patients with ischaemiccardiomyopathy (ICM) and left ventricular EF ≤40%.",Non-OADS,/arxiv_data1/oa_pdf/e5/03/heartjnl-2013-304261.PMC3913110.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ 212 Kwon DH, et al.Heart 2014; 100:206–213.",Non-OADS,/arxiv_data1/oa_pdf/e5/03/heartjnl-2013-304261.PMC3913110.pdf
"1National Nursing Research Unit, Florence Nightingale School of Nursing and Midwifery, King ’s College London, London, UK 2Florence Nightingale School of Nursing and Midwifery, King ’s College London, London, UK 3Faculty of Health Sciences, University of Southampton, London, UK Correspondence to Jane E Ball, National Nursing Research Unit, FlorenceNightingale School of Nursing and Midwifery, James Clerk Maxwell Building, 57 Waterloo Road, London SE1 8WA, UK; Jane.ball@kcl.ac.uk Received 18 December 2012 Revised 3 June 2013Accepted 6 June 2013 Published Online First 29 July 2013 ▸http://dx.doi.org/10.1136/ bmjqs-2013-002489 To cite: Ball JE, Murrells T, Rafferty AM, et al.BMJ Qual Saf2014; 23:116 –125.ABSTRACT Background There is strong evidence to show that lower nurse staffing levels in hospitals are associated with worse patient outcomes.",Non-OADS,/arxiv_data1/oa_pdf/44/e9/bmjqs-2012-001767.PMC3913111.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Ham C. Health policy in Britain, public policy and politics .",Non-OADS,/arxiv_data1/oa_pdf/44/e9/bmjqs-2012-001767.PMC3913111.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Branch Vein Occlusion Study Group.,Non-OADS,/arxiv_data1/oa_pdf/90/6b/bjophthalmol-2013-303121.PMC3913112.pdf
"Bethesda: US Department of Health and Human Services, 2011. http://www.nei.nih.gov/strategicplanning/np_low.asp 21 Hoeh AE, Ach T, Schaal KB, et al .",Non-OADS,/arxiv_data1/oa_pdf/90/6b/bjophthalmol-2013-303121.PMC3913112.pdf
An Excel spreadsheet ‘RD from BR and RR.xls ’to perform all the calculations described in this article is freely downloadable from: http://medicine.cf.ac.uk/primary-care-public-health/resources/ The calculations in the spreadsheet start with estimates of the BR and RR and the corresponding CIs.,Non-OADS,/arxiv_data1/oa_pdf/e1/f1/ebmed-2013-101340.PMC3913115.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/eb-2013-101340).,Non-OADS,/arxiv_data1/oa_pdf/e1/f1/ebmed-2013-101340.PMC3913115.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ References 1.Guyatt GH, Oxman AD, Schünemann HJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/f1/ebmed-2013-101340.PMC3913115.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org Open Access Scan to access more free content 8 Evid Based Med February 2014 |volume 19 |number 1 |Methods",Non-OADS,/arxiv_data1/oa_pdf/e1/f1/ebmed-2013-101340.PMC3913115.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Spivak JL, Silver RT.",Non-OADS,/arxiv_data1/oa_pdf/9e/cd/jclinpath-2013-201822.PMC3913116.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Stangier J, Rathgen K, Stahle H, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/a4/emermed-2012-201976.PMC3913117.pdf
2012; http://guidance.nice.org.uk/TA/Wave21/10 (accessed 18 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/37/a4/emermed-2012-201976.PMC3913117.pdf
2011; http://www.scottishmedicines.org.,Non-OADS,/arxiv_data1/oa_pdf/37/a4/emermed-2012-201976.PMC3913117.pdf
2012 (Last updated on eMC: 30/04/2012); http://www.medicines.org.uk/emc/medicine/24839/SPC/ (accessed 14Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/37/a4/emermed-2012-201976.PMC3913117.pdf
Am Soc Hematol 2011; http://www.hematology.org/Practice/Guidelines/2934.aspx (accessed 18 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/37/a4/emermed-2012-201976.PMC3913117.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite Stovitz SD, Shrier I. Br J Sports Med 2014; 48:285–286.",Non-OADS,/arxiv_data1/oa_pdf/9c/2a/bjsports-2012-091619.PMC3913118.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/REFERENCES 1 Kohn LT , Corrigan J, Donaldson MS. To err is human: building a safer health system .",Non-OADS,/arxiv_data1/oa_pdf/e4/07/bmjqs-2013-002220.PMC3913119.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/thoraxjnl-2013-204667).,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/thoraxjnl-2013-204667.PMC3913120.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Torbicki A, Perrier A, Konstantinides S, et al.",Non-OADS,/arxiv_data1/oa_pdf/bf/bb/thoraxjnl-2013-204667.PMC3913120.pdf
http://clinicaltrialresults.org/Slides/ACC%202013/Konstantinides_PEITHO_ACC%202013.pdf (accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/thoraxjnl-2013-204667.PMC3913120.pdf
http://www.medicines.org.uk/emc/document.aspx?documentId=308 (accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/thoraxjnl-2013-204667.PMC3913120.pdf
http://www.rcog.org.uk/ ﬁles/rcog-corp/GTG37b_230611.pdf (accessed Nov 2013).,OADS,/arxiv_data1/oa_pdf/bf/bb/thoraxjnl-2013-204667.PMC3913120.pdf
Rivaroxiban for treating pulmonary embolism and preventing recurrent venous thromboembolism.Technology Appraisal Guidance 287. http://guidance.nice.org.uk/TA287 (accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/thoraxjnl-2013-204667.PMC3913120.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Peto J, Hodgson JT, Matthews FE, et al .",Non-OADS,/arxiv_data1/oa_pdf/10/b9/thoraxjnl-2013-203846.PMC3913121.pdf
http://www.imig2012.org/documents/ iMig2012_AbstractBook_vF_Sept10_REV.pdf 29 NCCN guidelines for patients: malignant pleural mesothelioma: national cancer collaborative network.,Non-OADS,/arxiv_data1/oa_pdf/10/b9/thoraxjnl-2013-203846.PMC3913121.pdf
"http://www.nccn.org/patients/patient_guidelines/mpm/ ﬁles/ assets/basic-html/page22.html 30 Qaseem A, Forland F, Macbeth F, et al .",Non-OADS,/arxiv_data1/oa_pdf/10/b9/thoraxjnl-2013-203846.PMC3913121.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Easton JD, Saver JL, Albers GW ,et al.",Non-OADS,/arxiv_data1/oa_pdf/56/c1/practneurol-2013-000782.PMC3913122.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2012-304149).,OADS,/arxiv_data1/oa_pdf/50/8e/gutjnl-2012-304149.PMC3913123.pdf
11The protocol is accessible at https://www.healthstudies.umn.edu/trc/presept/presept_protocol _rev_2.pdf (accessed 5 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/50/8e/gutjnl-2012-304149.PMC3913123.pdf
"Assay accuracy measures Figure 3 plots the standardised positivity rates and CI for themSEPT9 assay results by diagnostic outcome of the Figure 1 Enhanced STAndards for the Reporting of Diagnostic accuracy studies (STARD) diagram of the disposition of subjects in the study,23 based on the template at http://www.stard-statement.org.aGerman law requires that data from subjects in Germany who withdrew cannot be retained or used for study purposes.bCR, colorectal.cSample either had too little volume or was unusable.dHGD, high grade dysplasia.eCases selected for laboratory analysis in a strati ﬁed random sampling.",Non-OADS,/arxiv_data1/oa_pdf/50/8e/gutjnl-2012-304149.PMC3913123.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Jemal A, Siegel R, Xu J, et al.",Non-OADS,/arxiv_data1/oa_pdf/50/8e/gutjnl-2012-304149.PMC3913123.pdf
http://clinicaltrials.gov/ct2/show/NCT00855348 (accessed 3 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/50/8e/gutjnl-2012-304149.PMC3913123.pdf
2003. http://www.census.gov/popest/data/historical/2000s/vintage_2003/index.html (accessed 3 Feb 2013).,OADS,/arxiv_data1/oa_pdf/50/8e/gutjnl-2012-304149.PMC3913123.pdf
"International Data Base (IDB), 2009. http://www.census.gov/ population/international/data/idb/informationGateway.php (accessed 3 Feb 2013).",OADS,/arxiv_data1/oa_pdf/50/8e/gutjnl-2012-304149.PMC3913123.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Nguyen DH, Luo J, Zhang K, et al.",Non-OADS,/arxiv_data1/oa_pdf/62/e7/bjophthalmol-2013-303444.PMC3913166.pdf
http://www.ema.europa.eu/ema/ (last updated 27 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/62/e7/bjophthalmol-2013-303444.PMC3913166.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bates DW , Larizgoitia I, Prasopa-Plaizier N, et al.",Non-OADS,/arxiv_data1/oa_pdf/31/f3/bmjqs-2012-001730.PMC3913182.pdf
"edu; Masaki Shirayama, Email: masaki.shirayama@umassmed.eduSubmitted: 06/10/2013; Revised: 08/10/2013; Accepted: 08/26/2013http://dx.doi.org/10.4161/worm.26276Inductive asymmetric cell division The WRM leads the way Takao i shidate1,†, Soyoung Kim1,†, Craig Mello1,*, and Masaki Shirayama1,* 1RnA Therapeutics i nstitute; Program in Molecular Medicine; University of Massachusetts Medical School; Howard Hughes Medical i nstitute; w orcester, MA USA; †These  authors contributed equally to this work.",OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell 1997; 90:707- 16; PMID:9288750 ; http://dx.doi.org/10.1016/ S0092-8674(00)80531-0 2.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Proc Natl Acad Sci U S A 2013 ; 110:E918 - 27; PMID:23431196 ; http://dx.doi.org/10.1073/ pnas.1300769110 3.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Nature  1992 ; 357:255-7; PMID:1589023 ;  http://dx.doi.org/10.1038/357255a0 4.,Non-OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
J Cell Biol  1995 ; 129:1071 -80; PMID:7744956 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell  1999 ; 97:717-26; PMID:10380924 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Nature   1999 ; 399:793-7; PMID:10391246 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Genes Dev 1999 ; 13:2028 - 38; PMID:10444600 ; http://dx.doi.org/10.1101/ gad.13.15.2028 11.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Dev Cell  2002 ; 3:113-25; PMID:12110172 ;  http://dx.doi.org/10.1016/S1534-5807(02)00185-5 12.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Dev Cell   2004 ; 7:831-41; PMID:15572126 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Development  2003 ; 130:5717 - 30; PMID:14534135 ; http://dx.doi.org/10.1242/ dev.0079014.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Development  2011 ; 138:4411 -22;  PMID:21903670 ; http://dx.doi.org/10.1242/ dev.070979 15.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Genes Dev 2003 ; 17:1225 -39; PMID:12730122 ;  http://dx.doi.org/10.1101/gad.1081203 16.,Non-OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Curr Biol  2003 ; 13:1029 - 37; PMID:12814548 ; http://dx.doi.org/10.1016/ S0960-9822(03)00371-3 17.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
J Cell Sci 2008 ;  121:155-61; PMID:18187449 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
EMBO J 2001 ; 20:7197 - 208; PMID:11742996 ; http://dx.doi.org/10.1093/ emboj/20.24.7197 19.,Non-OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Dev Biol  2005 ; 285:584-92; PMID:16112103 ;  http://dx.doi.org/10.1016/j.ydbio.2005.07.008 20.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell  1995 ; 83:599-609; PMID:7585963 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell  1998 ; 92:229-39; PMID:9458047 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Genes Dev  2005 ; 19:1749 -54; PMID:16077004 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell  2004 ; 117:95-106; PMID:15066285 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Genetics  2004 ;  166:171-86; PMID:15020416 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell 2005 ; 121:761- 72; PMID :15935762 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Development  2011 ; 138:4255 -65; PMID:21852394 ;  http://dx.doi.org/10.1242/dev.06905427.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Development  2007 ; 134:2685 -95; PMID:17567664 ;  http://dx.doi.org/10.1242/dev.008268 28.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Proc Natl Acad Sci U S A  2007 ; 104:3231 -6; PMID:17296929 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Dev Cell  2009 ; 17:27-34;  PMID:19619489 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Genes Dev  2005 ; 19:1743 -8; PMID:16077003 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell 2011 ; 146:942-54;  PMID:21925317 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Curr Biol  2000 ; 10:865- 8; PMID:10899006 ; http://dx.doi.org/10.1016/ S0960-9822(00)00600-X 34.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Dev Cell  2005 ; 9:223- 36; PMID:16054029 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Mol Cell  1999 ; 4:275-80;  PMID:10488343 ; http://dx.doi.org/10.1016/ S1097-2765(00)80375-5 38.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Dev Dyn 2000 ; 218:23-9;  PMID:10822257 ; http://dx.doi.org/10.1002/ (SICI)1097-0177(200005)218:1<23::AID- DVDY3>3.0.CO;2-Z 39.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Curr Opin Genet  Dev 1994 ; 4:563-8; PMID:7950325 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Annu Rev Genet 1998 ; 32:521-45;  PMID:9928490 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Annu Rev Cell Dev Biol 2004 ; 20:427- 53; PMID:15473847 ; http://dx.doi.org/10.1146/ annurev.cellbio.19.111301.113823 42.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell  2000 ; 101:345-8; PMID:10830161 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Cell 1995 ;  83:743-52; PMID:8521491 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
Science   2013 ; 339:1445 -8; PMID:23520113 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ef/worm-2-e26276.PMC3913193.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004279).,Non-OADS,/arxiv_data1/oa_pdf/78/7a/bmjopen-2013-004279.PMC3913205.pdf
"Competing interests AW and NS are funded by an unrestricted research grant from Sanofi Pasteur and also by the UK National Institute for Health Research(NIHR), via the Imperial College ’s Patient Safety Translational Research Centre (http://www.cpssq.org).",Non-OADS,/arxiv_data1/oa_pdf/78/7a/bmjopen-2013-004279.PMC3913205.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/7a/bmjopen-2013-004279.PMC3913205.pdf
http://www.unicef.org/ immunization/index_bigpicture.html (accessed 1 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/78/7a/bmjopen-2013-004279.PMC3913205.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/References BEnOWITZ, n. L., JACOB, P .",Non-OADS,/arxiv_data1/oa_pdf/3d/c0/vetrec-2013-101810.PMC3913206.pdf
"To view please visit the journal online (http://dx.doi.org/10.1136/bjsports-2013-092897) Health Economics Research Group (HERG), Brunel University, Uxbridge, Middlesex, UK Correspondence to Dr Nana K Anokye, HealthEconomics Research Group (HERG), Brunel University, Uxbridge, Middlesex UB8 3PH,UK;Nana.Anokye@brunel.ac.uk Accepted 28 November 2013 Published Online First18 December 2013 To cite: Anokye NK, Lord J, Fox-Rushby J. Br J Sports Med 2014; 48:202–206.ABSTRACT Aim This study models the cost-effectiveness of brief advice (BA) in primary care for physical activity (PA)addressing the limitations in the current limitedeconomic literature through the use of a time-basedmodelling approach.Methods A Markov model was used to compare the lifetime costs and outcomes of a cohort of 100 000people exposed to BA versus usual care.",Non-OADS,/arxiv_data1/oa_pdf/90/7d/bjsports-2013-092897.PMC3913207.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Department of Health.,Non-OADS,/arxiv_data1/oa_pdf/90/7d/bjsports-2013-092897.PMC3913207.pdf
2012. http://www.uspreventiveservicestaskforce.org/ uspstf11/physactivity/physrs.htm (accessed Nov 2012).,OADS,/arxiv_data1/oa_pdf/90/7d/bjsports-2013-092897.PMC3913207.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Global strategy for asthma management and prevention.,Non-OADS,/arxiv_data1/oa_pdf/f6/80/thoraxjnl-2013-203557.PMC3913208.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Car J. Urinary tract infections in women: diagnosis and management in primary care.,Non-OADS,/arxiv_data1/oa_pdf/3b/a3/jclinpath-2013-201686.PMC3913209.pdf
"Health Protection Agency 2011 24 January 2013. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947404720 4 Lifshitz E, Kramer L. Outpatient urine culture: does collection technique matter?",Non-OADS,/arxiv_data1/oa_pdf/3b/a3/jclinpath-2013-201686.PMC3913209.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Wilkinson TM.,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
http://www.wma.net/en/30publications/10policies/t7 (accessed 29 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
2010 http://www.nhsbt.nhs.uk/downloads/board_papers/nov10/ odr_review_report.pdf (accessed 19 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
http://www.organdonation.nhs.uk/ukt/newsroom/fact_sheets/language_lea ﬂets/ organ_donation_english.pdf (accessed 30 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
2008. http://www.hta.gov.uk/_db/_documents/ July_08_Authority_papers_for_the_website.doc (accessed 29 Oct 2012).,OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
Requested allocation of a deceased donor organ .U K Health Departments 2010. http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH_114800 (accessed 19 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
2008. http://news.bbc.co.uk/1/hi/ england/bradford/7344205.stm (accessed 29 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
http://www.organdonation.nhs.uk/ukt/how_to_become_a_donor/living_kidney_donation/pdf/altruistic_living_kidney_donation.pdf (accessed19 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
2011. http://www.dailymail.co.uk/ health/article-2022285/Donor-organs-Month-old-baby-UKs-super-transplant-list-just-weeks-live-waits-liver.html (accessed 19 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
2011. http://www.bbc.co.uk/news/magazine-15253928 (accessed 19 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
http://www.uktransplant.org.uk/ukt/ adverts_and_video/adverts_and_video.jsp (accessed 19 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
2008 http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_082120.pdf (accessed29 Oct 2012).,OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
2010. http://www.gmc-uk.org/static/documents/content/Treatment_and_care_towards_the_end_of_life_-_English_1011.pdf (accessed29 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
2011. http://www.nice.org.uk/cg135 (accessed 19 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/d7/37/medethics-2012-100528.PMC3913211.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/heartjnl-2013-304958).,Non-OADS,/arxiv_data1/oa_pdf/35/0e/heartjnl-2013-304958.PMC3913216.pdf
"org Received 13 September 2013 Revised 26 September 2013Accepted 27 September 2013 Published Online First 31 October 2013 ▸http://dx.doi.org/10.1136/ heartjnl-2013-305011 To cite: Valente AM, Gauvreau K, Egidy Assenza G, et al.Heart 2014; 100:247 –253.ABSTRACT Objective Patients with repaired tetralogy of Fallot (TOF) experience increased rates of mortality andmorbidity in adulthood.",Non-OADS,/arxiv_data1/oa_pdf/35/0e/heartjnl-2013-304958.PMC3913216.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Nollert G, Fischlein T, Bouterwek S, et al.",Non-OADS,/arxiv_data1/oa_pdf/35/0e/heartjnl-2013-304958.PMC3913216.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjsports-2013-092334).,OADS,/arxiv_data1/oa_pdf/a0/b5/bjsports-2013-092334.PMC3913217.pdf
METHOD Study cohort The sample comprised participants from the ALSPAC (http://www.alspac.bris.ac.uk25).,Non-OADS,/arxiv_data1/oa_pdf/a0/b5/bjsports-2013-092334.PMC3913217.pdf
26Please note that the study website contains details of all the datathat is available through a fully searchable data dic-tionary (http://www.bristol.ac.uk/alspac/researchers/data-access/data-dictionary/).,OADS,/arxiv_data1/oa_pdf/a0/b5/bjsports-2013-092334.PMC3913217.pdf
Data linkage with the National Pupil Database in England (http://www.adls.ac.uk/department-for-education/dcsf-npd/?detail) was performed by athird party company and checked extensively by the ALSPACteam.,Non-OADS,/arxiv_data1/oa_pdf/a0/b5/bjsports-2013-092334.PMC3913217.pdf
"This linkage provided results of assessments in English,Maths and Science at key stages 2 –4 (see Department of Education for further details http://www.education.gov.uk/).",Non-OADS,/arxiv_data1/oa_pdf/a0/b5/bjsports-2013-092334.PMC3913217.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Ekelund U, Luan J, Sherar LB, et al.",Non-OADS,/arxiv_data1/oa_pdf/a0/b5/bjsports-2013-092334.PMC3913217.pdf
"Sleep patterns in children with autistic spectrum disorders: a prospective cohort study Joanna S Humphreys,1Paul Gringras,2Peter S Blair,3Nicola Scott,4John Henderson,3 Peter J Fleming,3Alan M Emond3 1Hospital for Sick Children, Toronto, Canada 2Guy ’s and St. Thomas ’NHS Foundation Trust, London, UK 3Centre for Child and Adolescent Health, University of Bristol, School of Social & Community Medicine, Bristol,UK 4Department of Psychology, Crosshouse Hospital, Kilmarnock, Ayrshire, UK Correspondence to Professor Alan Emond, Centrefor Child and Adolescent Health, School of Social and Community Medicine,University of Bristol, Oak ﬁeld House, Oak ﬁeld Grove, Bristol BS8 2BN, UK; alan.emond@bristol.ac.uk Received 19 March 2013 Revised 16 July 2013 Accepted 31 July 2013 Published Online First23 September 2013 ▸http://dx.doi.org/10.1136/ archdischild-2013-304150 To cite: Humphreys JS, Gringras P, Blair PS, et al.",Non-OADS,/arxiv_data1/oa_pdf/a0/b2/archdischild-2013-304083.PMC3913218.pdf
Full details are available on theALSPAC website: http://www.bristol.ac.uk/alspac.,Non-OADS,/arxiv_data1/oa_pdf/a0/b2/archdischild-2013-304083.PMC3913218.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 American Psychiatric Association.,Non-OADS,/arxiv_data1/oa_pdf/a0/b2/archdischild-2013-304083.PMC3913218.pdf
"14 Avon Longitudinal Study of Parents and Children (ALSPAC) http://www.bristol.ac.uk/ alspac 15 Williams E, Thomas K, Sidebotham H, et al.",Non-OADS,/arxiv_data1/oa_pdf/a0/b2/archdischild-2013-304083.PMC3913218.pdf
"17 ALSPAC questionnaires: http://www.bristol.ac.uk/alspac/researchers/data-access/ data-dictionary/ 18 Berument SK, Rutter M, Lord C, et al.",OADS,/arxiv_data1/oa_pdf/a0/b2/archdischild-2013-304083.PMC3913218.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Chen LY, Shen WK.",Non-OADS,/arxiv_data1/oa_pdf/e6/3f/heartjnl-2013-304386.PMC3913219.pdf
http://www.ohri.,Non-OADS,/arxiv_data1/oa_pdf/e6/3f/heartjnl-2013-304386.PMC3913219.pdf
"ORIGINAL ARTICLE Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy Nika Skoro-Sajer,1Gabriel Marta,2Christian Gerges,1Gerald Hlavin,3Patrick Nierlich,2 Shahrokh Taghavi,2Roela Sadushi-Kolici,1Walter Klepetko,2Irene Marthe Lang1 1Department of Internal Medicine II, Division of Cardiology, Vienna GeneralHospital, Medical University ofVienna, Vienna, Austria 2Department of Cardiothoracic Surgery, Vienna GeneralHospital, Medical University ofVienna, Vienna, Austria 3Section of Medical Statistics, Vienna General Hospital,Medical University of Vienna,Vienna, Austria Correspondence to Professor Irene Marthe Lang,Department of InternalMedicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel18-20, Vienna 1090, Austria;irene.lang@meduniwien.ac.at Received 18 April 2013 Revised 8 August 2013Accepted 22 August 2013Published Online First 19 September 2013 ▸http://dx.doi.org/10.1136/ thoraxjnl-2013-203413 ▸http://dx.doi.org/10.1136/ thoraxjnl-2013-204193 To cite: Skoro-Sajer N, Marta G, Gerges C, et al.",Non-OADS,/arxiv_data1/oa_pdf/81/99/thoraxjnl-2013-203746.PMC3913220.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Jamieson SW, Kapelanski DP, Sakakibara N, et al.",Non-OADS,/arxiv_data1/oa_pdf/81/99/thoraxjnl-2013-203746.PMC3913220.pdf
2011; ISBN: 3-900051-07-0. http://www.R-project.org 14 Kim NH.,Non-OADS,/arxiv_data1/oa_pdf/81/99/thoraxjnl-2013-203746.PMC3913220.pdf
"Culture and behaviour in the English National Health Service: overview of lessons froma large multimethod study Mary Dixon-Woods,1Richard Baker,1Kathryn Charles,2Jeremy Dawson,3 Gabi Jerzembek,4Graham Martin,1Imelda McCarthy,4Lorna McKee,5 Joel Minion,1Piotr Ozieranski,6Janet Willars,1Patricia Wilkie,7 Michael West8 1Department of Health Sciences, University of Leicester, Leicester, UK 2Imperial College Centre for Patient Safety and Service Quality (CPSSQ), London, UK 3Institute of Work Psychology and School of Health and Related Research, University of Sheffield, Sheffield, UK 4Aston Business School, Aston University, Birmingham, UK 5Health Services Research Unit, University of Aberdeen,Aberdeen, UK 6Department of Social and Policy Sciences, University of Bath, Bath, UK 7National Association for Patient Participation, Surrey, UK 8Lancaster University Management School, Lancaster, UK Correspondence to Professor Mary Dixon-Woods, Department of Health Sciences,University of Leicester, 22–28 Princess Road West, Leicester LE1 6TP, UK; md11@le.ac.uk Received 3 March 2013 Revised 16 July 2013 Accepted 17 July 2013 Published Online First 9 September 2013 ▸http://dx.doi.org/10.1136/ bmjqs-2013-002471 To cite: Dixon-Woods M, Baker R, Charles K, et al.BMJ Qual Saf 2014; 23:106–115.ABSTRACT Background Problems of quality and safety persist in health systems worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d9/70/bmjqs-2013-001947.PMC3913222.pdf
See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 W achter RM.,Non-OADS,/arxiv_data1/oa_pdf/d9/70/bmjqs-2013-001947.PMC3913222.pdf
"2011. http://www.rightcare.nhs.uk 7 Hogan H, Healey F , Neale G, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/70/bmjqs-2013-001947.PMC3913222.pdf
"London: Department of Health, 2010. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_113018.",Non-OADS,/arxiv_data1/oa_pdf/d9/70/bmjqs-2013-001947.PMC3913222.pdf
http://www.lums.lancs.ac.uk/nhs-quality 20 Power M. Auditing and the production of legitimacy .,Non-OADS,/arxiv_data1/oa_pdf/d9/70/bmjqs-2013-001947.PMC3913222.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Landefeld CS, Winker MA, Chernof B.",Non-OADS,/arxiv_data1/oa_pdf/c1/0e/bjsports-2013-092993.PMC3913225.pdf
http://www.data-archive.ac.,OADS,/arxiv_data1/oa_pdf/c1/0e/bjsports-2013-092993.PMC3913225.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2013-203325) For numbered af ﬁliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/06/8f/annrheumdis-2013-203325.PMC3913257.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Smith EU, Diaz-Torne C, Perez-Ruiz F, et al.",Non-OADS,/arxiv_data1/oa_pdf/06/8f/annrheumdis-2013-203325.PMC3913257.pdf
"The Cochrane Collaboration, 2008. http://www.cochrane-handbook.org 18 Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews.",OADS,/arxiv_data1/oa_pdf/06/8f/annrheumdis-2013-203325.PMC3913257.pdf
http://www.ohri.,Non-OADS,/arxiv_data1/oa_pdf/06/8f/annrheumdis-2013-203325.PMC3913257.pdf
http://www.cebm.net/index.aspx?o=1025 (accessed 4 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/06/8f/annrheumdis-2013-203325.PMC3913257.pdf
http://www.3erheumatology.com/en/3emethodology.aspx (accessed 27 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/06/8f/annrheumdis-2013-203325.PMC3913257.pdf
"Data sharing statement Please note that the materials developed for this project are available online: http://tinyurl.com/ogqu879 Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, Eisen S, et al.Arch Dis Child 2014; 99:142–146.",Non-OADS,/arxiv_data1/oa_pdf/b0/2b/archdischild-2013-304277.PMC3913287.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Department of Health.,Non-OADS,/arxiv_data1/oa_pdf/b0/2b/archdischild-2013-304277.PMC3913287.pdf
2004. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4089395 2 Standing Committee on Postgraduate Medical and Dental Education (SCOPME).,Non-OADS,/arxiv_data1/oa_pdf/b0/2b/archdischild-2013-304277.PMC3913287.pdf
31 January 2013. http://www.rcpch.ac.uk/system/ ﬁles/protected/page/2010% 20General%20Paediatrics%20%20curriculum%202013%20update.pdf 12 Whittleworth KA.,Non-OADS,/arxiv_data1/oa_pdf/b0/2b/archdischild-2013-304277.PMC3913287.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Soong HK, Malta JB.",Non-OADS,/arxiv_data1/oa_pdf/ba/b2/bjophthalmol-2013-303415.PMC3913294.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2012-202485).,OADS,/arxiv_data1/oa_pdf/80/b0/annrheumdis-2012-202485.PMC3913295.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Guillemin F, Rat AC, Mazieres B, et al.",Non-OADS,/arxiv_data1/oa_pdf/80/b0/annrheumdis-2012-202485.PMC3913295.pdf
8 Berenbaum F. Targeted therapies in osteoarthritis: a systematic review of the trials on http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/80/b0/annrheumdis-2012-202485.PMC3913295.pdf
1. http://www.ema.europa.eu/ema/index.jsp?curl.../document.../document...search ... (accessed 20 Jan 2010).,Non-OADS,/arxiv_data1/oa_pdf/80/b0/annrheumdis-2012-202485.PMC3913295.pdf
The study was conducted in accordance with the amended Declaration of Helsinki (http://www.wma.net/en/30publications/ 10policies/b3/) and was approved by the ethics committee of the Royal Brompton and Hareﬁ  eld NHS Trust  (Ethics approval number 08/H0708/3).,Non-OADS,/arxiv_data1/oa_pdf/ec/c9/chest_145_2_305.PMC3913299.pdf
This is a  Wellcome-Trust-compliant open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/c9/chest_145_2_305.PMC3913299.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/06/rjt096.PMC3913423.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/d8/rjt098.PMC3913424.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/61/rjt106.PMC3913425.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/f3/rjt117.PMC3913426.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/51/rjt119.PMC3913427.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/6d/rjt123.PMC3913428.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/59/rjt124.PMC3913429.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/97/rjt125.PMC3913430.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/1d/rjt126.PMC3913431.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/0f/rjt128.PMC3913432.pdf
http://nvbdcp.gov.in/ﬁlariasis-new.html (cited on 13 January 2010).,Non-OADS,/arxiv_data1/oa_pdf/2f/0f/rjt128.PMC3913432.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/c0/rjt130.PMC3913433.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/43/rjt133.PMC3913436.pdf
"No significant correlations have been found between Molecular Vision  2014; 20:132-139 <http://www.molvis.org/molvis/v 20/132> Received 7 November 2013 | Accepted 28 January 2014 | Published 31 January 2014© 2014 Molecular Vision 132Novel mutations of the RS1 gene in a cohort of Chinese families  with X-linked retinoschisis Jieqiong Chen, Ke Xu, Xiaohui Zhang, Zhe Pan, Bing Dong, Yang Li (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/d9/e1/mv-v20-132.PMC3913487.pdf
"Molecular Vision  2014; 20:132-139 <http://www.molvis.org/molvis/v 20/132> © 2014 Molecular Vision  133genotype and phenotype in previous studies, except for one  recent study by Vincent et al., where mild ERG abnormalities  were reported to be more commonly associated with missense  changes [ 19].",Non-OADS,/arxiv_data1/oa_pdf/d9/e1/mv-v20-132.PMC3913487.pdf
Molecular Vision  2014; 20:132-139 <http://www.molvis.org/molvis/v 20/132> © 2014 Molecular Vision  134Table  2. c linical  fea Tures  and resul Ts of The rs1 gene  muTaTions screening  in The sTudy.,Non-OADS,/arxiv_data1/oa_pdf/d9/e1/mv-v20-132.PMC3913487.pdf
"Molecular Vision  2014; 20:132-139 <http://www.molvis.org/molvis/v 20/132> © 2014 Molecular Vision  135and purification kit (Vigorous Whole Blood Genomic DNA  Extraction Kit, Vigorous Beijing, China), according to the  manufacturer’s protocol.",Non-OADS,/arxiv_data1/oa_pdf/d9/e1/mv-v20-132.PMC3913487.pdf
Molecular Vision  2014; 20:132-139 <http://www.molvis.org/molvis/v 20/132> © 2014 Molecular Vision  136atrophy and sent to our laboratory for the related molecular  analysis.,Non-OADS,/arxiv_data1/oa_pdf/d9/e1/mv-v20-132.PMC3913487.pdf
"Molecular Vision  2014; 20:132-139 <http://www.molvis.org/molvis/v 20/132> © 2014 Molecular Vision  137acceptance site to 8,132 bp downstream of the exon splice  donor site); however, we were unable to perform an exact size  estimation or breakpoint characterization of the large deletion  due to the inability to amplify across this region in both the  patient and the healthy individuals.",Non-OADS,/arxiv_data1/oa_pdf/d9/e1/mv-v20-132.PMC3913487.pdf
Molecular Vision  2014; 20:132-139 <http://www.molvis.org/molvis/v 20/132> © 2014 Molecular Vision  138and phenotype correlation could be observed in this study.,Non-OADS,/arxiv_data1/oa_pdf/d9/e1/mv-v20-132.PMC3913487.pdf
Molecular Vision  2014; 20:132-139 <http://www.molvis.org/molvis/v 20/132> © 2014 Molecular Vision  139in the RS1 gene.,Non-OADS,/arxiv_data1/oa_pdf/d9/e1/mv-v20-132.PMC3913487.pdf
"Recent studies have suggested that complement  may participate in normal developmental processes, such  as pruning of synapses [ 11] and other developmental and  degenerative processes [ 9,12], implicating it in diseases such  as schizophrenia [ 13,14], Alzheimer disease [ 15], Parkinson  disease [ 16], and glaucoma [ 17].Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> Received 25 February 2013 | Accepted 28 January 2014 | Published 31 January 2014© 2014 Molecular Vision 140Complement expression in the retina is not influenced by short- term pressure elevation Konstantin Astafurov,1 Cecilia Q. Dong,2 Lampros Panagis,1 Gautam Kamthan,3 Lizhen Ren,1 Anna  Rozenboym,4 Tarique D. Perera,5 Jeremy D. Coplan,6 John Danias1,2 1Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY; 2Department of Ophthalmology, SUNY Downstate  Medical Center, Brooklyn, NY; 3Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY; 4Department of  Biological Sciences, CUNY Kingsborough Community College, Brooklyn, NY; 5Department of Psychiatry, Columbia University  Medical Center and New York State Psychiatric Institute, New York, NY; 6Department of Psychiatry, SUNY Downstate Medical  Center, Brooklyn, NY Purpose:  To determine whether short-term pressure elevation affects complement gene expression in the retina in vitro  and in vivo.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
"Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  141Given the central role of IOP elevation in glaucomatous  pathophysiology and the role of the complement system in the  same process, we examined whether short-term increases in  pressure affect complement expression in an immortalized  Muller cell line and organotypic retinal cultures in vitro .",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  142Pressure and temperature was continuously monitored and  recorded in each chamber for the duration of the experiment  by an in-house built data logger; data were downloaded to  a personal computer for evaluation.,OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  143accession number NM_013725.4 ) and primate RPS11  gene  (GenBank accession number NM_001195754.1 ).,Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  144Levels of mRNA of complement genes did not differ  across groups with different pressure exposure for either 24  h or 72 h of pressurization (two-way ANOVA comparison  by pressure exposure; p>0.05) for both mouse and primate  retinal explants.,Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  145statistically significantly higher peak IOP (ANOVA; p<0.013)  and average IOP (ANOVA; p<0.025) values compared to the  nontreated contralateral and naïve eyes.,Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
"Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  146DISCUSSION Circulating complement has traditionally been thought of as  an arm of the innate immune system, charged with opso - nizing and, in some instances, lysing invading pathogens.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  147Synthesis of these molecules by adjacent astroglial and  microglial cells could further damage RGCs.,Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  148components of less than 0.005% [ 55].,Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  149glaucoma in rodents have advantages of precise control of  pathology onset.,Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  15010.,Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  151adenosine and hypoxanthine levels in Muller cells and the  inner blood-retinal barrier.,Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
"Molecular Vision  2014; 20:140-152 <http://www.molvis.org/molvis/v 20/140> © 2014 Molecular Vision  152Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/mv-v20-140.PMC3913488.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/16/jmdh-7-065.PMC3913503.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 65–68Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  65SHort reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S5562 0exercise physiologists: essential players   in interdisciplinary teams for noncommunicable   chronic disease management esme J Soan1–3 Steven J Street1,2 Sharon M Brownie3,4 Andrew p Hills1–3 1Mater Mothers’ Hospital, South  Brisbane, 2Mater research  Institute – University of Queensland,   South Brisbane, 3Griffith Health  Institute, Griffith University, Gold  Coast, QLD, Australia; 4Green  templeton College, oxford  University, oxford, UK Correspondence: esme J Soan   Mater research Institute – University   of Queensland, Centre for Nutrition   and exercise, Level 2, Aubigny place,   raymond terrace, South Brisbane,   QLD, 4101, Australia   email esoan@mmri.mater.org.a uAbstract:  Noncommunicable diseases (NCDs), such as obesity and type 2 diabetes mellitus, are  a growing public health challenge in Australia, accounting for a significant and increasing cost  to the health care system.",Non-OADS,/arxiv_data1/oa_pdf/6f/16/jmdh-7-065.PMC3913503.pdf
"The Exercise is Medicine initiative aims to raise the pro - file of exercise physiology and incorporate physical activity  and exercise as standard components of a disease prevention  and treatment paradigm in Australia, improving community  health and reducing long-term health care costs.23 More  information about AEPs and Exercise is Medicine can be  found at http://exerciseismedicine.org.au / and http://www.",Non-OADS,/arxiv_data1/oa_pdf/6f/16/jmdh-7-065.PMC3913503.pdf
Available from: http://www.essa.org.au/wp/wp-content/uploads/ HEAL_research_article_June_2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/16/jmdh-7-065.PMC3913503.pdf
Available from: http://www.essa.org.a u/wp/wp- content/uploads/AEP-Scope-of-Practice-v2-14.03.2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/16/jmdh-7-065.PMC3913503.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/6f/16/jmdh-7-065.PMC3913503.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6f/16/jmdh-7-065.PMC3913503.pdf
Available from: http://exerciseismedicine.org.au /wp-content/ uploads/2011/10/Exercise-Is-Medicine-Aus-Strategic-Plan.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/16/jmdh-7-065.PMC3913503.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/40/jaa-7-001.PMC3913504.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2014:7 1–9Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  1CAse seriesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S53281Implementing specific oral tolerance induction   to milk into routine clinical practice:   experience from first 50 patients David Luyt Kristian Bravin Jessica Luyt Children’s Allergy service, University  Hospitals of Leicester, Leicester, UK Correspondence: David Luyt   Children’s Allergy service, Leicester  Royal Infirmary, University Hospitals of  Leicester, Leicester, UK, LE1 5WW   T el +44 116 258 6194   Fax +44 116 258 7637   email david.luyt@uhl-tr.nhs.u kBackground:  Although the natural history of cow’ s milk allergy is to resolve during childhood  or adolescence, a small but significant proportion of children will remain allergic.",Non-OADS,/arxiv_data1/oa_pdf/6b/40/jaa-7-001.PMC3913504.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal­of­asthma­and­allergy­journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/6b/40/jaa-7-001.PMC3913504.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/40/jaa-7-001.PMC3913504.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/b1/ijwh-6-149.PMC3913505.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 149–157International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  149RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4088 9Refractory fallopian tube carcinoma – current  perspectives in pathogenesis and management Ashwin R Sama Russell J Schilder Department of Medical Oncology,   Thomas Jefferson University,   Philadelphia, PA, USA Correspondence: Russell J Schilder   Department of Medical Oncology,  Thomas Jefferson University, 1025  Walnut Street, College Building, Suite 700,  Philadelphia, PA 19107, USA   email r ussell.schilder@jefferson.ed uAbstract:  Fallopian tube carcinoma (FTC) is considered a rare malignancy, but recent evidence  shows that its incidence may have been underestimated.",Non-OADS,/arxiv_data1/oa_pdf/c2/b1/ijwh-6-149.PMC3913505.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c2/b1/ijwh-6-149.PMC3913505.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/b1/ijwh-6-149.PMC3913505.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/b9/opth-8-305.PMC3913541.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 305–309Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  305Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5591 4Matrix metalloproteinase-2, tissue inhibitor   of matrix metalloproteinase-2, and transforming  growth factor beta 1 in the aqueous humor  and serum of patients with pseudoexfoliation  syndrome selcuk Kara1 nilgun Yildirim2 ahmet Ozer2 Omer Colak3 afsun sahin2 1Department of Ophthalmology,   Canakkale Onsekiz Mart University  school of Medicine, Canakkale,   2Department of Ophthalmology,   eskisehir Osmangazi University  hospitals, Meselik, eskisehir,   3Department of Biochemistry,   eskisehir Osmangazi University  hospitals, Meselik, eskisehir, T urkey Correspondence: nilgun Yildirim   Department of Ophthalmology,   eskisehir Osmangazi University hospitals,  Meselik, 26480, eskisehir, Turkey   Tel +90 222 229 1001   Fax +90 222 239 0928   email nyyildirim@yahoo.co mPurpose:  The aim of the study reported in this article was to determine the presence and  quantitative differences of matrix metalloproteinase-2 (MMP-2), its tissue inhibitor (TIMP-2)  and transforming growth factor beta 1 (TGF- β1) in the aqueous humor and serum samples of  patients with pseudoexfoliation (PEX) syndrome.",Non-OADS,/arxiv_data1/oa_pdf/61/b9/opth-8-305.PMC3913541.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/61/b9/opth-8-305.PMC3913541.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/b9/opth-8-305.PMC3913541.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/7f/ndt-10-183.PMC3913542.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 183–191Neuropsychiatric Disease and Treatment This article was published in the following Dove Press journal:  Neuropsychiatric Disease and Treatment 28 January 2014Dove press submit your manuscript | www.dovepress.co m Dove press  183Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5510 4Number of times this article has been viewedActivation of M1 and M4 muscarinic receptors   as potential treatments for Alzheimer’s disease  and schizophrenia Daniel J Foster Derrick L Choi P Jeffrey Conn Jerri M Rook Department of Pharmacology and  vanderbilt Center for Neuroscience  Drug Discovery, vanderbilt University  Medical Center, Nashville, TN, USA Correspondence: Jerri M Rook   Department of Pharmacology and  vanderbilt Center for Neuroscience  Drug Discovery, vanderbilt University  Medical Center, 1215 Light Hall,   2215-B Garland Avenue, Nashville,   TN 37232, USA   Tel +1 615 322 6730   Fax +1 615 343 3088   email jerri.m.rook@vanderbilt.ed uAbstract:  Alzheimer’ s disease (AD) and schizophrenia (SZ) are neurological disorders with  overlapping symptomatology, including both cognitive deficits and behavioral disturbances.",Non-OADS,/arxiv_data1/oa_pdf/05/7f/ndt-10-183.PMC3913542.pdf
Available from: http://www.alz.co.uk/research/WorldAlzheim  erReport2012.pd f. Accessed.,Non-OADS,/arxiv_data1/oa_pdf/05/7f/ndt-10-183.PMC3913542.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/05/7f/ndt-10-183.PMC3913542.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/7f/ndt-10-183.PMC3913542.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/22/ott-7-171.PMC3913543.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 171–176OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  171Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5636 1Thoracotomy in refractory gestational  trophoblastic neoplasia with lung metastasis  after normalization of serum beta human  chorionic gonadotropin ( β-hcg) with salvage  chemotherapy Fengzhi Feng huiying hu lei Wu T ong ren Xirun Wan Yang Xiang Department of Obstetrics and  gynecology, Peking Union Medical  college hospital, chinese academy  of Medical sciences, Beijing, People’s  republic of china correspondence: Fengzhi Feng;   Yang Xiang   Department of Obstetrics and  gynecology, Peking Union Medical  college hospital, chinese academy   of Medical sciences, no.",Non-OADS,/arxiv_data1/oa_pdf/70/22/ott-7-171.PMC3913543.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/70/22/ott-7-171.PMC3913543.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/22/ott-7-171.PMC3913543.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/d1/opth-8-289.PMC3913544.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 289–292Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  289Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5825 9periocular necrotizing fasciitis following  retrobulbar injection Yeshigeta Gelaw aemero abateneh Department of Ophthalmology,   College of public Health and Medical  sciences, Jimma University, Jimma,   ethiopia Correspondence: Yeshigeta Gelaw   Department of Ophthalmology, Jimma   University, pO Box 440, Jimma, ethiopia   tel +251 9122 4764   email dryeshi@yahoo.co mAbstract:  Necrotizing fasciitis is a rare, rapidly progressive severe bacterial soft tissue  infection  with a high mortality rate.",Non-OADS,/arxiv_data1/oa_pdf/34/d1/opth-8-289.PMC3913544.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/34/d1/opth-8-289.PMC3913544.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/d1/opth-8-289.PMC3913544.pdf
Available from:  http://www.woundsinternational.com/practice-development/the- diagnosis-and- management-of-necrotising-fasciitis/page- 1.,Non-OADS,/arxiv_data1/oa_pdf/34/d1/opth-8-289.PMC3913544.pdf
"Available from: http://membership.uhms.org/?page=NST I.  Accessed November, 2013.",Non-OADS,/arxiv_data1/oa_pdf/34/d1/opth-8-289.PMC3913544.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/a3/opth-8-311.PMC3913545.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 311–314Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  311Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5575 4periorbital muscle atrophy associated with topical  bimatoprost therapy priscilla Xinhui Wang Victor teck Chang Koh Jin Fong Cheng Department of Ophthalmology,   National University Health system,   singapore Correspondence: priscilla Xinhui Wang   Department of Ophthalmology,   NUHs tower Block Level 7,   1e Kent Ridge Road, singapore 119228   tel +65 9787 8632   Fax +65 6777 7161   email priscilla.wang@mohh.com.s gAbstract:  Topical Bimatoprost is a common and popular prostaglandin analog used as an  ocular hypotensive agent in the treatment of glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/5c/a3/opth-8-311.PMC3913545.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5c/a3/opth-8-311.PMC3913545.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/a3/opth-8-311.PMC3913545.pdf
Available  from: http://bmctoday.net/glaucomatoday/pdfs/gt0611_thera_pasquale.,Non-OADS,/arxiv_data1/oa_pdf/5c/a3/opth-8-311.PMC3913545.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/8d/opth-8-235.PMC3913546.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 235–241Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  235Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5457 8One-year results of intravitreal ranibizumab  combined with reduced-fluence photodynamic  therapy for polypoidal choroidal vasculopathy Madoka sakurai Takayuki Baba Masayasu Kitahashi hirotaka Y okouchi Mariko Kubota-Taniai guzel Bikbova T oshiyuki Oshitari shuichi Yamamoto Department of Ophthalmology   and Visual science, Chiba University  graduate school of Medicine,   Chiba, Japan Correspondence: Takayuki Baba   Department of Ophthalmology and Visual  science, Chiba University graduate  school of Medicine, 1-8-1 inohana,  Chuo-ku, Chiba 260-8670, Japan   Tel +81 43 226 2124   Fax +81 43 224 4162   email babatakayuki@nifty.co mPurpose:  To compare the 1-year results of intravitreal ranibizumab combined with  reduced-fluence photodynamic therapy (RF-PDT) to intravitreal ranibizumab (IVR) alone for  eyes with polypoidal choroidal vasculopathy (PCV).",Non-OADS,/arxiv_data1/oa_pdf/7b/8d/opth-8-235.PMC3913546.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7b/8d/opth-8-235.PMC3913546.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/8d/opth-8-235.PMC3913546.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/cd/ndt-10-153.PMC3913547.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 153–165Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  153OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5342 5Building a new rasch-based self-report   inventory of depression Michela Balsamo1 giuseppe giampaglia2 aristide saggino1 1DisPUT er, Department of  Psychological sciences, humanities  and Territory, “ g d’annunzio”  University, chieti-Pescara, italy;   2Department of economics and  statistics, “Federico-ii” University,   Naples, italy correspondence: Michela Balsamo   Dipartimento di scienze Psicologiche,   Umanistiche e del T erritorio, Università   “g d’annunzio”, chieti-Pescara, via dei   Vestini 30, 66100, chieti, italy   T el/Fax +39 0871 355 5309   email michela.balsamo@libero.i tAbstract:  This paper illustrates a sequential item development process to create a new self-report  instrument of depression refined with Rasch analysis from a larger pool of potential diagnostic  items elicited through a consensus approach by clinical experts according to the latest edition  of the Diagnostic and Statistical Manual of Mental Disorders  criteria for major depression.",Non-OADS,/arxiv_data1/oa_pdf/17/cd/ndt-10-153.PMC3913547.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/17/cd/ndt-10-153.PMC3913547.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/cd/ndt-10-153.PMC3913547.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/ab/ndt-10-167.PMC3913548.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 167–181Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  167OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4679 9Design and validation of standardized   clinical and functional remission criteria   in schizophrenia sergey N Mosolov1 andrey V Potapov1 Uriy V Ushakov2 aleksey a shafarenko1 anastasiya B Kostyukova1 1Department of Mental Disorders  Therapy, Moscow research institute  of Psychiatry, Moscow, russia;  2Moscow Psychiatric Outpatient  services #21, Moscow, russiaBackground:  International Remission Criteria (IRC) for schizophrenia were developed recently  by a group of internationally known experts.",Non-OADS,/arxiv_data1/oa_pdf/41/ab/ndt-10-167.PMC3913548.pdf
Available from: http://www.eufami.org/images/eufami/main/file/ syrvey/%20press%20-%20final.pd f.  4.,Non-OADS,/arxiv_data1/oa_pdf/41/ab/ndt-10-167.PMC3913548.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/41/ab/ndt-10-167.PMC3913548.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/ab/ndt-10-167.PMC3913548.pdf
Available from: http://dx.doi.org/10.1016/0191-8869(80)   90028- 8.,OADS,/arxiv_data1/oa_pdf/41/ab/ndt-10-167.PMC3913548.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/41/ott-7-165.PMC3913549.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 165–169OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  165Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5474 5effective use of everolimus as salvage  chemotherapy for ovarian clear cell   carcinoma: a case report eriko Takatori Tadahiro shoji Yuki Miura anna Takada satoshi Takeuchi T oru sugiyama Department of Obstetrics and  Gynecology, Iwate Medical University  school of Medicine, Morioka, Japan Correspondence: Tadahiro shoji   Department of Obstetrics and  Gynecology, Iwate Medical University  school of Medicine, 19-1, Uchimaru,  Morioka, Iwate 020-8505, Japan   Tel +81 19 651 5111   Fax +81 19 522 1900   email tshoji@iwate-med.ac.j pAbstract:  A case study using mammalian target of rapamycin complex 1 in recurrent ovarian  clear cell carcinoma (CCC) was recently conducted.",Non-OADS,/arxiv_data1/oa_pdf/10/41/ott-7-165.PMC3913549.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/10/41/ott-7-165.PMC3913549.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/41/ott-7-165.PMC3913549.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/tcrm-10-069.PMC3913602.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 69–72Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  69PeRsPeCTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S51404Could a revision of the current guidelines   for cancer drug use improve the quality   of cancer treatment?,Non-OADS,/arxiv_data1/oa_pdf/75/d8/tcrm-10-069.PMC3913602.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/75/d8/tcrm-10-069.PMC3913602.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/tcrm-10-069.PMC3913602.pdf
Available  from: http://www.NCCN.or g. Accessed.,Non-OADS,/arxiv_data1/oa_pdf/75/d8/tcrm-10-069.PMC3913602.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/16/prbm-7-037.PMC3913603.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2014:7 37–46Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  37Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S4087 9Current perspectives on internet-delivered   cognitive behavioral therapy for adults   with anxiety and related disorders Louise Mewton Jessica Smith Pieter Rossouw Gavin Andrews Clinical Research Unit for Anxiety   and Depression, St vincent’s   Hospital, Sydney, NSw, Australia Correspondence: Louise Mewton   Clinical Research Unit for Anxiety and   Depression, Level 4, O’Brien Centre,   St vincent’s Hospital, 394-404 victoria   Street, Darlinghurst, NSw, Australia   Tel +61 2 8382 1437   email louisem@unsw.edu.a uAbstract:  The aim of the current review is to provide a summary of research into  Internet-delivered cognitive behavioral therapy (iCBT) for anxiety disorders.",Non-OADS,/arxiv_data1/oa_pdf/93/16/prbm-7-037.PMC3913603.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/93/16/prbm-7-037.PMC3913603.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/93/16/prbm-7-037.PMC3913603.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/ppa-8-127.PMC3913604.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 127–133Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  127OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5491 7effects of hospital generic drug substitution   on diabetes therapy hui-Yin chen1 hui-ru chang2 hui-chu lang3 1Department of Auditing, Mackay  Memorial hospital, Taipei, Taiwan;   2Department of social insurance,   Ministry of health and Welfare, Taipei,   Taiwan; 3institute of hospital and  health care Administration, national  Yang-Ming University, Taipei, Taiwan correspondence: hui-chu lang   institute of hospital and health care   Administration, national Yang-Ming   University, no 155 sec 2 li-nong street,   Taipei 112, Taiwan   Tel +886 2 2826 7015   email hclang@ym.edu.t wObjectives:  To evaluate the effects on physicians’ prescribing behavior and on the therapeutic  outcome of non-insulin-dependent diabetes patients of substituting different generic brands of  metformin.",Non-OADS,/arxiv_data1/oa_pdf/9c/2a/ppa-8-127.PMC3913604.pdf
"Bureau of National Health Insurance (BNHI), Taiwan [ http://www.nhi.",Non-OADS,/arxiv_data1/oa_pdf/9c/2a/ppa-8-127.PMC3913604.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9c/2a/ppa-8-127.PMC3913604.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/ppa-8-127.PMC3913604.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/c1/tcrm-10-073.PMC3913608.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 73–76Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  73ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5785 3Risk factors for an early dialysis start in patients  with diabetic nephropathy end-stage renal disease T omohiro Mizuno1,2,* Takahiro hayashi3,* Rina Kato1 ayaka noguchi1 hiroki hayashi2 Yukio Yuzawa2 shigeki Yamada3 Tadashi nagamatsu1 1Department of analytical  Pharmacology, Meijo University  Faculty of Pharmacy, nagoya;   2Department of n ephrology,   3Department of Clinical Pharmacy,   school of Medicine, Fujita health  University, T oyoake, Japan *These authors contributed equally to  this work Correspondence: Tadashi nagamatsu   Department of analytical Pharmacology,  Meijo University Faculty of Pharmacy,   150 Yagotoyama, Tempaku,   nagoya 468-8503, Japan   email nagamats@meijo-u.ac.j pBackground:  Patients with end-stage renal disease (ESRD) have symptoms related to severe  anemia, edema, and heart failure.",Non-OADS,/arxiv_data1/oa_pdf/d1/c1/tcrm-10-073.PMC3913608.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d1/c1/tcrm-10-073.PMC3913608.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/c1/tcrm-10-073.PMC3913608.pdf
"Communicative & Integrative Biology 2013; 6:e25924; http://dx.doi.org/10.4161/cib.25924Vegetation structure on the east flank of Mount Pinatubo was investigated to determine the inventory of species at  15 y post-eruption, then to ascertain environmental variables that have influenced the early patterns of primary succes - sion.",OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Geol Soc Am Bull 2005; 117:195-211; http://dx.doi.org/10.1130/ B25528.1 4.,Non-OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Disasters 1998; 22:76-90;  PMID:9549174 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Pac Sci 2011;  65:157-73 ; http://dx.doi.org/10.2984/65.2.157 9.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Nature  2000; 405:220-7;  PMID:10821282 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Vegetatio 1987; 69:69-77; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Weed Res 2005; 45:48-56; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
J Biogeogr 2005; 32:1019-33; http://dx.doi.org/10.1111/j.1365-2699.2005.01219.x 15.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
"Biodiv Cons  2006; 15:1271-301; http://dx.doi.org/10.1007/ s10531-005-2576-4 16. del Moral R, Lacher IL.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Am J Bot 2005; 92:1948-56; PMID:21646112 ;  http://dx.doi.org/10.3732/ajb.92.12.1948 17.,Non-OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Ecol Monogr 1956; 26:1-80; http://dx.doi.org/10.2307/1943577 18.,Non-OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Earth Surf Process Landf 2012; 37:1012- 22; http://dx.doi.org/10.1002/esp.3241 20.,Non-OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Ecology 2001; 83:1146-61; http://dx.doi.org/10.1890/0012- 9658(2002)083[1146:NRAACC]2.0 .CO;2 21.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Plant Signal Behav 2011; 6:1380-2;  PMID:22019638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
J Veg Sci 2003; 14:637-44; http://dx.doi.org/10.1111/j.1654-1103.2003.tb02195.x 27.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
J Veg Sci 1993; 4:537-42; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Plant Ecol 2008; 195:165- 78; http://dx.doi.org/10.1007/s11258-007-9313-x 29.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
"Plant Ecol 2006; 184:223-36;  http://dx.doi.org/10.1007/s11258-005-9067-2 30. del Moral R, Titus JH, Cook AM.",OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
J Veg Sci 1995; 6:107-20; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
Trends Ecol Evol 1994; 9:191-3;  PMID:21236818 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/e4/cib-6-e25924.PMC3913662.pdf
"Communicative & Integrative Biology 2013; 6:e26005; http://dx.doi.org/10.4161/cib.26005Recently discovered R2TP complex is an important multiprotein complex involved in multiple cellular process like  snoRNP biogenesis, PIKK signaling, RN a polymerase II assembly and apoptosis.",OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
www.landesbioscience.com communicative & Integrative Biology e26005-3server (http://swissmodel.expasy.org/).17 LdRuvB1 primary  sequence residues 12 to 451 showed ~64% identities to human  RuvB-like 1 helicase.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Structural modeling of the L. donovani   RuvB1 (http://swissmodel.expasy.org) provided a basic tool to compare with human RuvB1 structure.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
"The ribbon diagram of  the template bound with ADP (known crystal structure of this homolog, PDB number 2C9Oa at http://www.rcsb.org) and the predicted structures of LdRuvB1 were superimposed, it is clear that these structures superimpose considerably and seems that both the proteins have similar ADP binding site [ Fig.",Non-OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Therefore the structural modeling of the LdRuvB2 was done using the known crystal structure of this homolog as the template (PDB number: 2XSZD at http://www.rcsb.org).,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
"5B (iii)] and molecular graphic images were produced using the UCSF Chimera package (http://www.cgl.ucsf.edu/chimera) from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081).",OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
"The molecular graphic images were produced using the U csF  chimera package from the resource for Biocomputing, Visualization, and Informatics (http://www.cgl.",OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
"Molecular graphic images were produced using the UCSF Chimera package (http://www.cgl.ucsf.edu/chimera) from the Resource for Biocomputing, Visualization, and Informatics (supported by NIH P41 RR-01081).",OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
"The molecular graphic images were produced using the U csF  chimera package from the resource for Biocomputing, Visualization,  and Informatics (http://www.cgl.ucsf.edu/chimera) at the University of  california, s an Francisco (supported by NI h P41 RR-01081).",OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Cell  2005; 120:715-27;  PMID:15766533 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
J Proteome Res 2007 ;  6:1963 -73; PMID:17348703 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Mol Cell  2009 ; 34:521-33;  PMID:19524533 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Biochem Cell Biol   2010 ; 88:29-40; PMID:20130677 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Commun Integr Biol  2012 ; 5:350-61; PMID:23060959 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Hepatology  2009 ;  50:1871 -83; PMID:19877184 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Mol Cancer   2010 ; 9:132; PMID:20509972 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Biochim Biophys Acta   2012 ; 1823 :101-7; PMID:21925213 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Mol Cell Biol  2001 ; 21:7731 - 46; PMID:11604509 ; http://dx.doi.org/10.1128/ MCB.21.22.7731-7746.2001 13.,Non-OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
RNA   2012 ; 18:1833 -45; PMID:22923768 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Mol Cell Biol  2009 ; 29:4971 -81;  PMID:19620283 ; http://dx.doi.org/10.1128/ MCB.00752-0915.,Non-OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Sci Signal 2010 ; 3:ra27;  PMID:20371770 ; http://dx.doi.org/10.1126/ scisignal.2000468 16.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Biochem Biophys  Res Commun  2006 ; 342:568-72; PMID:16487927 ;  http://dx.doi.org/10.1016/j.bbrc.2006.02.009 17.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Bioinformatics  2006 ; 22:195-201; PMID:16301204 ;  http://dx.doi.org/10.1093/bioinformatics/bti770 18.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
J Comput Chem 2004 ;  25:1605 -12; PMID :15264254 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Nucleic Acids Res 2005 ;  33(Web Server issue ):W116 -20; PMID:15980438 ;  http://dx.doi.org/10.1093/nar/gki442 20.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Cell Stress Chaperones  2004 ; 9:109-21; PMID:15497498 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Gene 2013; 515:99-109; PMID:23219504 ;  http://dx.doi.org/10.1016/j.gene.2012.11.020 23.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Mol Biochem Parasitol  2012 ; 185:58- 65; PMID:22705314 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
EMBO J  2012 ; 31:1506 -17; PMID:22227520 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
RNA Biol  2012 ; 9:148-54;  PMID:22418846 ; http://dx.doi.org/10.4161/ rna.18494 26.,OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
Mol Cancer  Res 2013 ; 11:133-9; PMID:23233483 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/eb/cib-6-e26005.PMC3913666.pdf
"Commun Integr Biol 2013; 6: e25659; http://dx.doi.org/10.4161/cib.25659Mango malformation affects mango production in several  tropical and subtropical countries, which leads to 50–80% fis - cal losses each year.1 It received great interest not only because  of its widespread and deleterious nature, but also because of its  unresolved etiology till date.2 Mango malformation was recog - nized in India at Darbhanga District of Bihar in 1981.3 Now, it  has also been recognized in several mango producing countries,  such as Pakistan, the Middle East, Egypt, South Africa, Brazil,  Sudan, Central America, Mexico, the USA, Cuba, Malaysia,  Australia, Israel, UAE, Bangladesh, and the Sultanate of Oman.4  The disease has been multifariously ascribed to be acarological,  viral, fungal, and physiological in nature.5 The different species  of Fusarium , including F. mangiferae , were found to be associ - ated with the disease.6 However, the latest reports claimed that Mango malformation is the most important and threatening disease of recent times, primarily because of persistent  lacuna in complete understanding of its nature.",Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Physiol Mol Plant Pathol  1989; 35:433-8; http://dx.doi.org/10.1016/0885- 5765(89)90062-3 22.,Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Trans Br  Mycol Soc 1976; 67:325-6; http://dx.doi.org/10.1016/ S0007-1536(76)80138-6 23.,Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Physiol Plant 1989; 77:369-72; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Plant Physiol 1970; 46:352- 4; PMID:16657465; http://dx.doi.org/10.1104/ pp.46.2.352 26.,Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Sci Hortic (Amsterdam)  1984; 23:331-6; http://dx.doi.org/10.1016/0304- 4238(84)90029-3 27.,OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Phytopathology  2006; 96:667-72; PMID:18943188; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Plant Dis 2012; 96:762-762;  http://dx.doi.org/10.1094/PDIS-12-11-1030 14.,OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Plant Signal Behav  2013; 8:e23167; PMID:23299320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Sci Hortic (Amsterdam)  1986; 28:235-41; http://dx.doi.org/10.1016/0304- 4238(86)90005-1 19.,OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
J Plant Physiol 1988; 132:720-4; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Asian J Plant Sci 2011;  10:1-23; http://dx.doi.org/10.3923/ajps.2011.1.23 2.,Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Asian J Plant  Sci 2012; 11:58-61; http://dx.doi.org/10.3923/ ajps.2012.58.61 3.,Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Plant Dis 2012; 96: 286-286.2; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Plant  Physiol Biochem 2013a; 69:34-8; PMID:23707883;  http://dx.doi.org/10.1016/j.plaphy.2013.04.019 8.,OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
Mycologia 2002; 94:722-30;  PMID:21156544; http://dx.doi.org/10.2307/3761722 9.,Non-OADS,/arxiv_data1/oa_pdf/5c/7f/cib-6-e25659.PMC3913667.pdf
"OncoImmunology 2013; 2:e27384; http://dx.doi.org/10.4161/onci.27384Immunopathogenesis of paraneoplastic  neurological syndromes associated   with anti-Hu antibodies A beneficial antitumor immune response going awry Béatrice SL Pignolet1,2,3,4, Christina MT Gebauer1,2,3, and r oland S Liblau1,2,3,4,* 1INSerM-UM r1043; Toulouse, France; 2CNr S, U5282; Toulouse, France; 3Universite de Toulouse; UPS; Centre de Physiopathologie Toulouse Purpan (CPTP); Toulouse, France;  4CHU Toulouse Purpan; Toulouse, France Keywords:  anti-Hu syndrome, autoimmunity, cancer, central nervous system, paraneoplastic neurological disorder Abbreviations: BDNF, brain-derived neurotrophic factor; CNS, central nervous system; CSF, cerebrospinal fluid;   DRG, dorsal root ganglia; ELAV, embryonic lethal abnormal visual; PBMC, peripheral blood mononuclear cell;   PEM, paraneoplastic encephalomyelopathy; PND, paraneoplastic neurological disorder;   PSN, paraneoplastic sensory neuronopathy; SCLC, small-cell lung cancer; TCR, T cell receptor Paraneoplastic neurological disorders (PNDs) are syn - dromes that develop in cancer patients when an efficient anti - tumor immune response, directed against antigens expressed  by both malignant cells and healthy neurons, damages the  nervous system.",Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
"69 Interestingly,  HuD is expressed, although at low levels, by MHCIIhigh thy- mic medullary epithelial cells and thymic CD8+ dendritic cells  (http://immgen.org/).",Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Nat Immunol  2003; 4:201; http://dx.doi.org/10.1038/ni0303-201 ;  PMID:12605223 2.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Cancer 2004;  100:801-6; http://dx.doi.org/10.1002/cncr.20043 ;  PMID:14770437 3.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1985; 35:538-43;  PMID:2984600 ; http://dx.doi.org/10.1212/ WNL.35.4.538 4.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Lancet 1993; 341:21-2;  PMID:8093269 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Medicine (Baltimore)  1992; 71:59-72;  PMID:1312211 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1999; 53:1719-23;  PMID:10563618 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Clin Oncol 2004; 22:795-800; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Brain 2001; 124:1138- 48; PMID:11353730 ; http://dx.doi.org/10.1093/ brain/124.6.1138 10.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Ann Neurol 1990; 27:544-52; http://dx.doi.org/10.1002/ana.410270515 ;  PMID:2163235 11.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Biol Chem 1996; 271:8144-51;  PMID:8626503 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Science  1988 ; 242:1570-2 ;  PMID:3144044 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurobiol  1991; 22:443-61; http://dx.doi.org/10.1002/ neu.480220503 ; PMID:1716300 17.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Biol Chem 1996; 271:11518- 24; PMID:8626712 ; http://dx.doi.org/10.1074/ jbc.271.19.11518 18.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurosci Res 2008; 86:481-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurosci Res 2002; 68:121- 6; PMID:11948657 ; http://dx.doi.org/10.1002/ jnr.10175 20.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
PLoS One 2013; 8:e55718; http://dx.doi.org/10.1371/journal.pone.0055718 ; PMID:23383270 21.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neuron 2012; 75:1067- 80; http://dx.doi.org/10.1016/j.neuron.2012.07.009 ;  PMID:22998874 22.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Exp Neurol  2003; 183:100-8;  PMID:12957493 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Genes Cells 1999; 4:667-83;  PMID:10620013 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Ann  Neurol 1995; 38:102-10; http://dx.doi.org/10.1002/ana.410380117 ; PMID:7541976 26.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1998; 50:1919;  PMID:9633765 ;  http://dx.doi.org/10.1212/WNL.50.6.191928.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Lung  Cancer 2010; 67:69-75; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Recent Results Cancer  Res 1985; 99:167-74; PMID:2999915 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Am J Med 1986; 80:45-52; PMID:2417479 ;  http://dx.doi.org/10.1016/0002-9343(86)90047-1 32.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology  1994; 44:2145-7;  PMID:7969974 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurol Neurosurg Psychiatry  1999; 67:353-7;  PMID:10449558 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Eur J Neurol 2002; 9:369-72;  PMID:12099920 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Cancer Immunol Immunother 2009; 58:1795-800;  http://dx.doi.org/10.1007/s00262-009-0690-y ;  PMID:19294382 36.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurol Sci 2001; 184:131-7; PMID:11239946 ;  http://dx.doi.org/10.1016/S0022-510X(01)00442-7 37.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1994; 44:140-7;  PMID:8290049 ; http://dx.doi.org/10.1212/ WNL.44.1.140 38.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurol Neurosurg Psychiatry 1999; 66:97- 9; PMID:9886463 ; http://dx.doi.org/10.1136/ jnnp.66.1.97 39.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1990;  40:1085-91;  PMID:2356009 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology  1992; 42:536-40;  PMID:1312683 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neuroimmunol 2000; 111:241-4;  PMID:11063845 ;  http://dx.doi.org/10.1016/S0165-5728(00)00391-X 42.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Cancer  1995; 75:99-109;  PMID:7804984 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurol 2002; 249:745-53; http://dx.doi.org/10.1007/s00415-002-0706-4 ; PMID:12111309 45.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1997; 48:735-41;  PMID:9065557 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Gastroenterology 2003; 125:70- 9; PMID:12851872 ; http://dx.doi.org/10.1016/ S0016-5085(03)00664-4 47.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1993; 43:2049-54;  PMID:8413965 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Autoimmun  2000; 15:479-84; http://dx.doi.org/10.1006/ jaut.2000.0454 ; PMID:11090247 49.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neuroimmunol 1994;  55:205-12;  PMID:7829670 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurol Sci 2004; 217:25-30; PMID:14675605 ;  http://dx.doi.org/10.1016/j.jns.2003.08.006 51.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1995; 45:1873-8; PMID:7477985 ;  http://dx.doi.org/10.1212/WNL.45.10.1873 52.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurol Neurosurg Psychiatry  1996; 60:388-92;  PMID:8774401 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J  Neuroimmunol 1995; 60:135-41; PMID:7642741 ;  http://dx.doi.org/10.1016/0165-5728(95)00063-8,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
"Ann Neurol 1999; 45:162-7;  PMID:9989617 ; http://dx.doi.org/10.1002/1531- 8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R 55. de Beukelaar JW, Sillevis Smitt PA, Hop WC,  Kraan J, Hooijkaas H, Verjans GM, Gratama JW.",OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neuroimmunol 2008; 196:166-9;  http://dx.doi.org/10.1016/j.jneuroim.2008.03.002 ;  PMID:18455243 57.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
"J Neurol Neurosurg Psychiatry  2010; 81:42-5; http://dx.doi.org/10.1136/ jnnp.2008.159483 ; PMID:19324868 58. de Jongste AH, de Graaf MT, van den Broek PD, Kraan J, Smitt PA, Gratama JW.",Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neuroimmunol 2013; 258:85-90;  http://dx.doi.org/10.1016/j.jneuroim.2013.02.006 ;  PMID:23566401 59.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Nat Med 1998; 4:1321-4; http://dx.doi.org/10.1038/3315 ;  PMID:9809559 60.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Trends Neurosci 2013; 36:315-24; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
"Cancer Immunol Immunother 2007;  56 :1501-6 ; http://dx.doi.org/10.1007/s00262-007- 0295-2 ; PMID:17597332 63. de Jongste AH, de Graaf MT, Martinuzzi E, van den Broek PD, Kraan J, Lamers CH, Mallone R, Gratama  JW, Sillevis Smitt PA. Three sensitive assays do not  provide evidence for circulating HuD-specific T cells  in the blood of patients with paraneoplastic neuro - logical syndromes with anti-Hu antibodies.",Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neuro  Oncol 2012; 14:841-8; http://dx.doi.org/10.1093/ neuonc/nos118 ; PMID:22591661 64.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neuroimmunol 2003; 142:93-100;  PMID:14512168 ; http://dx.doi.org/10.1016/ S0165-5728(03)00269-8 65.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neurooncol 2005; 71:231-6; http://dx.doi.org/10.1007/s11060-004-1723-1 ; PMID :15735910 66.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Expert  Rev Neurother 2002; 2:901-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Clin Invest 2009; 119:2042-51; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Immunity 2012; 36:907-19; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
PLoS One 2009; 4:e5739; http://dx.doi.org/10.1371/journal.pone.0005739 ;  PMID:19492067 70.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Brain Pathol 1993; 3:199-212; PMID:8293180 ;  http://dx.doi.org/10.1111/j.1750-3639.1993.tb00747.x 71.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Cold Spring Harb Perspect Med 2012;  2:a007765; http://dx.doi.org/10.1101/cshperspect.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Curr Opin Immunol  2011; 23:732-8; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neuroimmunol  2010; 226:147-9; http://dx.doi.org/10.1016/j.jneu - roim.2010.05.035 ; PMID:20547426 75.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1998; 50:565-6; PMID:9484403 ;  http://dx.doi.org/10.1212/WNL.50.2.565 76.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Arch Neurol 2009; 66:655-8; http://dx.doi.org/10.1001/archneu - rol.2009.56 ; PMID:19433667 77.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Acta Neuropathol 2002; 103:509-15; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1994; 44:2241-6; PMID:7991105 ;  http://dx.doi.org/10.1212/WNL.44.12.2241 79.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Brain 2012; 135:1622-38; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1991; 41:1757- 64; PMID:1944905 ; http://dx.doi.org/10.1212/ WNL.41.11.175781.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Muscle Nerve 1998; 21:850- 7; PMID:9626244 ; http://dx.doi.org/10.1002/ (SICI)1097-4598(199807)21:7<850::AID-MUS2>3.0.CO;2-5 83.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neuroimmunol 2002; 122:100- 5; PMID:11777548 ; http://dx.doi.org/10.1016/ S0165-5728(01)00452-0 85.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Exp Med  2013; 210:2087-103; http://dx.doi.org/10.1084/ jem.20122143 ; PMID:23999498 86.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Neurology 1998; 51:1146-50; PMID :9781545 ; http://dx.doi.org/10.1212/ WNL.51.4.1146 87.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Nat Med 2012;  18:824-8; http://dx.doi.org/10.1038/nm.2720 ;  PMID:22484809 88.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Neuroimmunol 2009; 217:38-45;  http://dx.doi.org/10.1016/j.jneuroim.2009.08.014 ;  PMID:19765830 90.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Brain 2004; 127:1822-30; http://dx.doi.org/10.1093/brain/awh205 ; PMID :15201193 91.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Muscle Nerve 1997; 20:1576-82; PMID:9390671 ; http://dx.doi.org/10.1002/ (SICI)1097-4598(199712)20:12<1576::AID-MUS13>3.0.CO;2-Z 92.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Brain 2011; 134:3560-77; http://dx.doi.org/10.1093/brain/awr268 ; PMID:22058139 94.,OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
Eur J Immunol 2012; 42:790-8; http://dx.doi.org/10.1002/ eji.201142108 ; PMID:2214434395.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
J Immunol 2012; 188:4731-5; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
N Engl J Med 2013; 369:187-9; http://dx.doi.org/10.1056/ NEJMe1305484 ; PMID:23724866,Non-OADS,/arxiv_data1/oa_pdf/02/b7/onci-2-e27384.PMC3913668.pdf
"OncoImmunology 2013; 2:e27059;  http://dx.doi.org/10.4161/onci.27059Dendritic cell-based immunotherapy   in ovarian cancer an Coosemans1,*, Ignace Vergote1, and s tefaan w Van Gool2 1Department of Gynecologic Oncology; Leuven Cancer Institute, K u Leuven, Belgium; 2Department of Microbiology and Immunology; Ku  Leuven, Belgium Keywords:  dendritic cell, DC, DC immunotherapy, ovarian cancer, WT1 worldwide, 80% of patients with ovarian cancer die of the disease.",Non-OADS,/arxiv_data1/oa_pdf/fc/79/onci-2-e27059.PMC3913669.pdf
N Engl J Med 2010; 363:943-53;  PMID:20818904 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/79/onci-2-e27059.PMC3913669.pdf
J Clin Invest 2007; 117:1195-203;  PMID:17476349 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/79/onci-2-e27059.PMC3913669.pdf
Gene Ther 2005; 12:772-82;  PMID :15750615 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/79/onci-2-e27059.PMC3913669.pdf
Hum Gene Ther 2010; 21:479- 85; PMID:19903083 ; http://dx.doi.org/10.1089/ hum.2009.080 7.,OADS,/arxiv_data1/oa_pdf/fc/79/onci-2-e27059.PMC3913669.pdf
Cancer Immunol Immunother 2012; 61:2033- 44; PMID:22527250 ; http://dx.doi.org/10.1007/ s00262-012-1261-18.,Non-OADS,/arxiv_data1/oa_pdf/fc/79/onci-2-e27059.PMC3913669.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626,Non-OADS,/arxiv_data1/oa_pdf/fc/79/onci-2-e27059.PMC3913669.pdf
"Communicative & Integrative Biology 2013; 6:e26035; http://dx.doi.org/10.4161/cib.26035A study of the electrical polarization   of Sepia officinalis  yolk envelope, a role   for Na+/K+-ATPases in osmoregulation?",Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
J Biol Chem 2001; 276:29617-20;   PMID:11404365 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Comp Biochem Physiol A Mol Integr Physiol  2005; 141:401-29;  PMID:16140237 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Nat  Struct Mol Biol 2007; 14:427-31; PMID:17460695 ;  http://dx.doi.org/10.1038/nsmb1237 4.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Adv Mar Biol 2003; 44:143-203;   PMID:12846042 ; http://dx.doi.org/10.1016/ S0065-2881(03)44003-0 7.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Mar Biol 1985;  90:35-9; http://dx.doi.org/10.1007/BF00428212 8.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Comp Biochem Physiol 1989; 94:477-81; http://dx.doi.org/10.1016/0300-9629(89)90124-2 9.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Mar Biol 1990;  107:17-23; http://dx.doi.org/10.1007/BF01313238 10.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
J Exp Mar Biol Ecol 2004; 313:225-40; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Aquacult Res 2005; 36:876-81; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Mar Environ Res 2009; 67:207-18;   PMID:19332355 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Philos Trans R Soc  Lond B Biol Sci 1996; 351:985-1002; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Aquaculture 1983; 35:259-64;  http://dx.doi.org/10.1016/0044-8486(83)90096-0 15.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
J Histochem Cytochem 2001; 49:1013-23;  PMID:11457929 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Comp Biochem  Physiol A Mol Integr Physiol 2007; 148:479-97;   PMID:17689996 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
J Exp Biol 2005; 208:2023-36; PMID:15914646 ;  http://dx.doi.org/10.1242/jeb.01611 20.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Gene Expr Patterns 2010; 10:185- 92; PMID:20388555 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Zoomorphology 1979; 93:193-207;  http://dx.doi.org/10.1007/BF00993999 22.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Histochemistry 1980; 69:27- 37; PMID:6254931 ; http://dx.doi.org/10.1007/ BF00508364 23.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Mar  Biol 1981; 63:143-50; http://dx.doi.org/10.1007/BF00406822 24.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Cell  Tissue Res 2010; 339:571-83; PMID:20127256 ;  http://dx.doi.org/10.1007/s00441-009-0921-825.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Am J Physiol Regul Integr Comp  Physiol 2011; 300:R1100-14;  PMID:21307359 ;  http://dx.doi.org/10.1152/ajpregu.00653.2010 26.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Pflugers Arch 1997; 434:559-67; PMID:9242719 ;  http://dx.doi.org/10.1007/s004240050436 28.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Mar Biol 1990; 106:315-21; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
J Exp Biol 2006; 209:1487-501; PMID:16574807 ;  http://dx.doi.org/10.1242/jeb.02167 32.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Life Sci 2010; 86:73-8; PMID:19909757 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Aquat Toxicol 2008; 86:437-46; PMID:18243362 ;  http://dx.doi.org/10.1016/j.aquatox.2007.12.00536.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Sci Total Environ 2009;  407:6188-95;  PMID:19783030 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Comp Biochem Physiol C 1985; 81:259-66;  PMID:2861945 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Environ Res 1987; 42:321-7; PMID:3569175 ; http://dx.doi.org/10.1016/ S0013-9351(87)80197-4 39.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Mar Pollut Bull  2006; 52:1278-86;  PMID:16797035 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
Ecotox Environ Safe  1989; 17:333-8;  PMID:2743922 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/74/cib-6-e26035.PMC3913672.pdf
"OncoImmunology 2013; 2:e27215; http://dx.doi.org/10.4161/onci.27215EGFR-mediated tumor immunoescape The imbalance between phosphorylated  STAT1 and phosphorylated STAT3 Fernando Concha-Benavente1, raghvendra M s rivastava2, soldano Ferrone3, and r obert L Ferris1,2,4,* 1Department of Immunology; u niversity of Pittsburgh; Pittsburgh, P a usa ; 2Department of Otolaryngology; u niversity of Pittsburgh; Pittsburgh, P a usa ; 3Department of s urgery;  Massachusetts General h ospital; h arvard Medical s chool; Boston, M a usa ; 4Cancer Immunology Program; u niversity of Pittsburgh Cancer Institute; Pittsburgh, P a usa Keywords:  APM, EGFR, immunoescape, immunotherapy, pSTAT1, pSTAT3, SHP2 Abbreviations: APM, antigen-processing machinery; CCR5, chemokine (C-C motif) receptor 5; CTL, cytotoxic T lymphocyte;  CXCR3, chemokine (C-X-C motif) receptor 3; DC, dendritic cell; EGFR, epidermal growth factor receptor; HNSCC, head and  neck squamous cell carcinoma; IFN γ, interferon γ ; IL, interleukin; MAPK, mitogen-activated protein kinase; PSMB9, proteasome  (prosome, macropain) subunit, beta type, 9; PTPN11, protein tyrosine phosphatase, non-receptor type 11; STAT, signal transducer  and activator of transcription; TAA, tumor-associated antigen; TAP, transporter of antigen processing, ATP-binding cassette,  sub-family B (MDR/TAP); TGF β1, transforming growth factor β 1; VEGF, vascular endothelial growth factor The epidermal growth factor receptor ( eGFr) supports the escape of malignant cells from immunosurveillance by  inhibiting the activation of signal transducer and activator of transcription 1 ( sTaT1) while promoting that of s TaT3.",Non-OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
Cancer Immunol  Immunother 2011; 60:525-35; PMID:21207025 ;  http://dx.doi.org/10.1007/s00262-010-0961-7 2.,Non-OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
Clin Cancer Res 2013;  19:798-808;  PMID:23363816 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
Mol Cell Biol 2003; 23:7875-86; PMID:14560030 ; http://dx.doi.org/10.1128/ MCB.23.21.7875-7886.2003 7.,Non-OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
Oncoimmunology  2013; 2:e22890;  PMID:23483066 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
Proc Natl Acad Sci U S A 2000; 97:4227- 32; PMID:10760290 ; http://dx.doi.org/10.1073/ pnas.97.8.4227 10.,OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
Nat Rev Immunol  2007; 7:41-51;  PMID:17186030 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
Nat Med 2005; 11:1314-21; PMID:16288283 ;  http://dx.doi.org/10.1038/nm132512.,OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
Nat Med 2004; 10:48-54; PMID:14702634 ;  http://dx.doi.org/10.1038/nm976 13.,OADS,/arxiv_data1/oa_pdf/a6/92/onci-2-e27215.PMC3913673.pdf
"Commun Integre Biol 2013; 6: e25783;  http://dx.doi.org/10.4161/cib.25783Claims of reciprocity (or reciprocal altruism) in animal societies  often ignite controversy because authors disagree over definitions, naturalistic studies tend to demonstrate correlation  not causation, and controlled experiments often involve  artificial conditions.",Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Nature 1984; 308:181-4; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Annu Rev Ecol Evol Syst 2005; 36:499-518; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Philos T rans R Soc Lond B Biol Sci 2010; 365:2687-97; PMID:20679112;  http://dx.doi.org/10.1098/rstb.2010.0150 14.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
J Evol Biol 2004; 17:1058-72; PMID:15312078; http://dx.doi.org/10.1111/j.1420- 9101.2004.00747.x 15.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Commun Integr Biol 2010; 3:561- 3; PMID:21331239; http://dx.doi.org/10.4161/ cib.3.6.12977 7.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Evol Hum Behav  2013; 34:69-77; http://dx.doi.org/10.1016/j.evolhum- behav.2012.09.005 9.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Proc Natl Acad Sci USA  2009; 106:12007-12; PMID:19581578; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Behav Brain  Sci 2004; 27:543-59; http://dx.doi.org/10.1017/ S0140525X04000123 2.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Adv Stud  Behav 2009; 39:45-69; http://dx.doi.org/10.1016/S0065-3454(09)39002-6 4.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Nature 2009; 462:51-7;  PMID:19890322; http://dx.doi.org/10.1038/ nature08366 5.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Anim  Behav 2006; 71:1-18; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Anim Behav 1986; 34:1562-6; http://dx.doi.org/10.1016/S0003-3472(86)80225-1 40.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Anim Behav 1992; 44:501-18; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Am Nat 2007; 170:465-72;  PMID:17879196; http://dx.doi.org/10.1086/520116 42.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Proc Biol Sci 2001; 268:187-96;  PMID:11209890; http://dx.doi.org/10.1098/rspb.2000.1349 43.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Curr Biol 2008; 18:R172- 4; PMID:18302923; http://dx.doi.org/10.1016/j.cub.2007.12.040 44.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Proc Biol Sci  2004; 271:451-6; PMID:15129953; http://dx.doi.org/10.1098/rspb.2003.2625 45.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Anim  Behav 2006; 71:953-63; http://dx.doi.org/10.1016/j.anbehav.2005.09.009 46.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
J Evol Biol 2009; 22:2445-57; PMID:19824927; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Behav Processes 2007; 76:61- 72; PMID:17703898; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Behav Ecol  Sociobiol 1994; 35:1-11; http://dx.doi.org/10.1007/ BF00167053 31.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Anim Behav  2011; 81:1223-30; http://dx.doi.org/10.1016/j.anbe- hav.2011.03.008 33.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Ethology  2011; 117:271-83; http://dx.doi.org/10.1111/j.1439- 0310.2011.01882.x 34.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Behav Ecol Sociobiol 2008; 62:599-605; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Science  2011; 333:880-2; PMID:21836016; http://dx.doi.org/10.1126/science.1208473 36.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Adapt Behav 2006; 14:223-38; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Adapt Behav 2007; 15:307- 28; http://dx.doi.org/10.1177/1059712307082092 18.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Q Rev Biol 1971; 46:35-57; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Ethol Sociobiol 1988; 9:73-84; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
J Evol Biol 2007; 20:415-32;  PMID:17305808; http://dx.doi.org/10.1111/j.1420- 9101.2006.01258.x 25.,Non-OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
Ecol  Lett 2010; 13:45-50; PMID:19840082; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/db/cib-6-e25783.PMC3913674.pdf
"Communicative & Integrative Biology 2013; 6:e26521; http://dx.doi.org/10.4161/cib.26521Collective learning in route navigation andrea Flack†,* and Dora Biro Department of Zoology, u niversity of o xford; South Parks r oad, o xford, u K; †Current address: m ax Planck i nstitute for o rnithology; r adolfzell, Germany Keywords:  collective learning, route recapitulation, homing, social navigation, Columba livia in a recent paper,1 we examined how experience of repeatedly flying with a specific partner influences pigeons’  subsequent navigational decision-making in larger flocks.",Non-OADS,/arxiv_data1/oa_pdf/6f/54/cib-6-e26521.PMC3913685.pdf
Biol Rev Camb Philos Soc 1989; 64:13-33;   PMID:2655726 ; http://dx.doi.org/10.1111/j.1469- 185X.1989.tb00636.x 4.,OADS,/arxiv_data1/oa_pdf/6f/54/cib-6-e26521.PMC3913685.pdf
Curr Biol  2006; 16:2123-8;  PMID:17084696 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/54/cib-6-e26521.PMC3913685.pdf
Anim  Behav 2008; 76:1165-72; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/cib-6-e26521.PMC3913685.pdf
Proc Biol Sci 2005; 272:17-23; PMID :15875565 ; http://dx.doi.org/10.1098/ rspb.2004.2873 8.,OADS,/arxiv_data1/oa_pdf/6f/54/cib-6-e26521.PMC3913685.pdf
Proc Biol Sci 2013; 280:20122160;   PMID:23135677 ; http://dx.doi.org/10.1098/ rspb.2012.2160 10.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/cib-6-e26521.PMC3913685.pdf
Trends Ecol Evol 2004; 19:453- 5; PMID:16701304 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6f/54/cib-6-e26521.PMC3913685.pdf
Behav Ecol 2006; 17:532-8; http://dx.doi.org/10.1093/beheco/arj060,Non-OADS,/arxiv_data1/oa_pdf/6f/54/cib-6-e26521.PMC3913685.pdf
"OncoImmunology 2013; 2:e27090; http://dx.doi.org/10.4161/onci.27090Biochemical and functional analyses of gp130  mutants unveil JAK1 as a novel therapeutic target  in human inflammatory hepatocellular adenoma Karine Poussin1,2,†, Camilla Pilati1,2,†, Gabrielle Couchy1,2, Julien Calderaro1,2,3, Paulette Bioulac-Sage4,5, yannick Bacq6,  Valérie Paradis7, emmanuelle Leteurtre8,9,10, Nathalie Sturm11, Jeanne r amos12, Catherine Guettier13, armelle Bardier-Dupas14,  anais Boulai1,2, Dominique Wendum15,16,17, Janick Selves18, Tina Izard19, Jean-Charles Nault1,2, and Jessica Zucman- rossi1,2,* 1INSerM, UM r-674; Génomique fonctionnelle des tumeurs solides; IUH; Paris, France; 2Université Paris Descartes; Labex Immuno-oncology; Sorbonne Paris Cité;   Faculté de Médecine; Paris, France; 3assistance Publique-Hôpitaux de Paris; Department of Pathology; CHU Henri Mondor; Créteil, France; 4Inserm, UMr -1053;   Université Victor Segalen Bordeaux 2; Bordeaux, France; 5CHU de Bordeaux; Pellegrin Hospital; Department of Pathology; Bordeaux, France;   6Service d’Hépatogastroentérologie; Hôpital Trousseau; CH rU de Tours; Tours, France; 7assistance Publique-Hôpitaux de Paris; Department of Pathology; Beaujon Hospital;  Université Paris Diderot; Clichy, France; 8Université de Lille 2; Lille, France; 9Institut de Pathologie; CH rU de Lille; Lille, France; 10INSerM U837; Lille, France;   11Depatment of Pathology; CHU Grenoble; Hôpital a lbert Michallon; La Tronche, France; 12Department of Pathology; Gui de Chauliac Hospital; Université Montpellier-Nîmes;  Montpellier, France; 13Department of Pathology; a ssistance Publique-Hôpitaux de Paris; Hôpital Paul Brousse; Villejuif, France; 14assistance Publique-Hôpitaux de Paris;  Department of Pathology; Groupe Hospitalier Pitié-Salpêtrière; Université Pierre et Marie Curie; Paris, France; 15UPMC Univ Paris 06; UM rS 938; Cd r Saint- antoine; Paris, France;  16INSerM, UM rS 938; Cd r Saint- antoine; Paris, France; 17aP-HP, Hôpital St a ntoine; Service d‘ anatomie Pathologique; Paris, France; 18Purpan Hospital; Pathology and Cancer  research Centre of Toulouse; Inserm UM r 1037/CN rS-erL 5294/Toulouse 3 University; Markers & Targets for Digestive Cancer Biotherapy; Toulouse, France;   19Department of Cancer Biology; The Scripps r esearch Institute; Scripps Florida; Jupiter, Florida US a †These authors contributed equally to this work Keywords:  IL6ST, JAK1, ruxolitinib, STAT3, targeted therapy Abbreviations: CRP, C-reactive protein, pentraxin-related; HCA, hepatocellular adenoma; HCC, hepatocellular carcinoma;  IHCA, inflammatory HCA; IL-6, interleukin-6; IL6R, IL-6 receptor; IL6ST, IL-6 signal transducer; OSM, oncostatin M;   OSMR, OSM receptor; STAT3, signal transducer and activator of transcription 3; SOCS3, suppressor of cytokine signaling 3;  TYK2, tyrosine kinase 2 Inflammatory hepatocellular adenomas (IHC as) are benign liver lesions that can be characterized histologically by  the presence of an inflammatory infiltrate and at the molecular level by the overexpression of acute phase inflammatory  response genes.",Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Hepatology 2006 ; 43:515-24 ;  PMID:16496320 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Hepatology 2007; 46:740- 8; PMID:17663417 ; http://dx.doi.org/10.1002/ hep.21743 4.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Nat Genet 2002; 32:312- 5; PMID:12355088 ; http://dx.doi.org/10.1038/ ng1001 5.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Nature 2009; 457:200- 4; PMID:19020503 ; http://dx.doi.org/10.1038/ nature07475 6.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
J Exp Med 2011; 208:1359-66; PMID:21690253 ;  http://dx.doi.org/10.1084/jem.201102837.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
J Hepatol  2012; 56:184-91;  PMID:21835143 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Molecular characterization  of hepatocellular adenomas developed in patients  with glycogen storage disease type I. J Hepatol  2013; 58:350-7;  PMID:23046672 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Hepatology 2012; 56:392-3; PMID:22611056 ;  http://dx.doi.org/10.1002/hep.25857 10.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Nat Rev Cancer 2009; 9:798-809; PMID :19851315 ;  http://dx.doi.org/10.1038/nrc2734 11.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Cancer Cell  2009; 15:103-13 ;  PMID:19185845 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
J Immunol  2010; 184:1543-51;  PMID:20042582 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Blood 2003; 101:2940- 54; PMID:12480704 ; http://dx.doi.org/10.1182/ blood-2002-04-1204 15.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Cancer Lett 2010; 292:197-207;  PMID:20053498 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Exp Cell Res 2012; 318:925-35; PMID:22394507 ;  http://dx.doi.org/10.1016/j.yexcr.2012.02.017 18.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
"Leukemia Research Fund, UK 2001; 15:1758-68; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Nat Genet 2012; 44:694-8; PMID :22561517 ; http://dx.doi.org/10.1038/ng.2256 20.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Oncoimmunology 2012; 1:1612- 3; PMID:23264911 ; http://dx.doi.org/10.4161/ onci.21480 21.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Science  2003; 300:2101-4;  PMID:12829785 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
FEBS Lett 2000; 468:120-4;  PMID:10692570 ; http://dx.doi.org/10.1016/ S0014-5793(00)01205-9 24.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
J Biol Chem 2000;  275:12848-56;  PMID:10777583 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Eur J Cell Biol 2012; 91:524-32; PMID:22018664 ;  http://dx.doi.org/10.1016/j.ejcb.2011.09.005 27.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Blood 2010; 115:3109-17; PMID:20130243 ;  http://dx.doi.org/10.1182/blood-2009-04-214957 28.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
N  Engl J Med 2012; 366:787-98;  PMID:22375970 ;  http://dx.doi.org/10.1056/NEJMoa1110556 29.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Expert Opin  Investig Drugs 2010; 19:605-14; PMID:20367532 ;  http://dx.doi.org/10.1517/13543781003789388 30.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Cancer Res 2008; 68:7283-92;  PMID :18794115 ; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6246 31.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Science 2007; 317:121- 4; PMID :17615358 ; http://dx.doi.org/10.1126/ science.114048532.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Biochem J 2013; 450:487-96; PMID:23294003 ; http://dx.doi.org/10.1042/ BJ20121660 33.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Gut 2000; 47:309-12;  PMID:10896929 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
J Biol Chem 2012; 287:13743-51; PMID:22523320 ;  http://dx.doi.org/10.1074/jbc.M111.349167 35.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Semin Liver Dis 2011; 31:91-103;  PMID:21344354 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
Hepatology 2009; 50:481-9; PMID:19585623 ; http://dx.doi.org/10.1002/ hep.22995 37.,Non-OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
J Biol Chem 2000; 275:18794-800;  PMID:10764767 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/fe/onci-2-e27090.PMC3913689.pdf
"OncoImmunology 2013; 2:e27091; http://dx.doi.org/10.4161/onci.27091Alerting the immune system via stromal cells   is central to the prevention of tumor growth shohreh Issazadeh-Navikas Neuroinflammation u nit, Biotech r esearch & Innovation Centre (B rIC); u niversity of Copenhagen; Copenhagen, Denmark Keywords:  inflammation and cancer, neurons, models for anticancer vaccination,  models for immunostimulation, glioblastoma, PD-L1, biomarkers anticancer immunotherapies are highly desired.",Non-OADS,/arxiv_data1/oa_pdf/b7/a7/onci-2-e27091.PMC3913691.pdf
Nat Rev Cancer  2010; 10:2-3;  PMID:20050335 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b7/a7/onci-2-e27091.PMC3913691.pdf
Nature  2008 ; 454:436- 44; PMID:18650914 ; http://dx.doi.org/10.1038/ nature07205 3.,Non-OADS,/arxiv_data1/oa_pdf/b7/a7/onci-2-e27091.PMC3913691.pdf
J Allergy Clin Immunol 2003 ; 111:550- 7; PMID:12642836 ; http://dx.doi.org/10.1067/ mai.2003.1125.,Non-OADS,/arxiv_data1/oa_pdf/b7/a7/onci-2-e27091.PMC3913691.pdf
Clin Cancer Res 2010 ; 16:3409 -19;  PMID:20472682 ; http://dx.doi.org/10.1158/1078- 0432.CCR-10-06448.,Non-OADS,/arxiv_data1/oa_pdf/b7/a7/onci-2-e27091.PMC3913691.pdf
J Neurosci  2013 ;  33:14231 -45; PMID:23986257 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b7/a7/onci-2-e27091.PMC3913691.pdf
"OncoImmunology 2013; 2:e26622; http://dx.doi.org/10.4161/onci.26622KIR/HLA immunogenetic background influences  the evolution of hepatocellular carcinoma elisabetta Cariani1 and Gabriele Missale2,* 1Clinical Pathology-Toxicology; Ospedale s  agostino- estense; Modena, Italy;   2u.O.",Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
Hepatology 2013; 57:1654-62;  PMID:23111952 ; http://dx.doi.org/10.1002/ hep.26115 2.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
Cancer Biol Ther 2009; 8:2211-20; PMID:19923897 ; http://dx.doi.org/10.4161/ cbt.8.23.10455 3.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
J Immunol 2013 ; 191:1509-15;  PMID:23913973 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
Nat  Rev Immunol 2010; 10:724-34; PMID:20818413 ;  http://dx.doi.org/10.1038/nri28355.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
Blood 2010; 115:1166-74;  PMID:19903900 ; http://dx.doi.org/10.1182/ blood-2009-09-245746 6.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
Semin Immunol 2008; 20:343-52;  PMID:18635379 ;  http://dx.doi.org/10.1016/j.smim.2008.06.003 7.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
J Biomed Biotechnol 2011;  2011:298348;  PMID:21629750 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
Oncoimmunology 2012; 1:38-47;  PMID:22720210 ;  http://dx.doi.org/10.4161/onci.1.1.18312 10.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
OncoImmunology 2013; 2:e25220; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/onci-2-e26622.PMC3913692.pdf
"OncoImmunology 2013; 2:e26837; http://dx.doi.org/10.4161/onci.26837Macrophage-based immunotherapy for the  treatment of pancreatic ductal adenocarcinoma Gregory L Beatty abramson Cancer Center; Department of Medicine; Division of h ematology-Oncology; u niversity of Pennsylvania Perelman s chool of Medicine; Philadelphia, P a usa Keywords:  cancer, fibrosis, macrophage, PET imaging, metabolism, pancreas, tumoricidal Abbreviations: APC, antigen-presenting cell; CEL, clodronate encapsulated liposome; ECM, extracellular matrix;   FDG, [18F]-fluorodeoxyglucose; KPC, KrasG12D/+, Trp53R172H/+, Pdx-1-Cre; PDAC, pancreatic ductal adenocarcinoma; PET/CT,  positron emission tomography/computed tomography Macrophages are critical proponents of the growth and development of pancreatic ductal adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/bc/28/onci-2-e26837.PMC3913694.pdf
Clin Cancer Res 2012; 18:4266-76; PMID:22896693 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-3114 2.,Non-OADS,/arxiv_data1/oa_pdf/bc/28/onci-2-e26837.PMC3913694.pdf
Science  2009; 324:1457-61;  PMID:19460966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/28/onci-2-e26837.PMC3913694.pdf
Cell 2010; 141:39-51; PMID:20371344 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bc/28/onci-2-e26837.PMC3913694.pdf
Cancer Cell  2013; 23:277-86;  PMID:23518347 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/28/onci-2-e26837.PMC3913694.pdf
Immunol Rev 2009;  229:152-72;  PMID:19426221 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/28/onci-2-e26837.PMC3913694.pdf
Science 2011; 331:1612-6; PMID:21436454 ; http://dx.doi.org/10.1126/ science.11984438.,Non-OADS,/arxiv_data1/oa_pdf/bc/28/onci-2-e26837.PMC3913694.pdf
"In resting cell with full ER Ca2+ stores, STIM1 is *Correspondence to: Christoph Romanin; Email: christoph.romanin@jku.at Submitted: 10/02/2013; Revised: 10/08/2013; Accepted: 10/08/2013 http://dx.doi.org/10.4161/chan.26742The STIM1/Orai signaling machinery Marc Fahrner, Isabella Derler, Isaac Jardin, and Christoph r omanin* Institute of Biophysics; Johannes Kepler University Linz; Linz, austria Keywords:  CRAC channels, Orai, STIM, coiled-coil domain, immune system Ca2+ influx via store-operated Ca2+ release activated Ca2+  (CraC) channels represents a main signaling pathway for T-cell  activation as well as mast-cell degranulation.",OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Biochim Biophys Acta 2009;  1793:933-40;  PMID:19010359 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Physiol Rev 2005; 85:757-810;   PMID :15788710 ; http://dx.doi.org/10.1152/ physrev.00057.2003 4.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Cell Biol 2005; 169:435- 45; PMID :15866891 ; http://dx.doi.org/10.1083/ jcb.200502019 5.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nature  2006; 441:179-85;  PMID:16582901 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Science 2006; 312:1220-3;  PMID:16645049 ;  http://dx.doi.org/10.1126/science.1127883 7.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Curr Biol 2005; 15:1235-41;  PMID:16005298 ;  http://dx.doi.org/10.1016/j.cub.2005.05.055 8.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nature 2006; 443:230- 3; PMID:16921383 ; http://dx.doi.org/10.1038/ nature05122 9.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Curr Biol  2006; 16:2073-9;  PMID:16978865 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nature 2006; 443:226-9;  PMID:16921385 ;  http://dx.doi.org/10.1038/nature05108 11.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2008; 283:20261-7;   PMID:18499656 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Curr Biol 2007;  17:794-800;  PMID:17442569 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2007; 282:17548- 56; PMID:17452328 ; http://dx.doi.org/10.1074/ jbc.M611374200 14.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2011;  286 :31565-75;  PMID:21724845 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J  Biol Chem 2008; 283:19265-73;  PMID:18487204 ;  http://dx.doi.org/10.1074/jbc.M801535200 16.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Cell Calcium 2010; 47:1- 10; PMID:19945161 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Physiol 2008; 586:3061- 73; PMID:18403424 ; http://dx.doi.org/10.1113/ jphysiol.2008.151365 18.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2009;  284:24933-8;  PMID:19622747 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2009; 106:14687-92;   PMID:19706554 ; http://dx.doi.org/10.1073/ pnas.0904664106 20.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2009;  106 :15495-500 ;  PMID:19706428 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Gen Physiol 2007; 130:525- 40; PMID:17968026 ; http://dx.doi.org/10.1085/ jgp.200709872 23.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nat Cell Biol 2009; 11:669-77;   PMID:19488056 ; http://dx.doi.org/10.1038/ ncb0609-669 25.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Cell 2007;  131:1327-39;  PMID:18160041 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Curr Biol 2008; 18:177- 82; PMID:18249114 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Cell  2009; 138:366-76;  PMID:19632184 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Biochim  Biophys Acta 2000; 1481:147-55;  PMID:11004585 ;  http://dx.doi.org/10.1016/S0167-4838(00)00105-9 29.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2006; 281:28254- 64; PMID:16870612 ; http://dx.doi.org/10.1074/ jbc.M604272200 30.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2008; 283:26252-62;   PMID:18635545 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Cell Signal 2013; 25:1328- 37; PMID:23395841 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Biochem Biophys Res Commun  2006; 350:969-76;  PMID:17045966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J  Biol Chem 2007; 282:29448-56;  PMID:17702753 ;  http://dx.doi.org/10.1074/jbc.M703573200 35.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nature  2008; 454:538-42;  PMID:18596693 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2008;  283:8014-22;  PMID:18187424 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Channels (Austin) 2009; 3:221- 5; PMID:19574740 ; http://dx.doi.org/10.4161/ chan.3.4.9198 38.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Channels (Austin)  2011; 5:424-31;  PMID:21747233 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Mol Cell Biol 2013;  33:3715-23 ;  PMID:23878392 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Circ Res 2013;  112:1013-25;  PMID:23349245 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Science 2012; 338:1308-13;  PMID:23180775 ;  http://dx.doi.org/10.1126/science.1228757 44.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Cell Sci  2008; 121:762-72;  PMID:18285445 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Cell Sci 2008; 121:3133- 9; PMID:18765567 ; http://dx.doi.org/10.1242/ jcs.034496 47.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Cell Biol 2006;  174:815-25;  PMID:16966423 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Cell Biol 2006; 174:803-13;  PMID:16966422 ;  http://dx.doi.org/10.1083/jcb.200604014 49.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nat Immunol 2008; 9:81- 8; PMID:18059272 ; http://dx.doi.org/10.1038/ ni1546 50.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Biochem Cell Biol 2010; 88:175-83;   PMID:20453920 ; http://dx.doi.org/10.1139/ O09-125 51.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Mol Biol Cell 2010;  21:1897-907;  PMID:20375143 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Biochem Biophys Res  Commun 2008; 369:240-6;  PMID :18166150 ;  http://dx.doi.org/10.1016/j.bbrc.2007.12.129 55.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2011;  108:1337-42;  PMID:21217057 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nat Cell Biol 2006; 8:1003-10;  PMID:16906149 ;  http://dx.doi.org/10.1038/ncb1454 57.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2009;  284:8421-6;  PMID:19189966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Cell 2009; 136:876- 90; PMID:19249086 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Biochem Biophys  Res Commun 2009; 385:49-54;  PMID:19433061 ;  http://dx.doi.org/10.1016/j.bbrc.2009.05.020 61.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
EMBO J 2011; 30:1678-89;  PMID:21427704 ;  http://dx.doi.org/10.1038/emboj.2011.79 63.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nat Rev  Mol Cell Biol 2012; 13:549-65;  PMID:22914293 ;  http://dx.doi.org/10.1038/nrm3414 64.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Cell Sci  2013; 126:2401-10;  PMID:23572507 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nat Struct Mol Biol 2013; 20:918- 9; PMID:23912356 ; http://dx.doi.org/10.1038/ nsmb.2647 67.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Sci Signal 2010;  3:ra82;  PMID:21081754 ; http://dx.doi.org/10.1126/ scisignal.2001122 68.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nat Struct Mol Biol  2013; 20:973-81;  PMID:23851458 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2009; 106:19623- 8; PMID:19887627 ; http://dx.doi.org/10.1073/ pnas.0907714106 70.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2007; 282:16232-43;   PMID:17293345 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2008; 283:17662-71;   PMID:18420579 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Adv  Exp Med Biol 2012; 740:383-410;  PMID:22453951 ;  http://dx.doi.org/10.1007/978-94-007-2888-2_16 73.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Front Biosci  (Landmark Ed) 2012; 17:1304-22;  PMID:22201805 ;  http://dx.doi.org/10.2741/3988,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nature 2008; 456:116- 20; PMID:18820677 ; http://dx.doi.org/10.1038/ nature07338 75.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Physiol 2008; 586:419- 25; PMID:18006576 ; http://dx.doi.org/10.1113/ jphysiol.2007.147249 76.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem  2009; 284:6620-6;  PMID :19075015 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2008; 105:13668- 73; PMID:18757751 ; http://dx.doi.org/10.1073/ pnas.0806499105 78.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J  Biol Chem 2010; 285:41135-42;  PMID:20961852 ;  http://dx.doi.org/10.1074/jbc.M110.177881 79.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2009; 284:13676-85;   PMID:19289460 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Channels (Austin)  2010; 4:398-410;  PMID:20818184 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2009;  106:22516-21;  PMID:20018736 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Immunol Rev 2009;  231:88-98;  PMID:19754891 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J  Biol Chem 2011; 286:8577-84;  PMID:21220423 ;  http://dx.doi.org/10.1074/jbc.M110.187179 89.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Physiol  2001; 536:3-19;  PMID :11579153 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Sci Rep  2013; 3:1961;  PMID:23743658 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2011;  286:35318-28;  PMID:21865174 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol Chem 2013;  288:29025-34;  PMID:23943619 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Sci Signal 2013; 6:pe9;   PMID:23512988 ; http://dx.doi.org/10.1126/ scisignal.2003971 99.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J  Biol Chem 2009; 284:15903-15;  PMID:19366689 ;  http://dx.doi.org/10.1074/jbc.M808312200 100.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J  Gen Physiol 2010; 136:673-86;  PMID:21115697 ;  http://dx.doi.org/10.1085/jgp.201010484101.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Gen Physiol 2013; 142:405- 12; PMID:24081982 ; http://dx.doi.org/10.1085/ jgp.201311030 102.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Biol  Chem 2009; 284:21696-706;  PMID:19506081 ;  http://dx.doi.org/10.1074/jbc.M109.018408 103.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Physiol 2008;  586:5383-401;  PMID:18832420 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Mol Biol Cell 2009; 20:389-99;   PMID:18987344 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Biochemistry 2010; 49:1067-71;  PMID:20073506 ;  http://dx.doi.org/10.1021/bi901936q 107.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Adv Protein Chem 2005; 70:79- 112; PMID :15837514 ; http://dx.doi.org/10.1016/ S0065-3233(05)70004-8 108.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Biochemistry 1996; 35:2824-9;  PMID:8608117 ;  http://dx.doi.org/10.1021/bi952784c 109.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nature 2005; 437:902- 5; PMID:16208375 ; http://dx.doi.org/10.1038/ nature04147 110.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2006; 103:4040- 5; PMID:16537481 ; http://dx.doi.org/10.1073/ pnas.0510050103 111.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2008; 105:2011- 6; PMID:18250319 ; http://dx.doi.org/10.1073/ pnas.0706122105,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Proc Natl Acad Sci U S A 2011;  108:13299-304;  PMID:21788510 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
J Physiol 2009; 587:2903- 18; PMID:19403622 ; http://dx.doi.org/10.1113/ jphysiol.2009.170662 116.,Non-OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nat Cell Biol 2010; 12:436-46;   PMID:20418871 ; http://dx.doi.org/10.1038/ncb2045117.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Cell  2012; 149:425-38;  PMID:22464749 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
Nature  2013; 499:238-42;  PMID:23792561 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/61/chan-7-330.PMC3913757.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Interactions of csgD with biofilm formation in Salmonella Z Liu et al 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/emi20141a.PMC3913822.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0Mechanisms of bacterial persisters Y Zhang 10 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/9e/4a/emi20143a.PMC3913823.pdf
Available at http://www.cdc.gov/flu/spotlights/ more-h3n2v-cases-reported.htm (accessed 30 August 2012).,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/emi20145a.PMC3913824.pdf
Available at http://www.cdc.gov/ flu/spotlights/h3n2v-new-cases.htm (assessed 30 August 2012).,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/emi20145a.PMC3913824.pdf
Available at http://www.Risk factors for influenza A virus at fairs AS Bowman et al 4 Emerging Microbes and Infections,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/emi20145a.PMC3913824.pdf
Available at http://epitools.ausvet.com.au (accessed 4 November 2010).,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/emi20145a.PMC3913824.pdf
Available at http://www.in.gov/boah/files/ Swine_Exhibition_Recommendations_(BOAH_10-11-2012)(Final).pdf (accessed 1 December 2012).,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/emi20145a.PMC3913824.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Risk factors for influenza A virus at fairs AS Bowman et al 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/6b/c2/emi20145a.PMC3913824.pdf
Convergence of the Markov chain Monte Carlo was assessed by calcu lating the effective sampling size of the runs using the program Tracer v1.5 (http://beast.bio.ed.ac.uk/ Tracer).,OADS,/arxiv_data1/oa_pdf/8e/15/emi20147a.PMC3913825.pdf
Analysis performedusing the Hypermut and Highlighter programs at the HIV sequence database atthe Los Alamos website (http://www.hiv.lanl.gov/).,OADS,/arxiv_data1/oa_pdf/8e/15/emi20147a.PMC3913825.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0A gorilla reservoir for HTLV-4 M LeBreton et al 12 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/8e/15/emi20147a.PMC3913825.pdf
"This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).NeuroImage: Clinical 4 (2014) 319 –325 Abbreviations: ADMA, asymmetric dimethylarginine; CSF, cerebrospinal ﬂuid; CHD, congenital heart disease; GM, gray matter; hsCRP, high-sensitivity C-reactive protein; MRI, mag- netic resonance imaging pro-brain natriuretic peptide; BNP, NT pro-brain natriuretic peptide; VBM, voxel-based morphometry; WM, white matter.",Non-OADS,/arxiv_data1/oa_pdf/a2/11/main.PMC3913831.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2013.12.0112213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/11/main.PMC3913831.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/11/main.PMC3913831.pdf
"Brain volumetric analysis Cortical reconstruction and volumetric segmentation was per- formed with the Freesurfer image analysis suite, which is documented and freely available for download online ( http://surfer.nmr.mgh.",OADS,/arxiv_data1/oa_pdf/a2/11/main.PMC3913831.pdf
http://dx.doi.org/10.1016/j.nicl.2013.12.002 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/eb/2a/main.PMC3913832.pdf
"Thirty-one individuals with a current diagnosis of AN according to DSM-IV criteria were recruited from the hospital and community services of the SouthLondon and Maudsley (SLaM) National Health Service Trust and from an online advertisement on the b-eat website (Beating Eating Disorders — http://www.b-eat.co.uk ), the UK's largest eating disorder charity (inpatients = 9, outpatients = 8, da ycare patients = 7, community = 7) .",Non-OADS,/arxiv_data1/oa_pdf/eb/2a/main.PMC3913832.pdf
http://dx.doi.org/10.1016/j.nicl.2014.01.006 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/84/5a/main.PMC3913833.pdf
"2.4. fMRI data analysis Data were preprocessed in FSL (v. 5; http://fsl.fmrib.ox.ac.uk/fsl ) which involved motion correction, brain extraction, high-pass ﬁltering (100 s) and spatial smoothing (6 mm FWHM).",OADS,/arxiv_data1/oa_pdf/84/5a/main.PMC3913833.pdf
"To accomplish this, we used the Artifact Rejection Toolbox (ART; http://www.nitrc.org/projects/artifact_detect/ ) to create confound regressors for motion parameters (3 translation and 3 rotation parameters), and additionalconfound regressors for speci ﬁc image frames with outliers based on brain activation and head movement.",OADS,/arxiv_data1/oa_pdf/84/5a/main.PMC3913833.pdf
"Figures of statistical maps were created using Caret software ver- sion 5.65 ( Van Essen et al., 2001 ;http://brainvis.wustl.edu/wiki/index.",OADS,/arxiv_data1/oa_pdf/84/5a/main.PMC3913833.pdf
http://dx.doi.org/10.1016/j.nicl.2013.12.010 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/16/3c/main.PMC3913834.pdf
http://dx.doi.org/10.1016/j.nicl.2014.01.007 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/72/74/main.PMC3913835.pdf
"If data did not meet the assumptions required to perform parametric analysis and transformation did not solve this, the non-parametric Mann –Whitney U-test was performed.For the MRI data, the structural data was analyzed with FSL-VBM (Douaud et al., 2007 )(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLVBM ), an optimized VBM protocol ( Good et al., 2001 ) carried out with FSL tools (Smith et al., 2004 ).",OADS,/arxiv_data1/oa_pdf/72/74/main.PMC3913835.pdf
Available from: http://www.fmrib.ox.,Non-OADS,/arxiv_data1/oa_pdf/72/74/main.PMC3913835.pdf
http://dx.doi.org/10.1093/cercor/bht151 (E-pub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/72/74/main.PMC3913835.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/2f/main.PMC3913836.pdf
http://dx.doi.org/10.1016/j.nicl.2013.12.0142213-1582 © 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/2f/main.PMC3913836.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/2f/main.PMC3913836.pdf
Hippocampal segmentation was performed with the fully automated Freesurfer image analysis package ( http://surfer.nmr.,OADS,/arxiv_data1/oa_pdf/39/2f/main.PMC3913836.pdf
US Food and Drug Administration (2013) FDA news release: FDA approves Stivarga for advanced gastrointestinal stromal tumors.http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm340958.htm .,Non-OADS,/arxiv_data1/oa_pdf/05/8b/520_2013_Article_2085.PMC3913844.pdf
http://clinicaltrials.gov/show/NCT01103323 .,Non-OADS,/arxiv_data1/oa_pdf/05/8b/520_2013_Article_2085.PMC3913844.pdf
http://clinicaltrials.gov/show/NCT01271712 .A c c e s s e d1 7S e p t2 0 1 3 11.,Non-OADS,/arxiv_data1/oa_pdf/05/8b/520_2013_Article_2085.PMC3913844.pdf
http://clinicaltrials.gov/show/NCT01538680 .,Non-OADS,/arxiv_data1/oa_pdf/05/8b/520_2013_Article_2085.PMC3913844.pdf
http://evs.nci.nih.,Non-OADS,/arxiv_data1/oa_pdf/05/8b/520_2013_Article_2085.PMC3913844.pdf
http://www.researchreview.co.nz/getmedia/ 8cc9638a-4d34-4761-a402-32d70b 4758bf/ss_ewer.pdf.aspx .,Non-OADS,/arxiv_data1/oa_pdf/05/8b/520_2013_Article_2085.PMC3913844.pdf
Amgen Europe B.V. http://www.mhra.gov.uk/hom e/groups/spcpil/documents/ spcpil/con1372737898391.pdf .A c c e s s e dJ u l y2 0 1 3 22.,Non-OADS,/arxiv_data1/oa_pdf/11/8f/520_2013_Article_2021.PMC3913845.pdf
http://evs.nci.nih.gov/ftp1/CTCAE/about.html : National Cancer Institute 9.,Non-OADS,/arxiv_data1/oa_pdf/b5/08/10637_2013_Article_9949.PMC3913846.pdf
"Trial Registration NCT00535522 [ http://clinicaltrials.gov/ct2/show/ NCT00535522 ] P. LoRusso ( *) Karmanos Cancer Institute, Wayne State University, 4100 John R St., Detroit, MI 48201, USAe-mail: lorussop@karmanos.org K. Venkatakrishnan:D. Noe :J.<T.",Non-OADS,/arxiv_data1/oa_pdf/06/27/10637_2013_Article_9988.PMC3913854.pdf
http://www.fda.gov/ NewsEvents/Newsroom/PressA nnouncements/ucm307549.htm .,Non-OADS,/arxiv_data1/oa_pdf/06/27/10637_2013_Article_9988.PMC3913854.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE143 REVIEW http://dx.doi.org/10.5653/cerm.2013.40.4.143 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):143-147 In vitro  maturation: Clinical applications Kyung Sil Lim, Soo Jin Chae, Chang Woo Choo, Yeon Hee Ku, Hye Jun Lee, Chang Young Hur, Jin Ho Lim, Won Don Lee Maria Fertility Hospital, Seoul, Korea Oocyte in vitro  maturation (IVM) is an assisted reproductive technology in which oocytes are retrieved from the antral follicles of unstimulated  or minimally stimulated ovaries.",Non-OADS,/arxiv_data1/oa_pdf/ea/0f/cerm-40-143.PMC3913892.pdf
"The present review describes clinical experiences with IVM and some  uncommon indications of IVM based on clinical reports.Received: Oct 17, 2013 ∙ Revised: Nov 27, 2013 ∙ Accepted:  Nov 28, 2013 Corresponding author:  Won Don Lee Maria Fertility Hospital, Cheonhodaero 20, Dongdaemun-gu, Seoul 130-812,  Korea Tel:+82-2-2250-5502 Fax: +82-2-2250-5593 E-mail: don@mariababy.com This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/0f/cerm-40-143.PMC3913892.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.143 Clin Exp Reprod Med 2013;40(4):143-147 144Clinical aspects of IVM 1.,OADS,/arxiv_data1/oa_pdf/ea/0f/cerm-40-143.PMC3913892.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.143 Clin Exp Reprod Med 2013;40(4):143-147 146cancellation of IVF in high responders.,OADS,/arxiv_data1/oa_pdf/ea/0f/cerm-40-143.PMC3913892.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE148 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.4.148 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):148-154 Closed vitrification of mouse oocytes using the  CryoLogic vitrification method: A modification that  improves developmental competence Jun Woo Jo1,2,3*, Byung Chul Jee1,2*, Chang Suk Suh1,2, Seok Hyun Kim2,4 1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam;  2Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul; 3Institute of Reproductive Medicine and Population,  Medical Research Center, Seoul National University, Seoul; 4Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul  National University College of Medicine, Seoul, Korea Objective:  To compare the mouse oocyte vitrification outcomes of the CryoLogic vitrification method (CVM) and the conventional open meth - od using a Cryotop.",Non-OADS,/arxiv_data1/oa_pdf/9f/db/cerm-40-148.PMC3913893.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/db/cerm-40-148.PMC3913893.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.148 Clin Exp Reprod Med 2013;40(4):148-154 150wall of the hole instead of into the numbered well.,Non-OADS,/arxiv_data1/oa_pdf/9f/db/cerm-40-148.PMC3913893.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.4.148 Clin Exp Reprod Med 2013;40(4):148-154 152cleavage, and blastocyst formation (per cleaved embryo) were simi - lar in the modified CVM protocol and the Cryotop group.",OADS,/arxiv_data1/oa_pdf/9f/db/cerm-40-148.PMC3913893.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.148 Clin Exp Reprod Med 2013;40(4):148-154 154105:542-4.,OADS,/arxiv_data1/oa_pdf/9f/db/cerm-40-148.PMC3913893.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE155 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.4.155 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):155-162 A role for endocannabinoids in acute stress-induced  suppression of the hypothalamic-pituitary-gonadal  axis in male rats Maryam Karamikheirabad1, Gila Behzadi2, Mahdieh Faghihi1, Reza Raoofian3, Shahram Ejtemaei Mehr4,   Wieteke Ameliek Zuure5, Hamid Reza Sadeghipour1 1Department of Physiology, School of Medicine, Tehran University of Medical Science, Tehran; 2Department of Physiology, Medical School, Shahid  Beheshti Medical Sciences University, Tehran; 3Department of Medical Genetics, Tehran University of Medical Sciences, Tehran; 4Department of  Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; 5Centre for Neuroendocrinology and Department of Anatomy,  University of Otago School of Medical Sciences, Dunedin, New Zealand  Objective:  Stress is known to be an inhibitor of the reproductive hypothalamic-pituitary-gonadal (HPG) axis.",Non-OADS,/arxiv_data1/oa_pdf/26/35/cerm-40-155.PMC3913894.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/35/cerm-40-155.PMC3913894.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.155 Clin Exp Reprod Med 2013;40(4):155-162 156axis during stress [5].,Non-OADS,/arxiv_data1/oa_pdf/26/35/cerm-40-155.PMC3913894.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.155 Clin Exp Reprod Med 2013;40(4):155-162 158of AM251 on this response.,OADS,/arxiv_data1/oa_pdf/26/35/cerm-40-155.PMC3913894.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.4.155 Clin Exp Reprod Med 2013;40(4):155-162 160tent stimulatory effect of central kisspeptin administration on the  HPG axis and LH secretion in mice, rats [56-59], and monkeys [60].",Non-OADS,/arxiv_data1/oa_pdf/26/35/cerm-40-155.PMC3913894.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.155 Clin Exp Reprod Med 2013;40(4):155-162 162and glutamate-activated channels in green fluorescent protein- tagged gonadotropin-releasing hormone neurons in transgenic  mice.,OADS,/arxiv_data1/oa_pdf/26/35/cerm-40-155.PMC3913894.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE163 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.4.163 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):163-168 Preimplantation genetic diagnosis for Charcot-Marie- Tooth disease Hyoung-Song Lee1, Min Jee Kim1, Duck Sung Ko1, Eun Jin Jeon1, Jin Young Kim2, Inn Soo Kang2 1Laboratory of Reproductive Biology and Infertility, 2Department of Obstetrics and Gynecology, Cheil General Hospital and Women’s Healthcare Center,  Kwandong University College of Medicine, Seoul, Korea Objective:  Preimplantation genetic diagnosis (PGD) is an assisted reproductive technique for couples carrying genetic risks.",Non-OADS,/arxiv_data1/oa_pdf/70/ef/cerm-40-163.PMC3913895.pdf
"On the other hand, CMT2 is an axonal (non-demyelinating) pe -Received: Nov 29, 2013 ∙ Revised: Dec 20, 2013 ∙ Accepted: Dec 23, 2013 Corresponding author:  Inn Soo Kang  Department of Obstetrics and Gynecology, Cheil General Hospital and Women’s  Healthcare Center, Kwandong University College of Medicine, 17 Seoae-ro 1-gil,  Jung-gu, Seoul 100-380, Korea Tel: +82-2-2000-7581  Fax: +82-2-2000-4793  E-mail: ikang67pgd@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/ef/cerm-40-163.PMC3913895.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.4.163 Clin Exp Reprod Med 2013;40(4):163-168 164ripheral neuropathy characterized by distal muscle weakness and at - rophy, mild sensory loss, and normal or near-normal NCV.",Non-OADS,/arxiv_data1/oa_pdf/70/ef/cerm-40-163.PMC3913895.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.4.163 Clin Exp Reprod Med 2013;40(4):163-168 166ples 3 and 4, PCR with polymorphic markers D17S9A, D17S9B, and  D17S2230 (couple 4 only) resulted in amplification rates ranging from  97.6% to 100.0%, and the ADO rates ranged from 0.0% to 5.1% (Ta - ble 3).",Non-OADS,/arxiv_data1/oa_pdf/70/ef/cerm-40-163.PMC3913895.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.163 Clin Exp Reprod Med 2013;40(4):163-168 16810.,OADS,/arxiv_data1/oa_pdf/70/ef/cerm-40-163.PMC3913895.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE169 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.4.169 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):169-173 Irish public opinion on assisted human reproduction  services: Contemporary assessments from a national  sample David J Walsh1,2, E Scott Sills3,4, Gary S Collins5, Christine A Hawrylyshyn1,2, Piotr Sokol1,2, Anthony PH Walsh1,2 1Division of Reproductive Endocrinology, The Sims Institute/Sims IVF, Dublin; 2Department of Obstetrics and Gynacology, School of Medicine, Royal  College of Surgeons in Ireland, Dublin, Ireland; 3Division of Applied Biotechnology, School of Life Sciences, University of Westminster, London, UK;  4Department of Reproductive Endocrinology & Infertility, HRC-Fertility/Orange County, Newport Beach, CA, USA; 5Centre for Statistics in Medicine,  Wolfson College Annexe, University of Oxford, Oxford, UK Objective:  To measure Irish opinion on a range of assisted human reproduction (AHR) treatments.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/cerm-40-169.PMC3913896.pdf
"More specifically  the CAHR Terms of Reference included publishing “a report on the Received: Aug 30, 2013 ∙ Revised: Nov 24, 2013 ∙ Accepted: Nov 26, 2013 Corresponding author:  E Scott Sills Office for Reproductive Research, HRC-Fertility/Orange Country, 500 Superior  Avenue, Suite 210, Newport Beach, California 92663, USA Tel: +1-949-287-5600  Fax: +1-949-642-2750    E-mail: eric.sills.md@my.westminster.ac.uk This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/cerm-40-169.PMC3913896.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.4.169 Clin Exp Reprod Med 2013;40(4):169-173 170possible approaches to the regulation of all aspects of AHR and the  social, ethical and legal factors to be taken into account in determin - ing public policy and in this area.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/cerm-40-169.PMC3913896.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.4.169 Clin Exp Reprod Med 2013;40(4):169-173 172for this policy to be highest among those respondents aged 18 to 24,  and among those with no children.",Non-OADS,/arxiv_data1/oa_pdf/ad/7b/cerm-40-169.PMC3913896.pdf
Available from: http://www.eshre.eu/sitecore/  content/Home/Press%20Room/Press%20releases/Press%20re - leases%20ESHRE%202012/5%20million%20babies.,Non-OADS,/arxiv_data1/oa_pdf/ad/7b/cerm-40-169.PMC3913896.pdf
Available from: http://debates.oireachtas.ie/dail/  2012/01/24/00437.asp.,Non-OADS,/arxiv_data1/oa_pdf/ad/7b/cerm-40-169.PMC3913896.pdf
Available from: http://www.thejournal.ie/ireland-atti - tudes-eu-759820-Jan2013/.,Non-OADS,/arxiv_data1/oa_pdf/ad/7b/cerm-40-169.PMC3913896.pdf
Available from:  https://www.mrs.org.uk/cgg/social_grade.,Non-OADS,/arxiv_data1/oa_pdf/ad/7b/cerm-40-169.PMC3913896.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE174 CASE REPORT http://dx.doi.org/10.5653/cerm.2013.40.4.174 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):174-176 A case of the rare variant of Klinefelter syndrome   47,XY ,i(X)(q10) Seung-Hun Song1, Hyung Jae Won2, Tae Ki Yoon2, Dong Hyun Cha2, Jeong Yun Shim3, Sung Han Shim4 1Department of Urology, Fertility Center of CHA Gangnam Medical Center, CHA University, Seoul; 2Department of Obstetrics and Gynecology, Fertility  Center of CHA Gangnam Medical Center, CHA University, Seoul; 3Department of Pathology, CHA Gangnam Medical Center, CHA University, Seoul;  4Genetics Laboratory, Fertility Center of CHA Gangnam Medical Center, CHA University, Seoul, Korea  Klinefelter syndrome is the most common genetic form of male hypogonadism, but the phenotype becomes evident only after puberty.",Non-OADS,/arxiv_data1/oa_pdf/95/c1/cerm-40-174.PMC3913897.pdf
"Endo - crinologic investigation revealed elevated FSH and LH levels with FSH Received: Sep 9, 2013 ∙ Revised: Oct 29, 2013 ∙ Accepted:  Nov 14, 2013 Corresponding author:  Sung Han Shim Genetics Laboratory, Fertility Center of CHA Gangnam Medical Center, CHA  University, 566 Nonhyeon-ro, Gangnam-gu, Seoul 135-913, Korea  Tel: +82-2-3468-3443  Fax: +82-2-3468-3449  E-mail: shshim@cha.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/c1/cerm-40-174.PMC3913897.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.4.174 Clin Exp Reprod Med 2013;40(4):174-176 176ble sperm before androgen replacement therapy.,Non-OADS,/arxiv_data1/oa_pdf/95/c1/cerm-40-174.PMC3913897.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE177 CORRESPONDENCE Letter to the Editorhttp://dx.doi.org/10.5653/cerm.2013.40.4.177 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):177 Serum anti-Müllerian hormone levels and  phenotypes of polycystic ovary syndrome  Beuy Joob1, Viroj Wiwanitkit2 1Sanitation 1 Medical Academic Center, Bangkok, Thailand; 2Hainan Medical University, Haikou, China Dear Editor:  The recent report on serum anti-Müllerian hormone (AMH) levels  and phenotypes of polycystic ovary syndrome is very interesting [1].",Non-OADS,/arxiv_data1/oa_pdf/07/88/cerm-40-177.PMC3913898.pdf
"Beuy Joob  Sanitation 1 Medical Academic Center, Bangkok, Thailand E-mail: beuyjoob@hotmail.com Received: Nov 22, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/88/cerm-40-177.PMC3913898.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE178 CORRESPONDENCE http://dx.doi.org/10.5653/cerm.2013.40.4.178 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):178 Serum anti-Müllerian hormone levels and  phenotypes of polycystic ovary syndrome  Hye Ok Kim  Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine, Seoul, Korea Reply:  We recently published an original article entitled “Can high serum  Anti-Müllerian hormone (AMH) levels predict the phenotypes of  polycystic ovary syndrome (PCOS) and metabolic disturbances in  PCOS patients?” [1].",Non-OADS,/arxiv_data1/oa_pdf/f6/61/cerm-40-178.PMC3913899.pdf
http://doi.dx.org/10.1093/humupd/dmt061.,OADS,/arxiv_data1/oa_pdf/f6/61/cerm-40-178.PMC3913899.pdf
"Hye Ok Kim  Department of Obstetrics and Gynecology, Cheil General Hospital,   Kwandong University College of Medicine, Seoul, Korea E-mail: ok58163@hanmail.net Received: Dec 26, 2013The Author Response This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/61/cerm-40-178.PMC3913899.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE179 ACKNOWLEDGMENT http://dx.doi.org/10.5653/cerm.2013.40.4.179 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2013;40(4):179 Acknowledgment to Reviewers for 2013 On behalf of the editor and editorial board, we would like to express our sincere gratitude for the reviewers and contributors who have gener - ously endowed with their time and efforts in appraising the manuscripts submitted to Clinical and Experimental Reproductive Medicine in 2013.",Non-OADS,/arxiv_data1/oa_pdf/b2/be/cerm-40-179.PMC3913900.pdf
"Chae, Hee Dong Ulsan University Chi, Hee Jun Mizmedi Hospital Choi, Won-Jun  Gyeongsang National University Hospital Choi, Young Seok CHA University Choi, Young Sik Yonsei University Chun, Sang-Young Chonnam National University Chun, Sungwook Inje University Chung, Mikyung Seoul Rachel Fertility Center Cui, Xiang-Shun  Chungbuk National University Gye, Myung Chan Hanyang University Huh, Sun Hallym University  Hwang, Jung Hae  Hanyang University Hwang, Kyuri Seoul National University Jee, Byung Chul Seoul National University Joo, Bo-sun Good Moonhwa Hospital Joo, Jong Kil Pusan National University Jun, Jin Hyun  Eulji University Jung, Kyung Ah  Ewha Womans University Kim, Hoon Seoul National University Kim, Hye Ok Kwandong University Kim, Hyung Joon  CHA University Kim, Jin Ju  Seoul National University Kim, Jong Hoon Korea University Kim, Jong Hyun MizMedi Hospital Kim, Mi Kyoung CHA University Kim, Miran Ajou University This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Kim, Nam-Hyung  Chungbuk National University Kim, Sung Hoon Ulsan University Kim, Young Ah  Ilsan Paik Hospital Ku, Seung-Yup  Seoul National University Kwak, Joanne Y.H.",Non-OADS,/arxiv_data1/oa_pdf/b2/be/cerm-40-179.PMC3913900.pdf
Published by Elsevier Inc.http://dx.doi.org/10.1016/j.neuroimage.2013.09.002 Contents lists available at ScienceDirect NeuroImage journal homepage: www.elsevier.com/locate/ynimg Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/c5/6c/main.PMC3913905.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.07.065 .,OADS,/arxiv_data1/oa_pdf/c5/6c/main.PMC3913905.pdf
"wrote the main manuscript text, and all authors participated inthe review of the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/b6/51/srep03969.PMC3913913.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3969 | DOI: 10.1038/srep03969 7",Non-OADS,/arxiv_data1/oa_pdf/b6/51/srep03969.PMC3913913.pdf
"Small molecule microarrays .1,364 compounds of the Diversity Set II library provided by the Drug Synthesis and Chemistry Branch of NCI (http://dtp.nci.nih.",OADS,/arxiv_data1/oa_pdf/ef/fc/srep03977.PMC3913914.pdf
"gov) were spotted from 10- mM dilutions in DMSO onto a hydrogel support developed by ProtNeteomix (http://www.protneteomix.com) with a GMS 417 contacting arrayer (Affymetrix, USA) or a 32-needle manual replicator (VP Scientific, USA).",OADS,/arxiv_data1/oa_pdf/ef/fc/srep03977.PMC3913914.pdf
"Scanning of microarrays was carried out at 21- mpixel density and 800-nm absorbance with the Odyssey infrared imagery system (Li-COR Biosciences, USA), and the signal intensity was monitored with GenePix Pro 4.0 software (http://www.moleculardevices.com).In competition assays, the IRDye-labeled sEGFR (the recombinant protein rhEGFR purchased from R&D Systems) and unlabeled protein DII/sEGFR corresponding to domain II of sEGFR were mixed in a 1 58 ratio and incubated at 4 uC for 90 min.",OADS,/arxiv_data1/oa_pdf/ef/fc/srep03977.PMC3913914.pdf
"Cell&Bioscience 2, 13, http://www.cellandbioscience.com/content/2/1/13 (2012).",Non-OADS,/arxiv_data1/oa_pdf/ef/fc/srep03977.PMC3913914.pdf
"The authors acknowledge the Drug Synthesis and Chemistry Branch of NCI for providing the Diversity Set II compound library (http://dtp.nci.nih.gov/dtpstandard/ChemData), and the French National Chemical Library for providing compound CV009543V (http://chimiotheque-nationale.enscm.fr/index.php).",OADS,/arxiv_data1/oa_pdf/ef/fc/srep03977.PMC3913914.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: V.S.,Non-OADS,/arxiv_data1/oa_pdf/ef/fc/srep03977.PMC3913914.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3977 | DOI: 10.1038/srep03977 11",Non-OADS,/arxiv_data1/oa_pdf/ef/fc/srep03977.PMC3913914.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/83/64/srep03976.PMC3913917.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3976 | DOI: 10.1038/srep03976 10",Non-OADS,/arxiv_data1/oa_pdf/83/64/srep03976.PMC3913917.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/99/99/srep03968.PMC3913918.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3968 | DOI: 10.1038/srep03968 6",Non-OADS,/arxiv_data1/oa_pdf/99/99/srep03968.PMC3913918.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/88/cb/srep03970.PMC3913920.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3970 | DOI: 10.1038/srep03970 7",Non-OADS,/arxiv_data1/oa_pdf/88/cb/srep03970.PMC3913920.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/bf/srep03989.PMC3913928.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3989 | DOI: 10.1038/srep03989 8",Non-OADS,/arxiv_data1/oa_pdf/4e/bf/srep03989.PMC3913928.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3983 | DOI: 10.1038/srep03983 8",Non-OADS,/arxiv_data1/oa_pdf/c2/e0/srep03983.PMC3913931.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3986 | DOI: 10.1038/srep03986 7",Non-OADS,/arxiv_data1/oa_pdf/1f/ef/srep03986.PMC3913932.pdf
http://epubs.surrey.ac.uk/2204/ [2012-8-30].,Non-OADS,/arxiv_data1/oa_pdf/57/0f/srep03992.PMC3913933.pdf
All authors contributed to the scientific planning and discussions.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/0f/srep03992.PMC3913933.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3992 | DOI: 10.1038/srep03992 9",Non-OADS,/arxiv_data1/oa_pdf/57/0f/srep03992.PMC3913933.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0d/cc/srep03978.PMC3913934.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3978 | DOI: 10.1038/srep03978 8",Non-OADS,/arxiv_data1/oa_pdf/0d/cc/srep03978.PMC3913934.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/50/c1/srep03982.PMC3913935.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3982 | DOI: 10.1038/srep03982 7",Non-OADS,/arxiv_data1/oa_pdf/50/c1/srep03982.PMC3913935.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)MAF phosphorylation in multiple myeloma NI Herath et al 7 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/bc/a6/bcj201367a.PMC3913936.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/BAALC expression in CN-AML and detection of residual disease S Weber et al 12 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/4b/f0/bcj201371a.PMC3913940.pdf
"Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, 2013, http://cgap.nci.nih.gov/ Chromosomes/Mitelman.",OADS,/arxiv_data1/oa_pdf/c2/c6/bcj201372a.PMC3913941.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Letter to the Editor 4 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c2/c6/bcj201372a.PMC3913941.pdf
MATERIALS AND METHODS Structural analysis The acquisition of the X-ray co-crystal structure of NS-018 bound to JAK2 was described previously.27All published X-ray crystal structures were taken from the Protein Data Bank (http://www.rcsb.org/pdb/home/ home.do).,OADS,/arxiv_data1/oa_pdf/37/2f/bcj201373a.PMC3913942.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Effect of NS-018, a selective JAK2V617F inhibitor Y Nakaya et al 6 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/37/2f/bcj201373a.PMC3913942.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)ASXL1 mutations in MDS T-C Chen et al 8 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/f8/d1/bcj201374a.PMC3913943.pdf
"Limiting dilution competitive transplantation analysis demonstrated a two- to fourfold increase inHSC number after short ex vivo PGE2 exposure, without creating an impact on multilineage hematopoietic differentiation or decreasing serial transplantation and self-renewal potential.4,5PGE2 functions through cyclic AMP (cAMP)-mediated regulation of the Wnt signaling pathway to control HSC homing, proliferation and survival.5–7On the basis of these ﬁndings, we performed a phase Ib pilot clinical trial of dUCBT, using one untreated and one ex vivo PGE2-treated UCB unit, to determine safety and engraftment parameters (http://www.clinicaltrials.gov (NCT00890500)).",Non-OADS,/arxiv_data1/oa_pdf/0a/4d/bcj201375a.PMC3913944.pdf
The trial was prospec- tively registered at http://www.clinicaltrials.gov (NCT00890500).,Non-OADS,/arxiv_data1/oa_pdf/0a/4d/bcj201375a.PMC3913944.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Effects of PGE2/Wnt/ b-catenin pathway on UCB T cells LL i et al 10 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/0a/4d/bcj201375a.PMC3913944.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):1-11 http://dx.doi.org/10.3341/kjo.2014.28.1.1 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Original ArticleGraded Decompression of Orbital Fat and Wall in Patients with  Graves’ Orbitopathy Kyou Ho Lee1, Sun Young Jang2, Sang Yeul Lee1, Jin Sook Yoon1 1Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Soonchunhyang Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea Purpose:  To investigate the results of graded decompression of orbital fat and walls in Graves’ orbitopathy  (GO) considering the degree of proptosis reduction at surgery and preoperative computed tomography (CT)  findings.",Non-OADS,/arxiv_data1/oa_pdf/91/90/kjo-28-1.PMC3913973.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):100-107 ht tp://dx.doi.org/10.33 41/k jo.2014.28.1.100 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.100Retinal Damage in Chloroquine Maculopathy, Revealed by High  Resolution Imaging: A Case Report Utilizing Adaptive Optics  Scanning Laser Ophthalmoscopy Eun Jin Bae1, Kyoung Rae Kim1, Stephen H. Tsang2, Sung Pyo Park1,2, Stanley Chang2 1Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University Medical Center, Seoul, Korea 2Department of Ophthalmology, Columbia University Medical Center, New York, NY, USA Chloroquine and its analogue hydroxychloroquine have  been used successfully for the treatment and prophylaxis of  malaria.",Non-OADS,/arxiv_data1/oa_pdf/51/54/kjo-28-100.PMC3913974.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):108-112 http://dx.doi.org/10.3341/kjo.2014.28.1.108 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.108Anaplastic Large Cell Lymphoma Involving Anterior Segment of the Eye Choul Yong Park1, Sang Won Hwang1, Do Yeu n K i m2, Hee Jin Huh3, Jong-Hyun Oh1 1Department of Ophthalmology, Dongguk University Seoul, Graduate School of Medicine, Seoul, Korea 2Department of Internal Medicine, Dongguk University Seoul, Graduate School of Medicine, Seoul, Korea 3Department of Laboratory Medicine, Dongguk University Seoul, Graduate School of Medicine, Seoul, Korea Anaplastic large cell lymphoma (ALCL) is a newly in - troduced T-cell lymphoma that is responsible for approxi - mately 3% of all non-Hodgkin’s lymphoma (NHL) in adults  and between 10% to 30% of NHL in children [1-3].",Non-OADS,/arxiv_data1/oa_pdf/b3/79/kjo-28-108.PMC3913975.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):113-114  http://dx.doi.org/10.3341/kjo.2014.28.1.113 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.113113Letter to the Editor Sneddon’s Syndrome versus Susac Syndrome Dear Editor, I read with interest the article titled “Acute central  retinal  artery occlusion  associated with livedoid vasculopathy: a  variant of Sneddon’s syndrome [1] and there may be a dif - ferent diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/b7/87/kjo-28-113.PMC3913976.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):12-18 http://dx.doi.org/10.3341/kjo.2014.28.1.12 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.12 Original ArticleThe Effect of 0.02% Mitomycin C Injection into the Hair Follicle with  Radiofrequency Ablation in Trichiasis Patients Gyu-Nam Kim1, Woong-Sun Yoo1, Seong-Jae Kim1,2, Yong-Seop Han1,2, In-Young Chung1,2, Jong-Moon Park1,2,  Ji-Myong Yoo1,2, Seong-Wook Seo1,2 1Department of Ophthalmology, Gyeongsang National University School of Medicine, Jinju, Korea 2Gyeongsang Institute of Health Science, Gyeongsang National University, Jinju, Korea Purpose:  To investigate the inhibitory effect of 0.02% mitomycin C on eyelash regrowth when injected to the  eyelash hair follicle immediately after radiofrequency ablation.",Non-OADS,/arxiv_data1/oa_pdf/ab/ad/kjo-28-12.PMC3913977.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):19-25 ht tp://dx.doi.org/10.33 41/k jo.2014.28.1.19 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.19 Original ArticleComparison of Injection of Intravitreal Drugs with Standard Care in  Macular Edema Secondary to Branch Retinal Vein Occlusion Kyungmin Lee, Heeyoung Jung, Joonhong Sohn  HanGil Eye Hospital, Incheon, Korea Purpose:  To compare the long-term efficacy and safety of intravitreal triamcinolon with or without rescue laser  therapy (intravitreal triamcinolone injection [IVTA] group), bevacizumab with or without rescue laser treatment  (intravitreal bevacizumab injection [IVB] group), or a combination of both with or without rescue laser therapy  (IVTA + IVB group), with standard care for patients with macular edema secondary to branch retinal vein oc - clusion (BRVO).",Non-OADS,/arxiv_data1/oa_pdf/d0/18/kjo-28-19.PMC3913978.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):26-31 http://dx.doi.org/10.3341/kjo.2014.28.1.26 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.26 Original ArticleOutcome and Significance of Silicone Oil Tamponade in Patients with  Chronic Serous Retinal Detachment Pan Sang Kim, Chang Wook Choi, Yun Sik Yang Department of Ophthalmology, Wonkwang University Hospital, Wonkwang University College of Medicine, Iksan, Korea Purpose:  To evaluate the effectiveness of silicone oil tamponade in patients with chronic serous retinal detach - ment (SRD) persisting for three months after the resolution of ocular inflammation.",Non-OADS,/arxiv_data1/oa_pdf/da/70/kjo-28-26.PMC3913979.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):32-38 http://dx.doi.org/10.3341/kjo.2014.28.1.32 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.32 Original ArticleSerum Concentration of Vascular Endothelial Growth Factor after  Bilateral Intravitreal Injection of Bevacizumab Donghyun Wang, Kyung Seek Choi, Sung Jin Lee Department of Ophthalmology, Soonchunhyang University College of Medicine, Seoul, Korea Purpose:  This study compared serum vascular endothelial growth factor (VEGF) concentration between pa - tients given the bilateral and unilateral intravitreal injections of bevacizumab.",Non-OADS,/arxiv_data1/oa_pdf/9e/b4/kjo-28-32.PMC3913980.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):39-48 http://dx.doi.org/10.3341/kjo.2014.28.1.39 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.39 Original ArticleDiurnal Intraocular Pressure with Bimatoprost/Timolol Fixed  Combination versus Latanoprost/Timolol Fixed Combination in  Healthy Subjects Seong Hee Shim1, Joon Mo Kim1, Chul Young Choi1, Chan Yun Kim2 1Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea 2Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea Purpose:  To evaluate the effects of a bimatoprost/timolol fixed combination (BTFC) and a latanoprost/timolol fixed  combination (LTFC) on diurnal intraocular pressure (IOP) and anterior ocular parameters in healthy subjects.",Non-OADS,/arxiv_data1/oa_pdf/16/06/kjo-28-39.PMC3913981.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):49-65 http://dx.doi.org/10.3341/kjo.2014.28.1.49 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.49 Original ArticleEvaluation of Hemifield Sector Analysis Protocol in Multifocal Visual  Evoked Potential Objective Perimetry for the Diagnosis and Early  Detection of Glaucomatous Field Defects Mohammad F. Mousa1, Robert P .",Non-OADS,/arxiv_data1/oa_pdf/b3/c4/kjo-28-49.PMC3913982.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):66-75 http://dx.doi.org/10.3341/kjo.2014.28.1.66 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.66 Original ArticleThe Relationship between Higher-order Aberrations and Amblyopia  Treatment in Hyperopic Anisometropic Amblyopia Soo Han Lee, Ji Woong Chang Department of Ophthalmology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea Purpose:  To investigate the relationship between higher-order aberrations (HOAs) and amblyopia treatment in  children with hyperopic anisometropic amblyopia.",Non-OADS,/arxiv_data1/oa_pdf/12/95/kjo-28-66.PMC3913983.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):76-82 http://dx.doi.org/10.3341/kjo.2014.28.1.76 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.76 Original ArticleEffects of Argon Laser Iridotomy on the Corneal Endothelium of  Pigmented Rabbit Eyes Jie Hyun Youm, Jeong-Hwa Heo, Hyo Myung Kim, Jong-Suk Song Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea Purpose : In Asian countries, laser iridotomy for the treatment of angle-closure glaucoma is a common cause of  bullous keratopathy, which may be associated with a shallow anterior chamber and dark iris pigmentation in  Asians.",Non-OADS,/arxiv_data1/oa_pdf/61/13/kjo-28-76.PMC3913984.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):83-85 http://dx.doi.org/10.3341/kjo.2014.28.1.83 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.83A Korean Patient with Lattice Corneal Dystrophy Type IV with  Leu527Arg Mutation in the TGFBI  Gene Jinsun Kim1, Kyung A Lee2, Eung Kweon Kim1,3, Hyung Keun Lee1,3 1Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea 2Department of Clinical Diagnosis, Yonsei University College of Medicine, Seoul, Korea 3Corneal Dystrophy Research Institute, Yonsei University, Seoul, Korea Recent advances have allowed us to understand corneal  dystrophies on a basic molecular level, and several studies  have reported specific mutations in the TGFBI  gene show - ing various phenotypes [1].",Non-OADS,/arxiv_data1/oa_pdf/3e/96/kjo-28-83.PMC3913985.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):86-90 http://dx.doi.org/10.3341/kjo.2014.28.1.86 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.86Treatment of an 8-mm Myxoma Using Acellular Corneal Tissue Kyung Sup Lim, Sung Wook Wee, Jae Chan Kim Department of Ophthalmology, Chung-Ang University College of Medicine, Seoul, Korea A myxoma is a benign tumor found in the heart and in var - ious soft tissues [1].",Non-OADS,/arxiv_data1/oa_pdf/6b/2e/kjo-28-86.PMC3913986.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):91-95 http://dx.doi.org/10.3341/kjo.2014.28.1.91 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.91Macular Hole Formation after Pars Plana Vitrectomy for the  Treatment of Valsalva Retinopathy: A Case Report Kook Young Kim1* , Seung-Young Yu1* , Moosang Kim2 , Hyung Woo Kwak1 1Department of Ophthalmology, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Korea 2Department of Ophthalmology, Kangwon National University School of Medicine, Chuncheon, Korea The Valsalva maneuver involves forcible exhalation  against the closed glottis and produces a sudden increase  in the venous blood pressure due to an increase in intratho - racic or intraabdominal pressure.",Non-OADS,/arxiv_data1/oa_pdf/b2/c3/kjo-28-91.PMC3913987.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(1):96-99 http://dx.doi.org/10.3341/kjo.2014.28.1.96 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.96Use of Optical Coherence Tomography to Evaluate Visual Acuity and  Visual Field Changes in Dengue Fever Taek Kwan Rhee, Jung Il Han  Department of Ophthalmology, Kim ’s Eye Hospital, Myung-Gok Eye Research Institute,  Konyang University College of Medicine, Seoul, Korea Dengue fever is a mosquito-transmitted viral disease  that affects humans.",Non-OADS,/arxiv_data1/oa_pdf/67/29/kjo-28-96.PMC3913988.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/f7/a1/aps2013161a.PMC3914023.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/62/srep03985.PMC3914175.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3985 | DOI: 10.1038/srep03985 6",Non-OADS,/arxiv_data1/oa_pdf/56/62/srep03985.PMC3914175.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1d/5e/jgenv02p0054.PMC3914308.pdf
Transcriptome assemblies and other sequence  data are available for download at  the International Asian Citrus Psyllid Genome Consortium website [ http://psyllid.org/download ]  and at NCBI [http://www.ncbi.nlm.nih.gov/bioproject/29447].,OADS,/arxiv_data1/oa_pdf/1d/5e/jgenv02p0054.PMC3914308.pdf
"OncoImmunology 2013; 2:e27184; http://dx.doi.org/10.4161/onci.27184Finding a needle in a haystack Activation-induced CD137 expression accurately identifies  naturally occurring tumor-reactive T cells in cancer patients Qunrui y e1, De-Gang s ong1, and Daniel J Powell Jr1,2,* 1Ovarian Cancer r esearch Center; Department of Obstetrics and Gynecology; Perelman s chool of Medicine; u niversity of Pennsylvania; Philadelphia, P a usa ;  2Department of Pathology and Laboratory Medicine; a bramson Cancer Center; Perelman s chool of Medicine; u niversity of Pennsylvania; Philadelphia, P a usa Keywords:  4-1BB, CD137, adoptive immunotherapy, enrichment, tumor-associated antigens, tumor-infiltrating lymphocytes we have recently identified tumor necrosis factor receptor superfamily, member 9 (TNF rsF9, best known as CD137  or 4–1BB) as a biomarker of tumor-reactive T cells naturally occurring in cancer patients, and developed a rapid, accurate  system to comprehensively isolate lymphocytes with tumor-rejecting properties from human biopsies.",Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
Annu Rev Immunol  2005; 23:23-68;  PMID :15771565 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
Blood  2007 ; 110:201- 10; PMID:17371945 ; http://dx.doi.org/10.1182/ blood-2006-11-056168 3.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
J Immunother  2011 ; 34:307- 19; PMID:21389867 ; http://dx.doi.org/10.1097/ CJI.0b013e318213cb904.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
Clin Cancer Res 2011 ; 17:4550 -7;  PMID:21498393 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0116 5.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
Nat Rev Cancer  2008 ; 8:299-308; PMID:18354418 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
Clin Cancer Res 2013 ; (Forthcoming );  PMID:24045181 ; http://dx.doi.org/10.1158/1078- 0432.CCR-13-0945 7.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
J  Immunother  2010 ; 33:956-64; PMID:20948441 ;  http://dx.doi.org/10.1097/CJI.0b013e3181fad2b08.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
Semin Oncol 2010 ; 37:508- 16; PMID:21074066 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
Clin Cancer Res  2010 ; 16:2646 -55; PMID:20406835 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/f0/onci-2-e27184.PMC3914380.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/26/awt308.PMC3914468.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/d5/awt327.PMC3914471.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/8e/awt329.PMC3914473.pdf
"Recent advances in hypertrophic cardiomyopathy Teerapat Yingchoncharoen and WH Wilson Tang* Address: Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA * Corresponding author: WH Wilson Tang (tangw@ccf.org) F1000Prime Reports 2014, 6:12 (doi:10.12703/P6-12) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/95/medrep-06-12.PMC3914503.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/12 Abstract Several advances in molecular genetics and cardiac imaging of patients with hypertrophic cardiomyopathy (HCM) have been developed in recent years.,Non-OADS,/arxiv_data1/oa_pdf/ae/95/medrep-06-12.PMC3914503.pdf
"Wolff-Parkinson-White pattern inPRKAG2 and LAMP2 , greatly increased precordial voltage and massive left ventricular hypertrophy (LVH) in patients with LAMP2 mutation, symmetric LVH and Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:12 http://f1000.com/prime/reports/m/6/12",Non-OADS,/arxiv_data1/oa_pdf/ae/95/medrep-06-12.PMC3914503.pdf
"Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:12 http://f1000.com/prime/reports/m/6/12",Non-OADS,/arxiv_data1/oa_pdf/ae/95/medrep-06-12.PMC3914503.pdf
"Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:12 http://f1000.com/prime/reports/m/6/12",Non-OADS,/arxiv_data1/oa_pdf/ae/95/medrep-06-12.PMC3914503.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:12 http://f1000.com/prime/reports/m/6/12",Non-OADS,/arxiv_data1/oa_pdf/ae/95/medrep-06-12.PMC3914503.pdf
"Page 6of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:12 http://f1000.com/prime/reports/m/6/12",Non-OADS,/arxiv_data1/oa_pdf/ae/95/medrep-06-12.PMC3914503.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:12 http://f1000.com/prime/reports/m/6/12",Non-OADS,/arxiv_data1/oa_pdf/ae/95/medrep-06-12.PMC3914503.pdf
"John Labbadia and Richard I. Morimoto* Address: Department of Molecular Biosciences, Rice Institute for Biomedical Research, 2205 Tech Drive, Hogan 2-100, Northwestern University, Evanston, IL 60208, USA * Corresponding author: Richard I. Morimoto (r-morimoto@northwestern.edu) F1000Prime Reports 2014, 6:7 (doi:10.12703/P6-7) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/f8/biolrep-06-07.PMC3914504.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/7 Abstract Aging is a complex process regulated by multiple cellular pathways, including the proteostasis network.",OADS,/arxiv_data1/oa_pdf/19/f8/biolrep-06-07.PMC3914504.pdf
"Therefore, reduction of Page 2 of 7 (page number not for citation purposes) F1000Prime Reports 2014, 6:7 http://f1000.com/prime/reports/b/6/7",Non-OADS,/arxiv_data1/oa_pdf/19/f8/biolrep-06-07.PMC3914504.pdf
"Page 3 of 7 (page number not for citation purposes) F1000Prime Reports 2014, 6:7 http://f1000.com/prime/reports/b/6/7",Non-OADS,/arxiv_data1/oa_pdf/19/f8/biolrep-06-07.PMC3914504.pdf
"One possibility is that neurons and the intestine in young adults coordinately Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:7 http://f1000.com/prime/reports/b/6/7",Non-OADS,/arxiv_data1/oa_pdf/19/f8/biolrep-06-07.PMC3914504.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:7 http://f1000.com/prime/reports/b/6/7",Non-OADS,/arxiv_data1/oa_pdf/19/f8/biolrep-06-07.PMC3914504.pdf
"Vilchez D, Morantte I, Liu Z, Douglas PM, Merkwirth C, Rodrigues APC, Manning G, Dillin A: RPN-6 determines C. Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:7 http://f1000.com/prime/reports/b/6/7",Non-OADS,/arxiv_data1/oa_pdf/19/f8/biolrep-06-07.PMC3914504.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:7 http://f1000.com/prime/reports/b/6/7",Non-OADS,/arxiv_data1/oa_pdf/19/f8/biolrep-06-07.PMC3914504.pdf
"2, 35043 Marburg, Germany;2University of Gießen and Marburg Lung Center (UGMLC), Member of the German Lung Center for Lung Research (DZL);3Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg, University Hospital Giessen and Marburg GmbH, Campus Marburg, Baldingerstrasse 33, 35043 Marburg * Corresponding author: Harald Renz (renzh@med.uni-marburg.de) F1000Prime Reports 2014, 6:11 (doi:10.12703/P6-11) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/11 Abstract More than 300 years after Antonie van Leeuwenhoek gave the first description of microbes that colonize human body surfaces, the re-discovery of this multifaceted microbial world within our bodies haschallenged our principal view on microbes.",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Early exposure toarichmicrobial flora, asfound in prototypic environments such astraditional farming Page 2of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:11 http://f1000.com/prime/reports/m/6/11",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:11 http://f1000.com/prime/reports/m/6/11",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:11 http://f1000.com/prime/reports/m/6/11",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:11 http://f1000.com/prime/reports/m/6/11",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:11 http://f1000.com/prime/reports/m/6/11",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:11 http://f1000.com/prime/reports/m/6/11",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:11 http://f1000.com/prime/reports/m/6/11",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:11 http://f1000.com/prime/reports/m/6/11",Non-OADS,/arxiv_data1/oa_pdf/b4/a7/medrep-06-11.PMC3914505.pdf
"Increasing the resolution of the adult neurogenesis picture Benjamin Lacar, Sarah L. Parylak, Krishna C. Vadodaria, Anindita Sarkar and Fred H. Gage* Address: The Salk Institute for Biological Studies Laboratory of Genetics, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA * Corresponding author: Fred H. Gage (gage@salk.edu) F1000Prime Reports 2014, 6:8 (doi:10.12703/P6-8) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/b0/biolrep-06-08.PMC3914506.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/8 Abstract The birth of new neurons in the adult mammalian brain —once thought impossible —is now a well- accepted phenomenon that takes place in the subventricular zone of the lateral ventricles and the hippocampus.,Non-OADS,/arxiv_data1/oa_pdf/bd/b0/biolrep-06-08.PMC3914506.pdf
"Hence, at 4 weeks after birth, new neurons receive input from the same sources as mature granule cells but, Page 2 of 5 (page number not for citation purposes) F1000Prime Reports 2014, 6:8 http://f1000.com/prime/reports/b/6/8",Non-OADS,/arxiv_data1/oa_pdf/bd/b0/biolrep-06-08.PMC3914506.pdf
"Therefore, it has been tempting to view our knowledge of rodent adult neurogenesis Page 3 of 5 (page number not for citation purposes) F1000Prime Reports 2014, 6:8 http://f1000.com/prime/reports/b/6/8",Non-OADS,/arxiv_data1/oa_pdf/bd/b0/biolrep-06-08.PMC3914506.pdf
"Clelland CD, Choi M, Romberg C, Clemenson GD, Fragniere A, Tyers P, Jessberger S, Saksida LM, Barker RA, Gage FH, Bussey TJ: A Page 4 of 5 (page number not for citation purposes) F1000Prime Reports 2014, 6:8 http://f1000.com/prime/reports/b/6/8",Non-OADS,/arxiv_data1/oa_pdf/bd/b0/biolrep-06-08.PMC3914506.pdf
"Page 5 of 5 (page number not for citation purposes) F1000Prime Reports 2014, 6:8 http://f1000.com/prime/reports/b/6/8",Non-OADS,/arxiv_data1/oa_pdf/bd/b0/biolrep-06-08.PMC3914506.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/9c/mzt079.PMC3914563.pdf
"http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=81027ned&D1=41-50&D2=3-13&D3=0&D4=l&VW=T (7 May 2012, date last accessed).Quality improvement project Quality improvement 47",OADS,/arxiv_data1/oa_pdf/70/9c/mzt079.PMC3914563.pdf
"http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=37296ned& D1=a&D2=0,10,20,30,40,50,(l-1)-l&HD=111125-1331&HDR= G1&STB=T (7 May 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/70/9c/mzt079.PMC3914563.pdf
http://www.zorgatlas.,Non-OADS,/arxiv_data1/oa_pdf/70/9c/mzt079.PMC3914563.pdf
"http://www.nivel.nl (7 May 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/70/9c/mzt079.PMC3914563.pdf
"http://www.vmszorg.nl/Over-het-programma(7 May 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/70/9c/mzt079.PMC3914563.pdf
All alignment and data ﬁles used in this analysis are available on the Dryad Digital Repository ( http://doi.org/10.5061/dryad.d85ng ).,OADS,/arxiv_data1/oa_pdf/01/f2/evu005.PMC3914681.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/f2/evu005.PMC3914681.pdf
All alignment and data ﬁles used in this analysis are avail- able on the Dryad Digital Repository http://doi.org/10.,OADS,/arxiv_data1/oa_pdf/01/f2/evu005.PMC3914681.pdf
Available from: http://www.geneious.com/ .,Non-OADS,/arxiv_data1/oa_pdf/01/f2/evu005.PMC3914681.pdf
"According to recent US census data, about 0.9% of males and 2.8% females survive to age 100 (U.S. Social Security Administration, 2009 Census [ http://www.ssa.gov/oact/ STATS/table4c6.html , last accessed November 30, 2013]).",OADS,/arxiv_data1/oa_pdf/51/55/evt180.PMC3914684.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/55/evt180.PMC3914684.pdf
Supplementary Material Supplementary ﬁgures S1–S6 andtables S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/51/55/evt180.PMC3914684.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/54/evu004.PMC3914693.pdf
"2010 ;http://www.hmmer.org ,l a s t accessed January 16, 2014) that allowed an iterative searchof a local database of 142 archaeal genomes including 98plasmid sequences and a local database of 56 complete ar-chaeal virus genomes downloaded from the Viral Genomesdatabase of NCBI (as of June 20, 2013) ( supplementary table S3,Supplementary Material online).",OADS,/arxiv_data1/oa_pdf/4c/54/evu004.PMC3914693.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/87/evt211.PMC3914694.pdf
"However, more than half of all known PVs correspond to human PVs (PAvE, Papillomavirus Episteme Database, http://pave.niaid.",Non-OADS,/arxiv_data1/oa_pdf/c7/87/evt211.PMC3914694.pdf
"2010 ;International Union for Conservation of Nature 2013 ,http://www.iucnredlist.org/ , last accessed December, 2013), we have little insight ofnonhuman PV diversity.",Non-OADS,/arxiv_data1/oa_pdf/c7/87/evt211.PMC3914694.pdf
Supplementary Material Supplementary ﬁgures S1–S6 andtables S1–S13 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/c7/87/evt211.PMC3914694.pdf
"Available from: http://www.iucn- redlist.org/ .Juste J, Benda P, Garcia-Mudarra JL, Iba ´n˜ez C. 2013.",Non-OADS,/arxiv_data1/oa_pdf/c7/87/evt211.PMC3914694.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/82/evt209.PMC3914696.pdf
"Overall, this study sug- gests P. torquis c o u l db ea ne x c e l l e n tm o d e lt os t u d ys e a - i c e functional biology and evolutionary processes linked with psy-chrophily, endemism, and algal interactions.Supplementary Material Supplementary ﬁgure S1 andtables S1–S3 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.",Non-OADS,/arxiv_data1/oa_pdf/fe/82/evt209.PMC3914696.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/de/evu008.PMC3914698.pdf
"The similarity of these sequences to those in public databases was obtained using Blast analysis ( http://www.ncbi.nlm.nih.gov/BLAST/ ,l a s t accessed January 24, 2014).",OADS,/arxiv_data1/oa_pdf/40/de/evu008.PMC3914698.pdf
Available at: http://news.albanianscreen.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/MSM-25-4-270.PMC3914738.pdf
12. http://bmg.gv.at/cms/home/attachments/3/6/8/CH1205/ CMS1126084167391/pp_englisch.pdf web site accessed on May  17th 2011 at 21:00 h 13.,Non-OADS,/arxiv_data1/oa_pdf/84/0a/MSM-25-4-246.PMC3914740.pdf
National Plan for Preparedness and Response to an Influenza  Pandemic; 15. http://www.salute.gov.it/imgs/C_17_pubblicazioni_511_alle - gato.pdf web site accessed on May 17th 2011 at 21:00 h.,Non-OADS,/arxiv_data1/oa_pdf/84/0a/MSM-25-4-246.PMC3914740.pdf
Available at http://lnweb18.worldbank.org/eca/albania.nsf 6.,Non-OADS,/arxiv_data1/oa_pdf/b5/7b/MSM-25-4-273.PMC3914742.pdf
Strategies and trends in the pharmaceutical industry; 2013: 1-3. http://www.pwc.com/gx/en/pharma-life-sciences/pharma2020/industry-strategies- and-trends-analysis.jhtml.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
17. http://www.industryweek.com/emerging-technologies/six-tech-trends-will-shape- pharmaceutical-industry-2013.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2012: 1-3. http://www.ey.com/Publication/vwLUAssets/The_shifting_pharmaceutical_industry_landscape/$FILE/The_shifting_pharmaceutical_industry_landscape.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2013: 1-2. http://www.contractpharma.com/issues/2013-06/ view_features/cro-outlook-market-trends/.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2013: 1-3. http://www.pwc.com/gx/en/pharma-life-sciences/pharma2020/index.jhtml.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
1-2. http://www.biospectrumasia.com/category/pharma#.UgGkxJJM9MA.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2009: 1-3. http://www.mce-ama.com/industry-expertise/pharma/trends-impacting-pharma-industry/.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2013: 1-2. http://www.pmlive.com/pharma_news/technology_trends_facing_pharma_in_2013_463678.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2013; 1-4. http://www.pmlive.com/or - phan_drugs_rare_diseases.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2013: 1-2. http://www.pmlive.com/pmhub/healthcare_digital_communications/blue_latitude/white_papers_and_resources/pharma_marketing_trends_to_watch_out_for_in_2013.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2013: 1-3. http://www.pmlive.com/pharma_intelligence/enabling_access_for_patients_with_rare_dis - eases_486398.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
2013: 1-4. http://www.pmlive.com/pharma_thought_leadership/payer_focus_in_the_personalised_world_of_oncology_and_orphan_diseases_476747 28.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
NICE demands more data from Roche for MabThera in rare autoim - mune disease; 2013: 1-2. http://www.pmlive.com/pharma_news/nice_demands_more_data_from_roche_for_mabthera_in_rare_autoimmune_disease_491399.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/MSM-25-4-286.PMC3914743.pdf
<URL:http://hea.gov.ba >(Accessed on August 10 2013) 18.,Non-OADS,/arxiv_data1/oa_pdf/e3/7b/MSM-25-4-282.PMC3914744.pdf
Society for Pharmacoecnomics and Outcomes Research in Bosnia and Herzegovina <URL:http://www.farmakoekonomika.ba >(Accessed on August 10 2013).,Non-OADS,/arxiv_data1/oa_pdf/e3/7b/MSM-25-4-282.PMC3914744.pdf
<URL:http://www.fmoh.gov.ba/index.php/usavrsa - vanja/specijalizacija>(Accessed on August 12 2013).,Non-OADS,/arxiv_data1/oa_pdf/e3/7b/MSM-25-4-282.PMC3914744.pdf
Available from: http://www.abenity.com/celebrate/hot-topic-why-is-employee-wellness-important/.,Non-OADS,/arxiv_data1/oa_pdf/05/56/MSM-25-4-233.PMC3914745.pdf
1389; Available at: URL:http://WWW.madomsalari.com/ template1/NEWS.aspx?NID=10091.,Non-OADS,/arxiv_data1/oa_pdf/6d/89/MSM-25-4-230.PMC3914749.pdf
2011; 9: 107. http://www.biomedcentral.com/1741-7015/9/107 7.,Non-OADS,/arxiv_data1/oa_pdf/a0/2c/MSM-25-4-277.PMC3914751.pdf
Available at:http://www.effectivehealthcare.ahrq.gov 10.,Non-OADS,/arxiv_data1/oa_pdf/a0/2c/MSM-25-4-277.PMC3914751.pdf
2. https://www.healthatoz.com/healthatoz/Atoz/ency/erythro - blastosis_fetalis_pr.jsp.,Non-OADS,/arxiv_data1/oa_pdf/01/d0/MSM-25-4-255.PMC3914752.pdf
"Wagle S. Hemolytic Disease of Newborn, http://www.emedi - cine.com/PED/topic959.htm.",Non-OADS,/arxiv_data1/oa_pdf/01/d0/MSM-25-4-255.PMC3914752.pdf
"Promocija prevencije–Udruženje roditelja djece i omladine sa posebnim potrebama, http://www.urdopp.org/srp/promocijaprevencije_s.htm.",Non-OADS,/arxiv_data1/oa_pdf/01/d0/MSM-25-4-255.PMC3914752.pdf
11. https://www.healthatoz.com/healthatoz/Atoz/ency/erythro - blastosis_fetalis_pr.jsp.,Non-OADS,/arxiv_data1/oa_pdf/01/d0/MSM-25-4-255.PMC3914752.pdf
"INSTRUCTIONS FOR THE AUTHORS All papers need to be sent to: Editorial board of the journal Mat Soc Med, electronically over the web site  http://scopemed.org/?jid=16.",Non-OADS,/arxiv_data1/oa_pdf/01/d0/MSM-25-4-255.PMC3914752.pdf
Available from URL:  http://www.who.int/whr/2000/en/statistics.htm; 2000.,OADS,/arxiv_data1/oa_pdf/23/d4/MSM-25-4-226.PMC3914753.pdf
http://dx.doi.org/10.1016/j.gpb.2012.11.003,OADS,/arxiv_data1/oa_pdf/61/4e/main.PMC3914773.pdf
"The tool, Structure Feature Analysis Tool (SFAT), is freely available to the public at http://hive.biochemistry.gwu.edu/tools/sfat .",OADS,/arxiv_data1/oa_pdf/61/4e/main.PMC3914773.pdf
"Formouse, the ﬁle rp-seqs-15.fasta.gz from http://pir.george- town.edu/rps/data/current/15/ was downloaded and parsed to obtain the complete proteome.",OADS,/arxiv_data1/oa_pdf/61/4e/main.PMC3914773.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/ j.gpb.",OADS,/arxiv_data1/oa_pdf/61/4e/main.PMC3914773.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/b1/ijwh-6-141.PMC3914829.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 141–147International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  141OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5668 7The incidence rate of corpus uteri cancer  among females in saudi arabia: an observational  descriptive epidemiological analysis of data from  saudi cancer registry 2001–2008 Ibrahim g alghamdi1 Issam I Hussain1 Mohamed s alghamdi2 Mohamed a el-sheemy1,3 1University of lincoln, Brayford Pool,   lincoln, UK; 2Ministry of Health,   general Directorate of Health affairs,   al-Baha, Kingdom of saudi arabia;   3research and Development, lincoln  Hospital,  lincolnshire Hospitals nHs  Trust, lincoln, UK correspondence: Ibrahim g alghamdi   University of lincoln, school of life  sciences, Brayford Pool, lincoln,   ln6 7Ts, UK   Tel +441 16 276 1913   email b io-stat@hotmail.co mBackground:  The present study reviews the epidemiological data on corpus uteri cancer among  Saudi women, including its frequency, crude incidence rate, and age-standardized incidence  rate (ASIR), adjusted by region and year of diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/fc/b1/ijwh-6-141.PMC3914829.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/fc/b1/ijwh-6-141.PMC3914829.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/b1/ijwh-6-141.PMC3914829.pdf
Available from http://www.oncology.org.sa /.,Non-OADS,/arxiv_data1/oa_pdf/fc/b1/ijwh-6-141.PMC3914829.pdf
"Avail - able from http://globocan.iarc.fr/factsheets/cancers/all.as p. Accessed  October 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fc/b1/ijwh-6-141.PMC3914829.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/f3/ijwh-6-095.PMC3914832.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 95–114International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  95RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5108 3Uterine fibroids: current perspectives Aamir T Khan1 Manjeet Shehmar1 Janesh K Gupta2 1Birmingham Women’s Hospital,   Edgbaston, Birmingham, UK;    2Academic Department of Obstetrics  and Gynaecology, University of  Birmingham, Birmingham, UK Correspondence: Janesh Gupta   Academic Department of Obstetrics and  Gynaecology, University of Birmingham,  Birmingham Women’s Hospital,  Edgbaston, Birmingham, B15 2TG, UK   Tel +44 (0) 121 607 4751   Fax +44 (0) 121 627 2667   email j.k.gupta@bham.ac.u kAbstract:  Uterine fibroids are a major cause of morbidity in women of a reproductive age  (and sometimes even after menopause).",Non-OADS,/arxiv_data1/oa_pdf/39/f3/ijwh-6-095.PMC3914832.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/39/f3/ijwh-6-095.PMC3914832.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/f3/ijwh-6-095.PMC3914832.pdf
"MATERIALS AND METHODS An expanded Methods section is available in the Online Data Supplement, http://links.lww.com/HJH/A299.",Non-OADS,/arxiv_data1/oa_pdf/27/3e/jhype-32-555.PMC3914904.pdf
"For each condition, 180 random cells were measured from 18 fields of view; experiments were repeated in triplicate on three independent occasions.The MitoQ 10analogue IBTP was colocalized to mitochon- dria using confocal microscopy as previously demonstrated (see supplementary methods, http://links.lww.com/HJH/ A299) [16].",Non-OADS,/arxiv_data1/oa_pdf/27/3e/jhype-32-555.PMC3914904.pdf
"No significant differences were observed for basal superoxide pro- duction in aortic rings or plasma lipid peroxidation (Supplementary Figure ii, http://links.lww.com/HJH/ A299).",Non-OADS,/arxiv_data1/oa_pdf/27/3e/jhype-32-555.PMC3914904.pdf
"3c) and collagen I and III immunohistochemistry (Supple- mentary Figure iii, http://links.lww.com/HJH/A299).",Non-OADS,/arxiv_data1/oa_pdf/27/3e/jhype-32-555.PMC3914904.pdf
"MitoQ 10 had no effect on cell size in unstimulated H9c2 cells and cell viability was not affected by MitoQ 10or dTPP (Supplementary Figure iv, http://links.lww.com/ HJH/A299).",OADS,/arxiv_data1/oa_pdf/27/3e/jhype-32-555.PMC3914904.pdf
Communicative & Integrative Biology 2013; 6:e26283; http://dx.doi.org/10.4161/cib.26283,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nat  Rev Mol Cell Biol 2000; 1:11-21; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nature 1993; 361:315-25; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Annu Rev Biochem 1987; 56:395-433; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Crit Rev Biochem Mol Biol 2001; 36:107-260; http://dx.doi.org/10.1080/20014091074183 5.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem 2013; 288:10750-8;  http://dx.doi.org/10.1074/jbc.R112.420752 6.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nature 1985; 316:541-2;  http://dx.doi.org/10.1038/316541a0 8.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nature 1990; 346:567-9; http://dx.doi.org/10.1038/346567a0 9.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Cell Calcium 1986; 7:1-12; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Cell Calcium  2007; 42:103-10; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Curr Biol 2005; 15:1235-41; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Cell Biol 2005; 169:435-45; http://dx.doi.org/10.1083/jcb.200502019 13.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nature 2005; 437:902-5; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem 2006; 281:35855-62; http://dx.doi.org/10.1074/jbc.M608247200 15.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Proc Natl Acad Sci  USA 2007; 104:9301-6; http://dx.doi.org/10.1073/ pnas.0702866104 16.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem 2008; 283:8014-22;  http://dx.doi.org/10.1074/jbc.M70889820017.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Cell Sci 2008;  121:762-72; http://dx.doi.org/10.1242/jcs.023903 18.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem  2006; 281:20661-5; http://dx.doi.org/10.1074/jbc.C600126200 19.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nature 2006; 443:226-9; http://dx.doi.org/10.1038/ nature05108 20.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Science 2006; 312:1220-3; http://dx.doi.org/10.1126/ science.1127883 22.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nature 2006;  441:179-85; http://dx.doi.org/10.1038/nature04702 23.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nat Cell Biol 2007; 9:636-45; http://dx.doi.org/10.1038/ ncb1590 24.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem 2010; 285:38666-73; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem 2007; 282:9105- 16; http://dx.doi.org/10.1074/jbc.M608942200 26.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nat Cell Biol 2009;  11:337-43; http://dx.doi.org/10.1038/ncb1842 28.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Sci Signal 2011; 3:ra82;  http://dx.doi.org/10.1126/scisignal.2001122 29.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
EMBO J 2011; 30:1678-89; http://dx.doi.org/10.1038/emboj.2011.79 30.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Mol Cell 2008; 32:439-48; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Science 2010; 330:101-5; http://dx.doi.org/10.1126/ science.1191027 32.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Biochim Biophys Acta 2000; 1481:147-55; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Cell 2006; 127:635-48; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Proc  Natl Acad Sci USA 2007; 104:1488-93; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Proteomics 2008; 8:4534-46; http://dx.doi.org/10.1002/pmic.200800105 37.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Nat Cell Biol 2009; 11:1465-72; http://dx.doi.org/10.1038/ncb1995 39.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Proc Natl Acad Sci USA 2009; 106:17401-6; http://dx.doi.org/10.1073/ pnas.090465110640.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem 2000; 275:38710-5;  http://dx.doi.org/10.1074/jbc.M007887200 41.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Cell Sci 2013; 126:3170-80; http://dx.doi.org/10.1242/jcs.125054 43.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Cell Biol 2000; 149:761-6; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Cell  Sci 2007; 120:3762-71; http://dx.doi.org/10.1242/jcs.015735 47.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem  2009; 284:17227-42; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Arch Histol Cytol 2008;  71:249-63; http://dx.doi.org/10.1679/aohc.71.249 49.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Cell Signal 2007; 19:2147- 54; http://dx.doi.org/10.1016/j.cellsig.2007.06.011 50.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Cell Calcium 2009; 45:439-46; http://dx.doi.org/10.1016/j.ceca.2009.02.010 52.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Curr Biol 2008; 18:177-82; http://dx.doi.org/10.1016/j.cub.2007.12.050 53.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Open  Biol 2012; 2:120132; http://dx.doi.org/10.1098/ rsob.120132 54.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Cell 2009; 138:366-76; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Curr Biol 2001; 11:44-9; http://dx.doi.org/10.1016/ S0960-9822(01)00002-1 56.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Annu Rev Cell Dev Biol 2004; 20:337-66; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Dev  Cell 2004; 6:253-68; http://dx.doi.org/10.1016/ S1534-5807(04)00025-5 58.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Cell Sci 2009; 122:2969-79; http://dx.doi.org/10.1242/jcs.046649 59.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Cell Biol 2009; 184:895-908; http://dx.doi.org/10.1083/jcb.200901042 60.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Curr  Biol 2012; 22:1487-93; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Cell Signal  2012; 24:1315-22; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J Biol Chem 2012; 287:39094-106;  http://dx.doi.org/10.1074/jbc.M112.383778 63.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Mol Biol Cell  2012; 23:1376-87; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Circulation  2011; 124:796-805; http://dx.doi.org/10.1161/ CIRCULATIONAHA.111.031229 65.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
J  Mol Cell Cardiol 2012; 52:136-47; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
Blood  2012; 120:1317-26; http://dx.doi.org/10.1182/ blood-2011-12-398438,Non-OADS,/arxiv_data1/oa_pdf/37/60/cib-6-e26283.PMC3914909.pdf
"Communicative & Integrative Biology 2013; 6:e26834;   http://dx.doi.org/10.4161/cib.26834SEC14 and Spectrin Domains 1 (Sestd1),  Dishevelled 2 (Dvl2) and Dapper Antagonist   of Catenin-1 (Dact1) co-regulate the Wnt/Planar  Cell Polarity (PCP) pathway during mammalian  development XiaoYong Yang, Daniel a Fisher, and Benjamin NR c heyette* The Nina Ireland Laboratory of Developmental Neurobiology; Department of Psychiatry; University of c alifornia s an Francisco; s an Francisco, ca U sa Keywords:  Sestd1, Dvl2, Dact1, Rho GTPase, Vangl2, planar cell polarity Abbreviations:  CE, convergent-extension cell movements; co-IP, co-immunoprecipitation; Dact1,  Dapper Antagonist of Catenin 1; Dvl2, Dishevelled 2; KO, genetically engineered knock-out; PCP, pla - nar cell polarity; Sestd1, SEC14 and Spectrin Domains 1; Vangl2, Van Gogh-like 2 We previously reported that Sestd1  KO phenocopies Dact1  KO in mice, consistent with a model in which s estd1 and  Dact1 form a crucial functional complex that regulates Vangl2 in the Wnt/Planar c ell Polarity (P cP) pathway.",Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Curr Top Dev Biol  2012; 101:77-110;  PMID:23140626 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Dev Cell 2008; 15:462-9;  PMID:18804440 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Biochem Soc Trans 2005; 33:891- 5; PMID:16246005 ; http://dx.doi.org/10.1042/ BST20050891 4.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Genes Dev  2009; 23:265-77;  PMID:19204114 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Genes Dev 1994; 8:118-30; PMID:8288125 ;  http://dx.doi.org/10.1101/gad.8.1.118 7.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Development 2002; 129:5815- 25; PMID:12421719 ; http://dx.doi.org/10.1242/ dev.00123 8.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Cell Signal 2010; 22:717-27; PMID:20006983 ;  http://dx.doi.org/10.1016/j.cellsig.2009.11.021 9.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Curr Top Dev Biol 2012; 101:213-35; PMID:23140631 ; http://dx.doi.org/10.1016/ B978-0-12-394592-1.00007-7 10.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Dev Biol 1994; 166:73- 86; PMID:7958461 ; http://dx.doi.org/10.1006/ dbio.1994.1297 11.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Mech Dev  1996; 58:1 5-26;  PMID:8887313 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Dev Dyn 1996; 207:253- 62; PMID:8922524 ; http://dx.doi.org/10.1002/ (SICI)1097-0177(199611)207:3<253::AID-AJA2>3.0.CO;2-G13.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Cell 1997; 90:895-905; PMID:9298901 ;  http://dx.doi.org/10.1016/S0092-8674(00)80354-2 14.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Development 2002; 129:5827-38; PMID:12421720 ; http://dx.doi.org/10.1242/ dev.00164 15.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Development 2006; 133:1767-78; PMID:16571627 ;  http://dx.doi.org/10.1242/dev.02347 16.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Development 2004; 131:5909-21; PMID:15539487 ;  http://dx.doi.org/10.1242/dev.01520 17.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Dev Dyn  2006; 235:2620-30;  PMID:16881060 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Cancer Cell 2008; 13:529- 41; PMID:18538736 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
J Neurosci  2010; 30:4362-8;  PMID:20335472 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Dev Cell 2002; 2:449- 61; PMID:11970895 ; http://dx.doi.org/10.1016/ S1534-5807(02)00140-5 21.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Nat Genet 2009; 41:977-85;  PMID:19701191 ; http://dx.doi.org/10.1038/ng.43523.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
J Biol Chem 2010; 285:11023-30; PMID:20145239 ;  http://dx.doi.org/10.1074/jbc.M109.085381 24.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
J Biol Chem 2013;  288:20111-20;  PMID:23696638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
BMC Biochem  2011; 12:33;  PMID:21718540 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Annu Rev Pharmacol Toxicol 2000; 40:459-89; PMID:10836144 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
J Biol Chem 2006; 281:8607-12; PMID:16446366 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Science 2005; 308:826-33;   PMID:15817814 ; http://dx.doi.org/10.1126/ science.1109374 30.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Biochim Biophys Acta 2007;  1771:727-36;  PMID:17512778 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
J Biol Chem 2004;  279:52703-13;  PMID:15456783 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Biochemistry 2011; 50:795- 804; PMID:21142127 ; http://dx.doi.org/10.1021/ bi101286d 34.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Mol Cell Biol 2000; 20:2228-38;  PMID:10688669 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
J Cell Biol 1999; 146:427-37; PMID:10427095 ; http://dx.doi.org/10.1083/ jcb.146.2.42736.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
J Cell Sci  2005; 118:5269-77;  PMID:16263762 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Science 2004; 306:114-7; PMID:15459392 ; http://dx.doi.org/10.1126/ science.1100569 38.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Nature 2002; 419:726-9; PMID:12384700 ;  http://dx.doi.org/10.1038/nature0105639.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
J Biol Chem 2000; 275:16478-83; PMID:10748216 ;  http://dx.doi.org/10.1074/jbc.M910362199 40.,OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
PLoS One 2009; 4:e4310; PMID:19183803 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/34/14/cib-6-e26834.PMC3914910.pdf
Communicative & Integrative Biology 2014;  7:e26760; http://dx.doi.org/10.4161/cib.26760,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
J Stat Mech Theory Exp 2013; P01001; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
J R Soc Interface  2013 ; 10:20130026 ;  PMID:23466559 ; http://dx.doi.org/10.1098/ rsif.2013.0026 3.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Rev Econ Stud  2000 ; 67:17-45; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Biochem Biophys Res Commun  2011 ; 406:218- 22; PMID:21303659 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Biol Direct   2013 ; 8:8; PMID:23557484 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Proc Natl Acad Sci U S A   1991 ; 88:4119-22; PMID:1851993 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Plant Cell   2003 ; 15:1507 -23; PMID:12837943 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
EMBO J  2012 ; 31:2714 - 36; PMID:22617422 ; http://dx.doi.org/10.1038/ emboj.2012.150 10.,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Plant Cell  2012 ; 24:1066 -80; PMID:22427339 ;  http://dx.doi.org/10.1105/tpc.111.09505911.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
J Pineal Res  2013 ; 55:131-7;  PMID:23521226 ; http://dx.doi.org/10.1111/jpi.12053 12.,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Plant Cell Physiol  2011 ; 52:490-508;  PMID:21252298 ; http://dx.doi.org/10.1093/pcp/ pcr006 13.,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Plant Physiol  2009 ; 150:1380 - 93; PMID:19439571 ; http://dx.doi.org/10.1104/ pp.109.138552 14.,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
J Integr Plant Biol   2013 ; 55:294-388; PMID:23462277 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Ecol Let  2013 ;  http://dx.doi.org/10.1111/ele.12152 .,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
J  Wood Sci  2007 ; 53:463-9; http://dx.doi.org/10.1007/ s10086-007-0899-3 21.,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Plant Cell  2003 ; 15:1685 -7; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Plant J  2006 ;  45:144-65; PMID:16367961 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Planta   2006 ; 224:828-37; PMID:16575593 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Am J Bot   2005 ; 92:985-9; PMID:21652482 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Theor Biol Med Model   2006 ; 3:31; PMID:16923189 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
Nature  2003 ; 421:939- 42; PMID:12607000 ; http://dx.doi.org/10.1038/ nature01444,Non-OADS,/arxiv_data1/oa_pdf/90/38/cib-6-e26760.PMC3914912.pdf
"Communica - tive & Integrative Biology 2013; 6:e26369;   http://dx.doi.org/10.4161/cib.26369*Correspondence to: Christopher A Shaw;  Email: cashawlab@gmail.com Marler TE, Yang J.",Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
"Econ Bot 2013; http://dx.doi.org/10.1007/s12231-013-9236-5, In press.",Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Toxicol Lett 2008; 180:131-6;  PMID:18602975; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Food Funct 2011; 2:760-8; PMID:21804969;  http://dx.doi.org/10.1039/c1fo10067j 7.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Econ Bot  2013; In press; PMID:23538880; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Immunol Res 2013; 56:304-16; PMID:23609067;  http://dx.doi.org/10.1007/s12026-013-8403-1 9.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Trends  Biochem Sci 2009; 34:589-93; PMID:19773172; http://dx.doi.org/10.1016/j.tibs.2009.07.006 10.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Coord Chem Rev  2012; 256:2142-6; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
J Theor Biol 1992; 159:83-98; PMID:1291812; http://dx.doi.org/10.1016/S0022-5193(05)80769-6 12.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
J Toxicol  Environ Health 1996; 48:569-84; PMID:8772799; http://dx.doi.org/10.1080/009841096161078 13.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
J Toxicol Environ Health B Crit Rev 2007; 10(Suppl 1):1-269; PMID:18085482; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Eur J Cancer Prev 2001;  10:389-93; PMID:11711753; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Struct Bond 2003; 104:139-80; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
JAMA 1911; 57:816-21; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Pharmacol Toxicol 2001; 88:159-67; PMID:11322172; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
J Neurol Neurosurg Psychiatry 2006; 77:877-9; PMID:16627535; http://dx.doi.org/10.1136/ jnnp.2005.086553 20.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
J Inorg Biochem  2009; 103:1548-54; PMID:19818510; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Neuromolecular  Med 2007; 9:83-100; PMID:17114826; http://dx.doi.org/10.1385/NMM:9:1:83 25.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
J Inorg Biochem 2009; 103:1555- 62; PMID:19740540; http://dx.doi.org/10.1016/j.jinorgbio.2009.05.019 26.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Brain 2001; 124:1821-31; PMID:11522584;  http://dx.doi.org/10.1093/brain/124.9.182128.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Curr Med Chem 2011;  18:2630-7; PMID:21568886; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
J Inorg Biochem 2011; 105:1489-99;  PMID:22099159; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
J Inorg Biochem 2013; In press;  PMID:23932735; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Entropy 2012; 14:2227-53; http://dx.doi.org/10.3390/e14112227 33.,Non-OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Sci Total Environ 2008; 400:356-68;  PMID:18657304; http://dx.doi.org/10.1016/j.scitotenv.2008.06.003 34.,OADS,/arxiv_data1/oa_pdf/23/1d/cib-6-e26369.PMC3914913.pdf
Communicative & Integrative Biology 2014;  7:e26658; http://dx.doi.org/10.4161/cib.26658,Non-OADS,/arxiv_data1/oa_pdf/c1/6e/cib-6-e26658.PMC3914914.pdf
Commun Integr Biol 2011; 4:245-6;   PMID:21980550 ; http://dx.doi.org/10.4161/ cib.4.3.15053 2.,OADS,/arxiv_data1/oa_pdf/c1/6e/cib-6-e26658.PMC3914914.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/79/opth-8-315.PMC3915018.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 315–320Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  315Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5528 4antiadenoviral effects of ganciclovir in types  inducing keratoconjunctivitis by quantitative  polymerase chain reaction methods Jane huang1 Kazuaki Kadonosono2 eiichi Uchio1 1Department of Ophthalmology,   Fukuoka University school of  Medicine, Fukuoka, 2Department  of Ophthalmology, Yokohama City  University Medical Center,    Y okohama, Japan Correspondence: eiichi Uchio   Department of Ophthalmology,   Fukuoka University school of   Medicine, 7-45-1 nanakuma,   Jonan-ku, Fukuoka 814-0180, Japan   Tel +81 92 801 1011   Fax +81 92 865 4445   email euchio@fukuoka-u.ac.j pPurpose:  The most common external ocular viral infections are caused by several human  adenovirus (HAdV) types.",Non-OADS,/arxiv_data1/oa_pdf/8a/79/opth-8-315.PMC3915018.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8a/79/opth-8-315.PMC3915018.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/79/opth-8-315.PMC3915018.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/87/clep-6-061.PMC3915019.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 61–70Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  61Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S5423 7Patient-reported health as a prognostic factor   for adverse events following percutaneous  coronary intervention Karin Biering1 hans Erik Bøtker2 Troels niemann3 niels henrik hjollund4,5 1Department of Occupational  Medicine, regional hospital West  Jutland, herning, 2Department  of Cardiology, aarhus University  hospital, skejby, aarhus, 3Department  of Cardiology, regional hospital  West Jutland, herning, 4WestChronic,   regional hospital West Jutland,   herning, 5Department of Clinical  Epidemiology, aarhus University  hospital, aarhus, Denmark Correspondence: Karin Biering   Department of Occupational Medicine,  regional hospital West Jutland,   DK-7400 herning, Denmark   Tel +45 7843 3518   Email karbie@rm.d kObjective:  A relation may exist between self-reported health and adverse events in coronary  heart disease.",Non-OADS,/arxiv_data1/oa_pdf/a4/87/clep-6-061.PMC3915019.pdf
Additional information is available on the webpage of the  National Committee on Health Research Ethics in sec - tion 14.2 of the Act on Research Ethics Review of Health  Research Projects (available from: http://www.cvk.sum.dk/ English/actonabiomedicalresearch.asp x).,Non-OADS,/arxiv_data1/oa_pdf/a4/87/clep-6-061.PMC3915019.pdf
http://www.ssi.dk/Sundhedsdataogit/Dataformidling/Sundhedsdata/ Behandling%20ved%20sygehuse/Sygehusaktivitet%20pa%20 diagnoseniveau.aspx.,OADS,/arxiv_data1/oa_pdf/a4/87/clep-6-061.PMC3915019.pdf
Available from: http://books.google.dk/books?id=Z8hGPgAACAAJ&d q=editions:ZTw92dlgXNEC&hl=da&sa=X&ei=6ducUvulOcuAywON 24L YBw&ved=0CDkQ6AEwAQ.,Non-OADS,/arxiv_data1/oa_pdf/a4/87/clep-6-061.PMC3915019.pdf
Available from: http://www.unesco.,Non-OADS,/arxiv_data1/oa_pdf/a4/87/clep-6-061.PMC3915019.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/a4/87/clep-6-061.PMC3915019.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/44/ijn-9-711.PMC3915020.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 711–726International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  711RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5371 7Nanoparticles for multimodal in vivo imaging   in nanomedicine Jaehong Key1–3 James F Leary1–4 1weldon School of Biomedical  engineering, 2Birck Nanotechnology  Center, 3Bindley Bioscience Center,   4College of veterinary Medicine,   Purdue University, west Lafayette,    IN, USA Correspondence: James F Leary   Birck Nanotechnology Center, Discovery  Park, Purdue University, 1205 west State  Street, west Lafayette, IN 47907, USA   Tel +1 765 494 7280   Fax +1 765 496 6443   email jfleary@purdue.ed uAbstract:  While nanoparticles are usually designed for targeted drug delivery, they can also  simultaneously provide diagnostic information by a variety of in vivo imaging methods.",Non-OADS,/arxiv_data1/oa_pdf/f3/44/ijn-9-711.PMC3915020.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f3/44/ijn-9-711.PMC3915020.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/44/ijn-9-711.PMC3915020.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/64/ijn-9-735.PMC3915021.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 735–744International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  735OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5580 5comparison of in vitro dialysis release methods  of loperamide-encapsulated liposomal gel   for topical drug delivery susan hua The school of Biomedical sciences  and Pharmacy, The University of  Newcastle, callaghan, N sW, australia correspondence: susan hua   The school of Biomedical sciences and  Pharmacy, The University of Newcastle,  callaghan, NsW 2038, australia   Tel +61 249 85 4063   Fax +61 249 21 7903   email s usan.hua@newcastle.edu.a uBackground:  The purpose of this study was to determine the most appropriate dialysis  equilibrium method to assess liposomal gel formulations containing hydrophobic drugs, to give  the most accurate indication of drug release.",Non-OADS,/arxiv_data1/oa_pdf/d1/64/ijn-9-735.PMC3915021.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d1/64/ijn-9-735.PMC3915021.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/64/ijn-9-735.PMC3915021.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/3c/opth-8-327.PMC3915022.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 327–334Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  327Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S3969 9P2Y2 receptor agonists for the treatment   of dry eye disease: a review Oliver C F Lau1 Chameen  Samarawickrama1,2 Simon e Skalicky1–3 1Sydney eye Hospital, Sydney, NSw ,   Australia; 2Save Sight institute,   University of Sydney, Sydney,   NSw , Australia; 3Ophthalmology  Department, Addenbrooke’s Hospital,   Cambridge, United Kingdom Correspondence: Simon e Skalicky   Ophthalmology Department,  Addenbrooke’s Hospital, Box 41 Hills Rd,  Cambridge CB2 0QQ, United Kingdom   Tel +44 1223 256 691   email seskalicky@gmail.co mAbstract:  Recent advances in the understanding of dry eye disease (DED) have revealed  previously unexplored targets for drug therapy.",Non-OADS,/arxiv_data1/oa_pdf/2b/3c/opth-8-327.PMC3915022.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2b/3c/opth-8-327.PMC3915022.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/3c/opth-8-327.PMC3915022.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/38/amep-5-001.PMC3915023.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 1–14Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  1OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S3833 6Ergonomic sui tability of educational furniture   and possible health implications in a university   setting nse A Odunaiya1 Dolapo D Owonuwa1 Oluwafemi O Oguntibeju2 1Department of Physiotherapy,   college of Medicine, University of  ibadan, nigeria; 2Department of  Biomedical sciences, Faculty of health  and Wellness sciences, cape Peninsula  University of T echnology, Bellville,   south Africa correspondence: Oluwafemi  O Oguntibeju Department of Biomedical  sciences, Faculty of health and Wellness   sciences, cape Peninsula University of   Technology, PO Box 1906, Bellville 7535,   south Africa   Tel +27 21 953 8495   Fax +27 21 953 8490   Email oguntibejuo@cput.ac.z aAbstract:  Ergonomically unsui table school furniture is frequently considered one of the major  causes of severe posture problems in adulthood.",Non-OADS,/arxiv_data1/oa_pdf/1f/38/amep-5-001.PMC3915023.pdf
"Available  from: http://www.spine-health.com/wellness/ergonomics/office- chair-choosing-right-ergonomic-office-chai r. Accessed January 24,   2011.",Non-OADS,/arxiv_data1/oa_pdf/1f/38/amep-5-001.PMC3915023.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/1f/38/amep-5-001.PMC3915023.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/38/amep-5-001.PMC3915023.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/07/f8/thnov04p0229.PMC3915087.pdf
This is an open- access article distributed under the terms of the Creativ e Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/47/92/thnov04p0240.PMC3915088.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/12/thnov04p0256.PMC3915089.pdf
"http://www.thno.org/v04p0 256s1.pdf   Acknowledgment   This work was financially supported, in part, by  the Outstanding Youth Fund  (81125011 ), “973” pr o- gram  (2013CB73380 2 and  2011CB707703),  National  Natural Science Foundation of China (NSFC) projects  (81000625, 30930030, 81222019, 30900373, 81201127 ,  81028009 and 81321003 ), grants from  the Ministry of  Science and Technology of China  (2012ZX09102301 -018, 2011YQ030114 , and  2012BAK25B03 -16), and  grants from the Ministry of  Education of  China ( 31300 and  BMU20110263).",Non-OADS,/arxiv_data1/oa_pdf/2f/12/thnov04p0256.PMC3915089.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/a5/thnov04p0267.PMC3915090.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0 /).,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.ema.europa.eu/docs/   en_GB/document_library/Scientific_guideline/2009/09/WC500003955.pdf   4.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.ema.europa.eu/docs/   en_GB/document_library/EPAR_-_Public_assessment_report/human/000825/WC500047793.pdf   10.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.who.i nt/biologicals/   areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf   13.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.worldmarrow.org/fileadmin/Committees/   CLWG/Biosimilars/Biosimilars_9Jan09.pdf   18.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.haematologica.org/content/96/supplement_2/1.full.pdf   21.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.nature.com/bmt/journal/v47/n1s/pdf/bmt201237a.pdf   22.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.nature.com/bmt/journal/v47/n1s /pdf/bmt201237a.pdf   24.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.nature.com/bmt/journal/v47/n1s/pdf/bmt201237a.pdf   25.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
2012; 47: S236  http://www.nature.com/bmt/journal/v47/n1s/pdf/bmt201237a.pdf   26.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.nature.com/bmt/journal/v47/n1s/pdf/bmt201237a.pdf   27.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
2012; 47: S231 http://www.nature.com/bmt/journal/v47/n1s/   pdf/bmt201237a.pdf   28.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
2012; 47:  S316 http://www.nature.com/bmt/journal/v47/n1s/pdf/bmt201237a.pdf   30.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://registration.akm.ch/einsicht.php?,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=170424&X NSPRACHE_ID=2&XNKONGRESS_ID=179&XNMASKEN_ID=900   33.,OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.nature.com/bmt/journal/v47/n1s/pdf/bmt201237a.pdf   34.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
2013. https://ash.confex.com/ash/2013/webprogram/   Paper59988.html   37.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://registration.akm.ch/einsicht.php?,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://registration.akm.ch/einsicht.php?,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
"http://www.nature.com/bmt/journal/v47/n1s/pdf/ bmt201237a.pdf   40. del Giglio A, Eniu A, Ganae -Motan D, Topuzov E, Lubenau H. XM02 is  superior to placebo and equivalent to Neupogen TM in reducing the duration of  severe neutropenia and the incidence of febrile neutropenia in cycle I in breast  cancer pati ents receiving decetaxel/doxorubicin chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
http://www.nature.com/bmt/journal/   v45/n2s/pdf/bmt201041a.pdf   47.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/thnov04p0280.PMC3915091.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/db/thnov04p0290.PMC3915092.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ae/thnov04p0307.PMC3915093.pdf
Available from http://globocan.iarc.fr/accessed on 15/07/2013.,Non-OADS,/arxiv_data1/oa_pdf/e2/cf/bjc2013686a.PMC3915107.pdf
Available at http://www.liguecancer.ch (accessed 1 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/10/8e/bjc2013708a.PMC3915108.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Incidental breast lesions in reduction mammaplasty specimens BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.708 791,Non-OADS,/arxiv_data1/oa_pdf/10/8e/bjc2013708a.PMC3915108.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER DNA demethylation in carcinoma in situ testis 678 www.bjcancer.com | DOI:10.1038/bjc.2013.727,Non-OADS,/arxiv_data1/oa_pdf/0e/61/bjc2013727a.PMC3915112.pdf
Available at http://www.oncoline.nl/index.php.Accessed (2004).,Non-OADS,/arxiv_data1/oa_pdf/56/11/bjc2013733a.PMC3915114.pdf
http://www.hscic.gov.uk/searchcatalogue?productid=59&q=NCASP%2c þNational þClinical þ AuditþSupport þProgramme.,Non-OADS,/arxiv_data1/oa_pdf/01/fd/bjc2013734a.PMC3915115.pdf
"NCIN, National Cancer Intelligence Network (2013) Cancer Outcomes and Services Dataset, http://www.ncin.org.uk/collecting_and_using_data/data_collection/cosd.",OADS,/arxiv_data1/oa_pdf/01/fd/bjc2013734a.PMC3915115.pdf
"ONS, Office of National Statistics (2013) The National Statistics Socio-Economic Classification (NS-SEC rebased on the SOC2010), http://www.ons.gov.uk/ons/guide-method/classifications/current-standard-classifications/soc2010/ soc2010-volume-3-ns-sec–rebased-on-soc2010–user-manual/index.html.",Non-OADS,/arxiv_data1/oa_pdf/01/fd/bjc2013734a.PMC3915115.pdf
Available from http://ctep.cancer.gov(accessed 28 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/43/37/bjc2013735a.PMC3915116.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)p53-dependent and p53-independent effects of HDACi BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.742 667,Non-OADS,/arxiv_data1/oa_pdf/67/5e/bjc2013742a.PMC3915118.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Urinary EpCAM in primary bladder cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.744 685,Non-OADS,/arxiv_data1/oa_pdf/40/8e/bjc2013744a.PMC3915119.pdf
"NICE (2013) Clinical Guideline 164, http://publications.nice.org.uk/familial- breast-cancer-cg164.",Non-OADS,/arxiv_data1/oa_pdf/71/68/bjc2013747a.PMC3915120.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Epiregulin and cetuximab in advanced colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.753 655,Non-OADS,/arxiv_data1/oa_pdf/67/d9/bjc2013753a.PMC3915121.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)MRS/MRI of cisplatin-treated ovarian cancer model BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.758 635,Non-OADS,/arxiv_data1/oa_pdf/fb/5f/bjc2013758a.PMC3915124.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER TMPRSS4 and integrin a5 through miR-205 regulate metastasis 774 www.bjcancer.com | DOI:10.1038/bjc.2013.761,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/bjc2013761a.PMC3915125.pdf
Available at http://www.medicine.mcgill.ca/rtamblyn/Readings%5CThe%20Newcastle%20%20Scale%20for%20assessing%20the%20quality%20of%20nonrandomised%20studies%20in%20meta-analyses.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e4/92/bjc2013762a.PMC3915126.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Statin use and skin cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.762 807,Non-OADS,/arxiv_data1/oa_pdf/e4/92/bjc2013762a.PMC3915126.pdf
Data are accessible through the open access database R2 for visualisation and analysis of microarray data (http://r2.amc.nl).,OADS,/arxiv_data1/oa_pdf/1d/a0/bjc2013764a.PMC3915127.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)miRNA-9 in medulloblastoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.764 647,Non-OADS,/arxiv_data1/oa_pdf/1d/a0/bjc2013764a.PMC3915127.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)ChREBP in breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.765 723,Non-OADS,/arxiv_data1/oa_pdf/09/37/bjc2013765a.PMC3915128.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER CAFs induce EMT of breast cancer cells 732 www.bjcancer.com | DOI:10.1038/bjc.2013.768,Non-OADS,/arxiv_data1/oa_pdf/e1/a9/bjc2013768a.PMC3915130.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Akt/Ezrin Tyr353/NF- kB in EGF-induced EMT BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.770 705,Non-OADS,/arxiv_data1/oa_pdf/33/21/bjc2013770a.PMC3915131.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Sodium, potassium, fluid and renal cell cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.771 801",Non-OADS,/arxiv_data1/oa_pdf/cd/c4/bjc2013771a.PMC3915132.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Influence of c-FOS on ovarian cancer cells BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.774 763,Non-OADS,/arxiv_data1/oa_pdf/b9/0c/bjc2013774a.PMC3915133.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Leukaemia and benzene BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.780 787,Non-OADS,/arxiv_data1/oa_pdf/ea/d0/bjc2013780a.PMC3915135.pdf
"Urgent referral rates rose from approximately 350 out of 100 000 to 1900 out of 100 000 between 2004 and 2010 (Leeds North West PCT, 2005; National Cancer Information Network, 2 011).The Cancer Re form Strategy (Department of Health, 2007) introduced a strong policy focus on earlier diagnosis of cancer and resulted in the NAEDI (http://www.cancerresearchuk.org/can cer-info/spotcancerearly/naedi/).",Non-OADS,/arxiv_data1/oa_pdf/a0/6f/bjc2013791a.PMC3915139.pdf
"A wide-ranging programme of engagement with primary care has developed, from improving consultation skills and decision support to practice cancer profiles (http://ncat.nhs.uk/our-work/diag nosing-cancer-earlier/gps-and- primary-care#).",Non-OADS,/arxiv_data1/oa_pdf/a0/6f/bjc2013791a.PMC3915139.pdf
Available at: http://www.york.ac.uk/yhpho/documents/hea/Website/NW%20PCT%20Cancer%20Equity%20Audit_Copy.pdf(accessed on 10/12/2013).,Non-OADS,/arxiv_data1/oa_pdf/a0/6f/bjc2013791a.PMC3915139.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Galectins contribute to cytokine circulation in cancer 752 www.bjcancer.com | DOI:10.1038/bjc.2013.793,Non-OADS,/arxiv_data1/oa_pdf/a7/de/bjc2013793a.PMC3915140.pdf
"1Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/31/aps-41-1.PMC3915148.pdf
"Received: 13 May 2013 • Revised: 11 Aug 2013 • Accepted: 12 Aug 2013   pISSN: 2234-6163 • eISSN: 2234-6171  http://dx.doi.org/10.5999/aps.2014.41.1.101  • Arch Plast Surg 2014;41:101-104 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.Communication",Non-OADS,/arxiv_data1/oa_pdf/b2/c1/aps-41-101.PMC3915149.pdf
"12Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/d7/aps-41-12.PMC3915150.pdf
"19Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/81/aps-41-19.PMC3915151.pdf
"29Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/71/aps-41-29.PMC3915152.pdf
"3Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/75/aps-41-3.PMC3915153.pdf
"35Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/5a/aps-41-35.PMC3915154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/5a/aps-41-35.PMC3915154.pdf
"40Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/71/aps-41-40.PMC3915155.pdf
Available from: http://www.who.int/ipcs/publications/en/ cicad25.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/71/aps-41-40.PMC3915155.pdf
"45Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/fb/aps-41-45.PMC3915156.pdf
"50Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/62/aps-41-50.PMC3915157.pdf
"57Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/aps-41-57.PMC3915158.pdf
Avail - able from: http://www.plasticsurgery.org/Documents/ news-resources/statistics/2012-Plastic-Surgery-Statistics/ reconstructive-surgery-demographics.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/51/aps-41-57.PMC3915158.pdf
Available from: http://www.fda.gov/ MedicalDevices/ProductsandMedicalProcedures/Device - ApprovalsandClearances/Recently-ApprovedDevices/ ucm343639.htm.,Non-OADS,/arxiv_data1/oa_pdf/d6/51/aps-41-57.PMC3915158.pdf
"63Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/f1/aps-41-63.PMC3915159.pdf
"71Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/f5/aps-41-71.PMC3915160.pdf
"77Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/9d/aps-41-77.PMC3915161.pdf
"81Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/06/aps-41-81.PMC3915162.pdf
"85Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/4c/aps-41-85.PMC3915163.pdf
"Received: 16 Jul 2013 • Revised: 4 Sep 2013 • Accepted: 12 Sep 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2014.41.1.89 • Arch Plast Surg 2014;41:89-90 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.upper and lower extremities, including most commonly, the forearm,  thigh, and shoulder girdle.",Non-OADS,/arxiv_data1/oa_pdf/7a/44/aps-41-89.PMC3915164.pdf
Available from: http://ispub.com/IJPA/7/1/12710.,Non-OADS,/arxiv_data1/oa_pdf/7a/44/aps-41-89.PMC3915164.pdf
"Received: 14 May 2013 • Revised: 3 Jul 2013 • Accepted: 4 Jul 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.1.91 • Arch Plast Surg 2014;41:91-93 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/7c/aps-41-91.PMC3915165.pdf
"Received: 29 Jun 2013 • Revised: 16 Aug 2013 • Accepted: 17 Aug 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.1.93 • Arch Plast Surg 2014;41:93-95 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/7c/aps-41-91.PMC3915165.pdf
"Received: 29 Jun 2013 • Revised: 16 Aug 2013 • Accepted: 17 Aug 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.1.93 • Arch Plast Surg 2014;41:93-95 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/b0/aps-41-93.PMC3915166.pdf
"Received: 7 Jun 2013 • Revised: 9 Jul 2013 • Accepted: 20 Jul 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.1.96 • Arch Plast Surg 2014;41:96-98 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.The most common location for extracutaneous XG  lesions is on the eyes, although other locations  including the lung, kidney, central nervous system,  colon, pericardium, ovary, liver, and spleen have been  reported as well [2].",Non-OADS,/arxiv_data1/oa_pdf/80/6c/aps-41-96.PMC3915167.pdf
"Received: 16 Jun 2013 • Revised: 16 Oct 2013 • Accepted: 17 Oct 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.1.98 • Arch Plast Surg 2014;41:98-100 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/6c/aps-41-96.PMC3915167.pdf
"Received: 16 Jun 2013 • Revised: 16 Oct 2013 • Accepted: 17 Oct 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.1.98 • Arch Plast Surg 2014;41:98-100 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/d3/aps-41-98.PMC3915168.pdf
"http://dx.doi.org/10.4041/kjod.2014.44.1.11www.e-kjo.orgpISSN 2234-7518 eISSN 2005-372X Continuing to make leaps and boundsEDITORIAL A mere decade ago, the Korean Association of Orthodontists (KAO) was exploring the idea  of internationalizing the Korean Journal of Orthodontics (KJO) and was seriously considering  hiring a multi-national publishing company to transform the KJO into an English publication.",Non-OADS,/arxiv_data1/oa_pdf/ce/3b/kjod-44-1.PMC3915170.pdf
"2 www.e-kjo.org http://dx.doi.org/10.4041/kjod.2014.44.1.1This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.sixth issue will be published in November, which will allow KJO articles a greater opportunity  for citations before the end of the calendar year, and in turn, raise the IF as well.",Non-OADS,/arxiv_data1/oa_pdf/ce/3b/kjod-44-1.PMC3915170.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.1.13",Non-OADS,/arxiv_data1/oa_pdf/86/57/kjod-44-13.PMC3915171.pdf
"Han et al • Pharyngeal airway changes after bionator www.e-kjo.org 14 http://dx.doi.org/10.4041/kjod.2014.44.1.13 INTRODUCTION   Patients with skeletal Class II malocclusions and  retrusive mandibles can have breathing problems.1 In  an analysis using cone-beam computed tomography   ima ging, children classified with skeletal Class II maloc- clusions and retrusive mandibles also had smaller pha - ryngeal airway dimensions than children with ske  le tal  Class I malocclusions.2 Without therapeutic intervention,  voluntary anterior-posterior compensation does not  occur with normal growth of the mandible.3-5 Therefore,  children with skeletal Class II malocclusions may  have a higher probability of maintaining the skeletal  phe notype, even after growth, as they have smaller  pharyngeal airway dimensions than children with Class I  malocclusions.",Non-OADS,/arxiv_data1/oa_pdf/86/57/kjod-44-13.PMC3915171.pdf
Han et al • Pharyngeal airway changes after bionator www.e-kjo.org 15 http://dx.doi.org/10.4041/kjod.2014.44.1.13 years.,OADS,/arxiv_data1/oa_pdf/86/57/kjod-44-13.PMC3915171.pdf
Han et al • Pharyngeal airway changes after bionator www.e-kjo.org 16 http://dx.doi.org/10.4041/kjod.2014.44.1.13 Wilcoxon rank sum test was used for gender comparison  of the pharyngeal airway measurements at T0.,OADS,/arxiv_data1/oa_pdf/86/57/kjod-44-13.PMC3915171.pdf
"Han et al • Pharyngeal airway changes after bionator www.e-kjo.org 17 http://dx.doi.org/10.4041/kjod.2014.44.1.13 control group, except for D1 ( p < 0.05).",OADS,/arxiv_data1/oa_pdf/86/57/kjod-44-13.PMC3915171.pdf
"Han et al • Pharyngeal airway changes after bionator www.e-kjo.org 18 http://dx.doi.org/10.4041/kjod.2014.44.1.13 studies demonstrated similar results in skeletal Class II  subjects with significantly smaller pharyngeal airway  dimensions in the oropharynx than skeletal Class I  subjects, in both adults and children.22,23 This is probably  because pharyngeal airway dimensions become narrower  due to posterior positioning of the tongue and soft  palate in subjects with retrognathic mandibles.12   After functional appliance treatment, pharyngeal air - way dimensions corresponding to the oropharynx in - creased in skeletal Class II subjects and reached similar  dimensions to that of the skeletal Class I subjects.",Non-OADS,/arxiv_data1/oa_pdf/86/57/kjod-44-13.PMC3915171.pdf
Han et al • Pharyngeal airway changes after bionator www.e-kjo.org 19 http://dx.doi.org/10.4041/kjod.2014.44.1.13 JD.,OADS,/arxiv_data1/oa_pdf/86/57/kjod-44-13.PMC3915171.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.1.20",Non-OADS,/arxiv_data1/oa_pdf/bd/47/kjod-44-20.PMC3915172.pdf
"Lee et al • Surface area of lingual fixed retainer www.e-kjo.org 21 http://dx.doi.org/10.4041/kjod.2014.44.1.20 INTRODUCTION   Relapse after orthodontic treatment is a frequent, yet  unpredictable, occurence.1-3 A previous study reported  that relapse occurs most commonly after treatment  of the lower anterior teeth.4 Many orthodontists have  worked towards achieving complete stability and long- term retention after treatment.5 Some studies have re - com mended the lingual bonded fixed retainer as the  most effective and esthetic method for maintaining the  dental arch after orthodontic treatment.6,7   The lingual bonded fixed retainer has been applied for  a long time in orthodontics.",Non-OADS,/arxiv_data1/oa_pdf/bd/47/kjod-44-20.PMC3915172.pdf
Lee et al • Surface area of lingual fixed retainer www.e-kjo.org 22 http://dx.doi.org/10.4041/kjod.2014.44.1.20 2B).,OADS,/arxiv_data1/oa_pdf/bd/47/kjod-44-20.PMC3915172.pdf
"Lee et al • Surface area of lingual fixed retainer www.e-kjo.org 23 http://dx.doi.org/10.4041/kjod.2014.44.1.20 set to 1.0 mm/min, and the maximum load necessary  to detach the wire for the first time was recorded in  Newtons (Figure 4).",OADS,/arxiv_data1/oa_pdf/bd/47/kjod-44-20.PMC3915172.pdf
Lee et al • Surface area of lingual fixed retainer www.e-kjo.org 24 http://dx.doi.org/10.4041/kjod.2014.44.1.20 retention.,OADS,/arxiv_data1/oa_pdf/bd/47/kjod-44-20.PMC3915172.pdf
Lee et al • Surface area of lingual fixed retainer www.e-kjo.org 25 http://dx.doi.org/10.4041/kjod.2014.44.1.20 differences.,OADS,/arxiv_data1/oa_pdf/bd/47/kjod-44-20.PMC3915172.pdf
"Lee et al • Surface area of lingual fixed retainer www.e-kjo.org 26 http://dx.doi.org/10.4041/kjod.2014.44.1.20 ted upon occlusal contacts during mastication.8 This  study was performed under ideal, or at least, well-con- trolled, circumstances, i.e., the enamel surfaces were  clean before bonding, and no saliva, calculus, or plaque  contamination occurred during the bonding procedure.",Non-OADS,/arxiv_data1/oa_pdf/bd/47/kjod-44-20.PMC3915172.pdf
Lee et al • Surface area of lingual fixed retainer www.e-kjo.org 27 http://dx.doi.org/10.4041/kjod.2014.44.1.20 parison of bond strengths of orthodontic brac  kets  bonded to enamel and debonded at various times.,OADS,/arxiv_data1/oa_pdf/bd/47/kjod-44-20.PMC3915172.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.1.28",Non-OADS,/arxiv_data1/oa_pdf/06/cc/kjod-44-28.PMC3915173.pdf
Toureno et al • The effect of western adaptation www.e-kjo.org 29 http://dx.doi.org/10.4041/kjod.2014.44.1.28 INTRODUCTION   Great strides in communication and transportation tech - no logies have contributed to the rapid pace of glo  ba- lization over the past few decades.,Non-OADS,/arxiv_data1/oa_pdf/06/cc/kjod-44-28.PMC3915173.pdf
Toureno et al • The effect of western adaptation www.e-kjo.org 30 http://dx.doi.org/10.4041/kjod.2014.44.1.28 shows the cephalometric measurements of the selected  male and female profiles.,Non-OADS,/arxiv_data1/oa_pdf/06/cc/kjod-44-28.PMC3915173.pdf
Toureno et al • The effect of western adaptation www.e-kjo.org 31 http://dx.doi.org/10.4041/kjod.2014.44.1.28 sex; respondents were not informed of the ethnic origin  of the facial profile silhouettes.,Non-OADS,/arxiv_data1/oa_pdf/06/cc/kjod-44-28.PMC3915173.pdf
Toureno et al • The effect of western adaptation www.e-kjo.org 32 http://dx.doi.org/10.4041/kjod.2014.44.1.28 posteriorly parallel to the FH plane.,Non-OADS,/arxiv_data1/oa_pdf/06/cc/kjod-44-28.PMC3915173.pdf
Toureno et al • The effect of western adaptation www.e-kjo.org 33 http://dx.doi.org/10.4041/kjod.2014.44.1.28 silhouette for LAHs had significantly more retruded lips  than that reported for Caucasians ( p < 0.05).,Non-OADS,/arxiv_data1/oa_pdf/06/cc/kjod-44-28.PMC3915173.pdf
"Toureno et al • The effect of western adaptation www.e-kjo.org 34 http://dx.doi.org/10.4041/kjod.2014.44.1.28   In general, although not to a statistically significant  degree (except for the second-most favored Korean  female profile), LAHs preferred a more retruded lip  position than HAHs.",Non-OADS,/arxiv_data1/oa_pdf/06/cc/kjod-44-28.PMC3915173.pdf
Toureno et al • The effect of western adaptation www.e-kjo.org 35 http://dx.doi.org/10.4041/kjod.2014.44.1.28 Dent Assoc 1993;124:99-102.,Non-OADS,/arxiv_data1/oa_pdf/06/cc/kjod-44-28.PMC3915173.pdf
- Korean J Orthod 2013;43:147-158 http://dx.doi.org/10.4041/kjod.2014.44.1.33www.e-kjo.orgpISSN 2234-7518 eISSN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/54/9e/kjod-44-3.PMC3915174.pdf
"4 www.e-kjo.org http://dx.doi.org/10.4041/kjod.2014.44.1.3This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.occasionally, which is usually improved after achieving  the maxillary total impaction.",Non-OADS,/arxiv_data1/oa_pdf/54/9e/kjod-44-3.PMC3915174.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.1.36",Non-OADS,/arxiv_data1/oa_pdf/37/5a/kjod-44-36.PMC3915175.pdf
"Ozdemir et al • Bone density in facial types www.e-kjo.org 37 http://dx.doi.org/10.4041/kjod.2014.44.1.36 INTRODUCTION   Orthodontic mini-implant anchorage is a valuable al - ter native to extraoral anchorage and has eliminated  most patient-compliance issues encountered during  treatment.1 Mini-implants are simple, easy to use, cost- effective, and convenient for achieving absolute skeletal  anchorage with an estimated success rate of 80–90%,  which means that the mini-implant is lost in 10–20% of  absolute anchorage cases.2      The success of orthodontic mini-implants is affected  by the quality and density of the alveolar cortical bone.",Non-OADS,/arxiv_data1/oa_pdf/37/5a/kjod-44-36.PMC3915175.pdf
"Ozdemir et al • Bone density in facial types www.e-kjo.org 38 http://dx.doi.org/10.4041/kjod.2014.44.1.36 indicated decreased, normal, and increased facial  heights, respectively.",Non-OADS,/arxiv_data1/oa_pdf/37/5a/kjod-44-36.PMC3915175.pdf
"Ozdemir et al • Bone density in facial types www.e-kjo.org 39 http://dx.doi.org/10.4041/kjod.2014.44.1.36 (48.8%) subjects, the normodivergent group included 44  male (44.0%) and 56 female (56.0%) subjects, and the  hyperdivergent group included 36 male (34.6%) and 68  female (65.4%) subjects.",Non-OADS,/arxiv_data1/oa_pdf/37/5a/kjod-44-36.PMC3915175.pdf
Ozdemir et al • Bone density in facial types www.e-kjo.org 40 http://dx.doi.org/10.4041/kjod.2014.44.1.36 difference between the buccal and palatal cortical bone  densities increased from the premolar region onward.,OADS,/arxiv_data1/oa_pdf/37/5a/kjod-44-36.PMC3915175.pdf
"Ozdemir et al • Bone density in facial types www.e-kjo.org 41 http://dx.doi.org/10.4041/kjod.2014.44.1.36 being available only for medical CT.12,13 Moreover, other  studies indicated the feasibility of deri  ving HUs from  CBCT14 and correlating CBCT-derived HUs and density  data from alternative sources.15-18 In particular, a recent  study examining bone mineral density and its influence  on mini-implant stability showed a strong positive cor- relation between dual-energy X-ray absorptiometry  and CBCT for bone density measurements.18 Another  recent study regarding CT and CBCT indicated that  a conversion can be used to define bone density by  CBCT.19 The present study focused on comparing the  cortical bone density among various maxillary and  man dibular areas rather than defining the density in a  certain anatomic region, for which CT images are pre - ferable to CBCT images.",Non-OADS,/arxiv_data1/oa_pdf/37/5a/kjod-44-36.PMC3915175.pdf
Ozdemir et al • Bone density in facial types www.e-kjo.org 42 http://dx.doi.org/10.4041/kjod.2014.44.1.36 present study showed similarities in the cortical bone  thickness and density when compared with the results  of researches evaluating cortical thickness in various  vertical facial types.,OADS,/arxiv_data1/oa_pdf/37/5a/kjod-44-36.PMC3915175.pdf
Ozdemir et al • Bone density in facial types www.e-kjo.org 43 http://dx.doi.org/10.4041/kjod.2014.44.1.36 16.,Non-OADS,/arxiv_data1/oa_pdf/37/5a/kjod-44-36.PMC3915175.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.1.44",Non-OADS,/arxiv_data1/oa_pdf/30/b1/kjod-44-44.PMC3915176.pdf
"Alessandri Bonetti et al • Ultrasonic instrumentation and bracket bond strength www.e-kjo.org 45 http://dx.doi.org/10.4041/kjod.2014.44.1.44 INTRODUCTION   The placement of fixed orthodontic appliances in - creases the difficulty in mechanical plaque removal  and thus predisposes orthodontic patients to plaque  accumulation and enamel demineralization.1-3 Fixed  orthodontic treatment is also associated with increased  probing pocket depths, elevated bacterial count in  plaque, and a shift in the healthy microbial composition  of subgingival plaque to a periodontal pathogenic one.4-6  Therefore, optimal oral home care and professional pro- phylactic programs are of paramount importance in  patients undergoing fixed orthodontic treatment.7,8   During professional oral hygiene procedures, ultrasonic  scalers are used around the bracket base, a critical site  of plaque accumulation, and can affect the bracket– enamel interface.9,10 Prolonged ultrasonic vibration at  maximum power is used to facilitate the removal of  posts, crowns, or bridges and could similarly debond  orthodontic brackets.11-15 This action is attributable to  the propagation of vibrations from the ultrasonic device  to the object that is to be removed, as well as to the  biophysical action of ultrasound within the coolant (i.e.,  cavitational activity and acoustic microstreaming).16  However, to date, no study of the effects of ultrasonic  instrumentation for oral hygiene maintenance on the  shear bond strength (SBS) of orthodontic brackets has  been conducted.",Non-OADS,/arxiv_data1/oa_pdf/30/b1/kjod-44-44.PMC3915176.pdf
"Alessandri Bonetti et al • Ultrasonic instrumentation and bracket bond strength www.e-kjo.org 46 http://dx.doi.org/10.4041/kjod.2014.44.1.44 initially inserted in a wax pedestal, which was molded  until the correct position was achieved and verified with  the aid of a parallelometer (Paraline; Dentaurum).",Non-OADS,/arxiv_data1/oa_pdf/30/b1/kjod-44-44.PMC3915176.pdf
"Alessandri Bonetti et al • Ultrasonic instrumentation and bracket bond strength www.e-kjo.org 47 http://dx.doi.org/10.4041/kjod.2014.44.1.44 Statistical analysis   Statistical analyses were performed by using statistical  software (PASW Statistics for Windows, version 18.0;  IBM Co., Armonk, NY, USA).",OADS,/arxiv_data1/oa_pdf/30/b1/kjod-44-44.PMC3915176.pdf
Alessandri Bonetti et al • Ultrasonic instrumentation and bracket bond strength www.e-kjo.org 48 http://dx.doi.org/10.4041/kjod.2014.44.1.44 a short period.,OADS,/arxiv_data1/oa_pdf/30/b1/kjod-44-44.PMC3915176.pdf
Alessandri Bonetti et al • Ultrasonic instrumentation and bracket bond strength www.e-kjo.org 49 http://dx.doi.org/10.4041/kjod.2014.44.1.44 phosphate on the in vitro shear bond strength of  orthodontic brackets.,Non-OADS,/arxiv_data1/oa_pdf/30/b1/kjod-44-44.PMC3915176.pdf
Available from: http://www.iso.org/iso/ home/store/catalogue_tc/catalogue_detail.htm?,Non-OADS,/arxiv_data1/oa_pdf/30/b1/kjod-44-44.PMC3915176.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Special Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.1.5",Non-OADS,/arxiv_data1/oa_pdf/3d/75/kjod-44-5.PMC3915177.pdf
"Kim and Hwang • Survey with questionnaire www.e-kjo.org 6 http://dx.doi.org/10.4041/kjod.2014.44.1.5 INTRODUCTION   Expanded medical coverage and governmental policies  for low medical costs have decreased the economic  burden of hospital-based care in Korea.1 In addition,  improved standard of living and heightened interest in  health and medical issues have increased the demand for  healthcare,2 while advanced information and commu - nication technologies have enabled the public to obtain  more medical information.",Non-OADS,/arxiv_data1/oa_pdf/3d/75/kjod-44-5.PMC3915177.pdf
"Kim and Hwang • Survey with questionnaire www.e-kjo.org 7 http://dx.doi.org/10.4041/kjod.2014.44.1.5 Geographic area of practice   In the experienced group, 64% of the respondents  practiced in Seoul and Gyeonggi.",OADS,/arxiv_data1/oa_pdf/3d/75/kjod-44-5.PMC3915177.pdf
"Kim and Hwang • Survey with questionnaire www.e-kjo.org 8 http://dx.doi.org/10.4041/kjod.2014.44.1.5 tients were crowding and protrusion, respectively.",OADS,/arxiv_data1/oa_pdf/3d/75/kjod-44-5.PMC3915177.pdf
"Kim and Hwang • Survey with questionnaire www.e-kjo.org 9 http://dx.doi.org/10.4041/kjod.2014.44.1.5 pulpal necrosis, temporomandibular disorder, inappro - priate occlusion, and accidents during extraction (6.8– 9.7%) (Figure 3).",OADS,/arxiv_data1/oa_pdf/3d/75/kjod-44-5.PMC3915177.pdf
Kim and Hwang • Survey with questionnaire www.e-kjo.org 10 http://dx.doi.org/10.4041/kjod.2014.44.1.5 nothing.,OADS,/arxiv_data1/oa_pdf/3d/75/kjod-44-5.PMC3915177.pdf
"Kim and Hwang • Survey with questionnaire www.e-kjo.org 11 http://dx.doi.org/10.4041/kjod.2014.44.1.5 experienced group, 81% had one or two medical  accidents and only 2% had more than six accidents.",OADS,/arxiv_data1/oa_pdf/3d/75/kjod-44-5.PMC3915177.pdf
Kim and Hwang • Survey with questionnaire www.e-kjo.org 12 http://dx.doi.org/10.4041/kjod.2014.44.1.5 reported that they spend more than 25 minutes on  a diagnosis.,OADS,/arxiv_data1/oa_pdf/3d/75/kjod-44-5.PMC3915177.pdf
"Key Words:  Natural orifice transluminal endoscopic surgery; Peroral endoscopic myotomy; Endoscopic full-thickness resectionJ Gastric Cancer 2013;13(4):199-206  http://dx.doi.org/10.5230/jgc.2013.13.4.199 Correspondence to: Chan Gyoo Kim Center for Gastric Cancer, National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 410-769, Korea  Tel: +82-31-920-1620, Fax: +82-31-920-2798 E-mail: glse@chol.com Received December 6, 2013 Revised December 16, 2013 Accepted December 17, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Natural orifice transluminal endoscopic surgery (NOTES) is  a new minimally invasive surgery that accesses the peritoneal or  thoracic spaces through a transvisceral incision instead of a skin  incision.",Non-OADS,/arxiv_data1/oa_pdf/2b/e7/jgc-13-199.PMC3915181.pdf
Original Article J Gastric Cancer 2013;13(4):207-213  http://dx.doi.org/10.5230/jgc.2013.13.4.207 Is Laparoscopy-assisted Radical Gastrectomy Safe   in Patients with Child-Pugh Class A Cirrhosis?,Non-OADS,/arxiv_data1/oa_pdf/92/2f/jgc-13-207.PMC3915182.pdf
"Key Words:  Stomach neoplasms; Liver cirrhosis; Gastrectomy Correspondence to: Seong Yeob Ryu Department of Surgery, Chonnam National University Medical School,  322 Seoyang-ro, Hwasun-eup, Hwasun-gun 519-763, Korea Tel: +82-61-379-7646, Fax: +82-61-379-7661 E-mail: drrsy@jnu.ac.kr Received September 9, 2013 Revised October 21, 2013 Accepted October 21, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Early diagnosis, radical operation, and advances in adjuvant  therapy have substantially improved the prognosis of gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/92/2f/jgc-13-207.PMC3915182.pdf
"Key Words:  Cytology; Peritoneal lavage; Stomach neoplasms; Variation; CytologyJ Gastric Cancer 2013;13(4):214-225  http://dx.doi.org/10.5230/jgc.2013.13.4.214 Correspondence to: Sung-Ho Jin  Department of Surgery, Korea Cancer Center Hospital, Korea Institute  of Radiological & Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul  139-706, Korea Tel: +82-2-970-1278, Fax: +82-2-970-2419 E-mail: shjin@kcch.re.kr Received October 4, 2013 Revised October 23, 2013 Accepted October 28, 2013 *In the article, the authors Young-Jun Ki and Sun-Hee Ji should be  listed as co-first authors as they contributed equally to the paper.",Non-OADS,/arxiv_data1/oa_pdf/23/5e/jgc-13-214.PMC3915183.pdf
"Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction The presence of free cancer cells in the peritoneal cavity of pa- tients with gastric cancer, demonstrated by positive peritoneal cy- tology (CY1), indicates an incurable condition and is the strongest  risk factor for peritoneal gastric cancer recurrence.1-3 Peritoneal la- vage cytology (PLC) during laparotomy was introduced by Japanese  surgeons in the early 1970s as a part of the routine staging workup  for patients with gastric cancer, and its clinical significance has  been studied by several Japanese researchers.1-6 According to the  Japanese Gastric Cancer Association staging system established in  1998, CY1 was considered to indicate metastatic disease.",Non-OADS,/arxiv_data1/oa_pdf/23/5e/jgc-13-214.PMC3915183.pdf
"Key Words:  Gastric cancer; Distant metastasis; Metastasectomy; Overall survivalJ Gastric Cancer 2013;13(4):226-231  http://dx.doi.org/10.5230/jgc.2013.13.4.226 Correspondence to: Sung Joon Kwon Department of Surgery, Hanyang University College of Medicine, 222  Wangsimni-ro, Seongdong-gu, Seoul 133-791, Korea Tel: +82-2-2990-8453, Fax: +82-2-2281-0224 E-mail: sjkwon@hanyang.ac.kr Received August 28, 2013 Revised October 1, 2013 Accepted October 21, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction The overall prognosis of gastric cancer patients with distant  metastasis remains very poor despite the decline in incidence and  mortality rate of gastric cancer in most parts of the world.1-4 Despite  many investigators reporting that their surgical methods improve  the overall survival of patients with gastric cancer and distant metastasis, the proper surgical management remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/37/96/jgc-13-226.PMC3915184.pdf
"Key Words:  Gastrokine 1; DNA methylation; microRNA-185; CagA protein; Gastric mucosaJ Gastric Cancer 2013;13(4):232-241  http://dx.doi.org/10.5230/jgc.2013.13.4.232 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.confined to the regulatory regions of most human genes.1 Aber- rant promoter methylation of cancer-related genes is detected in  gastric tumors, suggesting a connection to the induction/promotion  of gastric cancer.2,3 The three most-studied genes for promoter  hypermethylation in gastric carcinoma are p16, E-cadherin, and  hMLH1.4 Of these genes, p16 (CDKN2a/INK4a) is an important  tumor suppressor gene, and its protein is considered to be a nega- tive regulator of G1 phase progression.5 In addition, E-cadherin  (CDH1) is a transmembrane glycoprotein expressed on epithelial  cells, and is also responsible for calcium-dependent homotypic cell  adhesion.6 Cell-cell and cell-matrix interactions play a crucial role  in neoplastic transformation and metastasis.7,8 Hypermethylation of Correspondence to: Won Sang Park  Department of Pathology, The Catholic University of Korea, School of  Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel: +82-2-2258-7310, Fax: +82-2-537-6586 E-mail: wonsang@catholic.ac.kr Received December 2, 2013 Revised December 19, 2013 Accepted December 20, 2013 *Won Suk Choi and Ho Suk Seo equally contributed to this study.",Non-OADS,/arxiv_data1/oa_pdf/c0/1e/jgc-13-232.PMC3915185.pdf
"Key Words:  Stomach neoplasms; Postoperative complications; Gastrectomy; ReoperationJ Gastric Cancer 2013;13(4):242-246  http://dx.doi.org/10.5230/jgc.2013.13.4.242 Correspondence to: Sung Kim Department of Surgery, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135- 710, Korea  Tel: +82-2-3410-0294, Fax: +82-2-3410-6981 E-mail: skim.kim@samsung.com Received September 23, 2013 Revised October 24, 2013 Accepted November 13, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction According to GLOBALCAN, in 2008, gastric cancer was the  fourth most commonly diagnosed cancer in men and the fifth  most commonly diagnosed in women worldwide.1 In that year in Korea, gastric cancer was the second most common cancer leading  to death.2 Gastrectomy with lymph node dissections has been ac- cepted as the only curative treatment for gastric cancer.3 Although  the rate of complications after gastrectomy has decreased over the  last decade because of improved surgical techniques, nutritional  support, antibiotics, and anesthesia,4 complications requiring reop- eration have not decreased; the rate of these complications ranges  from 2% to 10%.4-7 Reports about reoperation after gastrectomy  have several flaws: excessively long observation periods, limited  number of patients observed, and variations in surgeons or surgical  techniques.",Non-OADS,/arxiv_data1/oa_pdf/fc/b5/jgc-13-242.PMC3915186.pdf
"Key Words:  Stomach neoplasms; Health insurance; SurvivalJ Gastric Cancer 2013;13(4):247-254  http://dx.doi.org/10.5230/jgc.2013.13.4.247 Correspondence to: Dong Gue Shin Department of Surgery, Seoul Medical Center, 156 Sinnae-ro,  Jungnang-gu, Seoul 131-865, Korea Tel: +82-2-2276-7871, Fax: +82-2-2276-7880 E-mail: shindonggue@naver.com Received November 29, 2013 Revised December 17, 2013 Accepted December 17, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction According to the Korean National Cancer Incidence Database,  gastric cancer was the second most prevalent cancer in Korea in  2010.",Non-OADS,/arxiv_data1/oa_pdf/00/e5/jgc-13-247.PMC3915187.pdf
"Key Words:  Stomach neoplasms; Minimally invasive surgical procedures; Robotics; LaparoscopyJ Gastric Cancer 2013;13(4):255-262  http://dx.doi.org/10.5230/jgc.2013.13.4.255 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.play a role in advanced laparoscopic surgery.",Non-OADS,/arxiv_data1/oa_pdf/53/05/jgc-13-255.PMC3915188.pdf
"Key Words:  Intussusception; Gastrectomy; Feeding tubeJ Gastric Cancer 2013;13(4):263-265  http://dx.doi.org/10.5230/jgc.2013.13.4.263 Correspondence to: Doo-Hyun Yang Department of Surgery, Chonbuk National University Medical School,  20 Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea Tel: +82-63-250-1570, Fax: +82-63-271-6197 E-mail: ydh@jbnu.ac.kr Received October 20, 2013 Revised November 28, 2013 Accepted December 9, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Intussusception is a rare cause of postoperative intestinal ob- struction in adults.1 Various kinds of symptoms have been ex- pressed such as epigastric pain, nausea/vomiting, and hematemesis.",Non-OADS,/arxiv_data1/oa_pdf/d7/c4/jgc-13-263.PMC3915189.pdf
"Key Words:  Situs inversus totalis; Laparoscopic-assisted gastrectomy; Gastric cancer; Lymph node dissectionJ Gastric Cancer 2013;13(4):266-272  http://dx.doi.org/10.5230/jgc.2013.13.4.266 Correspondence to: Han-Kwang Yang Department of Surgery and Cancer Research Institute, Seoul National  University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110- 744, Korea Tel: +82-2-2072-3797, Fax: +82-2-3672-0042 E-mail: hkyang@snu.ac.kr Received October 4, 2013 Revised October 28, 2013 Accepted October 28, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.a few cases of laparoscopy-assisted distal gastrectomy (LADG) for  gastric cancer with underlying SIT have been reported in Korea.",Non-OADS,/arxiv_data1/oa_pdf/a9/df/jgc-13-266.PMC3915190.pdf
"The genes upregulated in G0 or G1 cells were annotated for their associated biologicalprocesses with the Database for Annotation, Visualization, and Integrated Discovery (DAVID) (http://david.abcc.ncifcrf.gov/).",OADS,/arxiv_data1/oa_pdf/de/53/srep04012.PMC3915272.pdf
Normalized data were filtered forminimal fold change and GSEA 54(http://www.broadinstitute.org/gsea/index.jsp) was conducted as described elsewhere53.,OADS,/arxiv_data1/oa_pdf/de/53/srep04012.PMC3915272.pdf
The normalized data set of this analysis can be obtained at the Gene Expression Omnibus site (http://www.ncbi.nlm.nih.gov/geo) (GEO accession code: GSE46511).,OADS,/arxiv_data1/oa_pdf/de/53/srep04012.PMC3915272.pdf
No.CDB0486T:.http://www.cdb.riken.,Non-OADS,/arxiv_data1/oa_pdf/de/53/srep04012.PMC3915272.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports The GEO accession number for the microarray data reported in this paper is GSE46511.Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/de/53/srep04012.PMC3915272.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4012 | DOI: 10.1038/srep04012 10",Non-OADS,/arxiv_data1/oa_pdf/de/53/srep04012.PMC3915272.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3999 | DOI: 10.1038/srep03999 9",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/srep03999.PMC3915277.pdf
"The glycerol Molecular Vision  2014; 20:125-131 <http://www.molvis.org/molvis/v 20/125> Received 29 July 2013 | Accepted 27 January 2014 | Published 29 January 2014© 2014 Molecular Vision 125Measuring the viscosity of whole bovine lens using a fiber optic  oxygen sensing system Mai T. Thao, Daniel Perez, James Dillon, Elizabeth R. Gaillard Department of Chemistry and Biochemistry, Northern Illinois University DeKalb, IL Purpose:  To obtain a better understanding of oxygen and nutrient transport within the lens, the viscosity of whole lenses  was investigated using a fiber optic oxygen sensor (optode).",Non-OADS,/arxiv_data1/oa_pdf/f1/8d/mv-v20-125.PMC3915293.pdf
"Molecular Vision  2014; 20:125-131 <http://www.molvis.org/molvis/v 20/125> © 2014 Molecular Vision  126solutions were prepared with 0%, 10%, 20%, 30%, 40%,  50%, 60%, and 70% (w/v) of glycerol/water with known  viscosity of 1.0–22.5 cP at 25 °C as reported by Segur and  Oberstar [ 15].",Non-OADS,/arxiv_data1/oa_pdf/f1/8d/mv-v20-125.PMC3915293.pdf
"Molecular Vision  2014; 20:125-131 <http://www.molvis.org/molvis/v 20/125> © 2014 Molecular Vision  127The longer-lived component may correspond to the  approach to equilibrium:  kk kobs=+12   In Figure 1, a comparison of signals from two solutions  with different viscosity is shown.",Non-OADS,/arxiv_data1/oa_pdf/f1/8d/mv-v20-125.PMC3915293.pdf
"Molecular Vision  2014; 20:125-131 <http://www.molvis.org/molvis/v 20/125> © 2014 Molecular Vision  128DISCUSSION Since the viscosity of the whole lens is unknown, our study  sought to determine it by using an optode.",Non-OADS,/arxiv_data1/oa_pdf/f1/8d/mv-v20-125.PMC3915293.pdf
"Molecular Vision  2014; 20:125-131 <http://www.molvis.org/molvis/v 20/125> © 2014 Molecular Vision  129the heart, lungs, brain, and spleen [ 22].",Non-OADS,/arxiv_data1/oa_pdf/f1/8d/mv-v20-125.PMC3915293.pdf
Molecular Vision  2014; 20:125-131 <http://www.molvis.org/molvis/v 20/125> © 2014 Molecular Vision  130REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/f1/8d/mv-v20-125.PMC3915293.pdf
2012;  Available from: http://www.who.int/blindness/causes/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/f1/8d/mv-v20-125.PMC3915293.pdf
Molecular Vision  2014; 20:125-131 <http://www.molvis.org/molvis/v 20/125> © 2014 Molecular Vision  13131.,Non-OADS,/arxiv_data1/oa_pdf/f1/8d/mv-v20-125.PMC3915293.pdf
After removal of the introns the protein sequences were deduced bytranslating them using EXPASY translate tool (http://web.expasy.org/tools/translate/).,OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
"Sequence and database search for fungal OYEs .In an attempt to obtain all the OYEs, the predicted proteomes of 58 fungi were downloaded mainly from FungalGenome Initiative (FGI) site of Broad Institute (http://www.broadinstitute.org/ science/projects/projects) and DOE Joint Genome Institute (JGI) site.",OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
Subcellular localization prediction of each of the fungal OYEs was carried out using the WoLF PSORT server (http://www.genscript.com/psort/wolf_ psort.html).,OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
"Sequence alignment, phylogenetic analyses and identification of conserved motifs .Full-length OYE protein sequences were aligned with multiple sequence and structure alignment program PROMALS3D (http://prodata.swmed.edu/ promals3d) 34and trimmed using Gblocks (v0.91b) (http://molevol.cmima.csic.es/ castresana/Gblocks_server.html) with less stringent parameter settings35.The acquired alignment of 424 OYEs was used to carry out phylogenetic analyses using two different approaches.",OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
The tracefiles generated by the Bayesian MCMC runs were used to inspect convergence of the runs using Tracer software (v1.5) (http://tree.bio.ed.ac.uk/software/tracer/).,OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
"In a second approach, Maximum Likelihood (ML) was performed using RAxML 37as executed in T-REX server (http://www.trex.uqam.ca/)38.",OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
(http://tree.bio.ed.ac.uk/software/figtree/).,OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
"To detect potential conserved motifs, the program MEME (http://meme.nbcr.net/meme/cgi-bin/meme.cgi) was used withfollowing settings, distribution of motif was set to one per sequence, width of the motif was set to 12 for minimum and 15 for maximum, and the maximum number of motifs was set to 5.",OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
"Thegenome database of A. fumigatus ,A. nidulans (http://www.aspergillusgenome.org/), C. albicans (http://www.candidagenome.org/), S. cerevisiae (http://www.",Non-OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
"yeastgenome.org/), C. neoformans (http://www.broadinstitute.org), M. oryzae andU.",OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
maydis (http://www.ncbi.nlm.nih.gov/projects/mapview/) were searched.,OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4013 | DOI: 10.1038/srep04013 11",Non-OADS,/arxiv_data1/oa_pdf/38/81/srep04013.PMC3915301.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4011 | DOI: 10.1038/srep04011 9",Non-OADS,/arxiv_data1/oa_pdf/68/65/srep04011.PMC3915302.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/d7/srep03998.PMC3915303.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3998 | DOI: 10.1038/srep03998 9",Non-OADS,/arxiv_data1/oa_pdf/9a/d7/srep03998.PMC3915303.pdf
Gene Ontology analysis .Gene Ontology (GO) analysis was performed using the Webgestalt program (http://bioinfo.vanderbilt.edu/webgestalt/).,OADS,/arxiv_data1/oa_pdf/71/0a/srep03994.PMC3915307.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/0a/srep03994.PMC3915307.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3994 | DOI: 10.1038/srep03994 7",Non-OADS,/arxiv_data1/oa_pdf/71/0a/srep03994.PMC3915307.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3995 | DOI: 10.1038/srep03995 5",Non-OADS,/arxiv_data1/oa_pdf/5e/a6/srep03995.PMC3915308.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bd/74/srep03997.PMC3915310.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3997 | DOI: 10.1038/srep03997 6",Non-OADS,/arxiv_data1/oa_pdf/bd/74/srep03997.PMC3915310.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/10/b9/srep04000.PMC3915313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4000 | DOI: 10.1038/srep04000 6",Non-OADS,/arxiv_data1/oa_pdf/10/b9/srep04000.PMC3915313.pdf
"Photon helicity driven electric currents in graphene, Preprint at http://arxiv.org/pdf/1002.1047 (2010).",OADS,/arxiv_data1/oa_pdf/b8/fb/srep04007.PMC3915314.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/fb/srep04007.PMC3915314.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4007 | DOI: 10.1038/srep04007 6",Non-OADS,/arxiv_data1/oa_pdf/b8/fb/srep04007.PMC3915314.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/e7/TOOPHTJ-7-85.PMC3915315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4015 | DOI: 10.1038/srep04015 6",Non-OADS,/arxiv_data1/oa_pdf/fa/15/srep04015.PMC3915316.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/66/TODENTJ-7-181.PMC3915317.pdf
URLhttp://hdl.handle.net/2027.42/60830.,Non-OADS,/arxiv_data1/oa_pdf/f8/f8/srep04005.PMC3915318.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f8/f8/srep04005.PMC3915318.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4005 | DOI: 10.1038/srep04005 8",Non-OADS,/arxiv_data1/oa_pdf/f8/f8/srep04005.PMC3915318.pdf
"Available from: http://www.biomedcentral.com/1471-2334/12/166 [24] Del Amo J, Gonzalez C, Belda J, et al.",OADS,/arxiv_data1/oa_pdf/9f/23/TOAIDJ-7-58.PMC3915319.pdf
"Available from: http://www.biomedcentral.com/1471-2334/10/18/ [30] Juarez-Figueroa L, Wheeler CM, Uribe-Salas FJ, et al.",OADS,/arxiv_data1/oa_pdf/9f/23/TOAIDJ-7-58.PMC3915319.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415090/ [33] Canadas M, Bosch FX, Junquera ML, et al.",OADS,/arxiv_data1/oa_pdf/9f/23/TOAIDJ-7-58.PMC3915319.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779264/ [45] Ortiz M, Torres M, Munoz L, et al.",OADS,/arxiv_data1/oa_pdf/9f/23/TOAIDJ-7-58.PMC3915319.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/23/TOAIDJ-7-58.PMC3915319.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c2/f2/srep04016.PMC3915323.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4016 | DOI: 10.1038/srep04016 9",Non-OADS,/arxiv_data1/oa_pdf/c2/f2/srep04016.PMC3915323.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/1e/main.PMC3915324.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/7a/1e/main.PMC3915324.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.006J Ginseng Res 38 (2014) 52 e58,OADS,/arxiv_data1/oa_pdf/7a/1e/main.PMC3915324.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License  (http://creativecommons.org/licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reprodu ction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/8e/TODENTJ-7-186.PMC3915325.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/0c/main.PMC3915326.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/d7/0c/main.PMC3915326.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.007J Ginseng Res 38 (2014) 22 e27,OADS,/arxiv_data1/oa_pdf/d7/0c/main.PMC3915326.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/a6/main.PMC3915327.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/9a/a6/main.PMC3915327.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.005J Ginseng Res 38 (2014) 8 e15,OADS,/arxiv_data1/oa_pdf/9a/a6/main.PMC3915327.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/38/main.PMC3915329.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/7a/38/main.PMC3915329.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.013J Ginseng Res 38 (2014) 28 e33,OADS,/arxiv_data1/oa_pdf/7a/38/main.PMC3915329.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/e4/main.PMC3915330.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/d4/e4/main.PMC3915330.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.009J Ginseng Res 38 (2014) 78 e81,OADS,/arxiv_data1/oa_pdf/d4/e4/main.PMC3915330.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/4c/main.PMC3915331.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.008J Ginseng Res 38 (2014) 47 e51,OADS,/arxiv_data1/oa_pdf/c3/4c/main.PMC3915331.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/41/main.PMC3915332.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/6e/41/main.PMC3915332.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.012J Ginseng Res 38 (2014) 40 e46,OADS,/arxiv_data1/oa_pdf/6e/41/main.PMC3915332.pdf
Available from: http://www.who.int/in ﬂuenza/human_ animal_interface/EN_GIP_20130705CumulativeNumberH5N1cases_2.pdf .,OADS,/arxiv_data1/oa_pdf/6e/41/main.PMC3915332.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/61/main.PMC3915333.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/06/61/main.PMC3915333.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.004J Ginseng Res 38 (2014) 34 e39,OADS,/arxiv_data1/oa_pdf/06/61/main.PMC3915333.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0e/main.PMC3915334.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/98/0e/main.PMC3915334.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.001J Ginseng Res 38 (2014) 66 e72,OADS,/arxiv_data1/oa_pdf/98/0e/main.PMC3915334.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/cb/main.PMC3915335.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.003J Ginseng Res 38 (2014) 1 e7,OADS,/arxiv_data1/oa_pdf/c2/cb/main.PMC3915335.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/09/main.PMC3915336.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.002J Ginseng Res 38 (2014) 73 e77,OADS,/arxiv_data1/oa_pdf/47/09/main.PMC3915336.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/4e/main.PMC3915337.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.com 1226-8453/$ esee front matter Copyright /C2112013, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/e3/4e/main.PMC3915337.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.010J Ginseng Res 38 (2014) 16 e21,OADS,/arxiv_data1/oa_pdf/e3/4e/main.PMC3915337.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/9c/main.PMC3915342.pdf
http://dx.doi.org/10.1016/j.jgr.2013.11.011J Ginseng Res 38 (2014) 59 e65,OADS,/arxiv_data1/oa_pdf/4f/9c/main.PMC3915342.pdf
"Processed P. quinquefolius (cultivated red, large size) was purchased from Hsu ’s Ginseng Enterprises, Inc. (Marathon County, Wisconsin, U.S.A, http://www.hsuginseng.com ).",Non-OADS,/arxiv_data1/oa_pdf/4f/9c/main.PMC3915342.pdf
",2010 ,8(1), 69-80. http://dx.doi.org/10.2174/157015910790909520  [2] Mangialasche, F.; Solomon, A.; Winblad, B.; Mecocci, P.;  Kivipelto, M. Alzheimer's disease: clinical trials and drug  development.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 ,9(7), 702-716. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Cell,2012 ,148(6), 1204-1222. http://dx.doi.org/10.1016/  j.cell.2012.02.040 [4] Cavalli, A.; Bol ognesi, M.L.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2008 ,51(3),  347-372. http://dx.doi.org/10.1021/jm7009364  [5] Bajda, M.; Guzior, N.; Ignasik, M.; Malawska, B. Multi-  target-directed ligands in Alzheimer's disease treatment.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2013 ,8(2), 115-129. http://dx.doi.org/10.1517/17460441.2013.744746  [8] Csermely, P.; Korcsmaros, T.; Kiss, H.J.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
", 2013, 138(3), 333-408. http://dx.doi.org/10.1016/j.pharmthera.2013.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2005 ,26(4), 178-182. http://dx.doi.org/10.1016/  j.tips.2005.02.007  [10] Knapp, M.; Iemmi, V.; Romeo, R. Dementia care costs and  outcomes: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"L  ancet , 2005 ,366(9503), 2112-2117. http://dx.doi.org/10.1002/gps.3864  [12] Heun, R.; Schoepf, D.; Potluri, R.; Natalwala, A. Alzheimer's  disease and co-morbidity: Increased prevalence and possible risk  factors of excess mortality in a naturalistic 7-year follow-up.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Eur  Psychiatry ,2013 ,28(1), 40-48. http://dx.doi.org/10.1016/j.eurpsy.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",1983, 14(5), 497-506. http://dx.doi.org/10.1002/ana.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Nat Med ,2004 ,10(10), 1055-1063. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2008 ,22(3), 265-274. http://dx.doi.org/  10.1111/j.1472-8206.2008.00578.x  [19] Jellinger, K.A.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2011 ,22 1 (2), 555-563. http://dx.doi.org/10.1016/j.bbr.2010.11.058  [22] Palop, J.J.; Chin, J.; Mucke, L. A network dysfunction perspective  on neurodegenerative diseases.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Nature ,2006 ,443(7113), 768-773. http://dx.doi.org/10.1038/nature05289  [23] Sun, G.Y.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,46(1), 85-95. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2007 ,8(2), 101-112. http://dx.doi.org/  10.1038/nrm2101  [25] Standridge, J.B.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006 , 3(2), 95-108. http://dx.doi.org/10.2174/156720506776383068  [26] Hardy, J.; Selkoe, D.J.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 , 90(2), 465-494. http://dx.doi.org/10.1152/physrev.00023.2009  [28] Endres, K.; Fahrenholz, F. Regulation of al pha-secret ase ADAM10  expression and activity.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,217(3-4), 343-352. http://dx.doi.org/10.1007/s00221-011-2885-7  [29] Prox, J.; Rittger, A.; Saftig, P. Physiological functions of the  amyloid precursor protein secretases ADAM10, BACE1, and  Presenilin.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,217(3-4), 331-341. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 , 12(3), 111-124. http://dx.doi.org/10.1159/000342020  [36] Khlistunova, I.; Biernat, J.; Wang, Y.; Pickhardt, M.; von Bergen,  M.; Gazova, Z.; Mandelkow, E.; Mandelkow, E.M. Inducible  expression of Tau repeat domain in cell models of tauopathy:  aggregation is toxic to cells but can be reversed by inhibitor drugs.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"http://dx.doi.org/10.1038/475S9a  [39] Heinitz, K.; Beck, M.; Schliebs, R.; Perez-Polo, J.R.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006 ,98(6), 1930- 1945. http://dx.doi.org/10.1111/j.1471-4159.2006.04015.x  [40] LaFerla, F.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2007 ,8(7), 499-509. http://dx.doi.org/10.1038/nrn2168  [41] Fukumoto, H.; Tokuda, T.; Kasai, T.; Ishigami, N.; Hidaka, H.;  Kondo, M.; Allsop, D.; Nakagawa, M. High-molecular-weight  beta-amyloid oligomers are elevated in cerebrospinal fluid of  Alzheimer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"FEBS J ,2010 ,277(14), 3051-3067. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Acta , 2009 ,1792 (1), 3-13. http://dx.doi.org/10.1016/j.bbadis.2008.10.016  [48] Zhu, X.C.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2013, 55, 73-84. http://dx.doi.org/  10.1016/j.yjmcc.2012.09.012  [50] McCray, B.A.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neurosignals ,2008 ,16(1), 75-84. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Brain ,2011 ,134(Pt 1),  258-277. http://dx.doi.org/10.1093/brain/awq341  [52] Bell, K.F.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006 ,545(1), 11-21. http://dx.doi.org/10.1016/j.ejphar.2006.06.045  [53] Xu, Y.; Yan, J.; Zhou, P.; Li, J.; Gao, H.; Xia, Y.; Wang, Q.  Neurotransmitter receptors and cognitive dysfunction in  Alzheimer's disease and Parkinson's disease.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
", 2012 ,97(1), 1-13. http://dx.doi.org/10.1016/j.pneurobio.2012.02.002  [54] Francis, P.T.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Psychiatry ,1999 ,66(2), 137-147. http://dx.doi.org/10.1136/jnnp.66.2.137  [55] Ladner, C.J.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",1998 ,57(8), 719-731. http://dx.doi.org/  10.1097/00005072-199808000-00001  [56] Trinh, N.H.; Hoblyn, J.; Mohanty, S.; Yaffe, K. Efficacy of  cholinesterase inhibitors in the treatment of neuropsychiatric  symptoms and functional impairment in Alzheimer disease: a meta- analysis.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
", 2012 ,120 Suppl 1 , 22-33. http://dx.doi.org/10.1111/j.1471-4159.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Science ,1991 ,253(5022), 872-879. http://dx.doi.org/10.1126/  science.1678899  [59] Bartolini, M.; Bertucci, C.; Cavrini, V.; Andrisano, V. beta- amyloid aggregation induced by human acetylcholinesterase: inhibition studies.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2003 ,65(3), 407-416.  http://dx.doi.org/10.1016/S0006-2952(02)01514-9  [60] Chacon, M.A.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuron ,1996 ,16(4), 881-891. http://dx.doi.org/  10.1016/S0896-6273(00)80108-7  [62] Alvarez, A.; Alarcon, R.; Opazo, C.; Campos, E.O.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",1992 ,31(1), 103-111. http://dx.doi.org/10.1002/jnr.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Synapse ,1997 ,26(4),  341-350. http://dx.doi.org/10.1002/(SICI) 1098-2396(199708)26:  4<341::AID-SYN2>3.0.CO;2-6  [67] Zheng, W.H.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuroscience , 2002 ,115(1), 201-211. http://dx.doi.org/10.1016/S0306-4522(02)  00404-9  [68] Mills, J.; Reiner, P.B.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"J Neurochem ,1999 ,72(2), 443-460. http://dx.doi.org/  10.1046/j.1471-4159.1999.0720443.x  [69] Rampa, A.; Belluti, F.; Gobbi, S.; Bisi, A. Hybrid-based multi- target ligands for the treatment of Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2011 ,11( 22), 2716-2730. http://dx.doi.org/10.2174/  156802611798184409  [70] Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj,  E.K.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"http://dx.doi.org/  10.1038/nrn1434  [72] Sayre, L.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2009 ,8(4), 285-305. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 , 41(2-3), 73-86. http://dx.doi.org/10.1007/s12035-010-8107-7  [76] Pagani, L.; Eckert, A. Amyloid-Beta interaction with mitochondria.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
", 2008 ,106(1), 45-55. http://dx.doi.org/10.1111/j.1471-4159.2008.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2003 , 45(2), 205-213. http://dx.doi.org/10.1194/jlr.R 300016-JLR200  [81] Sun, G.Y.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2005 ,8(8), 1051-1058. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Nature ,2006 ,441(7092), 513-517. http://dx.doi.org/  10.1038/nature04782  [84] Bossy-Wetzel, E.; Talantova, M.V.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuron, 2004 ,41(3),  351-365. http://dx.doi.org/10.1016/S0896-6273(04)00015-7  [85] Iadecola, C.; Zhang, F.; Casey, R.; Nagayama, M.; Ross, M.E.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuroscience ,2009 ,158(3), 1143-1150. http://dx.doi.org/10.1016/j.neuroscience.2008.08.031  [87] Varadarajan, S.; Yatin, S.; Aksenova, M.; Butterfield, D.A.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2000 ,130(2-3),  184-208. http://dx.doi.org/10.1006/jsbi.2000.4274  [88] Horiguchi, T.; Uryu, K.; Giasson, B.I.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2003 ,163(3), 1021- 1031. http://dx.doi.org/10.1016/S0002-9440(10)63462-1  [89] Floyd, R.A. Neuroinflammatory processes are important in  neurodegenerative diseases: An hypothesis to explain the increased  formation of reactive oxygen and nitrogen species as major factors  involved in neurodegenerative disease development.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",1999 ,26(9-10), 1346-1355. http://dx.doi.org/10.1016/  S0891-5849(98)00293-7  [90] Benveniste, E.N.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 , 41(2-3), 242-247. http://dx.doi.org/10.1007/s12035-010-8105-9  [92] Thorns, V.; Hansen, L.; Masliah, E. nNOS expressing neurons in  the entorhinal cortex and hippocampus are affected in patients with  Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuron, 2010 ,68(2), 270-281. http://dx.doi.org/10.1016/j.neuron.2010.10.013  [94] De Jager, P.L.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"http://dx.doi.org/10.1371/journal.pone.0006617  [97] Babenko, O.; Kovalchuk, I.; Metz, G.A.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Aging ,2011 ,32(7), 1161-1180. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 ,45(4), 291-296. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,55(21), 8997-9008. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 , 287(8), 5253-5266. http://dx.doi.org/10.1074/jbc.M111.276162  [103] Huang, Y. Molecular and cellular mechanisms of apolipoprotein E4  neurotoxicity and potential therapeutic strategies.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 ,177(2), 563-569. http://dx.doi.org/10.2353/ajpath.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2011 ,286(19),  17217-17226. http://dx.doi.org/10.1074/jbc.M110.217380  [107] Li, G.; Bien-Ly, N.; Andrews-Zwilling, Y.; Xu, Q.; Bernardo, A.;  Ring, K.; Halabisky, B.; Deng, C.; Mahley, R.W.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Cell Stem Cell , 2009 ,5(6), 634-645. http://dx.doi.org/10.1016/j.stem.2009.10.015  [108] Witt, A.; Mac donald, N.; Kirkpatrick, P. Memantine hydrochloride.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2004 ,3(2), 109-110. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Psychiatry , 2005, 4(1), 43-47. http://dx.doi.org/10.1038/nrd1311  [110] Sugimoto, H.; Ogura, H.; Arai, Y.; Limura, Y.; Yamanishi, Y.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2002 ,89(1),  7-20. http://dx.doi.org/10.1254/jjp.89.7  [111] Lleo, A.; Greenberg, S.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006 ,57, 513-533. http://dx.doi.org/10.1146/annurev.med.57.121304.131442 [112] Salomone, S.; Caraci, F.; Leggio, G.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 , 73( 4), 504-517. http://dx.doi.org/10.1111/j.1365-2125.2011.04134.x  [113] Selkoe, D.J.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"http://dx.doi.org/10.1101/cshperspect.a004457  [114] Orgogozo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neurology ,2003 ,61(1), 46-54. http://dx.doi.org/  10.1212/01.WNL.0000073623.84147.A8  [115] Delrieu, J.; Ousset, P.J.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"J Neurochem , 2012 ,120 Suppl 1 , 186-193. http://dx.doi.org/10.1111/j.1471-4159.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Ann Neurol ,2011 ,69(2), 237- 239. http://dx.doi.org/10.1002/ana.22365  [117] Palmer, A.M. What are the prospects of slowing the progression of  Alzheimer's disease?",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Drug Discov Today ,2012 ,17(21-22), 1157- 1159. http://dx.doi.org/10.1016/j.drudis.2012.09.009  [118] Mandrekar-Colucci, S.; Landreth, G.E.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Targets ,2011 ,15(9), 1085-1097. http://dx.doi.org/10.1517/  14728222.2011.594043  [119] Campbell, V.A.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2009 ,152(5), 655-662. http://dx.doi.org/10.1038/sj.bjp.0707446  [120] Standridge, J.B. Current status and future promise of pharma-  cotherapeutic strategies for Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2009 ,13(3), 303-308. http://dx.doi.org/10.1016/  j.cbpa.2009.04.619  [122] Morphy, R.; Kay, C.; Rankovic, Z.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Today ,2004 ,9( 15), 641-651. http://dx.doi.org/10.1016/S1359-6446(04)03163-0  [123] Hopkins, A.L.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2008 ,4(11), 682-690. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,19(20),  3353-3387. http://dx.doi.org/10.2174/092986712801215883  [125] Mudher, A.; Lovestone, S. Alzheimer's disease-do tauists and  baptists finally shake hands?",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Trends Neurosci ,2002 ,25(1), 22-26. http://dx.doi.org/10.1016/S0166-2236(00)02031-2  [126] Romero, A.; Egea, J.; Garcia, A.G.; Lopez, M.G.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"BioDrugs ,2012 , 26(1), 21-31. http://dx.doi.org/10.2165/11597630-000000000-00000  [128] Han, H.J.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 ,93(4), 522-531. http://dx.doi.org/10.1016/j.nlm.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Possibility of a new anti-alzheimer's  disease pharmaceutical compos ition combining memantine and  vitamin D. Drugs Aging ,2012 ,29(2), 81-91. http://dx.doi.org/  10.2165/11597550-000000000-00000",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Psychiatry ,2013 ,44, 118-124. http://dx.doi.org/10.1016/j.pnpbp.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 ,79, 591-617. http://dx.doi.org/10.1146/  annurev.biochem.051908.125345  [133] Romero, J.; Martinez-Orgado, J. Cannabinoids and Neuro-  degenerative Diseases.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Disorders-Drug Targets, 2009 ,8(6), 440-450. http://dx.doi.org/10.2174/187152709789824589  [134] Maelicke, A.; Samochocki, M.; Jostock, R.; Fehrenbacher, A.;  Ludwig, J.; Albuquerque, E.X.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Psychiatry ,2001 ,49(3), 279-288. http://dx.doi.org/10.1016/S0006-3223(00)01109-4  [135] Mancini, F.; Naldi, M.; Cavrini, V.; Andrisano, V. Mu ltiwell  fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2007 , 388(5-6), 1175-1183. http://dx.doi.org/10.1007/s00216-007-1356-2  [136] Meunier, J.; Ieni, J.; Maurice, T. The anti-amnesic and  neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the  sigma1 receptor.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006 ,149(8), 998-1012. http://dx.doi.org/10.1038/sj.bjp.0706927  [137] Youdim, M.B.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006 ,3(5), 541-550.  http://dx.doi.org/10.2174/156720506779025288  [138] Lahtinen, H.; Koistinaho, J.; Kauppinen, R.; Haapalinna, A.;  Keinanen, R.; Sivenius, J. Selegiline treatment after transient global ischemia in gerbils enhances the survival of CA1 pyramidal cells in  the hippocampus.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",1997 ,757(2), 260-267. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
", 2000 , (60), 157-169. http://dx.doi.org/10.1007/978-3-7091-6301-6_10  [141] Zheng, H.; Amit, T.; Bar-Am, O.; Fridkin, M.; Youdim, M.B.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Curr Alzheimer Res ,2007 ,4(5), 522-536.  http://dx.doi.org/10.2174/156720507783018226  [144] Weinreb, O.; Amit, T.; Mandel, S.; Youdim, M.B.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,10(1-4), 112-115.  http://dx.doi.org/10.1159/000332597  [145] Bisogno, T.; Di Marzo, V. The role of the endocannabinoid system  in Alzheimer's disease: facts and hypotheses.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Des.,2008 ,14(23), 2299-3305. http://dx.doi.org/10.2174/  138161208785740027  [146] Gowran, A.; Noonan, J.; Campbell, V.A.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2011 ,17(6), 637-644. http://dx.doi.org/10.1111/  j.1755-5949.2010.00195.x  [147] Benito, C.; Nunez, E.; Tolon, R.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006 ,3(6), 773-777. http://dx.doi.org/10.1021/mp060066m  [150] Karl, T.; Cheng, D.; Garner, B.; Arnold, J.C.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Targets ,2012 ,16(4), 407-420. http://dx.doi.org/  10.1517/14728222.2012.671812  [151] Nagayama, T.; Sinor, A.D.; Simon, R.P.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006 ,3(6), 773-777. http://dx.doi.org/10.1021/  mp060066m  [153] Ehrhart, J.; Obregon, D.; Mori, T.; Hou, H.; Sun, N.; Bai, Y.;  Klein, T.; Fernandez, F.; Tan, J.; Shytle, R.D.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Med (Ber)., 2006 , 84(3), 253-258. http://dx.doi.org/10.1007/s00109-005-0025-1  [156] Haghani, M.; Shabani, M.; Javan, M.; Motamedi, F.; Janahmadi,  M. CB1 cannabinoid receptor activation rescues amyloid beta-induced alterations in behaviour and intrinsic electrophysiological  properties of rat hippocampal CA1 pyramidal neurones.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,29(3-4), 391-406. http://dx.doi.org/10.1159/  000338494  [157] Eshhar, N.; Striem, S.; Biegon, A. HU-211, a non-psychotropic  cannabinoid, rescues cortical-neurons from excitatory amino-acid  toxicity in culture.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuroreport ,1993 ,5(3), 237-240. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2001 ,309(3), 197-201. http://dx.doi.org/10.1016/S0304-3940(01)02065-1  [161] van der Stelt, M.; Veldhuis, W.B.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2004 ,89(1), 134-141. http://dx.doi.org/10.1111/j.1471-4159.2003.02327.x  [164] Sanchez-Montero, J.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
Available from: http://ranf.com/component/easytablepro/  concurso-cientifico.html?start=100.,OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2006, 14(2), 472-478. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 , 10(5), 711-728. http://dx.doi.org/10.1586/ern.10.29  [170] Van der Zee, E.A.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,14(2), 91-111. http://dx.doi.org/10.1007/  s12017-012-8180-3  [172] Motel, W.C.; Coop, A.; Cunningham, C.W.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,13(3), 456-466.  http://dx.doi.org/10.2174/138955713804999784  [173] Santangelo, R.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,22( 11),  1337-1352. http://dx.doi.org/10.1517/13543776.2012.728587  [174] Toda, N.; Kaneko, T.; Kogen, H. Development of an efficient  therapeutic agent for Alzheimer's disease: design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Bull (Tokyo) ,2010 ,58(3), 273-287. http://dx.doi.org/  10.1248/cpb.58.273  [175] Brioni, J.D.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2011 ,336(1), 38-46. http://dx.doi.org/  10.1124/jpet.110.166876  [176] Hieke, M.; Ness, J.; Steri, R.; Dittrich, M.; Greiner, C.; Werz, O.;  Baumann, K.; Schubert-Zsilavecz, M.; Weggen, S.; Zettl, H.  Design, synthesis, and biological evaluation of a novel class of  gamma-secretase modulators with PPARgamma activity.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2010 ,53(12), 4691-4700. http://dx.doi.org/10.1021/jm1003073  [177] Sheng, M.; Sabatini, B.L.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"http://dx.doi.org/10.1101/cshperspect.a005777  [178] Nistico, R.; Pignate lli, M.; Piccinin, S.; Mercuri, N.B.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuropharmacology ,2011 ,60(2-3), 460-466. http://dx.doi.org/10.1016/j.neuropharm.2010.10.026  [181] Day, T.; Greenfield, S.A. A non-cholinergic, trophic action of  acetylcholinesterase on hippocampal neurones in vitro : molecular mechanisms.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuroscience ,2002 ,111(3), 649-656. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2013 ,203( 1), 302-308. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Science ,1992 , 258(5080), 304-307. http://dx.doi.org/10.1126/science.1411529  [185] Forlenza, O.V.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2000 ,107(10), 1201-1212. http://dx.doi.org/10.1007/s007020070034  [186] Darvesh, S.; Hopkins, D.A.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2003 ,4(2), 131-138.  http://dx.doi.org/10.1038/nrn1035  [187] Schenk, D.; Basi, G.S.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"http://dx.doi.org/10.1038/nrn1035  [188] Brunden, K.R.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neurodegener Dis ,2012 ,10(1-4), 116-121. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Amyloid ,2011 ,18(3), 119-127. http://dx.doi.org/10.3109/13506129.2011.582902  [192] Boddapati, S.; Levites, Y.; Sierks, M.R.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2011 ,405(2  ),  436-447. http://dx.doi.org/10.1016/j.jmb.2010.10.054  [193] Weggen, S.; Rogers, M.; Eriksen, J. NSAIDs: small molecules for  prevention of Alzheimer's disease or precursors for future drug  development?",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2007 ,28(10), 536-543. http://dx.doi.org/10.1016/j.tips.2007.09.004  [194] Willem, M.; Garratt, A.N.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Science ,2006 ,314(5799), 664-666. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,287(15), 11810-11819. http://dx.doi.org/10.1074/jbc.M111.305227  [196] Jeon, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Aging , 2012, 33(9), 2062-2071. http://dx.doi.org/10.1016/j.neurobiolaging.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2005 , 38, 105-127. http://dx.doi.org/10.1007/0-387-23226-5_5  [199] Donmez, G.; Wang, D.; Cohen, D.E.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Psychiatry ,2012 , 25(3), 226-230. http://dx.doi.org/10.1097/YCO.0b013e32835112c1  [201] Li, F.; Gong, Q.; Dong, H.; Shi, J. Resveratrol, a neuroprotective  supplement for Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 , 18(1), 27-33. http://dx.doi.org/10.2174/138161212798919075  [202] Feng, Y.; Wang, X.-p.; Yang, S.-g.; Wang, Y.-j.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neurotoxicology ,2009 ,30(6), 986-995. http://dx.doi.org/10.1016/j.neuro.2009.08.013  [203] Huang, H.-C.; O’Brien, W.T.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"J Biol Chem ,2010 ,285(17), 13107-13120. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2013 ,20(1), 1-4. http://dx.doi.org/  10.1038/nsmb.2481  [208] Opattova, A.; Filipcik, P.; Cente, M.; Novak, M. Intracellular  degradation of misfolded tau protein induced by geldanamycin is as sociated with activation of proteasome.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2012 ,367(6), 570-572. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Science ,2012 ,335(6075), 1503-1506. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Cell Rep. ,2012 ,2(5), 1329-1339. http://dx.doi.org/10.1016/j.celrep.2012.09.030  [213] Boothby, L.A.; Doering, P.L.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2005 ,39(12), 2073- 2080. http://dx.doi.org/10.1345/aph.1E495  [214] Lerner, A.J.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Biofactors ,2012 , 38(2), 84-89. http://dx.doi.org/10.1002/biof.196  [215] Holmquist, L.; Stuchbury, G.; Berbaum, K.; Muscat, S.; Young, S.;  Hager, K.; Engel, J.; Münch, G. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
", 2007 ,113(1), 154-164. http://dx.doi.org/10.1016/j.pharmthera.2006.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2007 ,114( 2), 231-238. http://dx.doi.org/10.1007/s00702- 006-0597-0  [219] Schaeffer, E.L.; Gattaz, W.F.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Psychopharmacology  (Berl) ,2008 ,198(1), 1-27. http://dx.doi.org/10.1007/s00213-008- 1092-0  [220] Cordeiro, Q.; Noguti, R.; Bo ttino, C.M.C.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Arquivos De Neuro- Psiquiatria ,2010 ,68(2), 189-193. http://dx.doi.org/10.1590/S0004- 282X2010000200007  [221] Schaeffer, E.L.; Skaf, H.D.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Psychopharmacology (Berl) ,2009 , 202(1-3), 37-51. http://dx.doi.org/10.1007/s00213-008-1351-0  [223] Forlenza, O.V.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Prostaglandins Leukot Essent Fatty Acids ,2007 ,76(1),  47-55. http://dx.doi.org/10.1016/j.plefa.2006.10.002  [224] Schaeffer, E.L.; De-Paula, V.J.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
",2011 ,118(9), 1273-1279. http://dx.doi.org/10.1007/  s00702-011-0619-4  [225] Sun, A.Y.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Aging , 2001 ,22(6), 811-817. http://dx.doi.org/10.1016/S0197-4580(01)  00297-4  [227] Khoury, J.E.",OADS,/arxiv_data1/oa_pdf/7d/7c/CN-12-2.PMC3915347.pdf
"Neuron, 2012, 76, 51-69.  http://dx.doi.org/10.1016/j.neuron.2012.09.024  [2] Burnstock, G. Purine and pyrimidine receptors.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"2007 ,64(12),1471-83. http://dx.doi.org/10.1007/s00018-007-6497-0  [3] Mori, M.; Heuss, C.; Gähwiler, B. H.; Gerber, U.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Physiol., 2001 ,15, 115-123.  http://dx.doi.org/10.1111/j.1469-7793.2001.t01-1-00115.x  [4] Bowser, D. N.; Khakh, B. S.  Vesicular ATP is the predominant  cause of intercellular calcium waves in astrocytes.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Neuron Glia Biol.,  2007 ,3,199-208. http://dx.doi.org/10.1017/S1740925X08000069  [7] Koizumi, S. Synchronization of Ca2+ oscillations: i nvolvement of  ATP release in astrocytes.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Brain Res., 1978 ,154, 273-284.     http://dx.doi.org/10.1016/0006-8993(78)90700-X  [9] Latini, S.; Pedata, F. Adenosine in the central nervous system:  release mechanisms and extracellular concentrations.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Neurochem.,  2001 ,79, 463-484. http://dx.doi.org/10.1046/j.1471-4159.2001.00607.x  [10] Burnstock, G. Physiology and pathophysiology of purinergic  neurotransmission.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Neurosci.,  2005 ,2 5, 6286-6295. http://dx.doi.org/10.1523/JNEUROSCI.0628- 05.2005  [14] Bliss, T. V. P.; Collingridge, G. L. A synaptic model of memory:  long-term potentiation in the hippocampus.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Nature, 1993 ,361, 31- 39. http://dx.doi.org/10.1038/361031a0  [15] Burnstock, G.  Purinergic signa lling in the CNS.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Neurochem., 1994 ,63, 1731-1738. http://dx.doi.org/10.1046/j.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Sci., 2004 ,94, 103-106.   http://dx.doi.org/10.1254/jphs.94.103  [18] O'Kane, E. M.; Stone, T. W. Characterisation of ATP-induced  facilitation of transmission in rat hippocampus.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"2000 ,409, 159-166. http://dx.doi.org/10.1016/S0014-2999(00  00785-8  [19] Pankratov, Y.; Lalo, U.; Krishtal, O.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Hippocampus, 1995 ,5, 71-77. http://dx.doi.org/10.1002/hipo.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Science, 2005 ,310, 113-116. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Biosci., 2008 , 13,  2614-2632. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Toxicol., 2005 , 45, 385-412. http://dx.doi.org/10.1146/annurev.pharmtox.45.120403.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Synapse, 2005 ,57, 8-16. http://dx.doi.org/10.1002/  syn.20146  [26] Lang, U. E.; Lang, F.; Richter, K.; Vallon, V.; Lipp, H. P.;  Schnermann, J.; Wolfer, D. P.  Emotional instability but intact  spatial cogn ition in adenosine receptor 1 knock out mice.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Brain Res., 2003 ,145, 179-188.  http://dx.doi.org/10.1016/S0166- 4328(03)00108-6  [27] Scammell, T. E.; Arrigoni, E.; Thompson, M. A.; Ronan, P. J.;  Saper, C. B.; Green, R. W.  Focal deletion of the adenosine A1  receptor in adult mice using an adeno-associated viral vector.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Neuroscience, 2002 ,112, 319-329. http://dx.doi.org/10.1016/  S0306-4522(02)00080-5  [29] Dias, R. B.; Ribeiro, J.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Neuron, 2008 ,57, 121-134.  http://dx.doi.org/10.1016/j.neuron.2007.11.023",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Neuropharmacology,  2008 ,54, 924-933.  http://dx.doi.org/10.1016/j.neuropharm.2008.01.011  [32] Tebano, M. T.; Martire, A.; Potenza, R. L.; Gro, C.; Pepponi, R.;  Armida, M.; Domenici, M. R.; Schwarzschild, M. A.; Chen, J. F.;  Popoli, P. Adenosine A(2A) receptors are required for normal  BDNF levels and BDNF-induced potentiation of synaptic  transmission in the mouse hippocampus.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Brain Res., 2009 ,1303 , 74-83. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Mem., 2007 ,87, 42-56. http://dx.doi.org/10.1016/j.nlm.2006.05.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"http://dx.doi.org/10.1371/journal.pone.0006006  [41] Araque, A.; Li, N.; Doyle, R. T.; Haydon, P. G. SNARE protein- dependent glutamate release from astrocytes.",OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"U.S.A., 2003 ,100, 11023-11028. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Pharmacol., 2002 ,447, 247-260. http://dx.doi.org/10.1016/  S0014-2999(02)01756-9  Received: February 13, 2013 Revised: July 01, 2013 Accepted: August 02, 2013",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/CN-12-37.PMC3915348.pdf
"Prevalence of autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, 14  sites, United States, 2008 ,2012 ,61(3), 1-19. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
", 2012 ,22(12), 4314-22. http://dx.doi.org/10.1172/JCI63141  [6] Gurkan, C.K.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2012 ,6(4), 1311- 20. http://dx.doi.org/10.1016/j.rasd.2012.05.007  [7] Berry-Kravis, E., Kno,x A.; Hervey, C. Targeted treatments for  fragile X syndrome.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2010 , 127(1), 78-93. http://dx.doi.org/10.1016/j.pharmthera.2010.02.008  [9] Bassell, G.J.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"http://dx.doi.org/10.1542/peds.113.5.e472  [18] O'Roak, B.J.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Nature, 2012 ,485(7393), 246-250. http://dx.doi.org/10.1038/nature10989  [19] Betancur, C. Etiological heterogeneity in autism spectrum  disorders: more than 100 genetic and genomic disorders and still  counting.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2011 ,1380 , 42-77. http://dx.doi.org/10.1016/  j.brainres.2010.11.078  [20] Essa, M.M.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"2011 ,35(9), 1982-1988. http://dx.doi.org/  10.1016/j.neubiorev.2011.06.006  [23] Shinohe, A.; Hashimoto, K.; Nakamura, K.; Tsu jii, M.; Iwata, Y.;  Tsuchiya, K.J.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Psychiatry, 2006 ,30(8), 1472-1477. http://dx.doi.org/10.1016/j.pnpbp.2006.06.013  [24] Chao, H.T.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
", 2012 ,18(3), 556-564. http://dx.doi.org/10.1017/S1355617712000070  [28] Dichter, G.S.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"http://dx.doi.org/10.1038/ncomms2045  [32] Busquets-Garcia, A.; Gomis-Gonzalez, M.; Guegan, T.; Agustin- Pavon, C.; Pastor, A.; Mato, S.; Perez-Samartin A.; Matute, C.; de  la Torre, R.; Dierrsen, M.; Maldonaldo, R.; Ozaita, A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Behav., 2006 ,50(4), 518-528. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
", 2012 ,13(11), 1615-1629. http://dx.doi.org/10.1016/S0140-6736(03)  14236-5  [40] Tranfaglia, M.R.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Structure, 2011 ,19(10), 1370-1380.  http://dx.doi.org/10.1016/j.str.2011.08.009  [50] Mayer, M.L.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Rev., 2010 ,62(3), 405-496.  http://dx.doi.org/10.1124/pr.109.002451  [52] Collingridge, G.L.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuropharmacology , 2009 ,56(1), 2-5. http://dx.doi.org/10.1016/j.neuropharm.2008.06.063  [53] Contractor, A.; Swanson, G.; Heinemann, S.F.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2001 ,29(1), 209-216.  http://dx.doi.org/10.1016/S0896-6273(01)00191-X  [54] Contractor, A.; Mulle, C.; Swanson, G.T.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurobiol., 2012 , 22(3), 461-469. http://dx.doi.org/10.1016/j.conb.2011.12.006  [59] Wang, G.; Gilbert, J.; Man, H.Y.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuroscientist ,2013 ,19(1), 62-75. http://dx.doi.org/10.1177/  1073858411435129  [62] Fourie C.; Li, D.; Montgomery, J.M.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron, 1999 ,22(1), 179-187. http://dx.doi.org/10.1016/  S0896-6273(00)80689-3  [65] Dong, H.; O'Brien, R.J.; Fung, E.T.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron , 1998 ,21(1), 87-97. http://dx.doi.org/10.1016/S0896-6273(00)80517-6  [67] Li, D.; Specht, C.G.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2011 ,589 (Pt 18), 4491-510. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"2009 ,12(2), 172-181.  http://dx.doi.org/10.1038/nn.2249  [71] Bats, C.; Groc, L.; Choquet, D. The interaction between Stargazin  and PSD-95 regulates AMPA receptor surface trafficking.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron , 2007 ,53(5), 719-734. http://dx.doi.org/10.1016/j.neuron.2007.01.030  [72] Beique, J.C.; Lin, D.T.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurobiol., 2012 ,22(3), 488-495.  http://dx.doi.org/10.1016/j.conb.2011.09.005  [76] Groc, L.; Choquet, D. AMPA and NMDA glutamate receptor  trafficking: multiple roads for reaching and leaving the synapse.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2006 ,326(2), 423-438. http://dx.doi.org/10.1007/  s00441-006-0254-9  [77] Perez-Otano, I.; Ehlers, M.D.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Trends Neurosci., 2005 ,28(5), 229-238.  http://dx.doi.org/10.1016/j.tins.2005.03.004  [78] Carroll, R.C.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurosci., 2010 ,32(2), 250-260. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2004 ,44(1), 5-21. http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Nature ,2006 ,440(7087), 1054-1059. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2006 , 52(3), 475-484. http://dx.doi.org/10.1523/JNEUROSCI.5633-10.2011  [89] Hou, Q.; Zhang, D.; Jarzylo, L.; Huganir, R.L.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Sci., 2003 ,358(1432), 707-714.  http://dx.doi.org/10.1098/rstb.2002.1233  [100] Citri, A.; Bhattacharyya, S.; Ma, C.; Morishita, W.; Fang, S.; Rizo,  J.; Malenka, R.C.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurosci., 2010 ,30(49), 16437-16452. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuropharmacology ,2001 ,41(6), 664-671. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2006 ,51(2), 213-225. http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2008 ,39(3), 237-245. http://dx.doi.org/10.1007/s10578-  007-0084-3  [117] Chen, H.S.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Genet., 2005 ,76(6), 950-966. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2010 ,42(11), 1021-1026. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Psychiatry ,2002 ,7(3), 302-310. http://dx.doi.org/10.1038/sj.mp.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Genet .,  2004 ,131B (1), 48-50. http://dx.doi.org/10.1002/ajmg.b.30025  [128] Motazacker, M.M.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2007 ,81(4), 792-798.   http://dx.doi.org/10.1086/521275  [129] Ramoz, N.; Reiche rt, J.G.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Biomarkers ,2009 ,13(5), 611-615. http://dx.doi.org/10.1089/gtmb.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Psychiatry ,2010 ,34(7), 1269-1272. http://dx.doi.org/10.1016/  j.pnpbp.2010.07.005  [150] Doyle, C.A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Psychiatry ,2011 ,72(5), 716-721.  http://dx.doi.org/10.4088/JCP.09m05266gre  [152] Erickson, C.A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Lett., 2001 ,306(1-2), 81-84. http://dx.doi.org/10.1016/S0304- 3940(01)01872-9  [157] Becker, B.; Klein, E.M.; Striepens, N.; Mihov, Y.; Schlaepfer,  T.E.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Synapse ,2008 ,62(2), 149-153.  http://dx.doi.org/10.1002/syn.20472  [159] Blanpied, T.A.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Psychiatry ,2001 ,40(6), 658-665.  http://dx.doi.org/10.1097/00004583-200106000-00010  [161] Mann, K.; Kiefer, F.; Spanagel, R.; Littleton, J. Acamprosate:  recent findings and future research directions.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2007 ,1(3), 115-125.  http://dx.doi.org/10.1097/ADM.0b013e318156c26f  [164] Erickson, C.A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Psychopharmacology ,2013 ,228(1), 75-84. http://dx.doi.org/  10.1007/s00213-013-3022-z  [166] Goff, D.C. D-cycloserine: an evolving role in learning and  neuroplasticity in schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"J. Psychiatry ,2004 ,161(11),2115-2117.  http://dx.doi.org/10.1176/appi.ajp.161.11.2115  [168] Purce ll, A.E.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2011 ,1380 , 198-205. http://dx.doi.org/10.1016/  j.brainres.2010.12.057  [170] Rubenstein, J.L.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",1996 ,64(2), 246-251. http://dx.doi.org/  10.1002/(SICI) 1096-8628(19960809)64:2<246::AID-AJMG2>3.0.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurosci., 2005 , 25(41), 9460-9469.  http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Brain  Res.,2013 ,239,72-79. http://dx.doi.org/10.1016/j.bbr.2012.10.059 [177] Pop, A.S.; Levenga, J.; de Esch, C.E.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2012 ,74(1), 49-56. http://dx.doi.org/10.1016/  j.neuron.2012.03.009  [179] Levenga, J.; Hayashi, S.; de Vrij, F.M.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2011 ,42(3), 311-317.  http://dx.doi.org/10.1016/j.nbd.2011.01.022  [180] de Vrij, F.M.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2008 ,31(1), 127-132.  http://dx.doi.org/10.1016/j.nbd.2008.04.002  [181] Silverman, J.L.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuropsycho-  pharmacology ,2010 ,35(4), 976-989. http://dx.doi.org/10.1038/  npp.2009.201  [182] Suvrathan, A.; Hoeffer, C.A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2005 ,48(2), 289-301. http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2008 ,59(4), 634-47. http://dx.doi.org/10.1016/  j.neuron.2008.06.027  [187] Xu, Z.H.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"http://dx.doi.org/10.1186/1750-1326-7-24  [188] Krueger, D.D.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",1996 ,64(2), 241-245. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurosci., 2008 , 28(31), 7847-7862. http://dx.doi.org/10.1523/JNEUROSCI.1496- 08.2008  [195] Kaufmann, W.E.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",1999 ,83(4), 286-295.  http://dx.doi.org/10.1002/(SICI) 1096-8628(19990402)83:4<286::  AID-AJMG10>3.0.CO;2-H  [196] Hagerman, R.; Au, J.; Hagerman P. FMR1 premutation and full  mutation molecular mechanisms related to autism.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
", 2012 ,1439 , 96-107. http://dx.doi.org/10.1016/j.brainres.2011.12.040  [204] Burket, J.A.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2012 ,11(6), 740-750. http://dx.doi.org/10.1111/j.1601-  183X.2012.00816.x  [208] Saunders, J.A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
", 2012 ,54, 297-335. http://dx.doi.org/10.1007/978-3-642-21649-7_17  [211] Corbett, B.A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Psychoneuroendocrinology ,2002 ,27(7), 855-872. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2011 ,42(1), 85-98.  http://dx.doi.org/10.1016/j.nbd.2011.01.008  [217] Caudal, D.; Gods il, B.P.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"PloS One ,2009 ,4(3), 5. http://dx.doi.org/10.1371/  journal.pone.0004714",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Cerebellum, 2007 ,6(3), 237-241. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2010 ,30(44), 14805-14816.  http://dx.doi.org/10.1523/JNEUROSCI.1161-10.2010  [226] Safo, P.K.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"J.  Neurophysiology ,2011 ,105(2), 958-963. http://dx.doi.org/  10.1152/jn.00980.2010  [228] Bear, M.F.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Elongation factor 2  and fragile X mental retardation protein control the dynamic  translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron ,2008 , 59(1), 70-83. http://dx.doi.org/10.1016/j.neuron.2008.05.023  [230] Garber, K.B.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2008 ,16(6), 666-672. http://dx.doi.org/10.1038/  ejhg.2008.61  [231] Waung, M.W.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2010 ,65(4), 445-459. http://dx.doi.org/  10.1016/j.neuron.2010.01.016  [233] Nakamoto, M.; Nalavadi, V.; Epstein, M.P.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron , 2007 ,54(6), 859-871. http://dx.doi.org/10.1016/j.neuron.2007.06.001  [237] Zhang, Y.; Venkitaramani, D.V.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurosci., 2008 ,28(42), 10561-10566. http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2006 ,51(4), 441-454. http://dx.doi.org/  10.1016/j.neuron.2006.07.005  [239] Lu, R.; Wang, H.; Liang, Z.; Ku, L.; O'Donnell, W.T.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2012 ,64(1), 65-87.  http://dx.doi.org/10.1124/pr.110.003053  [242] Goebel-Goody, S.M.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
